Ned Pagliarulo | BioPharma Dive

<!DOCTYPE html> <html class="no-js" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb#"> <head> <meta charset="utf-8"> <meta http-equiv="x-ua-compatible" content="ie=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>Ned Pagliarulo | BioPharma Dive</title> <meta name="description" content="BioPharma"/> <meta property="fb:pages" content="398644486955359"> <script data-cfasync="false"> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('consent','default',{ 'ad_storage':'denied', 'analytics_storage':'denied', 'ad_user_data':'denied', 'ad_personalization':'denied', 'personalization_storage':'denied', 'functionality_storage':'granted', 'security_storage':'granted', 'wait_for_update': 500 }); gtag("set", "ads_data_redaction", true); </script> <script data-cfasync="false" src="https://cmp.osano.com/AzqdtLT8Mqkut2TZ/bdeb2f70-056f-4937-961a-e9db412e4c7a/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script data-cfasync="false"> window.Osano.cm.addEventListener("osano-cm-script-blocked", function (item) { console.log("Script blocked: " + item); }); window.Osano.cm.addEventListener("osano-cm-cookie-blocked", function (item) { console.log("Cookie blocked: " + item); }); </script> <script> window.dive_location = "NonEU"; window.dive_limit_data_processing = false; </script>  <link rel="icon" type="image/x-icon" sizes="any" href="/favicon.ico?v=2" /> <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png?v=2"> <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png?v=2"> <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png?v=2"> <link rel="manifest" href="/site.webmanifest?v=2"> <link rel="mask-icon" href="/safari-pinned-tab.svg?v=2" color="#5bbad5"> <meta name="msapplication-TileImage" content="/mstile-150x150.png?v=2"> <meta name="msapplication-TileColor" content="#603cba"> <meta name="theme-color" content="#ffffff"> <link rel="alternate" type="application/rss+xml" title="BioPharma Dive - Latest News Feed" href="https://www.biopharmadive.com/feeds/news/"/> <meta property="og:title" content="" /> <meta property="og:description" content="" /> <meta property="og:image" content="https://d12v9rtnomnebu.cloudfront.net/divesite/header_image_logos/biopharma_dive_feed_header.jpg" /> <link rel="stylesheet" href="/static/css/dive_app.css?041016210225"> <script> // Initialize dataLayer empty array for GTM events window.dataLayer = window.dataLayer || []; window.dataLayer.push({ 'site': 'BioPharma Dive', }); // wrapper function to push GTM events to dataLayer pushGTMEvent = (eventObject) => { // if window.datalayer is not defined, then set to an empty array window.dataLayer.push(eventObject); }; </script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-55G8WRR');</script>  <script> let eventParams = {}; const gtmEventObject = { event: 'page.content', 'page.content': { v:11, // seer version ...eventParams } }; window.pushGTMEvent(gtmEventObject); </script> <script type="module" src="/static/js/dist/lyticsHelper.bundle.js?481016210225" ></script> <script type="text/javascript" src="/static/js/ad_blocker_recovery.js?160016291122"></script>  <script async src="https://fundingchoicesmessages.google.com/i/pub-8553262192892817?ers=1" nonce="RORABhIXgMhQdZXbks8fZQ"></script> <script nonce="RORABhIXgMhQdZXbks8fZQ">(function() {function signalGooglefcPresent() {if (!window.frames['googlefcPresent']) {if (document.body) {const iframe = document.createElement('iframe'); iframe.style = 'width: 0; height: 0; border: none; z-index: -1000; left: -1000px; top: -1000px;'; iframe.style.display = 'none'; iframe.name = 'googlefcPresent'; document.body.appendChild(iframe);} else {setTimeout(signalGooglefcPresent, 0);}}}signalGooglefcPresent();})();</script>  <script>(function(){/* Copyright The Closure Library Authors. SPDX-License-Identifier: Apache-2.0 */ 'use strict';var aa=function(a){var b=0;return function(){return b<a.length?{done:!1,value:a[b++]}:{done:!0}}},ba="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},k;if("function"==typeof Object.setPrototypeOf)k=Object.setPrototypeOf;else{var m;a:{var ca={a:!0},n={};try{n.__proto__=ca;m=n.a;break a}catch(a){}m=!1}k=m?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null} var p=k,q=function(a,b){a.prototype=ba(b.prototype);a.prototype.constructor=a;if(p)p(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.v=b.prototype},r=this||self,da=function(){},t=function(a){return a};var u;var w=function(a,b){this.g=b===v?a:""};w.prototype.toString=function(){return this.g+""};var v={},x=function(a){if(void 0===u){var b=null;var c=r.trustedTypes;if(c&&c.createPolicy){try{b=c.createPolicy("goog#html",{createHTML:t,createScript:t,createScriptURL:t})}catch(d){r.console&&r.console.error(d.message)}u=b}else u=b}a=(b=u)?b.createScriptURL(a):a;return new w(a,v)};var A=function(){return Math.floor(2147483648*Math.random()).toString(36)+Math.abs(Math.floor(2147483648*Math.random())^Date.now()).toString(36)};var B={},C=null;var D="function"===typeof Uint8Array;function E(a,b,c){return"object"===typeof a?D&&!Array.isArray(a)&&a instanceof Uint8Array?c(a):F(a,b,c):b(a)}function F(a,b,c){if(Array.isArray(a)){for(var d=Array(a.length),e=0;e<a.length;e++){var f=a[e];null!=f&&(d[e]=E(f,b,c))}Array.isArray(a)&&a.s&&G(d);return d}d={};for(e in a)Object.prototype.hasOwnProperty.call(a,e)&&(f=a[e],null!=f&&(d[e]=E(f,b,c)));return d} function ea(a){return F(a,function(b){return"number"===typeof b?isFinite(b)?b:String(b):b},function(b){var c;void 0===c&&(c=0);if(!C){C={};for(var d="ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789".split(""),e=["+/=","+/","-_=","-_.","-_"],f=0;5>f;f++){var h=d.concat(e[f].split(""));B[f]=h;for(var g=0;g<h.length;g++){var l=h[g];void 0===C[l]&&(C[l]=g)}}}c=B[c];d=Array(Math.floor(b.length/3));e=c[64]||"";for(f=h=0;h<b.length-2;h+=3){var y=b[h],z=b[h+1];l=b[h+2];g=c[y>>2];y=c[(y&3)<< 4|z>>4];z=c[(z&15)<<2|l>>6];l=c[l&63];d[f++]=""+g+y+z+l}g=0;l=e;switch(b.length-h){case 2:g=b[h+1],l=c[(g&15)<<2]||e;case 1:b=b[h],d[f]=""+c[b>>2]+c[(b&3)<<4|g>>4]+l+e}return d.join("")})}var fa={s:{value:!0,configurable:!0}},G=function(a){Array.isArray(a)&&!Object.isFrozen(a)&&Object.defineProperties(a,fa);return a};var H;var J=function(a,b,c){var d=H;H=null;a||(a=d);d=this.constructor.u;a||(a=d?[d]:[]);this.j=d?0:-1;this.h=null;this.g=a;a:{d=this.g.length;a=d-1;if(d&&(d=this.g[a],!(null===d||"object"!=typeof d||Array.isArray(d)||D&&d instanceof Uint8Array))){this.l=a-this.j;this.i=d;break a}void 0!==b&&-1<b?(this.l=Math.max(b,a+1-this.j),this.i=null):this.l=Number.MAX_VALUE}if(c)for(b=0;b<c.length;b++)a=c[b],a<this.l?(a+=this.j,(d=this.g[a])?G(d):this.g[a]=I):(d=this.l+this.j,this.g[d]||(this.i=this.g[d]={}),(d=this.i[a])? G(d):this.i[a]=I)},I=Object.freeze(G([])),K=function(a,b){if(-1===b)return null;if(b<a.l){b+=a.j;var c=a.g[b];return c!==I?c:a.g[b]=G([])}if(a.i)return c=a.i[b],c!==I?c:a.i[b]=G([])},M=function(a,b){var c=L;if(-1===b)return null;a.h||(a.h={});if(!a.h[b]){var d=K(a,b);d&&(a.h[b]=new c(d))}return a.h[b]};J.prototype.toJSON=function(){var a=N(this,!1);return ea(a)}; var N=function(a,b){if(a.h)for(var c in a.h)if(Object.prototype.hasOwnProperty.call(a.h,c)){var d=a.h[c];if(Array.isArray(d))for(var e=0;e<d.length;e++)d[e]&&N(d[e],b);else d&&N(d,b)}return a.g},O=function(a,b){H=b=b?JSON.parse(b):null;a=new a(b);H=null;return a};J.prototype.toString=function(){return N(this,!1).toString()};var P=function(a){J.call(this,a)};q(P,J);function ha(a){var b,c=(a.ownerDocument&&a.ownerDocument.defaultView||window).document,d=null===(b=c.querySelector)||void 0===b?void 0:b.call(c,"script[nonce]");(b=d?d.nonce||d.getAttribute("nonce")||"":"")&&a.setAttribute("nonce",b)};var Q=function(a,b){b=String(b);"application/xhtml+xml"===a.contentType&&(b=b.toLowerCase());return a.createElement(b)},R=function(a){this.g=a||r.document||document};R.prototype.appendChild=function(a,b){a.appendChild(b)};var S=function(a,b,c,d,e,f){try{var h=a.g,g=Q(a.g,"SCRIPT");g.async=!0;g.src=b instanceof w&&b.constructor===w?b.g:"type_error:TrustedResourceUrl";ha(g);h.head.appendChild(g);g.addEventListener("load",function(){e();d&&h.head.removeChild(g)});g.addEventListener("error",function(){0<c?S(a,b,c-1,d,e,f):(d&&h.head.removeChild(g),f())})}catch(l){f()}};var ia=r.atob("aHR0cHM6Ly93d3cuZ3N0YXRpYy5jb20vaW1hZ2VzL2ljb25zL21hdGVyaWFsL3N5c3RlbS8xeC93YXJuaW5nX2FtYmVyXzI0ZHAucG5n"),ja=r.atob("WW91IGFyZSBzZWVpbmcgdGhpcyBtZXNzYWdlIGJlY2F1c2UgYWQgb3Igc2NyaXB0IGJsb2NraW5nIHNvZnR3YXJlIGlzIGludGVyZmVyaW5nIHdpdGggdGhpcyBwYWdlLg=="),ka=r.atob("RGlzYWJsZSBhbnkgYWQgb3Igc2NyaXB0IGJsb2NraW5nIHNvZnR3YXJlLCB0aGVuIHJlbG9hZCB0aGlzIHBhZ2Uu"),la=function(a,b,c){this.h=a;this.j=new R(this.h);this.g=null;this.i=[];this.l=!1;this.o=b;this.m=c},V=function(a){if(a.h.body&&!a.l){var b= function(){T(a);r.setTimeout(function(){return U(a,3)},50)};S(a.j,a.o,2,!0,function(){r[a.m]||b()},b);a.l=!0}},T=function(a){for(var b=W(1,5),c=0;c<b;c++){var d=X(a);a.h.body.appendChild(d);a.i.push(d)}b=X(a);b.style.bottom="0";b.style.left="0";b.style.position="fixed";b.style.width=W(100,110).toString()+"%";b.style.zIndex=W(2147483544,2147483644).toString();b.style["background-color"]=ma(249,259,242,252,219,229);b.style["box-shadow"]="0 0 12px #888";b.style.color=ma(0,10,0,10,0,10);b.style.display= "flex";b.style["justify-content"]="center";b.style["font-family"]="Roboto, Arial";c=X(a);c.style.width=W(80,85).toString()+"%";c.style.maxWidth=W(750,775).toString()+"px";c.style.margin="24px";c.style.display="flex";c.style["align-items"]="flex-start";c.style["justify-content"]="center";d=Q(a.j.g,"IMG");d.className=A();d.src=ia;d.style.height="24px";d.style.width="24px";d.style["padding-right"]="16px";var e=X(a),f=X(a);f.style["font-weight"]="bold";f.textContent=ja;var h=X(a);h.textContent=ka;Y(a, e,f);Y(a,e,h);Y(a,c,d);Y(a,c,e);Y(a,b,c);a.g=b;a.h.body.appendChild(a.g);b=W(1,5);for(c=0;c<b;c++)d=X(a),a.h.body.appendChild(d),a.i.push(d)},Y=function(a,b,c){for(var d=W(1,5),e=0;e<d;e++){var f=X(a);b.appendChild(f)}b.appendChild(c);c=W(1,5);for(d=0;d<c;d++)e=X(a),b.appendChild(e)},W=function(a,b){return Math.floor(a+Math.random()*(b-a))},ma=function(a,b,c,d,e,f){return"rgb("+W(Math.max(a,0),Math.min(b,255)).toString()+","+W(Math.max(c,0),Math.min(d,255)).toString()+","+W(Math.max(e,0),Math.min(f, 255)).toString()+")"},X=function(a){a=Q(a.j.g,"DIV");a.className=A();return a},U=function(a,b){0>=b||null!=a.g&&0!=a.g.offsetHeight&&0!=a.g.offsetWidth||(na(a),T(a),r.setTimeout(function(){return U(a,b-1)},50))},na=function(a){var b=a.i;var c="undefined"!=typeof Symbol&&Symbol.iterator&&b[Symbol.iterator];b=c?c.call(b):{next:aa(b)};for(c=b.next();!c.done;c=b.next())(c=c.value)&&c.parentNode&&c.parentNode.removeChild(c);a.i=[];(b=a.g)&&b.parentNode&&b.parentNode.removeChild(b);a.g=null};var pa=function(a,b,c,d,e){var f=oa(c),h=function(l){l.appendChild(f);r.setTimeout(function(){f?(0!==f.offsetHeight&&0!==f.offsetWidth?b():a(),f.parentNode&&f.parentNode.removeChild(f)):a()},d)},g=function(l){document.body?h(document.body):0<l?r.setTimeout(function(){g(l-1)},e):b()};g(3)},oa=function(a){var b=document.createElement("div");b.className=a;b.style.width="1px";b.style.height="1px";b.style.position="absolute";b.style.left="-10000px";b.style.top="-10000px";b.style.zIndex="-10000";return b};var L=function(a){J.call(this,a)};q(L,J);var qa=function(a){J.call(this,a)};q(qa,J);var ra=function(a,b){this.l=a;this.m=new R(a.document);this.g=b;this.i=K(this.g,1);b=M(this.g,2);this.o=x(K(b,4)||"");this.h=!1;b=M(this.g,13);b=x(K(b,4)||"");this.j=new la(a.document,b,K(this.g,12))};ra.prototype.start=function(){sa(this)}; var sa=function(a){ta(a);S(a.m,a.o,3,!1,function(){a:{var b=a.i;var c=r.btoa(b);if(c=r[c]){try{var d=O(P,r.atob(c))}catch(e){b=!1;break a}b=b===K(d,1)}else b=!1}b?Z(a,K(a.g,14)):(Z(a,K(a.g,8)),V(a.j))},function(){pa(function(){Z(a,K(a.g,7));V(a.j)},function(){return Z(a,K(a.g,6))},K(a.g,9),K(a.g,10),K(a.g,11))})},Z=function(a,b){a.h||(a.h=!0,a=new a.l.XMLHttpRequest,a.open("GET",b,!0),a.send())},ta=function(a){var b=r.btoa(a.i);a.l[b]&&Z(a,K(a.g,5))};(function(a,b){r[a]=function(c){for(var d=[],e=0;e<arguments.length;++e)d[e-0]=arguments[e];r[a]=da;b.apply(null,d)}})("__h82AlnkH6D91__",function(a){"function"===typeof window.atob&&(new ra(window,O(qa,window.atob(a)))).start()});}).call(this); window.__h82AlnkH6D91__("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"); </script> <script src="/static/js/jquery_360.min.js?543516150322"></script> <script> // waitForTriggerHandler() is library for queuing up javascript to be stored and then executed when a trigger // function is called. You can push() any number of functions which will be stored unless and until trigger() // is called. Once trigger() is called any future functions that you push() in will be executed immediately. // It is safe to call .trigger() multiple times. Any arguments passed to .trigger() will also be passed along // to the associated function function waitForTriggerHandler() { var function_queue = []; var trigger_arguments = []; this._triggered = false; this.push = function(fn) { if (this._triggered) { // just run it immediately if handler has already been triggered fn.apply(null, trigger_arguments); } else { // otherwise add to the queue to run later function_queue.push(fn); } }; this.trigger = function() { // any arguments passed to trigger(foo, bar, baz) will also be passed along to functions in the queue // first convert any arguments to an array trigger_arguments = Array.prototype.slice.call(arguments); while (function_queue.length){ // for each function in the queue, pop it off and then execute it while passing in any // args that may have been passed to trigger(). function_queue.pop().apply(null, trigger_arguments); // The "null" above is for the value of "this". // See https://developer.mozilla.org/en-US/docs/Web/JavaScript/Reference/Global_Objects/Function/apply#Parameters } this._triggered = true; } } // set up waitToLoadAds handler window.waitToLoadAds = new waitForTriggerHandler(); // We set up the triggers for this below, they depend on whether we're loading lytics on the page </script> <script type="text/javascript"> // This token is here for test_lytics_snippet.py test: lytics-is-enabled window.googletag = window.googletag || {}; googletag.cmd = googletag.cmd || []; // initialize callback (source: https://learn.lytics.com/product-docs/lytics-javascript-tag/receiving-data-from-lytics) !function(){"use strict";var o=window.jstag||(window.jstag={}),r=[];function n(e){o[e]=function(){for(var n=arguments.length,t=new Array(n),i=0;i<n;i++)t[i]=arguments[i];r.push([e,t])}}n("send"),n("mock"),n("identify"),n("pageView"),n("unblock"),n("getid"),n("setid"),n("loadEntity"),n("getEntity"),n("on"),n("once"),n("call"),o.loadScript=function(n,t,i){var e=document.createElement("script");e.async=!0,e.src=n,e.onload=t,e.onerror=i;var o=document.getElementsByTagName("script")[0],r=o&&o.parentNode||document.head||document.body,c=o||r.lastChild;return null!=c?r.insertBefore(e,c):r.appendChild(e),this},o.init=function n(t){return this.config=t,this.loadScript(t.src,function(){if(o.init===n)throw new Error("Load error!");o.init(o.config),function(){for(var n=0;n<r.length;n++){var t=r[n][0],i=r[n][1];o[t].apply(o,i)}r=void 0}()}),this}}(); // custom init + lytics default install tag from https://activate.getlytics.com/connect?aid=2751 // see https://learn.lytics.com/understanding/product-docs/lytics-javascript-tag/configuration#configuration-options var lyticsCid = '44fda7674f94228540d8fba6786f9770'; console.log('You are using the Lytics Prod account'); jstag.init({ src: `https://c.lytics.io/api/tag/${lyticsCid}/latest.min.js`, pageAnalysis: { dataLayerPull: { disabled: true } } }); jstag.pageView(); (function(){ var sailthru_cookie, sailthru_user_id; function read_cookie(cookieName) { var re = new RegExp('[; ]'+cookieName+'=([^\\s;]*)'); var sMatch = (' '+document.cookie).match(re); if (cookieName && sMatch) return unescape(sMatch[1]); return ''; } sailthru_cookie = read_cookie('sailthru_hid'); if (sailthru_cookie.length > 56) { sailthru_user_id = sailthru_cookie.slice(32,56); jstag.send({ st_profile_id: sailthru_user_id }); } })(); jstag.call('entityReady', waitToLoadAds.trigger); setTimeout(waitToLoadAds.trigger, 1000); // also trigger lytics if it's taking too long waitToLoadAds.push(function (lytics_data) { // lytics_data won't be defined if lytics failed to load correctly. In that case // we don't need to set any segments. if (lytics_data && lytics_data.segments) { googletag.cmd.push(function() { googletag.pubads().setTargeting("LyticsSegments", lytics_data.segments); }); } }); function getUID(id) { window.dataLayer.push({'user_id': id}); }; jstag.getid(getUID); </script> <script type="text/javascript" src="/static/js/mailcheck.min.js?192616240919"></script> <script type="text/javascript" src="/static/js/dive_mailcheck.js?192616240919"></script> <script src="/static/js/app.js?262317060225"></script> <script type="text/javascript"> var divecounter_settings = {}; divecounter_settings.showSignupAd = true; </script> <script type="text/javascript" src="/static/js/divecounter.js?261616040423"></script> <script type="text/javascript"> // Special unbounce signup thing for google traffic. Test with ?test_unbounce in the URL // Note: divecounter must already be loaded. Only enabled on pages that would normally have signup ads // Note: showSignupAd is always off if prestitial is enabled! if ((typeof divecounter !== "undefined") && ($(window).width() > 640)) { var test_unbounce = (window.location.href.indexOf("?test_unbounce")>=0); var force_unbounce = (window.location.href.indexOf("signupbounce=1")>=0) || (window.location.href.indexOf("utm_campaign=Linked-HR")>=0) || (window.location.href.indexOf("utm_source=outbrain")>=0); if (test_unbounce || force_unbounce || (document.referrer.match(/^https?:\/\/(www\.google\.|news\.google\.|t\.co|twitter\.com|www\.facebook\.com)/i) && divecounter.getOption('showSignupAd') && divecounter.canShow(1,1)) ) { // dyanmically load ouibounce.js only on pages where its needed $.getScript("/static/js/ouibounce.min.js?102717100918", function(){ // Once ouibounce.js loads, call the script // We're reusing divecounter's modal instead of OuiBounce's modal code (that's why we pass it 'false') var _ouibounce = ouibounce(false, { aggressive: test_unbounce, // ignore cookie in test mode cookieName: '_viewedOuiBounce', // underscored cookies should be ignored by Varnish callback: function() { divecounter_open_ad(); } }); }); } // end should show unbounce } // end divecounter defined </script> <script type="text/javascript"> function read_cookie(cookieName) { var re = new RegExp('[; ]'+cookieName+'=([^\\s;]*)'); var sMatch = (' '+document.cookie).match(re); if (cookieName && sMatch) return unescape(sMatch[1]); return ''; } var script = document.createElement('script'); script.type = 'text/javascript'; script.async = true; script.addEventListener('load', function(e) { // we only pass the template this context variable on newsposts let informaData = false; if (window.IIRISTracker) { var sailthru_id = read_cookie('sailthru_hid'); if (sailthru_id.length > 56) { sailthru_id = sailthru_id.slice(32,56); } var notProduction = 'False' === 'True'; var domain = 'www.biopharmadive.com'.split('.')[1]; // on non-prod environment, there is specific collector domain to send the data to. var cDomain = notProduction ? 'com-informa-prod1.mini.snplow.net' : 'c.' + domain + '.com' // removed .com previous line var cfg = { config: { td: {}, snowplow: { context: {} } } }; cfg.config.idsource = 'sailthruid'; cfg.config.snowplow.appId = domain; cfg.config.snowplow.cDomain = cDomain; cfg.config.td.lob = 'it'; cfg.config.td.domain = domain; cfg.config.snowplow.contentTagEnabled = !!informaData cfg.config.snowplow.context = informaData window.IIRISTracker.initConfig(cfg); window.IIRISTracker.setTrackingUID(sailthru_id); var irisEvt = new Event('trackerLoaded'); window.dispatchEvent(irisEvt); } else { window.addEventListener('trackerLoaded', function(evt) { if(window.IIRISTracker) { window.IIRISTracker.setTrackingUID(sailthru_id); } }); } }); script.src = 'https://static.iris.informa.com/widgets/v3.0/iris-t.js'; document.getElementsByTagName('head')[0].appendChild(script); </script> <script type="text/javascript"> jQuery.browser = {}; (function () { jQuery.browser.msie = false; jQuery.browser.version = 0; if (navigator.userAgent.match(/MSIE ([0-9]+)\./)) { jQuery.browser.msie = true; jQuery.browser.version = RegExp.$1; } })(); </script>  <script type="text/javascript" src="/static/js/jquery.simplemodal.divefork.min.js?093716120922"></script> <style> /* dynamic style overrides based on DB go here*/ </style> <script type="module" src="/static/js/dist/signupReferrer.bundle.js?481016210225" ></script> <script data-cfasync="false" type="text/javascript" src="/static/js/prestitial.js?270116210524"></script> <script async src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script> <script src="/static/js/dist/signupDataGam.bundle.js?481016210225"></script> <script type="text/javascript" src="/static/js/dist/adTemplates.bundle.js?481016210225"></script> <script> var eventMethod = window.addEventListener ? "addEventListener" : "attachEvent"; var eventer = window[eventMethod]; var messageEvent = eventMethod == "attachEvent" ? "onmessage" : "message"; // Build the site_logos object to be later referenced in house ads const site_logos = {}; site_logos['diveapi'] = { domain: 'diveapi', site_name: "API Site", alt_text: "API Site logo", is_current_site: false, white: { png: "None", svg: "None", }, black: { png: "None", svg: "None", } }; site_logos['agriculturedive'] = { domain: 'agriculturedive', site_name: "Agriculture Dive", alt_text: "Agriculture Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/agriculture_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/agriculture_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/agriculture_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/agriculture_black.svg", } }; site_logos['automotivedive'] = { domain: 'automotivedive', site_name: "Automotive Dive", alt_text: "Automotive Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/automotive_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/automotive_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/automotive_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/automotive_black.svg", } }; site_logos['bankingdive'] = { domain: 'bankingdive', site_name: "Banking Dive", alt_text: "Banking Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/banking_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/banking_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/banking_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/banking_black.svg", } }; site_logos['biopharmadive'] = { domain: 'biopharmadive', site_name: "BioPharma Dive", alt_text: "BioPharma Dive logo", is_current_site: true, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg", } }; site_logos['cfo'] = { domain: 'cfo', site_name: "CFO.com", alt_text: "CFO.com logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfodotcom_white.svg", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfodotcom_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfodotcom_black.svg", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfodotcom_black.svg", } }; site_logos['cfodive'] = { domain: 'cfodive', site_name: "CFO Dive", alt_text: "CFO Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfo_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfo_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfo_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cfo_black.svg", } }; site_logos['ciodive'] = { domain: 'ciodive', site_name: "CIO Dive", alt_text: "CIO Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cio_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cio_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cio_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cio_black.svg", } }; site_logos['constructiondive'] = { domain: 'constructiondive', site_name: "Construction Dive", alt_text: "Construction Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/construction_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/construction_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/construction_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/construction_black.svg", } }; site_logos['cstoredive'] = { domain: 'cstoredive', site_name: "C-Store Dive", alt_text: "C-Store Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cstore_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cstore_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cstore_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cstore_black.svg", } }; site_logos['customerexperiencedive'] = { domain: 'customerexperiencedive', site_name: "CX Dive", alt_text: "CX Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cx_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cx_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cx_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cx_black.svg", } }; site_logos['cybersecuritydive'] = { domain: 'cybersecuritydive', site_name: "Cybersecurity Dive", alt_text: "Cybersecurity Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cybersecurity_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cybersecurity_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cybersecurity_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/cybersecurity_black.svg", } }; site_logos['educationdive'] = { domain: 'educationdive', site_name: "Education Dive", alt_text: "Education Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/education_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/education_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/education_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/education_black.svg", } }; site_logos['esgdive'] = { domain: 'esgdive', site_name: "ESG Dive", alt_text: "ESG Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/esg_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/esg_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/esg_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/esg_black.svg", } }; site_logos['facilitiesdive'] = { domain: 'facilitiesdive', site_name: "Facilities Dive", alt_text: "Facilities Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/facilities_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/facilities_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/facilities_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/facilities_black.svg", } }; site_logos['fashiondive'] = { domain: 'fashiondive', site_name: "Fashion Dive", alt_text: "Fashion Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/fashion_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/fashion_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/fashion_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/fashion_black.svg", } }; site_logos['fooddive'] = { domain: 'fooddive', site_name: "Food Dive", alt_text: "Food Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/food_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/food_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/food_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/food_black.svg", } }; site_logos['grocerydive'] = { domain: 'grocerydive', site_name: "Grocery Dive", alt_text: "Grocery Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/grocery_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/grocery_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/grocery_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/grocery_black.svg", } }; site_logos['healthcaredive'] = { domain: 'healthcaredive', site_name: "Healthcare Dive", alt_text: "Healthcare Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg", } }; site_logos['highereddive'] = { domain: 'highereddive', site_name: "Higher Ed Dive", alt_text: "Higher Ed Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/highered_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/highered_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/highered_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/highered_black.svg", } }; site_logos['hoteldive'] = { domain: 'hoteldive', site_name: "Hotel Dive", alt_text: "Hotel Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hotel_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hotel_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hotel_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hotel_black.svg", } }; site_logos['hrdive'] = { domain: 'hrdive', site_name: "HR Dive", alt_text: "HR Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hr_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hr_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hr_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/hr_black.svg", } }; site_logos['k12dive'] = { domain: 'k12dive', site_name: "K-12 Dive", alt_text: "K-12 Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/k12_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/k12_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/k12_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/k12_black.svg", } }; site_logos['legaldive'] = { domain: 'legaldive', site_name: "Legal Dive", alt_text: "Legal Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/legal_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/legal_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/legal_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/legal_black.svg", } }; site_logos['manufacturingdive'] = { domain: 'manufacturingdive', site_name: "Manufacturing Dive", alt_text: "Manufacturing Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/manufacturing_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/manufacturing_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/manufacturing_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/manufacturing_black.svg", } }; site_logos['marketingdive'] = { domain: 'marketingdive', site_name: "Marketing Dive", alt_text: "Marketing Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/marketing_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/marketing_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/marketing_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/marketing_black.svg", } }; site_logos['medtechdive'] = { domain: 'medtechdive', site_name: "MedTech Dive", alt_text: "MedTech Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/medtech_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/medtech_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/medtech_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/medtech_black.svg", } }; site_logos['mobilemarketer'] = { domain: 'mobilemarketer', site_name: "Mobile Marketer", alt_text: "Mobile Marketer logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/mobilemarketer_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/mobilemarketer_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/mobilemarketer_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/mobilemarketer_black.svg", } }; site_logos['multifamilydive'] = { domain: 'multifamilydive', site_name: "Multifamily Dive", alt_text: "Multifamily Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/multifamily_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/multifamily_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/multifamily_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/multifamily_black.svg", } }; site_logos['packagingdive'] = { domain: 'packagingdive', site_name: "Packaging Dive", alt_text: "Packaging Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/packaging_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/packaging_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/packaging_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/packaging_black.svg", } }; site_logos['paymentsdive'] = { domain: 'paymentsdive', site_name: "Payments Dive", alt_text: "Payments Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/payments_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/payments_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/payments_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/payments_black.svg", } }; site_logos['pharmavoice'] = { domain: 'pharmavoice', site_name: "PharmaVoice", alt_text: "PharmaVoice logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/pharmavoice_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/pharmavoice_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/pharmavoice_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/pharmavoice_black.svg", } }; site_logos['proformative'] = { domain: 'proformative', site_name: "Proformative", alt_text: "Proformative logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/proformative_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/proformative_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/proformative_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/proformative_black.svg", } }; site_logos['restaurantdive'] = { domain: 'restaurantdive', site_name: "Restaurant Dive", alt_text: "Restaurant Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/restaurant_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/restaurant_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/restaurant_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/restaurant_black.svg", } }; site_logos['retaildive'] = { domain: 'retaildive', site_name: "Retail Dive", alt_text: "Retail Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/retail_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/retail_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/retail_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/retail_black.svg", } }; site_logos['smartcitiesdive'] = { domain: 'smartcitiesdive', site_name: "Smart Cities Dive", alt_text: "Smart Cities Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smartcities_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smartcities_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smartcities_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smartcities_black.svg", } }; site_logos['socialmediatoday'] = { domain: 'socialmediatoday', site_name: "Social Media Today", alt_text: "Social Media Today logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smt_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smt_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smt_color.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/smt_color.svg", } }; site_logos['supplychaindive'] = { domain: 'supplychaindive', site_name: "Supply Chain Dive", alt_text: "Supply Chain Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/supplychain_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/supplychain_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/supplychain_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/supplychain_black.svg", } }; site_logos['truckingdive'] = { domain: 'truckingdive', site_name: "Trucking Dive", alt_text: "Trucking Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/trucking_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/trucking_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/trucking_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/trucking_black.svg", } }; site_logos['utilitydive'] = { domain: 'utilitydive', site_name: "Utility Dive", alt_text: "Utility Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/utility_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/utility_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/utility_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/utility_black.svg", } }; site_logos['wastedive'] = { domain: 'wastedive', site_name: "Waste Dive", alt_text: "Waste Dive logo", is_current_site: false, white: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/waste_white.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/waste_white.svg", }, black: { png: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/waste_black.png", svg: "https://d12v9rtnomnebu.cloudfront.net/logo/publications/waste_black.svg", } }; // Get the dive domain and return the dive logo object, or null if it doesn't exist in site_logos function getDivesiteLogoObject(link_url, alt_domain='') { let dive_domain; // Split link URL on 'adurl=' and take what comes after as the ad url const ad_url = decodeURIComponent(link_url.split('adurl=')[1]); // Split on . to get an array of hostname segments const dive_domain_array = new URL(ad_url).hostname.split('.'); // Retrieve the second to last element of the hostname array, which should always be the domain dive_domain = dive_domain_array[dive_domain_array.length - 2] if (alt_domain) { // If alt_domain has been specified, normalize it. i.e. "HR Dive", "http://hrdive.com", etc. => "hrdive" // This will override the link url's domain. dive_domain = alt_domain.replace(/\s+/g, '').replace(/^(https?:\/\/)?(www\.)?|\.com.*|\?.*|#.*/gi, '').toLowerCase(); } // Return the site logos object for this domain if it exists, or null if it does not if (site_logos[dive_domain]) { return site_logos[dive_domain]; } else { // Fallback logo const url_prefix = "https://d12v9rtnomnebu.cloudfront.net/divesite/responsive_ad_assets/small_logos/"; return { domain: 'industrydive', site_name: 'Industry Dive', alt_text: 'Industry Dive logo', white: { svg: url_prefix + 'industrydive-small-white.svg', png: url_prefix + 'industrydive-small-white.png', }, black: { svg: url_prefix + 'industrydive-small-black.svg', png: url_prefix + 'industrydive-small-black.png', } } } } eventer(messageEvent, function (e) { var key = e.message ? "message" : "data"; var data = e[key]; var eventName = data.message || 'ignore'; if (eventName == 'adContentAvailable') { var $ad_element; $ad_element = $('div').filter('[data-container-ad-unit-id="' + data.adUnit + '-' + window.dfp_visibility + '"]'); $ad_element.hide() var nativeAdEditorialSelector = '.sidebar .hybrid-ad-wrapper .native-ad-editorial'; var nativeAdEditorialExists = $(nativeAdEditorialSelector).length > 0; if ( nativeAdEditorialExists ) { $(nativeAdEditorialSelector).closest('.hybrid-ad-wrapper').addClass('native-ad-editorial-sidebar-border'); } // Inline homepage ad $('.feed-item-ad .hybrid-ad-wrapper a').each(function (index, element) { window.updateGamAdUrl(element, 'inline'); }); // Editorial native ad sidebar // NOTE: must go before inline native ad to ensure correct location added $('.sidebar .native-ad.editorial a').each(function (index, element) { window.updateGamAdUrl(element, 'sidebar'); }); // Editorial native ad inline $('.native-ad.editorial a').each(function (index, element) { window.updateGamAdUrl(element, 'inline'); }); // Sidebar ad $('.sidebar .hybrid-ad-wrapper a').each(function (index, element) { window.updateGamAdUrl(element, 'sidebar'); }); } }, false); var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; googletag.cmd.push(function () { var desktopWidth = 1024; if (window.innerWidth >= desktopWidth) { window.dfp_visibility = 'desktop'; } else { window.dfp_visibility = 'mobile'; } var dfpDisplayConfiguration = { "prestitialEnabled": true, "leaderboardEnabled": true, "sidebarAdsEnabled": true, "visibility": window.dfp_visibility }; if (window.dfp_visibility == 'desktop') { if (typeof prestitialAds == 'object' && prestitialAds.pageIsPrestitialEligible()) { googletag.defineSlot('/21662595662/biopharmadive/biopharmadiveprestitial', [[500, 300], [640, 480]], 'paychekgoeshere').addService(googletag.pubads()); } if (dfpDisplayConfiguration.leaderboardEnabled) { googletag.defineSlot('/21662595662/biopharmadive/biopharmadiveleaderboard', [[970, 180], [728, 90], [970, 90]], 'dfp-leaderboard-desktop').addService(googletag.pubads()); googletag.pubads().addEventListener('slotRenderEnded', function (event) { if ((event.slot.getAdUnitPath() === '/21662595662/biopharmadive/biopharmadiveleaderboard' || event.slot.getAdUnitPath() === '/21662595662/biopharmadive/biopharmadiveleaderboard') && !event.isEmpty ) { $(window).blur(function () { if (document.activeElement === $('#dfp-leaderboard-desktop iframe')[0] || document.activeElement === $('#dfp-leaderboard-desktop iframe')[0]) { try { localStorage.setItem('leaderboard_signup_path', document.location.pathname); } catch (e) { // local storage could not be available due to privacy settings or something } } }); } }); } if (dfpDisplayConfiguration.sidebarAdsEnabled) { googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid1', [[300, 250], 'fluid', [160, 600]], 'dfp-hybrid1-desktop').addService(googletag.pubads()); } googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid2', [[300, 250], 'fluid'], 'dfp-hybrid2-desktop').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid3', [[300, 250], 'fluid'], 'dfp-hybrid3-desktop').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid4', [[300, 250], 'fluid'], 'dfp-hybrid4-desktop').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivethankyouhybrid1', ['fluid'], 'dfp-thankyouhybrid1-desktop').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivethankyouhybrid2', ['fluid'], 'dfp-thankyouhybrid2-desktop').addService(googletag.pubads()); } else { googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid1', [[300, 250], 'fluid'], 'dfp-hybrid1-mobile').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid2', [[300, 250], 'fluid'], 'dfp-hybrid2-mobile').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid3', [[300, 250], 'fluid'], 'dfp-hybrid3-mobile').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivehybrid4', [[300, 250], 'fluid'], 'dfp-hybrid4-mobile').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivethankyouhybrid1', ['fluid'], 'dfp-thankyouhybrid1-mobile').addService(googletag.pubads()); googletag.defineSlot('/21662595662/biopharmadive/biopharmadivethankyouhybrid2', ['fluid'], 'dfp-thankyouhybrid2-mobile').addService(googletag.pubads()); } if ((typeof divecounter !== "undefined") && (divecounter.getData().is_subscriber)) { googletag.pubads().setTargeting("is_subscriber", "yes"); } var site = window.location.host; googletag.pubads().setTargeting("site", site); var first_path = window.location.pathname.split( '/' )[1]; googletag.pubads().setTargeting("first_path", first_path); // Set ad targeting on the trendline to show the ads designated for it var isTopicPage = window.location.pathname.indexOf('/topic/') !== -1; if(isTopicPage) { googletag.pubads().setTargeting('is_topics_page', 'true'); } googletag.pubads().setCentering(true); googletag.pubads().collapseEmptyDivs(false); // Whether to collapse the slots even before the ads are fetched. googletag.pubads().enableSingleRequest(); googletag.enableServices(); }); </script> <script>window.fallbackAds = '[{\u0022adType\u0022: \u0022editorial_native_ad\u0022, \u0022link\u0022: \u0022/trendline/gene\u002Dtherapy/41/?utm_source\u003DBP\u0026utm_medium\u003DNativeFB\u0026utm_campaign\u003DTrendlineFB\u0022, \u0022label\u0022: \u0022Trendline\u0022, \u0022image\u0022: \u0022https://imgproxy.divecdn.com/5LT_0BgyN9INIFYrcAApYQsHcLd2IGBOy8bAOF6Yz\u002Dc/g:ce/rs:fit:212:100/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzE5NDM5MjQzLmpwZw\u003D\u003D.webp\u0022, \u0022attribution\u0022: \u0022\u0022, \u0022headline\u0022: \u0022The latest developments on the gene therapy frontier\u0022, \u0022ctaText\u0022: \u0022Access now\u0022, \u0022description\u0022: \u0022Rapid scientific advances have put the gene therapy field at the forefront of biomedical research. But, as recent setbacks have shown, researchers and drugmakers still face major challenges.\u005Cu00a0\u0022}]'</script> <script type="module" src="/static/js/dist/onBoardDiagnostics.bundle.js?481016210225" ></script>   <script src="https://d12v9rtnomnebu.cloudfront.net/informa_banner/techtarget-informa-banner.min.js"></script> </head> <body class="detail-page"> <techtarget-informa-banner theme="light" language="en" class="no-print"></techtarget-informa-banner>  <a href="#skip-link-target" class="button button--loud skip-nav-link" tabindex="1">Skip to main content</a>  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-55G8WRR" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript>  <div id="prestitial-init" style="display: none;" class="prestitial-init"></div> <div id="prestitial-outer" class="prestitial content-overlay" style="display:none;"> <section class="site-menu" aria-label="Site menu"> <div class="site-menu-inner"> <img src="https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg" alt="BioPharma Dive" class="pub-logo"> </div> </section> <section class="paychek-page-wrapper row"> <div class="paychek-button large-4 large-push-8 columns"> <div> CONTINUE TO SITE ➞ </div> </div> <div class="paychek large-8 large-pull-4 columns"> <div id="paychekgoeshere"></div> <script data-cfasync="false" type="text/javascript"> if (typeof prestitialAds !== 'undefined' && prestitialAds.pageIsPrestitialEligible()) { prestitialAds.showOverlay(); } </script> <script type="text/javascript"> if (typeof prestitialAds !== 'undefined' && prestitialAds.pageIsPrestitialEligible()) { prestitialAds.initialize(4); prestitialAds.setPrestitialPossibleCookie(); var prestitial_ad_is_loaded = false; var prestitial_ad_is_empty = false; googletag.cmd.push(function () { googletag.pubads().addEventListener('slotRenderEnded', function (event) { if (event.slot.getAdUnitPath() == '/21662595662/biopharmadive/biopharmadiveprestitial') { if (event.isEmpty || prestitialAds.testingNoAd()) { prestitial_ad_is_empty = true; prestitialAds.closePrestitial(); } else { prestitial_ad_is_loaded = true; $.modal.close(); $('div#prestitial-init').hide(); // hide the all white overlay prestitialAds.setCookie( "_prestitialViewed", (new Date()).getTime(), prestitialAds.daysBetweenPrestitial ); } } }); }); if (prestitialAds.testingNoAd()) { } else { waitToLoadAds.push(function() { googletag.cmd.push(function () { googletag.display('paychekgoeshere'); }); }); } setTimeout( function () { if (!prestitial_ad_is_loaded && !prestitialAds.overrideTimeout()) { if (!prestitial_ad_is_empty) { // if the prestitial is already hidden, then don't hide it again. if (!prestitialAds.prestitialAdIsClosed()) { prestitialAds.closePrestitial(); prestitialAds.logClosePrestitialAdBy('failed'); } } } else if (!prestitialAds.overrideTimeout()) { setTimeout( function () { // if the prestitial is already hidden, then don't hide it again. if (!prestitialAds.prestitialAdIsClosed()) { prestitialAds.closePrestitial(); prestitialAds.logClosePrestitialAdBy('timeout'); } }, prestitialAds.timeoutSeconds() ); } else { } }, 2900 ); prestitialAds.sentPrestitialEligibleEvent(); } else if (typeof prestitialAds !== 'undefined' && !prestitialAds.pageIsPrestitialEligible()){ prestitialAds.closePrestitial(); } </script> </div> </section> </div> <div id="signup-inter" class="modal_dialog" style="display:none;"> <form id="signup-inter-form" class="form-basic" name="signup-inter-form" action="/signup/" method="POST"> <input type="hidden" name="signup_box_location" value="interstitial"> <input type="hidden" name="signup_initial_url_path" value=""> <h1> Don't miss tomorrow's biopharma industry news </h1> <p class="interstitial-text"> Let BioPharma Dive's free newsletter keep you informed, straight from your inbox. </p> <p class="form-error__message" id="interstitial-error"></p> <div id="form-interstitial"> <input type="email" name="email" placeholder="Work email address" class="email" required id="id_1538fc_email"> <div id="newsletter-list-section"> <ul id="id_1538fc_site_newsletters" class="list-no-bullets"> <li><label for="id_1538fc_site_newsletters_0"><input type="checkbox" name="site_newsletters" value="20" class="list-no-bullets" id="id_1538fc_site_newsletters_0"> Daily Dive <span class="secondary-label">M-F</span></label> </li> <li><label for="id_1538fc_site_newsletters_1"><input type="checkbox" name="site_newsletters" value="42" class="list-no-bullets" id="id_1538fc_site_newsletters_1"> Commercialization Weekly <span class="secondary-label">Every Wednesday</span></label> </li> <li><label for="id_1538fc_site_newsletters_2"><input type="checkbox" name="site_newsletters" value="43" class="list-no-bullets" id="id_1538fc_site_newsletters_2"> Gene Therapy Weekly <span class="secondary-label">Every Thursday</span></label> </li> <li><label for="id_1538fc_site_newsletters_3"><input type="checkbox" name="site_newsletters" value="2934" class="list-no-bullets" id="id_1538fc_site_newsletters_3"> Emerging Biotech Weekly <span class="secondary-label">Every Tuesday</span></label> </li> </ul> </div> <div id="interstitial-consent-container"> <input name="user_consent" value="1" id="id_user_consent" type="checkbox"> <span> By signing up to receive our newsletter, you agree to our <a href="https://www.techtarget.com/terms-of-use/" target="_blank">Terms of Use</a> and <a href="https://www.techtarget.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span> </div> </div> <input id="signup-inter-submit" class="email_submit submit button" type="submit" data-role="none" value="Subscribe today"> </form> </div>  <div class="leaderboard-wrap"> <div class="hide-small show-large"> <div data-container-ad-unit-id="/21662595662/biopharmadive/biopharmadiveleaderboard-desktop"></div> <div id='dfp-leaderboard-desktop' style="min-height: 90px"> <script> waitToLoadAds.push(function() { googletag.cmd.push(function() { if (window.dfp_visibility == 'desktop') { googletag.display('dfp-leaderboard-desktop'); } }) }); </script> </div> </div> </div> <div class="page-container"> <header role="banner"> <nav id="top" class="site-menu" aria-label="Site menu"> <div class="site-menu-inner">  <div class="pub-logo-wrapper"> <a href="/" class="analytics t-dash-navigation"> <img class="pub-logo" src="https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg" alt="BioPharma Dive" height="28"> </a> </div>  <div class="menu-content-wrapper"> <ul class="desktop-menu-main"> <li> <a href="/deep-dive/" class="nav-menu-item analytics t-deepdive-navigation">Deep Dive</a> </li> <li> <a href="/library/" class="nav-menu-item analytics t-library-navigation">Library</a> </li> <li> <a href="/events/" class="nav-menu-item analytics t-events-navigation">Events</a> </li> <li> <a href="/press-release/" class="nav-menu-item analytics t-press-releases-navigation">Press Releases</a> </li> <li class="topics top-nav-dropdown-item"> <button class="nav-menu-item topics-dropdown-item"> Topics <span class="dropdown-toggle-arrow"></span> </button> </li> </ul>  <a href="/signup/?signup_location=header" class="nav-menu-item nav-signup-button mobile-nav-signup-button analytics t-signup-navigation button"> Sign up </a> <button class="mobile-menu-toggle"> <img src="/static/img/menu_icons/menu.svg?273117231121" alt="menu" loading="lazy"> </button>  <ul class="desktop-menu-sub list-no-bullets"> <li> <button class="search-toggle search-button-front analytics t-search-navigation-top"> <img src="/static/img/menu_icons/search.svg?320116291121" alt="search" width="16" height="16" loading="lazy"> <span class="sub-link">Search</span> </button> </li> <li> <a href="/signup/?signup_location=header" class="nav-menu-item nav-signup-button desktop-nav-signup-button analytics t-signup-navigation button"> <img src="/static/img/email_icons/mail.svg?273117231121" width="16" height="11" loading="lazy" alt=""> Sign up </a> </li> </ul> </div> </div> </nav> </header> <div class="menu-search js-search-hide"> <div class="menu-search-inner-wrapper row"> <form action="/search/" method="GET" data-ajax="false"> <label for="search-desktop"> <span class="screen-reader-text search">Search</span> </label> <input id="search-desktop" type="search" name="q" placeholder="Search" data-role="none"> <button type="submit" value="" data-role="none" class="search-button-front analytics t-search-navigation-drawer"> <img src="/static/img/menu_icons/search.svg?320116291121" alt="search" height="16" width="16" loading="lazy"> </button> <img class="close" src="/static/img/menu_icons/close.svg?273117231121" width="16" height="16" alt="close search" loading="lazy"> </form> </div> </div> <nav class="topics menu-bar" aria-label="Menu bar"> <ul class="list-no-bullets"> <li> <a class="analytics t-topic-navigation-pharma" href="/topic/pharma/">Pharma</a> </li> <li> <a class="analytics t-topic-navigation-biotech" href="/topic/biotech/">Biotech</a> </li> <li> <a class="analytics t-topic-navigation-fda" href="/topic/fda/">FDA</a> </li> <li> <a class="analytics t-topic-navigation-clinical-trials" href="/topic/clinical-trials/">Clinical Trials</a> </li> <li> <a class="analytics t-topic-navigation-deals" href="/topic/deals/">Deals</a> </li> <li> <a class="analytics t-topic-navigation-drug-pricing" href="/topic/drug-pricing/">Drug Pricing</a> </li> <li> <a class="analytics t-topic-navigation-gene-therapy" href="/topic/gene-therapy/">Gene Therapy</a> </li> </ul> </nav> <script type="module" src="/static/js/dist/navSignupHelper.bundle.js?481016210225" ></script> <script> window.siteName = 'BioPharma Dive'; </script> <div class="search-overlay"></div> <div class="page-wrapper"> <div class="page-inner-wrapper" id="skip-link-target"> <div class="row"> <div class="medium-10 medium-centered large-12"> <section id="main-content" class="main-content large-8 columns"> <section class="breadcrumb"> <a href="/editors/">← Editorial Team</a> <div class="clear-fix"></div> </section> <div class="editor-detail-wrapper"> <div class="row">  <div class="medium-3 large-2 columns"> <img src="https://d1b6lhn2ymmy1x.cloudfront.net/journalist-headshots/biopharma/pagliarulo-ned-square-600x600.jpg" class="editor-headshot" alt="Author's Photo"> </div> <div class="medium-9 large-10 columns"> <div class="editor-detail-info"> <h1 class="editor-name display-heading-04"> Ned Pagliarulo </h1> <span class="editor-title">  Lead Editor | <a class="analytics t-editors-bio-social-twitter" href="https://www.twitter.com/NedPagliarulo">@NedPagliarulo</a> </span> <p class="editor-bio">Ned is a lead editor for BioPharma Dive. Before joining Industry Dive, Ned covered economic news for a Japanese newswire and contributed articles on political risk for Global Risk Insights. He has a B.A. from Georgetown University.</p> <div class="editor-outreach"> <h3 class="editor-outreach__header">Get in touch</h3> <a href="/cdn-cgi/l/email-protection#90b0fee0f1f7fcf9f1e2e5fcffd0f9fef4e5e3e4e2e9f4f9e6f5bef3fffd" class="editor-outreach__link analytics t-editors-bio-email"> <div class="editor-outreach__text"> <span>Email <span class="__cf_email__" data-cfemail="d9b7a9b8beb5b0b8abacb5b699b0b7bdacaaadaba0bdb0afbcf7bab6b4">[email protected]</span></span> <img class="editor-outreach__chevron" src="/static/img/menu_icons/chevron--loud.svg?214618250321" alt="chevron"> </div> </a> <a href=/submit-tip/ class="editor-outreach__link analytics t-tip-editors-bio"> <div class="editor-outreach__text"> <span>Submit a tip to our team</span> <img class="editor-outreach__chevron" src="/static/img/menu_icons/chevron--loud.svg?214618250321" alt="chevron"> </div> </a> </div> </div> </div> </div> <hr class="section-divider"> </div> <div class="past-articles"> <h3 id="article-count"> 2579 articles by Ned Pagliarulo </h3> <label for="filter-month-select">Filter by month:</label> <select id="filter-month-select" name="month" class="js-list-select"> <option value="all">Show All</option> </select> <ul class="feed"> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/regeneron-otoferlin-deafness-gene-therapy-db-oto-results/740810/" class="analytics t-editors-bio-article">Regeneron gene therapy helps deaf children hear in small study</a></h3> <span class="secondary-label">Feb. 25, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/pfizer-patrizia-cavazzoni-fda-chief-medical-officer-appoint/740749/" class="analytics t-editors-bio-article">Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer</a></h3> <span class="secondary-label">Feb. 24, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/sanofi-teva-tl1a-duvakitug-ecco-new-data/740730/" class="analytics t-editors-bio-article">Sanofi, Teva add to case for new bowel disease drug</a></h3> <span class="secondary-label">Feb. 24, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/pfizer-beqvez-hemophilia-halt-sales-gene-therapy/740590/" class="analytics t-editors-bio-article">Pfizer stops selling hemophilia gene therapy, citing weak demand</a></h3> <span class="secondary-label">Feb. 21, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/trump-doge-order-shrink-federal-workforce-health-agencies/739876/" class="analytics t-editors-bio-article">Trump orders agencies to plan for ‘large-scale’ job cuts</a></h3> <span class="secondary-label">Feb. 12, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/vertex-stuart-arbuckle-retire-charlie-wagner-duncan-mckechnie/739746/" class="analytics t-editors-bio-article">Vertex COO Arbuckle to step down later this year</a></h3> <span class="secondary-label">Feb. 10, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/axsome-teva-patent-settlement-auvelity-generic-launch/739664/" class="analytics t-editors-bio-article">Axsome secures top drug’s future with Teva patent settlement</a></h3> <span class="secondary-label">Feb. 10, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/amgen-hold-amg-513-regeneron-dividend-advancell-series-c/739268/" class="analytics t-editors-bio-article">Amgen obesity drug on hold; Regeneron sets first dividend</a></h3> <span class="secondary-label">Feb. 5, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/itm-radiopharma-gep-net-compete-study-results/738477/" class="analytics t-editors-bio-article">Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says</a></h3> <span class="secondary-label">Jan. 28, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/akero-efruxifermin-mash-reverse-cirrhosis-symmetry-results/738334/" class="analytics t-editors-bio-article">Akero says MASH drug reverses liver damage in study, doubling shares</a></h3> <span class="secondary-label">Jan. 27, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/biotech-pharma-trends-outlook-2025/737657/" class="analytics t-editors-bio-article">The biopharma industry outlook on 2025: Uncertainty and change</a></h3> <span class="secondary-label">Jan. 24, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/jnj-medicare-part-d-earnings-q4-2024/737959/" class="analytics t-editors-bio-article">J&J joins Pfizer in detailing impact of Part D redesign</a></h3> <span class="secondary-label">Jan. 22, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/medicare-drug-price-negotiations-second-round-semaglutide/736999/" class="analytics t-editors-bio-article">Ozempic, Ibrance among next drugs picked by Medicare for price talks</a></h3> <span class="secondary-label">Jan. 17, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/jpm25-the-fdas-future-abbvies-second-thoughts-and-lillys-lesson/737487/" class="analytics t-editors-bio-article">JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson</a></h3> <span class="secondary-label">Jan. 16, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/regenxbio-nippon-shinyaku-gene-therapy-mps-hunter-hurler/737250/" class="analytics t-editors-bio-article">Regenxbio licenses gene therapies to Japan’s Nippon Shinyaku</a></h3> <span class="secondary-label">Jan. 14, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/biotech-outlook-2025-startups-venture-ipo/737213/" class="analytics t-editors-bio-article">5 questions facing emerging biotech in 2025</a></h3> <span class="secondary-label">Jan. 14, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-intra-cellular-acquire-deal-schizophrenia-caplyta/737126/" class="analytics t-editors-bio-article">J&J to buy psychiatric drug developer Intra-Cellular for $14.6B</a></h3> <span class="secondary-label">Jan. 13, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/fda-patrizia-cavazzoni-retire-cder-trump-administration/737014/" class="analytics t-editors-bio-article">Patrizia Cavazzoni, key FDA official, to leave agency</a></h3> <span class="secondary-label">Jan. 10, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/intellia-layoffs-restructuring-aatd-discontinuation/736987/" class="analytics t-editors-bio-article">Intellia to stop work on rare disease therapy, lay off staff</a></h3> <span class="secondary-label">Jan. 10, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/pharma-outlook-2025-trump-obesity-immunology-vaccines/736908/" class="analytics t-editors-bio-article">5 questions facing pharma in 2025</a></h3> <span class="secondary-label">Jan. 9, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-mariposa-survival-rybrevant-lazcluze-tagrisso-cancer/736634/" class="analytics t-editors-bio-article">J&J says cancer drug combination showed survival benefit over Tagrisso</a></h3> <span class="secondary-label">Jan. 7, 2025</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/fda-tirzepatide-shortage-resolved-lilly-zepbound-compounding/736020/" class="analytics t-editors-bio-article">Zepbound, Mounjaro shortages are resolved, FDA confirms</a></h3> <span class="secondary-label">Dec. 19, 2024</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/fda-namandje-bumpus-depart-agency-trump/735810/" class="analytics t-editors-bio-article">Namandjé Bumpus, FDA’s No. 2 official, to depart agency at end of year</a></h3> <span class="secondary-label">Dec. 17, 2024</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/pfizer-2025-guidance-forecast-wall-street/735725/" class="analytics t-editors-bio-article">Pfizer predicts stability, to Wall Street’s relief</a></h3> <span class="secondary-label">Dec. 17, 2024</span> </li> <li class="feed__item" > <h3 class="feed__title feed__title"><a href="/news/jazz-ceo-retire-bruce-cozadd-successor-search/735712/" class="analytics t-editors-bio-article">Jazz to search for new chief as CEO plans retirement</a></h3> <span class="secondary-label">Dec. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/edgewise-becker-dystrophy-sevasemten-biomarker/735637/" class="analytics t-editors-bio-article">Edgewise weighs fast approval path for muscular dystrophy drug</a></h3> <span class="secondary-label">Dec. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-holdings-catalent-deal-ftc-regulatory-clearance/735599/" class="analytics t-editors-bio-article">Novo Holdings’ purchase of Catalent set to close after regulators’ green light</a></h3> <span class="secondary-label">Dec. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-nimble-acquire-deal-immune-drug-il-23/735498/" class="analytics t-editors-bio-article">AbbVie to acquire Roche spinout Nimble in immune drug deal</a></h3> <span class="secondary-label">Dec. 13, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-layoffs-reni-cel-discontinue-pivot-in-vio/735465/" class="analytics t-editors-bio-article">Editas to lay off staff after search for sickle cell partner comes up empty</a></h3> <span class="secondary-label">Dec. 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chroma-nvelop-merge-epigenetic-editing-nchroma-walsh-liu/735189/" class="analytics t-editors-bio-article">Chroma, Nvelop merge to marry genetic medicine ‘cargo’ to delivery</a></h3> <span class="secondary-label">Dec. 11, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash24-leukemia-drug-sequencing-sickle-cell-questions-and-a-new-kind-of-ca/735091/" class="analytics t-editors-bio-article">ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T</a></h3> <span class="secondary-label">Dec. 10, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2024-darzalex-beam-merck-ror1-arcellx/734969/" class="analytics t-editors-bio-article">ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug</a></h3> <span class="secondary-label">Dec. 9, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sickle-cell-gene-therapy-slow-uptake-casgevy-lyfgenia/734938/" class="analytics t-editors-bio-article">Gene therapy uptake in sickle cell stays slow, despite patient interest</a></h3> <span class="secondary-label">Dec. 9, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/applied-fda-crl-rejection-govorestat-galactosemia/733684/" class="analytics t-editors-bio-article">Applied’s rare disease drug rejected by FDA</a></h3> <span class="secondary-label">Dec. 2, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-arrowhead-licensing-deal-sirna-dm1-fshd/734125/" class="analytics t-editors-bio-article">Sarepta rebuilds drug pipeline with Arrowhead deal</a></h3> <span class="secondary-label">Nov. 27, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-tigit-skyscraper-01-survival-negative-failure/733999/" class="analytics t-editors-bio-article">Roche’s TIGIT-targeting drug for cancer fails its biggest test</a></h3> <span class="secondary-label">Nov. 26, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-fda-martin-makary-surgeon-nominate/733498/" class="analytics t-editors-bio-article">Johns Hopkins surgeon Makary is Trump’s pick to lead FDA</a></h3> <span class="secondary-label">Nov. 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lexicon-layoffs-restructuring-zynquista-deficiencies-fda/733712/" class="analytics t-editors-bio-article">Lexicon to disband sales team, lay off 60% of staff</a></h3> <span class="secondary-label">Nov. 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-venture-capital-funding-startup-tracker/726829/" class="analytics t-editors-bio-article">Biotech startups are built on venture capital. Track funding rounds here.</a></h3> <span class="secondary-label">Nov. 21, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-protagonist-icotrokinra-il-23-psoriasis/733306/" class="analytics t-editors-bio-article">J&J pill clears skin in two late-stage psoriasis studies</a></h3> <span class="secondary-label">Nov. 19, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intellia-crispr-attr-amyloidosis-nex-z-data-nejm/733186/" class="analytics t-editors-bio-article">CRISPR therapy from Intellia may ameliorate rare heart disorder, data suggest</a></h3> <span class="secondary-label">Nov. 18, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-new-normal-tips-advice-survive-funding/732917/" class="analytics t-editors-bio-article">Surviving in biotech’s new normal: 5 tips from industry VCs and CEOs</a></h3> <span class="secondary-label">Nov. 15, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-name-rfk-kennedy-hhs-secretary-nomination/733013/" class="analytics t-editors-bio-article">Trump names RFK Jr. as his pick to lead HHS</a></h3> <span class="secondary-label">Nov. 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/neurogene-rett-syndrome-setback-gene-therapy/732636/" class="analytics t-editors-bio-article">Neurogene hits a setback in the clinic, days after fundraise</a></h3> <span class="secondary-label">Nov. 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-rsv-vaccine-sales-third-quarter-bancel/732241/" class="analytics t-editors-bio-article">Moderna earnings beat forecasts, but analysts question whether sales spike will last</a></h3> <span class="secondary-label">Nov. 7, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-election-fda-ftc-drug-biotech-rfk/732194/" class="analytics t-editors-bio-article">With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC</a></h3> <span class="secondary-label">Nov. 7, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beam-sickle-cell-base-editing-study-data-abstract/731931/" class="analytics t-editors-bio-article">Sickle cell patient dies in Beam study of base editing therapy</a></h3> <span class="secondary-label">Nov. 5, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/viking-obesity-drug-results-vk2735-oral/731862/" class="analytics t-editors-bio-article">Viking data provide latest test of oral obesity drug potential</a></h3> <span class="secondary-label">Nov. 4, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jade-aerovate-reverse-merger-paragon-april-igan/731597/" class="analytics t-editors-bio-article">Jade, another biotech spinout of Paragon, to merge with Aerovate</a></h3> <span class="secondary-label">Oct. 31, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-semaglutide-shortage-doses-available-us/731510/" class="analytics t-editors-bio-article">Novo takes big step toward ending Ozempic, Wegovy shortages</a></h3> <span class="secondary-label">Oct. 30, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-obesity-sales-third-quarter-zepbound-mounjaro/731441/" class="analytics t-editors-bio-article">Lilly shares fall as obesity drug sales miss forecasts</a></h3> <span class="secondary-label">Oct. 30, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-chimagen-t-cell-engager-licensing-deal-lupus/731316/" class="analytics t-editors-bio-article">GSK to pay $300M to license drug it sees as potential lupus treatment</a></h3> <span class="secondary-label">Oct. 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-third-quarter-beat-raise-paxlovid-starboard-challenge/731286/" class="analytics t-editors-bio-article">Pfizer answers Starboard challenge with beat-and-raise quarter</a></h3> <span class="secondary-label">Oct. 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/monte-rosa-novartis-molecular-glue-degraders/731185/" class="analytics t-editors-bio-article">Monte Rosa joins with Novartis in ‘molecular glue’ drug deal</a></h3> <span class="secondary-label">Oct. 28, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-starboard-value-activist-presentation-management-criticism/730584/" class="analytics t-editors-bio-article">Starboard makes case for change at Pfizer, citing research, M&A missteps</a></h3> <span class="secondary-label">Oct. 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-reni-cel-partner-research-pivot-in-vivo-gene-editing/730530/" class="analytics t-editors-bio-article">Editas, changing course again, looks to partner lead CRISPR therapy</a></h3> <span class="secondary-label">Oct. 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-orano-radiopharmaceutical-lead-isotope/730130/" class="analytics t-editors-bio-article">Sanofi, expanding in radiopharma, strikes a joint venture deal</a></h3> <span class="secondary-label">Oct. 17, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wave-rna-editing-aatd-first-trial-data/729981/" class="analytics t-editors-bio-article">Wave sees RNA editing validation in early trial results</a></h3> <span class="secondary-label">Oct. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-hemophilia-hympavzi-fda-approval/729723/" class="analytics t-editors-bio-article">Pfizer drug for hemophilia approved by FDA</a></h3> <span class="secondary-label">Oct. 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/new-data-underline-cancer-risk-of-bluebird-therapy-for-brain-disease/729399/" class="analytics t-editors-bio-article">New data underline cancer risk of Bluebird therapy for brain disease</a></h3> <span class="secondary-label">Oct. 10, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-chief-ai-office-thomas-fuchs-mount-sinai/729326/" class="analytics t-editors-bio-article">Lilly names Mount Sinai scientist as first chief AI officer</a></h3> <span class="secondary-label">Oct. 9, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/city-therapeutics-launch-maraganore-rnai-sirna-arch/729175/" class="analytics t-editors-bio-article">Startup led by John Maraganore raises $135M to build ‘future of RNAi’</a></h3> <span class="secondary-label">Oct. 8, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intellia-hae-phase-3-study-start-ntla-2002/729052/" class="analytics t-editors-bio-article">Intellia starts late-stage test of CRISPR therapy for rare swelling disease</a></h3> <span class="secondary-label">Oct. 7, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-drug-negotiation-rules-second-round-ira/728789/" class="analytics t-editors-bio-article">Medicare tweaks rules for second round of drug price talks</a></h3> <span class="secondary-label">Oct. 3, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/4d-molecular-wet-amd-eye-gene-therapy/727506/" class="analytics t-editors-bio-article">4D Molecular data ‘bode well’ for eye gene therapy, but shares fall</a></h3> <span class="secondary-label">Sept. 19, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ascendis-achondroplasia-transcon-cnp-biomarin-bridgebio/727198/" class="analytics t-editors-bio-article">Ascendis trial data piles pressure on BioMarin</a></h3> <span class="secondary-label">Sept. 17, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/esmo-johnson-johnson-tar200-vegf-pd1-pfizer-ponsegromab/727060/" class="analytics t-editors-bio-article">ESMO24: A cancer cachexia drug, VEGF enthusiasm and immunotherapy’s survival impact</a></h3> <span class="secondary-label">Sept. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/iteos-tigit-esmo-lung-cancer-belrestotug-gsk-jemperli/727039/" class="analytics t-editors-bio-article">TIGIT drug from iTeos shrinks lung tumors in trial</a></h3> <span class="secondary-label">Sept. 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridgebio-gene-therapy-budget-cah-study-results/726704/" class="analytics t-editors-bio-article">BridgeBio trims gene therapy budget after seeing data on adrenal gland medicine</a></h3> <span class="secondary-label">Sept. 11, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-pi3ka-breast-cancer-pfs-study-results/726406/" class="analytics t-editors-bio-article">Relay breast cancer drug shows potential in early trial</a></h3> <span class="secondary-label">Sept. 9, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lykos-amy-emerson-ceo-step-down-mdma-fda-rejection/726221/" class="analytics t-editors-bio-article">Lykos CEO to depart after FDA rejection, layoffs</a></h3> <span class="secondary-label">Sept. 5, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/recursion-study-results-cerebral-cavernous-malformation-ai-drug/725846/" class="analytics t-editors-bio-article">AI specialist Recursion says lead drug is safe, but efficacy less clear</a></h3> <span class="secondary-label">Sept. 3, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-zepbound-obesity-self-pay-single-dose-vials/725346/" class="analytics t-editors-bio-article">Lilly rolls out Zepbound vials at a discount price</a></h3> <span class="secondary-label">Aug. 27, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approve-updated-covid-vaccine-mrna-pfizer-moderna/725021/" class="analytics t-editors-bio-article">Updated COVID shots from Pfizer, Moderna cleared by FDA</a></h3> <span class="secondary-label">Aug. 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gondolabio-bridgebio-spinout-viking-neil-kumar/724820/" class="analytics t-editors-bio-article">BridgeBio sends rare disease drugs to new company</a></h3> <span class="secondary-label">Aug. 21, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-fda-approval-lazcluze-rybrevant-egfr-lung-cancer/724714/" class="analytics t-editors-bio-article">J&J drug combo for lung cancer approved by FDA</a></h3> <span class="secondary-label">Aug. 20, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-tirzepatide-diabetes-risk-obesity-study-results/724685/" class="analytics t-editors-bio-article">Lilly’s tirzepatide cuts diabetes risk, study data show</a></h3> <span class="secondary-label">Aug. 20, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-manufacturing-koge-pharmatech-invest/724583/" class="analytics t-editors-bio-article">Novo plans new plant as it races to meet drug demand</a></h3> <span class="secondary-label">Aug. 19, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-drug-price-negotiations-results/723064/" class="analytics t-editors-bio-article">Medicare reveals results of drug price negotiations</a></h3> <span class="secondary-label">Aug. 15, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acelyrin-izokibep-discontinue-partner-layoffs-lonigutamab/724087/" class="analytics t-editors-bio-article">Acelyrin shifts from main drug, lays off staff</a></h3> <span class="secondary-label">Aug. 13, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/galderma-fda-approval-nemluvio-prurigo-nodularis/724068/" class="analytics t-editors-bio-article">Galderma wins FDA approval for skin condition treatment</a></h3> <span class="secondary-label">Aug. 13, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ascendis-fda-approval-yorvipath-hypoparathyroidism-pth/723924/" class="analytics t-editors-bio-article">FDA approves Ascendis drug for rare endocrine condition</a></h3> <span class="secondary-label">Aug. 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/apellis-drug-pegcetacoplan-success-kidney-disease-trial/723699/" class="analytics t-editors-bio-article">Apellis plans FDA filing after drug success in kidney trial</a></h3> <span class="secondary-label">Aug. 8, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-zepbound-obesity-sales-second-quarter-guidance/723679/" class="analytics t-editors-bio-article">Lilly boosts outlook on rising Zepbound revenue</a></h3> <span class="secondary-label">Aug. 8, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-roctavian-limit-sales-us-germany-italy-hemophilia/723402/" class="analytics t-editors-bio-article">BioMarin pares Roctavian spending as it narrows sales focus</a></h3> <span class="secondary-label">Aug. 6, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-tirzepatide-supply-fda-doses-shortage/723269/" class="analytics t-editors-bio-article">Zepbound, Mounjaro back in supply as Lilly resolves shortage</a></h3> <span class="secondary-label">Aug. 5, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jim-wilson-upenn-depart-gemma-bio-franklin-biolabs-gene-therapy/723110/" class="analytics t-editors-bio-article">Jim Wilson, prominent gene therapy researcher, to depart UPenn</a></h3> <span class="secondary-label">Aug. 1, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-vaccines-arexvy-rsv-shingrix-second-quarter/722888/" class="analytics t-editors-bio-article">GSK cuts vaccine forecasts, while predicting faster overall growth</a></h3> <span class="secondary-label">July 31, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-cancer-pipeline-cut-refocus-pd-l1-lag-3/722753/" class="analytics t-editors-bio-article">Incyte trims cancer drug pipeline in R&D refocus</a></h3> <span class="secondary-label">July 30, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-ingelheim-nerio-acquire-checkpoint-inhibitor/722623/" class="analytics t-editors-bio-article">Boehringer adds to cancer drug pipeline with deal for startup Nerio</a></h3> <span class="secondary-label">July 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-second-quarter-beat-raise-earnings/722503/" class="analytics t-editors-bio-article">Bristol Myers’ beat completes strong week of pharma earnings</a></h3> <span class="secondary-label">July 26, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/third-arc-launch-series-a-peter-lebowitz-oncology-immunology/722096/" class="analytics t-editors-bio-article">Startup led by former J&J executives raises $165M for cancer, immune disease drugs</a></h3> <span class="secondary-label">July 23, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-fertility-gene-therapy-hhs-inspector-general-negative-opinion/722055/" class="analytics t-editors-bio-article">US government declines to clear Bluebird fertility support for Zynteglo patients</a></h3> <span class="secondary-label">July 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-spravato-depression-second-quarter-sales/721634/" class="analytics t-editors-bio-article">In strengthening Spravato sales, a positive sign for psychedelic drugs</a></h3> <span class="secondary-label">July 17, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-merdad-parsey-cmo-departure-research-development/721572/" class="analytics t-editors-bio-article">Gilead’s CMO to depart next year</a></h3> <span class="secondary-label">July 17, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-sue-hhs-casgevy-sickle-cell-fertility-treatment-aks/721417/" class="analytics t-editors-bio-article">Vertex sues US over limits on providing fertility services to Casgevy patients</a></h3> <span class="secondary-label">July 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/revolution-medicine-kras-pancreatic-cancer-study-update/721319/" class="analytics t-editors-bio-article">Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data</a></h3> <span class="secondary-label">July 15, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uniqure-genezen-lexington-manufacturing-sale-gene-therapy/720266/" class="analytics t-editors-bio-article">UniQure, with sale of plant, outsources Hemgenix manufacturing</a></h3> <span class="secondary-label">July 1, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/rocket-pharma-fda-reject-gene-therapy-kresladi-manufacturing/720145/" class="analytics t-editors-bio-article">Rocket gene therapy rejected by FDA over manufacturing</a></h3> <span class="secondary-label">June 28, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/2seventy-novo-hemophilia-asset-sale-divestiture/720014/" class="analytics t-editors-bio-article">2seventy slims down with sale of hemophilia assets to Novo</a></h3> <span class="secondary-label">June 27, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wave-huntingtons-select-hd-results-silencing-takeda/719734/" class="analytics t-editors-bio-article">Wave, with new data, plots path forward for Huntington’s drug</a></h3> <span class="secondary-label">June 25, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-hemophilia-mim-8-isth-results/719616/" class="analytics t-editors-bio-article">Novo fills in positive picture for preventive hemophilia drug</a></h3> <span class="secondary-label">June 24, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-hiv-lenacapavir-purpose-1-prevention-women/719362/" class="analytics t-editors-bio-article">Twice-yearly shots of Gilead HIV drug effective in large prevention study</a></h3> <span class="secondary-label">June 20, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/telix-ipo-withdraw-nasdaq-radiopharmaceuticals/718997/" class="analytics t-editors-bio-article">Radiopharma drugmaker Telix pulls US IPO plans</a></h3> <span class="secondary-label">June 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-duchenne-gene-therapy-study-failure-ciffreo/718804/" class="analytics t-editors-bio-article">Pfizer gene therapy for Duchenne fails to meet goals of key trial</a></h3> <span class="secondary-label">June 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regenxbio-kenneth-mills-step-down-ceo-curran-simpson/718733/" class="analytics t-editors-bio-article">Regenxbio CEO to step down after 15 years</a></h3> <span class="secondary-label">June 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ipsen-genfit-elafibranor-pbc-liver-iqirvo/718567/" class="analytics t-editors-bio-article">Ipsen drug for rare liver disease approved by FDA</a></h3> <span class="secondary-label">June 11, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/itm-funding-temasek-radiopharmaceuticals-lutetium/718164/" class="analytics t-editors-bio-article">Germany’s ITM raises $205M as radiopharma field booms</a></h3> <span class="secondary-label">June 6, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridgebio-infigratinib-achondroplasia-propel-study-results/717914/" class="analytics t-editors-bio-article">BridgeBio data show sustained benefit for achondroplasia drug</a></h3> <span class="secondary-label">June 4, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-trodelvy-bladder-lung-cancer-survival-results/717611/" class="analytics t-editors-bio-article">Gilead’s Trodelvy misses goal in bladder cancer study</a></h3> <span class="secondary-label">May 31, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-scemblix-cml-asco-asc4first-study-results/717554/" class="analytics t-editors-bio-article">Novartis study points to larger role for targeted leukemia drug</a></h3> <span class="secondary-label">May 31, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-seltorexant-mdd-antidepressant-orexin/717336/" class="analytics t-editors-bio-article">J&J antidepressant eases symptoms, improves sleep in key trial</a></h3> <span class="secondary-label">May 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/insmed-aspen-brensocatib-bronchiectasis-trial-results/717222/" class="analytics t-editors-bio-article">Insmed shares double as lung drug data convince Wall Street</a></h3> <span class="secondary-label">May 28, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-zepbound-manufacturing-invest-indiana-tirzepatide/717108/" class="analytics t-editors-bio-article">Lilly to pour $5B more into expanding Zepbound, Mounjaro production</a></h3> <span class="secondary-label">May 24, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cytokinetics-royalty-aficamten-omecamtiv-mecarbil-funding/716972/" class="analytics t-editors-bio-article">Cytokinetics secures up to $575M in royalty deal, frustrating investors</a></h3> <span class="secondary-label">May 23, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-cost-cuts-spending-cogs-restructuring/716905/" class="analytics t-editors-bio-article">Pfizer expands cost cuts with new $1.5B target</a></h3> <span class="secondary-label">May 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bio-to-restructure-lay-off-staff-in-shakeup-of-lobbying-group/716610/" class="analytics t-editors-bio-article">BIO to restructure, lay off staff in shakeup of lobbying group</a></h3> <span class="secondary-label">May 20, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dyne-myotonic-duchenne-dystrophy-data-accelerated-approval-plans/716557/" class="analytics t-editors-bio-article">Dyne shares jump on trial data for muscle disease drugs</a></h3> <span class="secondary-label">May 20, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-insulin-once-weekly-efsitora-alfa-diabetes/716331/" class="analytics t-editors-bio-article">Lilly’s once-weekly insulin matches daily shots in late-stage tests</a></h3> <span class="secondary-label">May 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-holdings-buys-stake-in-life-sciences-tools-company-biomarin-lays-off/716126/" class="analytics t-editors-bio-article">Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170</a></h3> <span class="secondary-label">May 15, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fogpharma-artbio-radiopharmaceuticals-lead-cancer/716034/" class="analytics t-editors-bio-article">FogPharma, Artbio join forces to design a different radiopharma drug</a></h3> <span class="secondary-label">May 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novavax-sanofi-covid-vaccine-licensing-equity-investment/715749/" class="analytics t-editors-bio-article">Novavax gets a lifeline with Sanofi vaccine pact</a></h3> <span class="secondary-label">May 10, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-restructuring-layoffs-pipeline-first-quarter-2024/715629/" class="analytics t-editors-bio-article">Takeda targets ‘efficiency’ in restructuring, pipeline cuts</a></h3> <span class="secondary-label">May 9, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-102-first-dosing-pcsk9-base-editing/715363/" class="analytics t-editors-bio-article">Verve moves forward with backup base editing therapy</a></h3> <span class="secondary-label">May 7, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-lyfgenia-first-cell-collection-sickle-cell/715252/" class="analytics t-editors-bio-article">Bluebird, Vertex prep for first commercial use of sickle cell gene therapies</a></h3> <span class="secondary-label">May 6, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-radiopharmaceuticals-rlt-mariana-cancer-manufacturing/715082/" class="analytics t-editors-bio-article">Why selling to Novartis made sense for Mariana</a></h3> <span class="secondary-label">May 3, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridge-bio-oncology-launch-kras-cancer-drug-theras/714885/" class="analytics t-editors-bio-article">BridgeBio spinout launches with $200M for KRAS cancer drugs</a></h3> <span class="secondary-label">May 2, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-vyndaqel-vyndamax-first-quarter-sales-beat/714844/" class="analytics t-editors-bio-article">Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life</a></h3> <span class="secondary-label">May 1, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-zepbound-sales-first-quarter-2024-guidance-raise/714669/" class="analytics t-editors-bio-article">Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb</a></h3> <span class="secondary-label">April 30, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/prime-medicine-editing-ind-clearance-fda-chronic-granulomatous/714547/" class="analytics t-editors-bio-article">Prime gets FDA green light to begin first trial test of ‘prime editing’</a></h3> <span class="secondary-label">April 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-layoffs-restructuring-cost-savings/714254/" class="analytics t-editors-bio-article">Bristol Myers to cut 6% of workforce, trim drug pipeline</a></h3> <span class="secondary-label">April 25, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-openai-gpt-generative-ai-biotech-dose-id/714140/" class="analytics t-editors-bio-article">Moderna turns to AI to change how its employees work</a></h3> <span class="secondary-label">April 24, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-beat-raise-first-quarter-entresto-cosentyx/713968/" class="analytics t-editors-bio-article">Novartis raises forecasts as top drug sales beat Wall Street estimates</a></h3> <span class="secondary-label">April 23, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cellares-bristol-myers-car-t-manufacturing-cell-shuttle/713822/" class="analytics t-editors-bio-article">Bristol Myers taps startup to boost cell therapy production</a></h3> <span class="secondary-label">April 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cerevel-parkinsons-tavapadon-study-results-abbvie/713566/" class="analytics t-editors-bio-article">Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study</a></h3> <span class="secondary-label">April 18, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-tecvayli-carvykti-myeloma-sales-q1/713294/" class="analytics t-editors-bio-article">J&J sees mixed performance from new multiple myeloma drugs</a></h3> <span class="secondary-label">April 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ultragenyx-angelman-gtx-102-interim-results/713169/" class="analytics t-editors-bio-article">Ultragenyx says Angelman therapy is working, but safety questions remain</a></h3> <span class="secondary-label">April 15, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abecma-fda-earlier-approval-bristol-myers-car-t-myeloma/712393/" class="analytics t-editors-bio-article">FDA approves CAR-T therapies from J&J, Bristol Myers for earlier myeloma use</a></h3> <span class="secondary-label">April 5, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-kras-phase-3-lung-cancer-keytruda/712272/" class="analytics t-editors-bio-article">Merck puts KRAS cancer drug competitor to the test</a></h3> <span class="secondary-label">April 4, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-pcsk-liver-enzyme-pause-trial/711936/" class="analytics t-editors-bio-article">Verve pauses base editing trial, shifts strategy after treatment side effect</a></h3> <span class="secondary-label">April 2, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-xilio-cancer-deal-il-12-immunotherapy/711613/" class="analytics t-editors-bio-article">Gilead bets on Xilio cancer drug as biotech restructures</a></h3> <span class="secondary-label">March 28, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/stoke-dravet-seizure-trial-results/711334/" class="analytics t-editors-bio-article">Stoke shares surge on updated results for Dravet drug</a></h3> <span class="secondary-label">March 26, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-cardior-rna-heart-failure-deal-acquisition/711212/" class="analytics t-editors-bio-article">Novo to acquire heart failure drug in $1B deal for Cardior</a></h3> <span class="secondary-label">March 25, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/blossomhill-jean-cui-cancer-small-molecule-series-b/708901/" class="analytics t-editors-bio-article">With BlossomHill, former Turning Point execs take aim at cancer, autoimmune disease</a></h3> <span class="secondary-label">Feb. 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/janux-t-cell-engager-cancer-drug-data-shares/708621/" class="analytics t-editors-bio-article">Janux shares triple on early cancer immunotherapy data</a></h3> <span class="secondary-label">Feb. 27, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/minerva-fda-rejection-schizophrenia-complete-response-letter/708602/" class="analytics t-editors-bio-article">Minerva schizophrenia drug rejected by FDA</a></h3> <span class="secondary-label">Feb. 27, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-carvykti-europe-early-use-multiple-myeloma-chmp/708357/" class="analytics t-editors-bio-article">J&J secures EMA backing for earlier CAR-T use in multiple myeloma</a></h3> <span class="secondary-label">Feb. 23, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-covid-rsv-vaccine-q4-earnings-transition/708205/" class="analytics t-editors-bio-article">Moderna pitches RSV shot, new vaccines after ‘difficult year of transition’</a></h3> <span class="secondary-label">Feb. 22, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-tagrisso-approval-lung-cancer-egfr-laura/707912/" class="analytics t-editors-bio-article">AstraZeneca gets new Tagrisso OK as drug succeeds in another trial</a></h3> <span class="secondary-label">Feb. 20, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ipsen-onivyde-fda-approval-first-line-pancreatic-cancer/707507/" class="analytics t-editors-bio-article">Ipsen drug approved by FDA for early pancreatic cancer</a></h3> <span class="secondary-label">Feb. 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/latigo-launch-biotech-pain-nav-18-non-opioid/707433/" class="analytics t-editors-bio-article">Hunting a non-opioid painkiller, a biotech reveals plans to chase Vertex</a></h3> <span class="secondary-label">Feb. 14, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-cymabay-deal-acquire-seladelpar-liver-pbc/707218/" class="analytics t-editors-bio-article">Gilead to buy CymaBay in $4.3B deal for liver disease drug</a></h3> <span class="secondary-label">Feb. 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-obesity-amg-133-earnings-call-maritide/706798/" class="analytics t-editors-bio-article">Obesity drug mania takes over Amgen’s earnings call</a></h3> <span class="secondary-label">Feb. 7, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-dealmaking-15-billion-keytruda-cliff-davis/706309/" class="analytics t-editors-bio-article">Merck keeps deal focus with Keytruda patent cliff on horizon</a></h3> <span class="secondary-label">Feb. 1, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicaid-sickle-cell-gene-therapy-pilot-outcomes-payment/706079/" class="analytics t-editors-bio-article">New CMS pilot to test payment scheme for pricey sickle cell gene therapies</a></h3> <span class="secondary-label">Jan. 31, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-2seventy-cell-therapy-pipeline-purchase/705955/" class="analytics t-editors-bio-article">Regeneron to acquire 2seventy’s cell therapy pipeline</a></h3> <span class="secondary-label">Jan. 30, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-pain-drug-positive-trial-results-vx-548/705342/" class="analytics t-editors-bio-article">Non-opioid drug from Vertex cuts pain in major trial tests</a></h3> <span class="secondary-label">Jan. 30, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-5051-duchenne-dystrophin-study-results/705854/" class="analytics t-editors-bio-article">Sarepta data show new Duchenne drug’s potency, but highlight side effects</a></h3> <span class="secondary-label">Jan. 29, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-rayzebio-deal-bidders-radiopharmaceuticals/705594/" class="analytics t-editors-bio-article">RayzeBio drew other pharma interest before Bristol Myers deal</a></h3> <span class="secondary-label">Jan. 25, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-hearing-loss-gene-therapy-akuous-pipeline/705459/" class="analytics t-editors-bio-article">Lilly gene therapy finding puts focus on hearing loss treatment pipeline</a></h3> <span class="secondary-label">Jan. 24, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-inhibrx-acquire-spinout-alpha-1-antitrypsin/705292/" class="analytics t-editors-bio-article">Sanofi to buy Inhibrx in deal worth up to $2.2B</a></h3> <span class="secondary-label">Jan. 23, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-lutathera-netter-2-results-asco/705053/" class="analytics t-editors-bio-article">Novartis details first-line data for radiopharma drug Lutathera</a></h3> <span class="secondary-label">Jan. 19, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jaguar-gene-therapy-spinout-deerfield-arch-advanced-medicine/704901/" class="analytics t-editors-bio-article">Gene therapy biotech Jaguar spins out manufacturing company</a></h3> <span class="secondary-label">Jan. 18, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridge-bio-financing-royalties-blue-owl-canada-pension/704881/" class="analytics t-editors-bio-article">BridgeBio strikes drug royalty deal for cash infusion</a></h3> <span class="secondary-label">Jan. 18, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-casgevy-approval-beta-thalassemia-vertex-crispr/704663/" class="analytics t-editors-bio-article">FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia</a></h3> <span class="secondary-label">Jan. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-pharma-trends-outlook-2024/704572/" class="analytics t-editors-bio-article">The biopharma industry outlook on 2024: Guarded optimism for a rebound</a></h3> <span class="secondary-label">Jan. 16, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/arena-bioworks-biotech-launch-schreiber-joung/704449/" class="analytics t-editors-bio-article">Backed by billionaires, a new biomedical institute tests an unorthodox approach</a></h3> <span class="secondary-label">Jan. 12, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-outlook-2024-obesity-cancer-ira-alzheimers/704138/" class="analytics t-editors-bio-article">5 questions facing pharma in 2024</a></h3> <span class="secondary-label">Jan. 10, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-24-biotech-maze-ftc-radiopharmaceuticals-bluebird-price/704210/" class="analytics t-editors-bio-article">JPM24: Novartis’ head start, FTC fallout and Bluebird’s price defense</a></h3> <span class="secondary-label">Jan. 10, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-aiolos-acquire-asthma-tslp-drug/704030/" class="analytics t-editors-bio-article">GSK to buy asthma drug startup Aiolos for $1B</a></h3> <span class="secondary-label">Jan. 9, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-layoffs-2023-pharma-workforce-jpm-outlook/703939/" class="analytics t-editors-bio-article">Year of biotech layoffs leaves industry looking for spark</a></h3> <span class="secondary-label">Jan. 8, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-ambrx-acquire-deal-antibody-drug-conjugate-prostate/703867/" class="analytics t-editors-bio-article">J&J to acquire ADC drug developer Ambrx for $2B</a></h3> <span class="secondary-label">Jan. 8, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-canada-drug-import-florida-approve-plan/703759/" class="analytics t-editors-bio-article">FDA authorizes Florida to import drugs from Canada</a></h3> <span class="secondary-label">Jan. 5, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-pharmacy-direct-zepbound-obesity-home-delivery/703649/" class="analytics t-editors-bio-article">Lilly launches online service for home delivery of weight loss drug</a></h3> <span class="secondary-label">Jan. 4, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-watch-first-quarter-2024/703377/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the first quarter</a></h3> <span class="secondary-label">Jan. 4, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-10-clinical-trials-watch-2024-first-half/702964/" class="analytics t-editors-bio-article">10 clinical trials to watch in the first half of 2024</a></h3> <span class="secondary-label">Jan. 2, 2024</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-fda-application-elevidys-duchenne-expand-approval/703336/" class="analytics t-editors-bio-article">Sarepta tests FDA flexibility with bid to expand Duchenne gene therapy’s approval</a></h3> <span class="secondary-label">Dec. 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-karuna-acquire-schizophrenia-kar-xt/703313/" class="analytics t-editors-bio-article">Bristol Myers to acquire brain drug developer Karuna for $14B</a></h3> <span class="secondary-label">Dec. 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-tecfidera-europe-generic-entry-2025/702934/" class="analytics t-editors-bio-article">Biogen holds onto Tecfidera market in Europe for a little longer</a></h3> <span class="secondary-label">Dec. 19, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/point-splash-radiopharma-prostate-cancer-lilly-close/702773/" class="analytics t-editors-bio-article">Point radiopharma drug results disappoint in prostate cancer study</a></h3> <span class="secondary-label">Dec. 18, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sickle-cell-gene-therapy-uptake-launch-casgevy-lyfgenia/702359/" class="analytics t-editors-bio-article">At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details</a></h3> <span class="secondary-label">Dec. 13, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2023-editas-sickle-cell-myeloma-diversity-pharma-advertisting/702172/" class="analytics t-editors-bio-article">ASH23: Pharma branding, Editas’ high bar and clinical trial diversity</a></h3> <span class="secondary-label">Dec. 11, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-casgevy-oral-history-vertex-sickle-cell-disease/701075/" class="analytics t-editors-bio-article">‘No tolerance for failure’: An oral history of the first CRISPR medicine</a></h3> <span class="secondary-label">Dec. 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2023-car-t-autoimmune-multiple-myeloma-real-world/702082/" class="analytics t-editors-bio-article">ASH23: CAR-T for autoimmune disease, real-world questions and sickle cell’s social media mentions</a></h3> <span class="secondary-label">Dec. 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-sickle-cell-price-millions-gene-therapy-vertex-bluebird/702066/" class="analytics t-editors-bio-article">Pricey new gene therapies for sickle cell pose access test</a></h3> <span class="secondary-label">Dec. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-fda-approval-sickle-cell-gene-editing-vertex-casgevy/701522/" class="analytics t-editors-bio-article">CRISPR therapy for sickle cell approved by FDA in gene editing milestone</a></h3> <span class="secondary-label">Dec. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-cerevel-acquire-deal-schizophrenia-drug/701803/" class="analytics t-editors-bio-article">AbbVie to buy Cerevel in $8.7B bet on brain drugs</a></h3> <span class="secondary-label">Dec. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-fabhalta-iptacopan-fda-approval-pnh-oral/701687/" class="analytics t-editors-bio-article">Novartis gets FDA approval of closely watched rare disease drug</a></h3> <span class="secondary-label">Dec. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-pharma-forecast-20-new-drugs-business-review/701575/" class="analytics t-editors-bio-article">J&J pitches investors on sales growth from cancer, immune disease drugs</a></h3> <span class="secondary-label">Dec. 5, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eyepoint-wet-amd-trial-results-davio-stock-jump/701421/" class="analytics t-editors-bio-article">EyePoint sees stock surge on AMD drug trial data</a></h3> <span class="secondary-label">Dec. 4, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-obesity-danuglipron-trial-results-negative/701248/" class="analytics t-editors-bio-article">Pfizer plans for oral obesity drug hit new setback</a></h3> <span class="secondary-label">Dec. 1, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-mid-sales-guidance-drug-pipeline-prioritization/700846/" class="analytics t-editors-bio-article">Novartis sees brighter sales future as R&D revamp continues</a></h3> <span class="secondary-label">Nov. 28, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dupixent-copd-sanofi-regeneron-notus-fda-submission/700685/" class="analytics t-editors-bio-article">Regeneron, Sanofi to seek new Dupixent approval in US after COPD success</a></h3> <span class="secondary-label">Nov. 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/freeline-syncona-acquire-take-private-deal/700583/" class="analytics t-editors-bio-article">Freeline, after cuts, agrees to take-private deal with Syncona</a></h3> <span class="secondary-label">Nov. 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-abecma-fda-advisory-committee-2seventy/700303/" class="analytics t-editors-bio-article">Bristol Myers faces FDA delay on cancer cell therapy decision</a></h3> <span class="secondary-label">Nov. 20, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-first-approval-uk-vertex-sickle-cell-casgevy/700020/" class="analytics t-editors-bio-article">World’s first CRISPR medicine approved in UK for sickle cell, beta thalassemia</a></h3> <span class="secondary-label">Nov. 16, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/anthos-aha-abelacimab-blood-thinner-factor-xia/699555/" class="analytics t-editors-bio-article">Anthos blood thinner bests Xarelto on safety in mid-stage study</a></h3> <span class="secondary-label">Nov. 13, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-aha-base-editing-first-data-pcsk9-cholesterol/699507/" class="analytics t-editors-bio-article">First look at Verve study data offers base editing ‘proof of principle’</a></h3> <span class="secondary-label">Nov. 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-manufacturing-glp-1-kalundborg-denmark/699424/" class="analytics t-editors-bio-article">Novo takes aim at obesity drug shortages with $6B manufacturing plan</a></h3> <span class="secondary-label">Nov. 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-zepbound-obesity-fda-approval-tirzepatide/699189/" class="analytics t-editors-bio-article">Lilly rival to weight loss drug Wegovy approved by FDA</a></h3> <span class="secondary-label">Nov. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sickle-cell-crispr-gene-editing-vertex-exa-cel-barriers/698121/" class="analytics t-editors-bio-article">What if a CRISPR cure isn’t such an easy choice?</a></h3> <span class="secondary-label">Nov. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-sage-zurzuvae-price-set-postpartum-depression/698996/" class="analytics t-editors-bio-article">Biogen, Sage set price of postpartum depression pill at $15,900</a></h3> <span class="secondary-label">Nov. 7, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celldex-barzolvolimab-hives-urticara-phase-2-results/698856/" class="analytics t-editors-bio-article">Celldex’s reinvention advances with inflammatory disease drug data</a></h3> <span class="secondary-label">Nov. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-layoffs-third-quarter-sangamo-seres-kronos-rani/698728/" class="analytics t-editors-bio-article">November brings new flurry of biotech layoffs</a></h3> <span class="secondary-label">Nov. 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-crispr-therapy-sickle-cell-passes-fda-advisers/698355/" class="analytics t-editors-bio-article">Vertex, CRISPR therapy for sickle cell passes FDA panel test</a></h3> <span class="secondary-label">Oct. 31, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-crispr-exa-cel-fda-advisory-committee-live-coverage-tracking/698214/" class="analytics t-editors-bio-article">A play-by-play of the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy</a></h3> <span class="secondary-label">Oct. 31, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-beam-verve-base-editing-heart-disease-rights/698229/" class="analytics t-editors-bio-article">Lilly buys out Beam in heart drug alliance with Verve</a></h3> <span class="secondary-label">Oct. 31, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-duchnne-embark-study-failure-gene-therapy-elevidys/698243/" class="analytics t-editors-bio-article">Sarepta gene therapy for Duchenne misses main goal of key study</a></h3> <span class="secondary-label">Oct. 30, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-atrasentan-igan-chinook-phase-3-study-results/698144/" class="analytics t-editors-bio-article">Novartis bet on kidney disease drug yields positive study data</a></h3> <span class="secondary-label">Oct. 30, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-neuroscience-cns-reserach-ken-rhodes/698062/" class="analytics t-editors-bio-article">Bristol Myers’ neuroscience research head explains the big pharma’s return to brain drugs</a></h3> <span class="secondary-label">Oct. 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/exa-cel-vertex-crispr-fda-documents-off-target-editing/698011/" class="analytics t-editors-bio-article">FDA staff focus on ‘off-target’ risk in review of Vertex, CRISPR sickle cell therapy</a></h3> <span class="secondary-label">Oct. 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-third-quarter-earnings-forecast-new-drugs/697903/" class="analytics t-editors-bio-article">Bristol Myers says new drugs sales will grow more slowly</a></h3> <span class="secondary-label">Oct. 26, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/excision-crispr-gene-editing-in-vivo-hiv-safety/697739/" class="analytics t-editors-bio-article">Excision gives first look at gene editing therapy for HIV</a></h3> <span class="secondary-label">Oct. 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seagen-esmo-padcev-bladder-cancer-trial-merck-pfizer/697446/" class="analytics t-editors-bio-article">Seagen trial data impresses at ESMO, lifting Merck, Pfizer in the process</a></h3> <span class="secondary-label">Oct. 23, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roivant-roche-pfizer-tl1a-telavant-acquire-ibd-drug/687882/" class="analytics t-editors-bio-article">Roche to gain gut disease drug in $7.1B deal for Roivant subsidiary</a></h3> <span class="secondary-label">Oct. 23, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-fda-lift-hold-ind-clearance-base-editing-trial/697419/" class="analytics t-editors-bio-article">Verve gets FDA green light to run base editing study in US</a></h3> <span class="secondary-label">Oct. 23, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-daiichi-sankyo-adc-antibody-cancer-drug/697260/" class="analytics t-editors-bio-article">Merck allies with Daiichi Sankyo in major bet on antibody cancer drugs</a></h3> <span class="secondary-label">Oct. 20, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beam-layoffs-restructuring-base-editing/697151/" class="analytics t-editors-bio-article">Beam to lay off 100 employees, seek partners in research restructuring</a></h3> <span class="secondary-label">Oct. 19, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ardelyx-fda-approval-xphozah-ckd-kidney-phosphorus/696950/" class="analytics t-editors-bio-article">After long journey, Ardelyx gets FDA OK for kidney disease drug</a></h3> <span class="secondary-label">Oct. 18, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-q3-sales-forecast-hike-stelara-carvykti/696783/" class="analytics t-editors-bio-article">J&J again bumps forecasts on strong immune drug sales</a></h3> <span class="secondary-label">Oct. 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/top-biotech-pharma-medical-conferences-2024/696665/" class="analytics t-editors-bio-article">The top biopharma conferences in 2024</a></h3> <span class="secondary-label">Oct. 16, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-layoffs-cost-cuts-covid-paxlovid-comirnaty/696623/" class="analytics t-editors-bio-article">Pfizer to cut costs, lay off staff on waning demand for COVID products</a></h3> <span class="secondary-label">Oct. 13, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/akero-nash-symmetry-trial-results-fibrosis-liver/696109/" class="analytics t-editors-bio-article">Akero drug for NASH misses goal in mid-stage study</a></h3> <span class="secondary-label">Oct. 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-mirati-acquire-deal-kras-cancer-drug/695931/" class="analytics t-editors-bio-article">Bristol Myers to buy KRAS cancer drug developer Mirati for $4.8B</a></h3> <span class="secondary-label">Oct. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lumakras-fda-panel-vote-amgen-confirmatory-study-results/695846/" class="analytics t-editors-bio-article">FDA panel finds KRAS drug data unreliable, in blow to Amgen</a></h3> <span class="secondary-label">Oct. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/orchard-kyowa-kirin-acquire-gene-therapy-libmeldy/695704/" class="analytics t-editors-bio-article">Orchard sells to Kyowa Kirin in gene therapy buyout</a></h3> <span class="secondary-label">Oct. 5, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-sanofi-tl1a-inflammatory-bowel-disease-deal-collaboration/695579/" class="analytics t-editors-bio-article">Sanofi buys into Teva gut disease drug</a></h3> <span class="secondary-label">Oct. 4, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-point-biopharma-radiopharmaceutical-cancer-deal-acquire/695453/" class="analytics t-editors-bio-article">Lilly to enter radiopharmaceutical drug field with $1.4B Point buyout</a></h3> <span class="secondary-label">Oct. 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-fourth-quarter-2023/695271/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the fourth quarter</a></h3> <span class="secondary-label">Oct. 2, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/structure-glp-1-obesity-drug-data-stock-sale/695161/" class="analytics t-editors-bio-article">Structure boosted by early data for experimental obesity drug</a></h3> <span class="secondary-label">Sept. 29, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-mariposa-rybrevant-egfr-lung-cancer-tagrisso/695031/" class="analytics t-editors-bio-article">J&J cancer drug combo beats Tagrisso in closely watched trial</a></h3> <span class="secondary-label">Sept. 28, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/brainstorm-fda-als-vote-advisory-committee-nurown/694958/" class="analytics t-editors-bio-article">BrainStorm’s ALS therapy not effective, FDA panel finds</a></h3> <span class="secondary-label">Sept. 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/john-tsai-forecefield-ceo-appoint-biotech-heart/694877/" class="analytics t-editors-bio-article">Former Novartis executive Tsai to lead UK heart drug startup</a></h3> <span class="secondary-label">Sept. 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/immunovant-fcrn-autoimmune-roivant-study-results/694719/" class="analytics t-editors-bio-article">Immunovant data show potential for autoimmune disease drug</a></h3> <span class="secondary-label">Sept. 26, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/leqembi-japan-approval-alzheimers-eisai-biogen/694622/" class="analytics t-editors-bio-article">Eisai’s Alzheimer’s drug Leqembi approved in Japan</a></h3> <span class="secondary-label">Sept. 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/brainstorm-fda-als-nurown-advisory-committee-documents/694577/" class="analytics t-editors-bio-article">FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show</a></h3> <span class="secondary-label">Sept. 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/janssen-brand-retire-johnson-johnson-innovative-medicine/693744/" class="analytics t-editors-bio-article">J&J to phase out Janssen name in corporate rebrand</a></h3> <span class="secondary-label">Sept. 15, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/actio-bio-launch-series-a-goldstein-jax-mouse/693427/" class="analytics t-editors-bio-article">Actio, a precision medicine startup, launches with $55M and a mouse lab partnership</a></h3> <span class="secondary-label">Sept. 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/2seventy-layoffs-nich-leschly-restructuring-abecma/693382/" class="analytics t-editors-bio-article">2Seventy CEO Leschly to step down as company cuts staff, spending</a></h3> <span class="secondary-label">Sept. 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/madrigal-bill-sibold-appoint-ceo-sanofi-friedman/693237/" class="analytics t-editors-bio-article">Ex-Sanofi executive Sibold joins Madrigal as new CEO</a></h3> <span class="secondary-label">Sept. 11, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/otsuka-pharmaceutical-taps-shape-therapeutics-deal-eye-gene-therapies/693135/" class="analytics t-editors-bio-article">Otsuka partners with Shape in deal to design eye gene therapies</a></h3> <span class="secondary-label">Sept. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-withdraw-lawsuit-ira-xtandi-medicare-price-negotiations/692957/" class="analytics t-editors-bio-article">Astellas withdraws lawsuit challenging Medicare drug price program</a></h3> <span class="secondary-label">Sept. 7, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/catalent-board-elliott-deal-activist-review/692146/" class="analytics t-editors-bio-article">Catalent expands board in deal with activist investor Elliott</a></h3> <span class="secondary-label">Aug. 29, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-10-drugs-price-negotiation-ira/692044/" class="analytics t-editors-bio-article">Medicare names first 10 drugs for price negotiations</a></h3> <span class="secondary-label">Aug. 29, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-ira-lawsuit-drug-pricing/691869/" class="analytics t-editors-bio-article">AstraZeneca the latest pharma to challenge drug pricing law</a></h3> <span class="secondary-label">Aug. 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/royalty-ferring-adstiladrin-gene-therapy-rights-deal/691736/" class="analytics t-editors-bio-article">Royalty Pharma buys into Ferring’s cancer treatment in first gene therapy deal</a></h3> <span class="secondary-label">Aug. 24, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-ira-lawsuit-sue-drug-price-jardiance/691493/" class="analytics t-editors-bio-article">Boehringer sues to block US drug price program</a></h3> <span class="secondary-label">Aug. 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-ingelheim-glp-1-obesity-phase-3-trials/691152/" class="analytics t-editors-bio-article">Boehringer moves Wegovy competitor into late-stage testing</a></h3> <span class="secondary-label">Aug. 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-tentarix-research-deal-cancer-immune/690855/" class="analytics t-editors-bio-article">Gilead allies with targeted drug startup Tentarix in latest research bet</a></h3> <span class="secondary-label">Aug. 15, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/taysha-funding-investment-ra-capital-gene-therapy/690765/" class="analytics t-editors-bio-article">Taysha gets cash lifeline from new investor RA Capital</a></h3> <span class="secondary-label">Aug. 14, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amylyx-als-relyvrio-drug-sales-launch-second-quarter/690651/" class="analytics t-editors-bio-article">Amylyx ALS drug sales tick higher after fast US launch</a></h3> <span class="secondary-label">Aug. 11, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-mounjaro-obesity-second-quarter-stock-value/690224/" class="analytics t-editors-bio-article">Lilly market value soars on higher sales, obesity drug potential</a></h3> <span class="secondary-label">Aug. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-adakveo-europe-revoke-withdraw-sickle-cell/690000/" class="analytics t-editors-bio-article">Novartis sickle cell drug’s approval formally revoked by EU regulators</a></h3> <span class="secondary-label">Aug. 4, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-lumakras-colon-cancer-phase-3-study-results/689933/" class="analytics t-editors-bio-article">Amgen says KRAS drug met goal in late-stage colon cancer trial</a></h3> <span class="secondary-label">Aug. 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-crispr-sickle-cell-insurers-launch-preparation/689690/" class="analytics t-editors-bio-article">Vertex taking ‘flexible’ approach to payment talks for experimental CRISPR therapy</a></h3> <span class="secondary-label">Aug. 2, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-weighs-cutting-costs-as-covid-drug-sales-ebb/689544/" class="analytics t-editors-bio-article">Pfizer weighs cutting costs as COVID drug sales ebb</a></h3> <span class="secondary-label">Aug. 1, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridgebio-limb-girdle-fda-surrogate-endpoint/689424/" class="analytics t-editors-bio-article">BridgeBio explores path forward for muscular disease drug</a></h3> <span class="secondary-label">July 31, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-reata-acquire-deal-skyclarys-viehbacher/689281/" class="analytics t-editors-bio-article">Biogen to acquire rare disease drugmaker Reata for $7.3B</a></h3> <span class="secondary-label">July 28, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/homology-layoffs-restructure-pku-gene-therapy/689260/" class="analytics t-editors-bio-article">Gene editing biotech Homology hits reset and seeks a sale</a></h3> <span class="secondary-label">July 28, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-layoffs-cost-cuts-jobs-second-quarter-earnings/688854/" class="analytics t-editors-bio-article">Biogen to eliminate 1,000 jobs in further cost cuts</a></h3> <span class="secondary-label">July 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-roche-rnai-cardiovascular-zilebresian/688730/" class="analytics t-editors-bio-article">Roche buys into Alnylam heart drug in cardiovascular research bet</a></h3> <span class="secondary-label">July 24, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mirati-ema-krazati-recommend-rejection-cancer/688626/" class="analytics t-editors-bio-article">Mirati’s KRAS-blocking cancer drug hits setback in Europe</a></h3> <span class="secondary-label">July 21, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-raise-forecast-drug-sales-second-quarter/688510/" class="analytics t-editors-bio-article">J&J shares jump on strong sales, boosted outlook</a></h3> <span class="secondary-label">July 20, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wilson-bryan-greenleaf-health-fda-gene-therapy/688418/" class="analytics t-editors-bio-article">Wilson Bryan, former FDA gene therapy leader, joins consulting firm</a></h3> <span class="secondary-label">July 19, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/argenx-fundraise-secondary-offering-vyvgart-data/688346/" class="analytics t-editors-bio-article">Argenx raises $1.1B on heels of rare disease drug data</a></h3> <span class="secondary-label">July 19, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-stock-buyback-guidance-raise-second-quarter/688227/" class="analytics t-editors-bio-article">Novartis raises drug sales forecast, plans new stock buybacks</a></h3> <span class="secondary-label">July 18, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-versanis-obesity-drug-acquire-deal/687539/" class="analytics t-editors-bio-article">Lilly to buy Versanis, adding to obesity drug pipeline</a></h3> <span class="secondary-label">July 14, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tenpoint-biotech-launch-eye-regenerative-medicine/686631/" class="analytics t-editors-bio-article">Startup Tenpoint raises $70M to develop regenerative medicines for the eye</a></h3> <span class="secondary-label">July 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/avrobio-strategic-alternatives-sale-gene-therapy-research/686643/" class="analytics t-editors-bio-article">Avrobio halts gene therapy research and considers a sale</a></h3> <span class="secondary-label">July 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-neuroscience-prothena-evotec-license-option/686246/" class="analytics t-editors-bio-article">Bristol Myers licenses Prothena, Evotec brain drugs, inching back into neuroscience</a></h3> <span class="secondary-label">July 11, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-patent-entresto-district-court-decision-appeal/686004/" class="analytics t-editors-bio-article">Novartis to appeal district court ruling on heart drug patent</a></h3> <span class="secondary-label">July 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nanobiotix-johnson-johnson-licensing-head-neck-cancer-radioenhancer/685982/" class="analytics t-editors-bio-article">Nanobiotix licenses cancer treatment to J&J, extending runway</a></h3> <span class="secondary-label">July 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bausch-lomb-johnson-johnson-blink-eye-drops-deal/685228/" class="analytics t-editors-bio-article">Bausch + Lomb bulks up OTC business with J&J deal</a></h3> <span class="secondary-label">July 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spyre-aeglea-reverse-merger-paragon-tl1a-ibd/653672/" class="analytics t-editors-bio-article">Spyre, a new biotech spinout, launches via merger with Aeglea</a></h3> <span class="secondary-label">June 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/argenx-vyvgart-subcutaneous-fda-approval/653493/" class="analytics t-editors-bio-article">Argenx wins FDA approval for under-the-skin injection of rare disease drug</a></h3> <span class="secondary-label">June 21, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-eli-lilly-lpa-heart-disease-ascvd-gene-editing/653034/" class="analytics t-editors-bio-article">Verve partners with Lilly on gene editing therapy for heart disease</a></h3> <span class="secondary-label">June 15, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-refile-ftc-seagen-deal-paperwork-hsr/652962/" class="analytics t-editors-bio-article">Pfizer refiles Seagen deal paperwork with regulators</a></h3> <span class="secondary-label">June 14, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/2seventy-trial-pause-patient-death-aml-car-t/652943/" class="analytics t-editors-bio-article">Study of 2seventy Bio’s AML cell therapy paused after patient death</a></h3> <span class="secondary-label">June 14, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-price-hike-penalties-ira-43-drugs-part-b/652597/" class="analytics t-editors-bio-article">Medicare sets next tranche of drugs to face price hike penalties</a></h3> <span class="secondary-label">June 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kate-therapeutics-launch-astellas-xlmtm-gene-therapy/652303/" class="analytics t-editors-bio-article">Armed with new gene therapy tools, a biotech startup promises a better way to target muscle diseases</a></h3> <span class="secondary-label">June 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-astrazeneca-soriot-adaura-gilead-yescarta-survival-pfizer-parp/652258/" class="analytics t-editors-bio-article">Closing ASCO: AstraZeneca’s ‘very special’ meeting, more CAR-T survival data and Pfizer’s PARP play</a></h3> <span class="secondary-label">June 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/enhertu-asco-her2-solid-tumor-agnostic-astrazeneca/651911/" class="analytics t-editors-bio-article">AstraZeneca study points to new uses for targeted cancer drug Enhertu</a></h3> <span class="secondary-label">June 5, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/carvykti-asco-multiple-myeloma-cartitude-4-johnson-johnson/651958/" class="analytics t-editors-bio-article">J&J sees trial data supporting earlier CAR-T use in multiple myeloma</a></h3> <span class="secondary-label">June 5, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-luspatercept-commands-mds-asco-rebloyzyl/651284/" class="analytics t-editors-bio-article">Bristol Myers data make case for earlier use of bone marrow disease drug</a></h3> <span class="secondary-label">May 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-antibody-drug-conjugate-merck-biontech-daiichi-trop2-her2/651334/" class="analytics t-editors-bio-article">ASCO puts spotlight on advancing antibody-drug conjugate pipeline</a></h3> <span class="secondary-label">May 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/avrobio-novartis-gene-therapy-sale-cystinosis/650855/" class="analytics t-editors-bio-article">Novartis buys rare disease gene therapy from Avrobio</a></h3> <span class="secondary-label">May 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cindy-perettie-gilead-kite-appoint-name/650477/" class="analytics t-editors-bio-article">Gilead picks former Roche executive to run cell therapy unit Kite</a></h3> <span class="secondary-label">May 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/siren-launch-paulk-cytokine-gene-therapy-cancer/650441/" class="analytics t-editors-bio-article">Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy</a></h3> <span class="secondary-label">May 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ray-therapeutics-launch-optogenetics-gene-therapy/650359/" class="analytics t-editors-bio-article">Biotech startup Ray raises $100M for vision-restoring gene therapies</a></h3> <span class="secondary-label">May 16, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-panel-narrowly-backs-approval-of-sareptas-duchenne-gene-therapy/650200/" class="analytics t-editors-bio-article">FDA panel narrowly backs approval of Sarepta’s Duchenne gene therapy</a></h3> <span class="secondary-label">May 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-xinthera-acquire-parp1-mk2-cancer-immune/649783/" class="analytics t-editors-bio-article">Gilead acquires San Diego startup for early-stage cancer, immune drugs</a></h3> <span class="secondary-label">May 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eqrx-reset-restructuring-layoffs-pipeline/649740/" class="analytics t-editors-bio-article">EQRx resets strategy, abandoning plans to disrupt drug pricing</a></h3> <span class="secondary-label">May 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/catalent-earnings-delay-financial-forecasts-manufacturing/649665/" class="analytics t-editors-bio-article">Catalent cuts outlook, delays results as it reveals new hurdles</a></h3> <span class="secondary-label">May 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/apellis-syfovre-geographic-atrophy-launch-sales-iveric/649556/" class="analytics t-editors-bio-article">Apellis reports strong start for new vision loss drug</a></h3> <span class="secondary-label">May 5, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-alzheimers-donanemab-study-success-positive-amyloid/649274/" class="analytics t-editors-bio-article">Lilly drug slows Alzheimer’s decline in large study</a></h3> <span class="secondary-label">May 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/travere-sparsentan-fsgs-study-failure-kidney/649156/" class="analytics t-editors-bio-article">Travere set back by study failure of kidney disease drug</a></h3> <span class="secondary-label">May 2, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/initial-biotech-launch-undruggable-ribosome-apple-tree/649028/" class="analytics t-editors-bio-article">Initial launches with $75M and a new idea for targeting problematic proteins</a></h3> <span class="secondary-label">May 1, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-humira-sales-amgen-biosimilar/648861/" class="analytics t-editors-bio-article">AbbVie weathers first months of biosimilar challenge to top-selling Humira</a></h3> <span class="secondary-label">April 28, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-layoffs-restructuring-pipeline/648822/" class="analytics t-editors-bio-article">Sangamo to lay off 120 as it pares pipeline</a></h3> <span class="secondary-label">April 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/morphic-ulcerative-colitis-study-results-oral-entyvio/648524/" class="analytics t-editors-bio-article">Morphic shares swing on study data for drug viewed as ‘oral Entyvio’</a></h3> <span class="secondary-label">April 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-consumer-spinoff-ipo-terms-kenvue/648498/" class="analytics t-editors-bio-article">J&J’s consumer health spinoff seeking $3B stock offering in test of IPO market</a></h3> <span class="secondary-label">April 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-ionis-eplontersen-attr-alnylam-competitor/648398/" class="analytics t-editors-bio-article">Ionis, AstraZeneca detail data backing rare disease rival to Alnylam drugs</a></h3> <span class="secondary-label">April 24, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abdera-launch-funding-radiopharmaceutical-cancer/648161/" class="analytics t-editors-bio-article">Startup Abdera raises $110M to fuel radiopharmaceutical research</a></h3> <span class="secondary-label">April 20, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/carvykti-multiple-myeloma-abstract-leaked-johnson-johnson-legend/648030/" class="analytics t-editors-bio-article">J&J study data show dramatic benefit to multiple myeloma cell therapy</a></h3> <span class="secondary-label">April 19, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-bellus-health-deal-acquire-chronic-cough/647915/" class="analytics t-editors-bio-article">GSK to buy Bellus Health and its chronic cough drug for $2B</a></h3> <span class="secondary-label">April 18, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vagelos-retire-regeneron-chair-board/647817/" class="analytics t-editors-bio-article">Biotech leader Vagelos to retire as Regeneron board chair</a></h3> <span class="secondary-label">April 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-layoffs-job-cuts-industry-consolidation/647164/" class="analytics t-editors-bio-article">Biotech layoffs gather pace as industry downturn persists</a></h3> <span class="secondary-label">April 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clovis-rubraca-sale-pharma-schweiz-bankruptcy/647111/" class="analytics t-editors-bio-article">Navigating bankruptcy, Clovis reaches deal to sell cancer drug Rubraca</a></h3> <span class="secondary-label">April 7, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/makena-fda-withdrawal-order-califf-bumpus/647015/" class="analytics t-editors-bio-article">FDA withdraws preterm birth drug’s approval, denying maker’s request for delay</a></h3> <span class="secondary-label">April 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seagen-padcev-bladder-cancer-fda-approval-keytruda/646768/" class="analytics t-editors-bio-article">Seagen, Astellas win expanded FDA approval for bladder cancer drug</a></h3> <span class="secondary-label">April 4, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sartorius-polyplus-acquisition-gene-therapy-vectors-manufacturing/646545/" class="analytics t-editors-bio-article">Pharma partner Sartorius eyes gene therapy market with $2.6B deal</a></h3> <span class="secondary-label">March 31, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mathai-mammen-fogpharma-ceo-greg-verdine/646334/" class="analytics t-editors-bio-article">Mathai Mammen, former J&J executive, to become FogPharma CEO</a></h3> <span class="secondary-label">March 30, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-sickle-cell-fda-delay-application-bla/646258/" class="analytics t-editors-bio-article">Bluebird, awaiting FDA feedback, says it’s likely to miss filing goal for sickle cell gene therapy</a></h3> <span class="secondary-label">March 29, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-returns-cancer-immunotherapy-rights-to-merck-kgaa/646033/" class="analytics t-editors-bio-article">Pfizer returns cancer immunotherapy rights to Merck KGaA</a></h3> <span class="secondary-label">March 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/brainstorm-fda-als-advisory-committee-meeting-file-protest/645985/" class="analytics t-editors-bio-article">BrainStorm files ALS drug application over FDA protest</a></h3> <span class="secondary-label">March 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ptc-peltz-ceo-retire-matthew-klein-successor/645938/" class="analytics t-editors-bio-article">Stuart Peltz, founder of PTC, retires after 25 years as CEO</a></h3> <span class="secondary-label">March 24, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clay-siegall-morphimmune-ceo-seagen/645807/" class="analytics t-editors-bio-article">Former Seagen CEO Siegall returns to biotech as head of early-stage startup</a></h3> <span class="secondary-label">March 23, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-tyk2-licensing-deal-brain-neuroscience/645673/" class="analytics t-editors-bio-article">Biohaven strikes a deal to take TYK2 drugs in a new direction</a></h3> <span class="secondary-label">March 22, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-tofersen-fda-confirmatory-trial-advisory-committee/645513/" class="analytics t-editors-bio-article">FDA staff signal support for Biogen ALS drug, but highlight data hurdles</a></h3> <span class="secondary-label">March 20, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-fda-advisory-committee-duchenne-reversal/645289/" class="analytics t-editors-bio-article">FDA reversal sets up high-stakes hearing on Sarepta gene therapy</a></h3> <span class="secondary-label">March 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-seagen-acquisition-cancer-drug-adc-deal/627976/" class="analytics t-editors-bio-article">Pfizer to buy Seagen in $43B cancer drug deal</a></h3> <span class="secondary-label">March 13, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cargo-cd22-car-t-raise-funding-series-a/643848/" class="analytics t-editors-bio-article">Cancer drug startup Cargo raises $200M to solve CAR-T relapse</a></h3> <span class="secondary-label">March 1, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theravance-layoffs-ampreloxetine-jak-discontinue/643726/" class="analytics t-editors-bio-article">Theravance, under pressure from activist investor, cuts back research, trims staff</a></h3> <span class="secondary-label">Feb. 28, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/billy-dunn-fda-depart-agency-neuroscience-alzheimers/643627/" class="analytics t-editors-bio-article">Billy Dunn, FDA official in charge of neuroscience drug reviews, to leave agency</a></h3> <span class="secondary-label">Feb. 27, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eqrx-biotech-layoffs-jobs-restructuring/643507/" class="analytics t-editors-bio-article">EQRx, having redrawn strategy, to trim workforce by 18%</a></h3> <span class="secondary-label">Feb. 24, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intellia-graphite-sangamo-sickle-cell-gene-therapy-discontinue/643400/" class="analytics t-editors-bio-article">Sickle cell pipeline narrows as gene therapy developers rethink research plans</a></h3> <span class="secondary-label">Feb. 23, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-medicaid-payment-model-outcomes/643102/" class="analytics t-editors-bio-article">Medicaid, with planned payment pilot, girds for influx of pricey gene therapies</a></h3> <span class="secondary-label">Feb. 21, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-christi-shaw-depart-exit-kite-cell-therapy/643042/" class="analytics t-editors-bio-article">Gilead’s Shaw to step down from role running cell therapy unit</a></h3> <span class="secondary-label">Feb. 17, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/puretech-orasome-research-deprioritization-jobs-bolen/642752/" class="analytics t-editors-bio-article">PureTech, tweaking research, trims a ‘small number’ of positions</a></h3> <span class="secondary-label">Feb. 14, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-earnings-cancer-drug-sales-fourth-quarter/642402/" class="analytics t-editors-bio-article">AstraZeneca sees run of growth continuing in 2023</a></h3> <span class="secondary-label">Feb. 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-bill-anderson-ceo-appoint-roche/642318/" class="analytics t-editors-bio-article">Bayer names former Roche executive Bill Anderson as new CEO</a></h3> <span class="secondary-label">Feb. 8, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/idorsia-react-study-failure-clazosentan/642056/" class="analytics t-editors-bio-article">Idorsia shares sink on ‘unexpected’ failure of drug study</a></h3> <span class="secondary-label">Feb. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-fda-approval-trodelvy-hr-breast-cancer/641968/" class="analytics t-editors-bio-article">FDA approves Gilead’s Trodelvy for expanded use in breast cancer</a></h3> <span class="secondary-label">Feb. 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-promotes-teresa-graham-pharma-head-earnings/641853/" class="analytics t-editors-bio-article">Roche promotes from within to replace pharma head</a></h3> <span class="secondary-label">Feb. 2, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-daprodustat-fda-approval-kidney-anemia-limitations/641843/" class="analytics t-editors-bio-article">GSK secures FDA approval of anemia drug, but with limitations</a></h3> <span class="secondary-label">Feb. 2, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-lilly-menarini-cancer-drug-approval-btk-serd/641496/" class="analytics t-editors-bio-article">FDA approves cancer drugs from Lilly, Menarini</a></h3> <span class="secondary-label">Jan. 30, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-covid-vaccine-bivalent-variant-advisers-vote/641360/" class="analytics t-editors-bio-article">FDA advisers back agency plan to simplify COVID-19 vaccination</a></h3> <span class="secondary-label">Jan. 26, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-breyanzi-cll-leukemia-car-t-study/641291/" class="analytics t-editors-bio-article">Bristol Myers says CAR-T therapy curbed leukemia in long-running study</a></h3> <span class="secondary-label">Jan. 26, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-prostate-biliary-trial-success-setback/641189/" class="analytics t-editors-bio-article">Merck reports one success, one setback from late-stage Keytruda trials</a></h3> <span class="secondary-label">Jan. 25, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/finch-layoffs-microbiome-drug-study-discontinue/641038/" class="analytics t-editors-bio-article">Finch to lay off 95% of staff, scrap microbiome drug study</a></h3> <span class="secondary-label">Jan. 24, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-covid-vaccine-shift-strategy-annual-strain-match/640954/" class="analytics t-editors-bio-article">FDA weighs shift in COVID vaccination strategy</a></h3> <span class="secondary-label">Jan. 23, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-reject-lilly-donanemab-alzheimers-drug-accelerated-approval/640819/" class="analytics t-editors-bio-article">FDA rejects Lilly Alzheimer’s drug, citing insufficient data</a></h3> <span class="secondary-label">Jan. 20, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-shoreline-sell-deal-nk-cell-therapy/640748/" class="analytics t-editors-bio-article">Editas, in next restructuring step, to sell cell therapy work to Shoreline</a></h3> <span class="secondary-label">Jan. 19, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-hiv-vaccine-stop-study-ineffective-mosaico/640612/" class="analytics t-editors-bio-article">Large study of J&J’s HIV vaccine stopped after shot found ineffective</a></h3> <span class="secondary-label">Jan. 18, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-editing-trends-outlook-2023/640234/" class="analytics t-editors-bio-article">5 questions facing gene therapy in 2023</a></h3> <span class="secondary-label">Jan. 12, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-2023-califf-fda-startups-funding-cliff-editas/640107/" class="analytics t-editors-bio-article">JPM23: Califf on accelerated approvals, biotech startups’ looming cliff and an explanation from Editas</a></h3> <span class="secondary-label">Jan. 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-viehbacher-jp-morgan-culture-costs-/640013/" class="analytics t-editors-bio-article">New Biogen CEO seeks to ‘redefine’ company after challenging year</a></h3> <span class="secondary-label">Jan. 10, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-restructuring-layoffs-edit-301-sickle-cell/639912/" class="analytics t-editors-bio-article">Editas to cut jobs, narrow research focus in restructuring</a></h3> <span class="secondary-label">Jan. 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-astrazeneca-ipsen-chiesi-biotech-buyouts-deal/639906/" class="analytics t-editors-bio-article">Trio of biotech buyouts jumpstarts J.P. Morgan healthcare meeting</a></h3> <span class="secondary-label">Jan. 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-first-quarter-2023/639507/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the first quarter</a></h3> <span class="secondary-label">Jan. 9, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eisai-biogen-leqembi-alzheimers-price-cost/639878/" class="analytics t-editors-bio-article">Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy</a></h3> <span class="secondary-label">Jan. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-prv-voucher-sale-gene-therapy/639803/" class="analytics t-editors-bio-article">Bluebird bolsters balance sheet with sale of second regulatory fast pass</a></h3> <span class="secondary-label">Jan. 6, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approval-lunsumio-sunlenca-briumvi-2022-total/639487/" class="analytics t-editors-bio-article">FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022</a></h3> <span class="secondary-label">Jan. 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/emerging-biotech-interviews-keiper-booth-jonas-zhang-truex/639225/" class="analytics t-editors-bio-article">Disappearing IPOs, building startups and closing deals: Views from an up-and-down year in biotech</a></h3> <span class="secondary-label">Jan. 3, 2023</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-kelun-adc-antibody-drug-conjugate-cancer/639402/" class="analytics t-editors-bio-article">Merck builds out cancer drug pipeline with Kelun-Biotech deal</a></h3> <span class="secondary-label">Dec. 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tigit-gilead-arcus-lung-cancer-domvanalimab/639177/" class="analytics t-editors-bio-article">Doubts around cancer drug target persist after Gilead, Arcus study results offer ‘mixed picture’</a></h3> <span class="secondary-label">Dec. 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-sickle-cell-fda-lift-hold-gene-therapy/639064/" class="analytics t-editors-bio-article">FDA lifts hold on Bluebird’s sickle cell gene therapy</a></h3> <span class="secondary-label">Dec. 19, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/third-harmonic-discontinue-drug-liver-toxicity-urticaria/638833/" class="analytics t-editors-bio-article">Third Harmonic halts study of lead drug over safety risk</a></h3> <span class="secondary-label">Dec. 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kymera-sanofi-phase-2-advance-protein-degradation/638743/" class="analytics t-editors-bio-article">Kymera shares jump on Sanofi’s decision to advance protein-degrading drug</a></h3> <span class="secondary-label">Dec. 14, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mirati-krazati-fda-approval-kras-cancer-amgen/638594/" class="analytics t-editors-bio-article">Mirati’s KRAS-blocking cancer drug approved by FDA</a></h3> <span class="secondary-label">Dec. 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2022-talquetamab-myeloma-efgartigimod-argenx-bluebird/638534/" class="analytics t-editors-bio-article">J&J’s next myeloma drug, Argenx’s second act and a new question for Bluebird: 3 ASH takeaways</a></h3> <span class="secondary-label">Dec. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-zynteglo-launch-gene-therapy-insurance-coverage/638484/" class="analytics t-editors-bio-article">Gene therapy approval won, Bluebird takes on next challenge: selling it</a></h3> <span class="secondary-label">Dec. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-horizon-acquire-biotech-drug-deal/638485/" class="analytics t-editors-bio-article">Amgen to buy Horizon in year’s biggest biotech deal</a></h3> <span class="secondary-label">Dec. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/esperion-cardiovascular-outcomes-study-nexletol-cholesterol/638176/" class="analytics t-editors-bio-article">Esperion, without data, says cholesterol pill lowered heart risk in study</a></h3> <span class="secondary-label">Dec. 7, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-approvals-bring-validation-as-field-closes-year-on-high/628575/" class="analytics t-editors-bio-article">Gene therapy approvals bring validation as field closes year on high</a></h3> <span class="secondary-label">Dec. 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-pluvicto-prostate-cancer-radiopharmaceutical/637961/" class="analytics t-editors-bio-article">Novartis prostate cancer drug succeeds in study key to company’s sales hopes</a></h3> <span class="secondary-label">Dec. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sqz-layoffs-ceo-step-down-restructuring/637755/" class="analytics t-editors-bio-article">SQZ CEO steps down as company restructures, cuts jobs</a></h3> <span class="secondary-label">Dec. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-donanemab-amyloid-clearance-aduhelm-ctad/637721/" class="analytics t-editors-bio-article">Lilly’s Alzheimer’s drug bests Aduhelm in plaque clearance study</a></h3> <span class="secondary-label">Dec. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/horizon-acquisition-talks-amgen-janssen-sanofi/637582/" class="analytics t-editors-bio-article">Large pharmas probe takeover of Horizon Therapeutics</a></h3> <span class="secondary-label">Nov. 30, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lecanemab-alzheimers-eisai-biogen-full-study-results-ctad/637568/" class="analytics t-editors-bio-article">What to make of Eisai and Biogen’s Alzheimer’s drug results</a></h3> <span class="secondary-label">Nov. 29, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/emerging-biotech-biopharma-dive-state-of-play/637380/" class="analytics t-editors-bio-article">State of Play: A closer look at hotspots of emerging biotech research</a></h3> <span class="secondary-label">Nov. 29, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hemophilia-gene-therapy-fda-approval-hemgenix-csl-uniqure/636999/" class="analytics t-editors-bio-article">FDA approves first gene therapy for hemophilia B</a></h3> <span class="secondary-label">Nov. 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-blenrep-withdrawal-fda-confirmatory-multiple-myeloma/637154/" class="analytics t-editors-bio-article">GSK to pull blood cancer drug from US market after study failure</a></h3> <span class="secondary-label">Nov. 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-kgaa-double-drug-research-productivity/637066/" class="analytics t-editors-bio-article">Merck KGaA outlines plan to rev up drug R&D</a></h3> <span class="secondary-label">Nov. 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-pause-study-partner-lca-crisp-gene-editing/636814/" class="analytics t-editors-bio-article">Editas to seek partner for CRISPR medicine after lackluster study results</a></h3> <span class="secondary-label">Nov. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-ceo-name-viehbacher-succeed-vounatsos/636223/" class="analytics t-editors-bio-article">Biogen names former Sanofi head Viehbacher to replace Vounatsos as CEO</a></h3> <span class="secondary-label">Nov. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/arrowhead-royalty-pharma-olpasiran-lpa-rights/636118/" class="analytics t-editors-bio-article">Arrowhead capitalizes on Amgen drug progress with royalty rights deal</a></h3> <span class="secondary-label">Nov. 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-roctavian-fda-review-three-year-data/636036/" class="analytics t-editors-bio-article">BioMarin signals lengthier FDA review for hemophilia gene therapy</a></h3> <span class="secondary-label">Nov. 8, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-blenrep-myleoma-confirmatory-study-negative-failure/635918/" class="analytics t-editors-bio-article">GSK myeloma drug comes up short in confirmatory test</a></h3> <span class="secondary-label">Nov. 7, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-olpasiran-lipoprotein-a-heart-phase-3/635875/" class="analytics t-editors-bio-article">Amgen to test new way to lower heart risk with large drug trial</a></h3> <span class="secondary-label">Nov. 7, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2022-bispecific-gene-therapy-preview/635829/" class="analytics t-editors-bio-article">Bispecific cancer drugs and gene therapy advances: What to watch at this year’s ASH meeting</a></h3> <span class="secondary-label">Nov. 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lusaris-launch-ra-capital-5-meo-dmt-depression/635569/" class="analytics t-editors-bio-article">RA Capital backs another startup hunting for a better antidepressant</a></h3> <span class="secondary-label">Nov. 2, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-mounjaro-diabetes-obesity-quarter-sales/635427/" class="analytics t-editors-bio-article">Lilly sales of new diabetes drug accelerate on rising patient demand</a></h3> <span class="secondary-label">Nov. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-frazier-board-davis-third-quarter-earnings-keytruda/635094/" class="analytics t-editors-bio-article">Merck reveals chairman succession as earnings beat forecasts</a></h3> <span class="secondary-label">Oct. 27, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-sales-slow-newborn-screening/634896/" class="analytics t-editors-bio-article">Novartis sales of Zolgensma gene therapy slow as market shifts</a></h3> <span class="secondary-label">Oct. 25, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-iptacopan-pnh-alexion-complement/634793/" class="analytics t-editors-bio-article">Novartis rival to AstraZeneca rare disease drugs succeeds in study</a></h3> <span class="secondary-label">Oct. 24, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-covid-vaccine-higher-price-commercial-market/634687/" class="analytics t-editors-bio-article">Pfizer planning steep price hike for COVID-19 vaccine</a></h3> <span class="secondary-label">Oct. 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-refuge-cell-therapy-partner-synbio/634604/" class="analytics t-editors-bio-article">Gilead, working to improve cancer cell therapy, partners with California startup</a></h3> <span class="secondary-label">Oct. 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-djs-antibodies-fibrosis-ipf-acquisition/634580/" class="analytics t-editors-bio-article">AbbVie to buy UK biotech DJS for $255M</a></h3> <span class="secondary-label">Oct. 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/makena-fda-advisory-committee-meeting-withdrawal-preterm-birth/634225/" class="analytics t-editors-bio-article">FDA opens case to withdraw controversial drug for preterm births</a></h3> <span class="secondary-label">Oct. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-questions-facing-drugmakers-as-third-quarter-earnings-begin/634184/" class="analytics t-editors-bio-article">5 questions facing drugmakers as third quarter earnings begin</a></h3> <span class="secondary-label">Oct. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/marks-fda-gene-therapy-commercial-viability-ultra-rare/634041/" class="analytics t-editors-bio-article">‘We have to find a way’: FDA seeks solutions to aid bespoke gene therapy</a></h3> <span class="secondary-label">Oct. 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/odyssey-gary-glick-series-b-precision-medicine/634009/" class="analytics t-editors-bio-article">Odyssey recruits new investors to fund precision drug research</a></h3> <span class="secondary-label">Oct. 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-authorize-omicron-booster-children-pfizer-moderna/633921/" class="analytics t-editors-bio-article">Omicron boosters from Pfizer, Moderna cleared by FDA for younger children</a></h3> <span class="secondary-label">Oct. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-alpha-1-antitrypsin-study-start-vx-634/633827/" class="analytics t-editors-bio-article">Vertex, after setbacks, moves forward with second-generation rare disease drug</a></h3> <span class="secondary-label">Oct. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bio-mcmurry-heath-resign-biotech-lobby-rachel-king/633789/" class="analytics t-editors-bio-article">BIO’s McMurry-Heath steps down as head of biotech lobby</a></h3> <span class="secondary-label">Oct. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cytokinetics-als-courage-study-continue-data-monitoring/633683/" class="analytics t-editors-bio-article">Cytokinetics pushes on with late-stage study of ALS drug</a></h3> <span class="secondary-label">Oct. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-spin-starts-life-pfizer-complete-acquisition/633394/" class="analytics t-editors-bio-article">Biohaven starts life as new company following Pfizer buyout</a></h3> <span class="secondary-label">Oct. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kalvista-hae-drug-discontinue-liver-enzyme/633291/" class="analytics t-editors-bio-article">KalVista stops work on rare disease drug over safety concerns</a></h3> <span class="secondary-label">Oct. 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/marrazzo-chroma-board-director-epigenetics-biotech/633191/" class="analytics t-editors-bio-article">Former Spark CEO Marrazzo joins epigenetics startup’s board</a></h3> <span class="secondary-label">Oct. 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-fourth-quarter-2022/632732/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the fourth quarter</a></h3> <span class="secondary-label">Oct. 3, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-scribe-gene-editing-nk-cell-therapy-cancer/632718/" class="analytics t-editors-bio-article">Sanofi partners with Scribe to gain gene editing tools for cell therapy work</a></h3> <span class="secondary-label">Sept. 27, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-quantum-computing-copenhagen-drug-development/632333/" class="analytics t-editors-bio-article">Foundation behind Novo Nordisk to invest $200M in building quantum research ‘powerhouse’</a></h3> <span class="secondary-label">Sept. 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-islatravir-hiv-lower-dose-phase-3-fda-hold/632233/" class="analytics t-editors-bio-article">Merck to resume testing of closely watched HIV drug, but at lower dose</a></h3> <span class="secondary-label">Sept. 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-gene-therapy-approvals-zynteglo-skysona/632153/" class="analytics t-editors-bio-article">Back-to-back gene therapy approvals give Bluebird shot at survival</a></h3> <span class="secondary-label">Sept. 19, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-skysona-fda-accelerated-approval-cald-gene-therapy/631797/" class="analytics t-editors-bio-article">Bluebird wins FDA approval of gene therapy for rare brain disorder</a></h3> <span class="secondary-label">Sept. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-alnylam-nash-drug-gene-clinical-trial/631938/" class="analytics t-editors-bio-article">Alnylam, Regeneron to advance NASH drug after early signs of potential</a></h3> <span class="secondary-label">Sept. 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-esmo-kras-lumakras-chemo-data-results/631617/" class="analytics t-editors-bio-article">Amgen data supports KRAS cancer drug, but survival benefit remains in question</a></h3> <span class="secondary-label">Sept. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amylyx-fda-als-meeting-dunn-flexibility-withdrawal/631533/" class="analytics t-editors-bio-article">How a top FDA official’s words helped push a closely watched ALS drug toward approval</a></h3> <span class="secondary-label">Sept. 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-esmo-fgfr-cholangiocarcinoma-study-results/631402/" class="analytics t-editors-bio-article">Relay impresses with early study data for targeted cancer drug</a></h3> <span class="secondary-label">Sept. 8, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-fda-lift-clinical-hold-duchenne-5051/631203/" class="analytics t-editors-bio-article">Sarepta to restart Duchenne drug study after FDA lifts hold</a></h3> <span class="secondary-label">Sept. 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-fabry-gene-therapy-phase-1-study-results/631081/" class="analytics t-editors-bio-article">Sangamo presses ahead with Fabry disease gene therapy</a></h3> <span class="secondary-label">Sept. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-lumakras-phase-3-chemotherapy-study-results/630904/" class="analytics t-editors-bio-article">Amgen says KRAS drug beat chemo in lung cancer study</a></h3> <span class="secondary-label">Aug. 31, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sonoma-treg-manufacturing-seattle/630399/" class="analytics t-editors-bio-article">‘Treg’ startup Sonoma expands with plans for manufacturing plant</a></h3> <span class="secondary-label">Aug. 24, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-omicron-booster-fda-application/630185/" class="analytics t-editors-bio-article">Pfizer, BioNTech submit omicron booster for FDA clearance</a></h3> <span class="secondary-label">Aug. 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharvaris-hae-fda-clinical-hold/630162/" class="analytics t-editors-bio-article">Pharvaris studies of rare disease drug put on hold by FDA</a></h3> <span class="secondary-label">Aug. 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-gene-therapy-price-zynteglo-million/629967/" class="analytics t-editors-bio-article">With $2.8M gene therapy, Bluebird sets new bar for US drug pricing</a></h3> <span class="secondary-label">Aug. 18, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-fda-approval-beti-cel-beta-thalassemia-zynteglo/629914/" class="analytics t-editors-bio-article">Bluebird gene therapy approved by FDA for rare blood disease</a></h3> <span class="secondary-label">Aug. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-cfo-appoint-james-mock/629873/" class="analytics t-editors-bio-article">Moderna, after firing newly hired CFO, finds replacement in PerkinElmer executive</a></h3> <span class="secondary-label">Aug. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-canakinumab-lung-cancer-phase-3-study-failure/629636/" class="analytics t-editors-bio-article">Novartis bid to repurpose rare disease drug for cancer falls short in third trial</a></h3> <span class="secondary-label">Aug. 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wyden-amgen-tax-investigation-enbrel-puerto-rico/629580/" class="analytics t-editors-bio-article">Amgen’s low tax rates draw attention of top Democratic senator</a></h3> <span class="secondary-label">Aug. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-patient-death-liver-injury/629542/" class="analytics t-editors-bio-article">Novartis reports deaths of two patients treated with Zolgensma gene therapy</a></h3> <span class="secondary-label">Aug. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/zantac-litigation-gsk-pfizer-sanofi-haleon-shares-fall/629435/" class="analytics t-editors-bio-article">GSK, Pfizer, Sanofi shares drop amid Zantac litigation concerns</a></h3> <span class="secondary-label">Aug. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-abecma-multiple-myeloma-earlier-use-study/629333/" class="analytics t-editors-bio-article">Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma</a></h3> <span class="secondary-label">Aug. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-mathai-mammen-depart-exit/629189/" class="analytics t-editors-bio-article">J&J’s head of R&D departs as pharma’s leadership turns over</a></h3> <span class="secondary-label">Aug. 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samantha-truex-upstream-biotech-startup-venture-funding/629106/" class="analytics t-editors-bio-article">Samantha Truex on biotech hiring, competing for funding and Upstream’s next steps</a></h3> <span class="secondary-label">Aug. 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-lumakras-combo-pd1-toxicity-liver-mirati/629078/" class="analytics t-editors-bio-article">Amgen data on KRAS cancer drug disappoints, opening door for rival Mirati</a></h3> <span class="secondary-label">Aug. 8, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-global-blood-acquisition-sickle-cell-disease/629041/" class="analytics t-editors-bio-article">Pfizer buys sickle cell drugmaker Global Blood for $5.4B</a></h3> <span class="secondary-label">Aug. 8, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/enhertu-her2-low-breast-cancer-fda-approval-astrazeneca/629003/" class="analytics t-editors-bio-article">FDA approves AstraZeneca, Daiichi drug in breast cancer first</a></h3> <span class="secondary-label">Aug. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acadia-fda-reject-pimavanserin-nuplazid-alzheimers/628982/" class="analytics t-editors-bio-article">Acadia turned back by FDA on second attempt to get psychosis drug approved</a></h3> <span class="secondary-label">Aug. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-donanemab-fda-priority-review-alzheimers/628954/" class="analytics t-editors-bio-article">Lilly takes long view on Alzheimer’s drug as FDA starts expedited review</a></h3> <span class="secondary-label">Aug. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/idrx-borisy-biotech-startup-cancer-combination/628636/" class="analytics t-editors-bio-article">IDRx, a new biotech startup, raises $122M to develop better cancer drug combinations</a></h3> <span class="secondary-label">Aug. 2, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/becraft-strand-biotech-founder-led-venture-capital/628608/" class="analytics t-editors-bio-article">Strand CEO on founder-led biotech, venture capital and the market’s retreat</a></h3> <span class="secondary-label">Aug. 2, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/concert-hair-loss-study-results-alopecia-fda-application/628497/" class="analytics t-editors-bio-article">Concert to seek approval for hair loss drug after second study success</a></h3> <span class="secondary-label">Aug. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-abbvie-imbruvica-calquence-cll-market-sales/628442/" class="analytics t-editors-bio-article">AbbVie cancer drug sales fall as AstraZeneca competitor gains ground</a></h3> <span class="secondary-label">July 29, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-reveals-longer-wait-for-anticipated-drug-trial-results/628340/" class="analytics t-editors-bio-article">Alnylam reveals longer wait for anticipated drug trial results</a></h3> <span class="secondary-label">July 28, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-sickle-cell-trial-fda-lift-hold/628300/" class="analytics t-editors-bio-article">Editas treats first patient in sickle cell trial as FDA lifts partial hold</a></h3> <span class="secondary-label">July 28, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-car-t-sales-abecma-breyanzi/628226/" class="analytics t-editors-bio-article">Bristol Myers CAR-T sales rise despite production problems</a></h3> <span class="secondary-label">July 27, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abcellera-versant-antibody-partnership-startup/628196/" class="analytics t-editors-bio-article">Versant partners with AbCellera to arm startups with better antibodies</a></h3> <span class="secondary-label">July 27, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridgebio-achondroplasia-study-results-infigratinib/628120/" class="analytics t-editors-bio-article">BridgeBio advances drug for dwarfism after study data</a></h3> <span class="secondary-label">July 26, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seagen-astellas-padcev-bladder-cancer-results-merck/628090/" class="analytics t-editors-bio-article">Seagen, Astellas claim positive results in study key to cancer drug's success</a></h3> <span class="secondary-label">July 26, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/rona-sanofi-rna-licensing-drug-technology/628005/" class="analytics t-editors-bio-article">China-based biotech licenses Sanofi's RNA drug technology</a></h3> <span class="secondary-label">July 25, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-daiichi-enhertu-fda-priority-review-her2-low/627985/" class="analytics t-editors-bio-article">AstraZeneca, Daiichi breast cancer drug set for speedy FDA review</a></h3> <span class="secondary-label">July 25, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-biotech-center-san-francisco-cell-gene-therapy/627912/" class="analytics t-editors-bio-article">Astellas to bring research units under one roof in new West Coast center</a></h3> <span class="secondary-label">July 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/freeline-hemophilia-gene-therapy-nejm/627806/" class="analytics t-editors-bio-article">Freeline gives detailed look at hemophilia gene therapy results</a></h3> <span class="secondary-label">July 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-sandoz-forecast-review/627580/" class="analytics t-editors-bio-article">Novartis forecasts improving generic drug business as it weighs unit's future</a></h3> <span class="secondary-label">July 19, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ultragenyx-gene-tx-option-acquisition-angelman-therapy/627546/" class="analytics t-editors-bio-article">Ultragenyx buys gene therapy partner after new study results</a></h3> <span class="secondary-label">July 19, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-second-quarter-2022-merck-gsk-biogen-lilly-bristol/627488/" class="analytics t-editors-bio-article">Drug deals, launches in focus as pharma earnings begin</a></h3> <span class="secondary-label">July 18, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/marinus-novo-priority-review-voucher-sale/627377/" class="analytics t-editors-bio-article">Novo strikes $110M deal for regulatory fast pass</a></h3> <span class="secondary-label">July 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-beigene-tislelizumb-fda-delay-decision-inspection/627252/" class="analytics t-editors-bio-article">Novartis, BeiGene cancer drug faces delay as FDA puts off approval decision</a></h3> <span class="secondary-label">July 14, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/atara-multiple-sclerosis-interim-trial-results-shares/627159/" class="analytics t-editors-bio-article">Atara shares sink after update on multiple sclerosis trial</a></h3> <span class="secondary-label">July 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-base-editing-first-human-dosing-trial/627042/" class="analytics t-editors-bio-article">Verve starts first human test of gene editing treatment for heart disease</a></h3> <span class="secondary-label">July 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-10-clinical-trials-watch-2022-second-half/625359/" class="analytics t-editors-bio-article">10 clinical trials to watch in the second half of 2022</a></h3> <span class="secondary-label">July 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-third-quarter-2022/625983/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the third quarter</a></h3> <span class="secondary-label">June 29, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-meiragtx-xlrp-gene-therapy-study-results/626205/" class="analytics t-editors-bio-article">J&J-backed gene therapy for the eye clears early study test</a></h3> <span class="secondary-label">June 28, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-drug-pipeline-breast-cancer-fgfr-fda/626111/" class="analytics t-editors-bio-article">Relay details new research plans in quest to design better cancer drugs</a></h3> <span class="secondary-label">June 27, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-breyanzi-second-line-fda-approval/626011/" class="analytics t-editors-bio-article">Bristol Myers CAR-T therapy cleared by FDA for earlier lymphoma use</a></h3> <span class="secondary-label">June 23, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-precision-gene-editing-sickle-cell/625857/" class="analytics t-editors-bio-article">Novartis hunting for sickle cell cure with Precision deal</a></h3> <span class="secondary-label">June 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ptc-translarna-duchenne-confirmatory-study-europe/625783/" class="analytics t-editors-bio-article">Mixed results for PTC Duchenne drug put spotlight on EU approval</a></h3> <span class="secondary-label">June 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-covid-vaccine-children-under-5-authorization/625704/" class="analytics t-editors-bio-article">FDA authorizes Pfizer, Moderna COVID-19 vaccines for young children</a></h3> <span class="secondary-label">June 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-study-results-show-paxlovid-benefit-less-clear-in-lower-risk-patient/625549/" class="analytics t-editors-bio-article">Pfizer study results show Paxlovid benefit less clear in lower-risk patients</a></h3> <span class="secondary-label">June 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amylyx-icer-als-drug-price-cost-effective/625443/" class="analytics t-editors-bio-article">Watchdog group cautious on Amylyx’s ALS drug benefits, potential cost</a></h3> <span class="secondary-label">June 14, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-pfizer-moderna-covid-vaccine-young-children-meeting/625349/" class="analytics t-editors-bio-article">FDA staff supportive of Pfizer, Moderna COVID vaccines in young children</a></h3> <span class="secondary-label">June 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-fda-meeting-gene-therapy-beta-thalassemia/625298/" class="analytics t-editors-bio-article">FDA advisers offer unanimous support to second Bluebird gene therapy</a></h3> <span class="secondary-label">June 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-fda-meeting-gene-therapy-eli-cel/625226/" class="analytics t-editors-bio-article">FDA panel backs Bluebird gene therapy despite safety risks</a></h3> <span class="secondary-label">June 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-fda-review-gene-therapy-rare-disease/625171/" class="analytics t-editors-bio-article">Bluebird's future in balance as FDA weighs gene therapy approvals</a></h3> <span class="secondary-label">June 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-2022-gilead-bispecific-antibody-gamma-delta-cell-therapy/624948/" class="analytics t-editors-bio-article">ASCO 2022: Gilead's tough weekend, bispecific progress and 'gamma delta' cell therapy</a></h3> <span class="secondary-label">June 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amylyx-fda-review-delay-three-months/624872/" class="analytics t-editors-bio-article">FDA extends review of Amylyx ALS drug, delaying approval decision</a></h3> <span class="secondary-label">June 3, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tessera-michael-severino-flagship-abbvie-gene-writing/624656/" class="analytics t-editors-bio-article">Former AbbVie executive Severino joins Flagship-backed startup as CEO</a></h3> <span class="secondary-label">June 2, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/upstream-bio-sam-truex-series-a-launch/624742/" class="analytics t-editors-bio-article">Upstream Bio, a richly funded startup, reveals its lead drug and research plans</a></h3> <span class="secondary-label">June 2, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-biogen-zuranolone-postpartum-depression-skylark/624697/" class="analytics t-editors-bio-article">Sage, Biogen drug meets goal in postpartum depression study</a></h3> <span class="secondary-label">June 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-fda-resubmission-delay-hemophilia-gene-therapy/624606/" class="analytics t-editors-bio-article">BioMarin delays planned FDA filing for hemophilia gene therapy</a></h3> <span class="secondary-label">May 31, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mirati-asco-kras-adagrasib-lung-cancer-updated-results/624429/" class="analytics t-editors-bio-article">Mirati matches Amgen with updated data for KRAS-blocking cancer drug</a></h3> <span class="secondary-label">May 26, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-2022-cancer-meeting-preview-gilead-astrazeneca-roche/624477/" class="analytics t-editors-bio-article">3 cancer drug studies to watch at next month's ASCO meeting</a></h3> <span class="secondary-label">May 26, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/katrine-bosley-advent-venture-capital-editas/624449/" class="analytics t-editors-bio-article">Former Editas CEO Bosley joins UK venture capital firm</a></h3> <span class="secondary-label">May 26, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/csl-behring-gene-therapy-fda-hemophilia-uniqure/624360/" class="analytics t-editors-bio-article">FDA starts clock on review of CSL, UniQure gene therapy</a></h3> <span class="secondary-label">May 25, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/springworks-desmoid-tumors-nirogacestat-trial-fda/624286/" class="analytics t-editors-bio-article">Springworks shares fall despite drug trial's success</a></h3> <span class="secondary-label">May 24, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-eli-lilly-ulcerative-colitis-etrasimod-mirikizumab/624268/" class="analytics t-editors-bio-article">Pfizer, Lilly bolster cases for experimental ulcerative colitis drugs</a></h3> <span class="secondary-label">May 24, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/concert-pharma-alopecia-areata-clinical-trial-phase-3/624172/" class="analytics t-editors-bio-article">Concert drug helps regrow hair in study, boosting shares</a></h3> <span class="secondary-label">May 23, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/atara-bayer-car-t-cell-end-collaboration/624133/" class="analytics t-editors-bio-article">Bayer backs out of Atara cell therapy deal</a></h3> <span class="secondary-label">May 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ultragenyx-abeona-sanfilippo-gene-therapy-licensing/623899/" class="analytics t-editors-bio-article">Ultragenyx strikes deal with struggling Abeona for rare disease gene therapy</a></h3> <span class="secondary-label">May 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-bladder-cancer-first-line-results/623804/" class="analytics t-editors-bio-article">Bristol Myers' Opdivo comes up short in bladder cancer trial</a></h3> <span class="secondary-label">May 16, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridgebio-priority-review-prv-sale-fda/623719/" class="analytics t-editors-bio-article">BridgeBio sale of FDA voucher good news for Bluebird, other biotech sellers</a></h3> <span class="secondary-label">May 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bridge-bio-bristol-myers-shp2-licensing/623646/" class="analytics t-editors-bio-article">Bristol Myers acquires BridgeBio drug aimed at emerging cancer target</a></h3> <span class="secondary-label">May 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/adc-therapeutics-ceo-ameet-mallik/623408/" class="analytics t-editors-bio-article">Former Novartis exec joins ADC Therapeutics as CEO after brief stint as Rafael head</a></h3> <span class="secondary-label">May 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-bavarian-nordic-discontinue-hep-b-hpv/623390/" class="analytics t-editors-bio-article">J&J ends hepatitis B, HPV vaccine work with Bavarian Nordic</a></h3> <span class="secondary-label">May 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-radiopharmaceutical-production-stop-lutathera-pluvicto/623311/" class="analytics t-editors-bio-article">Novartis suspends production of two radiopharmaceutical drugs over quality concerns</a></h3> <span class="secondary-label">May 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intercept-ocaliva-license-deal-advanz-pbc/623248/" class="analytics t-editors-bio-article">Intercept sells international rights to liver drug in $400M deal</a></h3> <span class="secondary-label">May 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-covid-vaccine-sales-pfizer-forecast/623180/" class="analytics t-editors-bio-article">Moderna vaccine sales surpass expectations as company looks to fall boosters</a></h3> <span class="secondary-label">May 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-diabetes-clinical-hold-cell-therapy/623010/" class="analytics t-editors-bio-article">Vertex surprised by FDA halt of diabetes cell therapy study</a></h3> <span class="secondary-label">May 2, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-aduhelm-europe-withdraw-alzheimers-drug/622538/" class="analytics t-editors-bio-article">Biogen pulls European application for Aduhelm in another setback for the Alzheimer's drug</a></h3> <span class="secondary-label">April 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-price-hike-slow-inflation-iqvia/622465/" class="analytics t-editors-bio-article">Drug price hikes moderate as rebates rise, report finds</a></h3> <span class="secondary-label">April 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-bioarctic-parkinsons-alpha-synuclein-terminate/622358/" class="analytics t-editors-bio-article">AbbVie ends research alliance on BioArctic Parkinson's drug</a></h3> <span class="secondary-label">April 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/satellite-bio-launch-bhatia-lennon-tissue-bioengineered/622246/" class="analytics t-editors-bio-article">Satellite Bio launches with new approach to bioengineering tissues</a></h3> <span class="secondary-label">April 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-kite-car-t-manufacturing-maryland/622295/" class="analytics t-editors-bio-article">Gilead gets cell therapy boost with FDA clearance of Maryland factory</a></h3> <span class="secondary-label">April 19, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-acquires-sierra-oncology-myelofibrosis-drug/622033/" class="analytics t-editors-bio-article">GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history</a></h3> <span class="secondary-label">April 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cimeio-versant-stem-cell-transplant-shielding-immunotherapy/622003/" class="analytics t-editors-bio-article">Versant-backed startup launches with plans to broaden cell therapy's reach</a></h3> <span class="secondary-label">April 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-2022-takeaways-immunotherapy-tigit-car-t/621880/" class="analytics t-editors-bio-article">AACR 2022: NK cell promise, more TIGIT questions and extending CAR-T's reach</a></h3> <span class="secondary-label">April 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisers-covid-vaccine-update-booster-fall/621692/" class="analytics t-editors-bio-article">FDA advisers grapple with how to update COVID-19 vaccines</a></h3> <span class="secondary-label">April 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-alpelisib-fda-approval-pros-real-world/621669/" class="analytics t-editors-bio-article">Novartis breast cancer drug approved for ultra-rare condition</a></h3> <span class="secondary-label">April 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-cardiovascular-heart-drug-sales-forecast/621576/" class="analytics t-editors-bio-article">Merck counting on heart drugs to boost business next decade</a></h3> <span class="secondary-label">April 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-car-t-second-line-lymphoma-fda-approval/621494/" class="analytics t-editors-bio-article">CAR-T treatment moves earlier as FDA widens approval of Gilead's Yescarta</a></h3> <span class="secondary-label">April 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-euroapi-cdmo-spinout-list-shares-market/621437/" class="analytics t-editors-bio-article">Sanofi API spinout takes step toward market listing</a></h3> <span class="secondary-label">April 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-second-quarter-2022/621342/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the second quarter</a></h3> <span class="secondary-label">March 31, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-acute-pain-phase-2-trial-results/621327/" class="analytics t-editors-bio-article">Vertex gets positive trial results for non-opioid painkiller in boost to pipeline</a></h3> <span class="secondary-label">March 31, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/orchard-layoffs-restructuring-gene-therapy/621261/" class="analytics t-editors-bio-article">Orchard turns to layoffs in cutting gene therapy research</a></h3> <span class="secondary-label">March 30, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-moderna-second-covid-booster-fda-older-adults/621187/" class="analytics t-editors-bio-article">FDA clears second COVID booster for older adults, immunocompromised</a></h3> <span class="secondary-label">March 29, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-arena-etrasimod-ulcerative-colitis-second-study/621169/" class="analytics t-editors-bio-article">Pfizer inflammatory disease drug hits goal in second study</a></h3> <span class="secondary-label">March 29, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-biotech-restructuring-jobs-pipeline/620980/" class="analytics t-editors-bio-article">As biotech retreats, gene therapy companies retrench and redraw plans</a></h3> <span class="secondary-label">March 24, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/veretx-apol1-kidney-pivotal-clinical-trial/620785/" class="analytics t-editors-bio-article">Vertex plans path to FDA for top drug prospect</a></h3> <span class="secondary-label">March 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-lag-3-approval-bristol-myers-opdualag-immunotherapy/620702/" class="analytics t-editors-bio-article">Bristol Myers melanoma drug approved by FDA in immunotherapy advance</a></h3> <span class="secondary-label">March 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-suit-moderna-pfizer-lnp-covid-vaccine/620565/" class="analytics t-editors-bio-article">Alnylam sues Pfizer, Moderna over technology used in COVID vaccines</a></h3> <span class="secondary-label">March 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-gene-editing-guidance-gene-therapy/620484/" class="analytics t-editors-bio-article">FDA sets out advice to developers of gene editing medicines</a></h3> <span class="secondary-label">March 16, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/passage-bio-layoffs-restructure-cuts/620402/" class="analytics t-editors-bio-article">Passage Bio to cut jobs in latest biotech restructuring</a></h3> <span class="secondary-label">March 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-nektar-immunotherapy-trial-failure/620322/" class="analytics t-editors-bio-article">Nektar, Bristol Myers drug combination fails in late-stage melanoma trial</a></h3> <span class="secondary-label">March 14, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-carisma-contract-manufacturing-cell-therapy/620180/" class="analytics t-editors-bio-article">Novartis turns cell therapy skill into contract manufacturing deal</a></h3> <span class="secondary-label">March 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-alvotech-humira-biosimilar-settlement-launch/620100/" class="analytics t-editors-bio-article">AbbVie holds off another Humira challenger with Alvotech deal</a></h3> <span class="secondary-label">March 9, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-wegovy-obesity-sales-demand-outlook/619834/" class="analytics t-editors-bio-article">Novo sees fast growth ahead of obesity drugs despite production hurdles</a></h3> <span class="secondary-label">March 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/atlas-venture-raise-fund-biotech-startups/619765/" class="analytics t-editors-bio-article">Amid biotech downturn, Atlas raises $450M to build new drug startups</a></h3> <span class="secondary-label">March 3, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-business-russia-ties-ukraine-war/619611/" class="analytics t-editors-bio-article">'We have to make a stand': Biotech leaders vow to break ties with Russia over Ukraine war</a></h3> <span class="secondary-label">March 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-legend-carvykti-myeloma-fda-approval/619430/" class="analytics t-editors-bio-article">J&J, Legend cell therapy approved by FDA for multiple myeloma</a></h3> <span class="secondary-label">Feb. 28, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-arbutus-roivant-lawsuit-patents-lnp-vaccine/619502/" class="analytics t-editors-bio-article">Moderna sued for allegedly infringing patents tied to COVID-19 vaccine</a></h3> <span class="secondary-label">Feb. 28, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spark-ceo-jeff-marrazzo-ron-philip-gene-therapy/619246/" class="analytics t-editors-bio-article">Spark CEO Marrazzo, who led company to historic gene therapy approval, to step down</a></h3> <span class="secondary-label">Feb. 23, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/adagio-tillman-gerngross-antibody-covid-omicron/619198/" class="analytics t-editors-bio-article">Adagio pledges to press forward with COVID drug as CEO to resign</a></h3> <span class="secondary-label">Feb. 22, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-pku-gene-therapy-hold-fda-cancer/619109/" class="analytics t-editors-bio-article">BioMarin says gene therapy hold will endure as FDA questions cancer risk</a></h3> <span class="secondary-label">Feb. 18, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-breyanzi-fda-decision-second-line/619016/" class="analytics t-editors-bio-article">Bristol Myers gets FDA decision date for earlier use of CAR-T therapy</a></h3> <span class="secondary-label">Feb. 17, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/holles-ceo-third-harmonic-biotech-launch/618948/" class="analytics t-editors-bio-article">Third Harmonic, led by former Audentes CEO, launches with $155M in funding</a></h3> <span class="secondary-label">Feb. 16, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-lumakras-pancreatic-kras-mirati/618865/" class="analytics t-editors-bio-article">Amgen sees potential for KRAS drug in treating pancreatic cancer</a></h3> <span class="secondary-label">Feb. 15, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-jak-inhibitors-safety-review/618799/" class="analytics t-editors-bio-article">EMA follows FDA in scrutinizing safety of certain immune drugs</a></h3> <span class="secondary-label">Feb. 14, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/proqr-lca-eye-sepofarsen-trial-failure/618709/" class="analytics t-editors-bio-article">ProQR eye drug comes up short in key study, surprising company and investors</a></h3> <span class="secondary-label">Feb. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-duchenne-phase-3-study-reopen/618642/" class="analytics t-editors-bio-article">Pfizer aims to restart late-stage trial of Duchenne gene therapy following safety setback</a></h3> <span class="secondary-label">Feb. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-covid-sales-vaccine-paxlovid-earnings/618467/" class="analytics t-editors-bio-article">Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill</a></h3> <span class="secondary-label">Feb. 8, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/al-sandrock-verge-genomics-board-biogen/618443/" class="analytics t-editors-bio-article">Al Sandrock, former top Biogen scientist, to join drug discovery startup's board</a></h3> <span class="secondary-label">Feb. 8, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pressed-by-wall-street-pharma-executives-signal-openness-to-ma/618409/" class="analytics t-editors-bio-article">Pressed by Wall Street, pharma executives signal openness to M&A</a></h3> <span class="secondary-label">Feb. 7, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/orchard-gene-therapy-coverage-uk-libmeldy/618330/" class="analytics t-editors-bio-article">In England, Orchard secures rare agreement on gene therapy coverage</a></h3> <span class="secondary-label">Feb. 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intellia-rewrite-therapeutics-gene-editing-deal/618241/" class="analytics t-editors-bio-article">Intellia, expanding in gene editing, buys startup Rewrite for $45M</a></h3> <span class="secondary-label">Feb. 3, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-genedit-gene-editing-neuromuscular-deal/618083/" class="analytics t-editors-bio-article">Sarepta reveals gene editing alliance with biotech exploring alternative delivery methods</a></h3> <span class="secondary-label">Feb. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-roche-mosunetuzumab-rights-cancer-lymphoma/618104/" class="analytics t-editors-bio-article">Biogen buys into fast-advancing Roche cancer drug</a></h3> <span class="secondary-label">Feb. 1, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-ionis-vupanorsen-angptl3-cardivoascular-discontinue/618023/" class="analytics t-editors-bio-article">Pfizer stops development of once-promising heart drug, handing back rights to partner Ionis</a></h3> <span class="secondary-label">Jan. 31, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-samsung-bioepis-sale-biosimilars-deal/617932/" class="analytics t-editors-bio-article">Biogen, facing pressure on all sides, sells stake in biosimilars business</a></h3> <span class="secondary-label">Jan. 28, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/atara-fujifilm-cell-therapy-plant-sale/617859/" class="analytics t-editors-bio-article">Atara sells cell therapy plant to Fujifilm for $100M</a></h3> <span class="secondary-label">Jan. 27, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cortexyme-fda-hold-alzheimers-atuzaginstat/617774/" class="analytics t-editors-bio-article">Cortexyme to shift focus after FDA places hold on experimental Alzheimer's drug</a></h3> <span class="secondary-label">Jan. 26, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-deals-acquisitions-biotech/617671/" class="analytics t-editors-bio-article">J&J 'constantly looking' at biotech M&A, but focused on small, mid-sized deals</a></h3> <span class="secondary-label">Jan. 25, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/metagenomi-gene-editing-venture-fundraising-series-b/617621/" class="analytics t-editors-bio-article">Gene editing startup Metagenomi raises $175M to advance research pipeline</a></h3> <span class="secondary-label">Jan. 25, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-chronic-cough-fda-reject-crl-gefapixant/617575/" class="analytics t-editors-bio-article">Merck drug for chronic cough rejected by FDA</a></h3> <span class="secondary-label">Jan. 24, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-huntington-tominersen-ionis-data-details/617518/" class="analytics t-editors-bio-article">Roche sees cause for optimism with failed Huntington's disease drug. Others aren't so sure.</a></h3> <span class="secondary-label">Jan. 21, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-clyburn-depart-iff-ceo/617430/" class="analytics t-editors-bio-article">Top Merck executive to depart company for CEO role at ingredients maker</a></h3> <span class="secondary-label">Jan. 20, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-hal-barron-depart-altos-labs-walmsley/617355/" class="analytics t-editors-bio-article">GSK loses R&D chief Barron to high-powered startup amid investor pressure</a></h3> <span class="secondary-label">Jan. 19, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-fda-delay-review-decision-gene-therapy/617269/" class="analytics t-editors-bio-article">Bluebird faces longer wait for FDA verdict on experimental gene therapies</a></h3> <span class="secondary-label">Jan. 18, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-editing-trends-questions-2022/617142/" class="analytics t-editors-bio-article">5 questions facing gene therapy in 2022</a></h3> <span class="secondary-label">Jan. 13, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-22-lilly-alzheimers-editas-crispr-bluebird/617057/" class="analytics t-editors-bio-article">JPM22: Aftershocks for Lilly, CRISPR versus CRISPR and Bluebird's crucial year</a></h3> <span class="secondary-label">Jan. 12, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-22-biotech-deals-roche-tigit-eqrx-vir/616982/" class="analytics t-editors-bio-article">JPM22: M&A anxiety, Roche's comeback plan and Vir's omicron moment</a></h3> <span class="secondary-label">Jan. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-arrakis-rna-degrader-small-molecule/616997/" class="analytics t-editors-bio-article">Amgen partners with Arrakis to develop drugs aimed at RNA</a></h3> <span class="secondary-label">Jan. 11, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-22-pfizer-mrna-biogen-price-cell-therapy/616903/" class="analytics t-editors-bio-article">JPM22: Pfizer's big bet on mRNA, Biogen 'proven wrong' on Aduhelm price and the next cell therapies</a></h3> <span class="secondary-label">Jan. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-hemophilia-gene-therapy-two-year-results-fda/616878/" class="analytics t-editors-bio-article">BioMarin plans return to FDA with updated data on hemophilia gene therapy</a></h3> <span class="secondary-label">Jan. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-beam-gene-base-editing-deal-mrna/616866/" class="analytics t-editors-bio-article">Pfizer expands into gene editing with Beam research deal</a></h3> <span class="secondary-label">Jan. 10, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-neurimmune-attr-heart-licensing/616825/" class="analytics t-editors-bio-article">AstraZeneca adds to rare disease drug pipeline with Neurimmune deal</a></h3> <span class="secondary-label">Jan. 7, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/german-merck-exelead-acquisition-lnp-mrna/616759/" class="analytics t-editors-bio-article">German Merck buys manufacturer of key component in mRNA medicines</a></h3> <span class="secondary-label">Jan. 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-alnylam-liver-failure-rna-research/616736/" class="analytics t-editors-bio-article">Novartis turns to Alnylam in research deal aimed at liver failure</a></h3> <span class="secondary-label">Jan. 6, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-shingles-vaccine-mrna/616673/" class="analytics t-editors-bio-article">Pfizer, BioNTech bet mRNA can make a better shingles vaccine</a></h3> <span class="secondary-label">Jan. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-first-quarter-2022/616660/" class="analytics t-editors-bio-article">5 FDA approval decisions to watch in the first quarter</a></h3> <span class="secondary-label">Jan. 5, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/avrobio-fabry-discontinue-gene-therapy-data/616594/" class="analytics t-editors-bio-article">Avrobio stops work on rare disease gene therapy after unexpected study results</a></h3> <span class="secondary-label">Jan. 4, 2022</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-amunix-cancer-t-cell-acquire-deal/616401/" class="analytics t-editors-bio-article">Sanofi to buy cancer immunotherapy biotech for $1B</a></h3> <span class="secondary-label">Dec. 21, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-fda-hold-sickle-cell-gene-therapy-study/611807/" class="analytics t-editors-bio-article">Bluebird hit with another hold for sickle cell gene therapy</a></h3> <span class="secondary-label">Dec. 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approval-amgen-argenx-intra-cellular-biotech/611775/" class="analytics t-editors-bio-article">FDA OKs drugs from Amgen, Argenx, Intra-Cellular in year-end push</a></h3> <span class="secondary-label">Dec. 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spark-gene-therapy-drexel-philadelphia-center/611711/" class="analytics t-editors-bio-article">Spark expands in Philadelphia, with new facility meant to be Roche's gene therapy hub</a></h3> <span class="secondary-label">Dec. 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-europe-pfizer-paxlovid-advice-early-use/611673/" class="analytics t-editors-bio-article">EU regulator says member countries can use Pfizer's experimental COVID pill</a></h3> <span class="secondary-label">Dec. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/flush-with-cash-large-drugmakers-turn-to-share-buybacks-deals/611634/" class="analytics t-editors-bio-article">Flush with cash, large drugmakers turn to share buybacks, deals</a></h3> <span class="secondary-label">Dec. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-gsk-covid-vaccine-booster/611547/" class="analytics t-editors-bio-article">Sanofi, GSK say COVID vaccine works as booster, but delay key study results</a></h3> <span class="secondary-label">Dec. 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/car-t-lymphoma-kymriah-novartis-negative-study/611481/" class="analytics t-editors-bio-article">Two cancer cell therapy studies succeeded. Why did a third fail?</a></h3> <span class="secondary-label">Dec. 14, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-car-t-therapy-lymphoma-second-line-yescarta-breyanzi/611368/" class="analytics t-editors-bio-article">CAR-T therapy trials show promise for earlier use in lymphoma</a></h3> <span class="secondary-label">Dec. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-influenza-vaccine-first-study-results/611335/" class="analytics t-editors-bio-article">Moderna reveals first study results for seasonal flu vaccine</a></h3> <span class="secondary-label">Dec. 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-regor-diabetes-research-deal-china/611330/" class="analytics t-editors-bio-article">Lilly deepens research ties in China with biotech deal</a></h3> <span class="secondary-label">Dec. 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-antibody-cleared-by-fda-for-preventive-use-against-covid-19/611216/" class="analytics t-editors-bio-article">AstraZeneca antibody cleared by FDA for preventive use against COVID-19</a></h3> <span class="secondary-label">Dec. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-omicron-covid-vaccine-booster/611149/" class="analytics t-editors-bio-article">Omicron cuts Pfizer vaccine's potency, but data show booster may restore protection</a></h3> <span class="secondary-label">Dec. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acadia-rett-syndrome-phase-3-study-results/611091/" class="analytics t-editors-bio-article">Acadia shares rise on study success for Rett syndrome drug</a></h3> <span class="secondary-label">Dec. 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/odyssey-biotech-gary-glick-launch-series-a/611045/" class="analytics t-editors-bio-article">A serial biotech entrepreneur launches his next startup with high-dollar backing</a></h3> <span class="secondary-label">Dec. 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-migraine-zavegepant-intranasal-nda/611003/" class="analytics t-editors-bio-article">Biohaven to seek FDA approval for second migraine drug after study success</a></h3> <span class="secondary-label">Dec. 6, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/former-immunomedics-executive-charged-with-insider-trading-around-trial-dat/610938/" class="analytics t-editors-bio-article">Former Immunomedics executive charged with insider trading around trial data</a></h3> <span class="secondary-label">Dec. 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vir-gsk-omicron-variant-antibody-potency/610857/" class="analytics t-editors-bio-article">Early tests suggest Vir, GSK antibody could hold up versus omicron</a></h3> <span class="secondary-label">Dec. 2, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-apol1-kidney-disease-study-results-advance/610725/" class="analytics t-editors-bio-article">Vertex, needing research spark, finds promising results in small study of kidney disease drug</a></h3> <span class="secondary-label">Dec. 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-hires-away-top-pfizer-vaccine-scientist/610698/" class="analytics t-editors-bio-article">GSK hires away top Pfizer vaccine scientist</a></h3> <span class="secondary-label">Nov. 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-omicron-adapt-moderna-pfizer/610613/" class="analytics t-editors-bio-article">Vaccine makers move quickly to confront omicron threat</a></h3> <span class="secondary-label">Nov. 29, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-arrowhead-nash-rna-interference-deal/610485/" class="analytics t-editors-bio-article">GSK dives into NASH, RNA interference with Arrowhead deal</a></h3> <span class="secondary-label">Nov. 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-beti-cel-fda-filing-beta-thalassemia/610441/" class="analytics t-editors-bio-article">Bluebird, after delays, gets speedy FDA review for beta thalassemia gene therapy</a></h3> <span class="secondary-label">Nov. 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-aduhelm-alzheimers-patient-death-investigation/610352/" class="analytics t-editors-bio-article">Biogen seeking more information in investigation of Aduhelm patient's death</a></h3> <span class="secondary-label">Nov. 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-kidney-cancer-adjuvantd-fda-approval/610260/" class="analytics t-editors-bio-article">FDA approves Merck's Keytruda as first immunotherapy for early kidney cancer</a></h3> <span class="secondary-label">Nov. 18, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-aduhelm-europe-ema-negative-view-alzheimers/610180/" class="analytics t-editors-bio-article">European drugs regulator signals rejection likely for Biogen's Aduhelm</a></h3> <span class="secondary-label">Nov. 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-paxlovid-covid-pill-fda-application/610149/" class="analytics t-editors-bio-article">Pfizer asks FDA to authorize COVID-19 pill</a></h3> <span class="secondary-label">Nov. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-covid-pill-license-patent-pool-countries/610103/" class="analytics t-editors-bio-article">Pfizer will allow generic drugmakers to produce promising COVID-19 pill</a></h3> <span class="secondary-label">Nov. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biden-fda-robert-califf-commissioner/608252/" class="analytics t-editors-bio-article">Biden nominates Robert Califf to return as FDA head</a></h3> <span class="secondary-label">Nov. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cortexyme-alzheimers-detailed-study-data-ctad/609920/" class="analytics t-editors-bio-article">Cortexyme plans path forward for Alzheimer's drug that failed study</a></h3> <span class="secondary-label">Nov. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-split-spin-consumer-health-restructuring/609950/" class="analytics t-editors-bio-article">J&J, world's largest drugmaker, plans to split in two</a></h3> <span class="secondary-label">Nov. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-pfizer-migraine-nurtec-rights/609713/" class="analytics t-editors-bio-article">Pfizer buys into Biohaven's fast-selling migraine medicine</a></h3> <span class="secondary-label">Nov. 9, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mirati-kras-adagrasib-keytruda-lung-cancer/609676/" class="analytics t-editors-bio-article">Mirati gives first look at KRAS drug combination in lung cancer</a></h3> <span class="secondary-label">Nov. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beam-clinical-trial-sickle-cell-base-editing-maraganore/609658/" class="analytics t-editors-bio-article">Beam gets green light to begin first clinical test of base editing</a></h3> <span class="secondary-label">Nov. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-covid-vaccine-sales-manfuacturing-delay/609489/" class="analytics t-editors-bio-article">Moderna cuts vaccine sales, delivery targets for 2021</a></h3> <span class="secondary-label">Nov. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-gene-therapy-delay-dmd-hemophilia/609390/" class="analytics t-editors-bio-article">Pfizer gene therapy research delayed by trial changes, safety questions</a></h3> <span class="secondary-label">Nov. 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-comirnaty-covid-vaccine-sales-third-quarter/609308/" class="analytics t-editors-bio-article">Pfizer sales of COVID-19 vaccine climb, with tens of billions more expected next year</a></h3> <span class="secondary-label">Nov. 2, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-cell-therapy-gammadelta-acquire-deal/608996/" class="analytics t-editors-bio-article">Takeda reels in a cell therapy research partner with 'build-to-buy' deal</a></h3> <span class="secondary-label">Oct. 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-pfizer-vaccine-children-advisers-vote-recommend/608936/" class="analytics t-editors-bio-article">FDA advisers support Pfizer's coronavirus vaccine for young children</a></h3> <span class="secondary-label">Oct. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cortexyme-alzheimers-gain-study-results-gingivalis/608879/" class="analytics t-editors-bio-article">Cortexyme drug fails in Alzheimer's trial, but company sees validation of unorthodox approach</a></h3> <span class="secondary-label">Oct. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-sandoz-review-options-sale-spin/608881/" class="analytics t-editors-bio-article">Novartis to consider sale or separation of Sandoz business</a></h3> <span class="secondary-label">Oct. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-canakinumab-lung-cancer-study-results-negative/608820/" class="analytics t-editors-bio-article">Novartis hits another setback in plan to repurpose rare disease drug in lung cancer</a></h3> <span class="secondary-label">Oct. 25, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-coronavirus-vaccine-kids-fda-meeting-preview/608746/" class="analytics t-editors-bio-article">What to watch at the FDA's high-stakes meeting on COVID-19 vaccines for kids</a></h3> <span class="secondary-label">Oct. 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-withdraw-gene-therapy-europe-skysona/608666/" class="analytics t-editors-bio-article">Bluebird, winding down in Europe, withdraws another rare disease gene therapy</a></h3> <span class="secondary-label">Oct. 21, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-vaccine-not-for-profit-price/608477/" class="analytics t-editors-bio-article">J&J foresees end to not-for-profit sales of coronavirus vaccine</a></h3> <span class="secondary-label">Oct. 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-humira-biosimilar-interchangeable-2023/608389/" class="analytics t-editors-bio-article">Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat</a></h3> <span class="secondary-label">Oct. 18, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-tremelimumab-liver-cancer-study-survival/608311/" class="analytics t-editors-bio-article">AstraZeneca immunotherapy combo extends survival in liver cancer trial</a></h3> <span class="secondary-label">Oct. 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-fda-cervical-cancer-keytruda-approval/608219/" class="analytics t-editors-bio-article">Merck advantage grows as FDA approves Keytruda for first-line cervical cancer</a></h3> <span class="secondary-label">Oct. 14, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-therapeutics-fgfr-cancer-study-results/607885/" class="analytics t-editors-bio-article">Relay’s targeted cancer drug could be safer than its competitors. Is it more effective?</a></h3> <span class="secondary-label">Oct. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intergalactic-gene-therapy-apple-tree-launch/607814/" class="analytics t-editors-bio-article">Intergalactic Therapeutics launches with $75M to build a new type of gene therapy</a></h3> <span class="secondary-label">Oct. 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-narcolepsy-stop-study-drug-safety/607764/" class="analytics t-editors-bio-article">Takeda halts studies of touted sleep disorder drug over safety concern</a></h3> <span class="secondary-label">Oct. 6, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-covid-vaccine-booster-submit-fda/607673/" class="analytics t-editors-bio-article">J&J asks FDA to clear booster dose of its coronavirus vaccine</a></h3> <span class="secondary-label">Oct. 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-tecartus-car-t-leukemia-approval-fda/607614/" class="analytics t-editors-bio-article">Gilead wins approval of CAR-T therapy in adult leukemia</a></h3> <span class="secondary-label">Oct. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-approval-decisions-fourth-quarter-2021/607550/" class="analytics t-editors-bio-article">5 FDA approval decisions to watch in the fourth quarter</a></h3> <span class="secondary-label">Oct. 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-merck-kgaa-end-cancer-drug-partnership/607541/" class="analytics t-editors-bio-article">GSK, Merck KGaA end cancer drug partnership after study results disappoint</a></h3> <span class="secondary-label">Oct. 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-crispr-gene-editing-first-results-blindness/607287/" class="analytics t-editors-bio-article">After long wait, Editas reveals first data for CRISPR gene editing treatment</a></h3> <span class="secondary-label">Sept. 29, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eisai-biogen-fda-seek-alzheimers-approval-lecanemab/607266/" class="analytics t-editors-bio-article">Eisai, Biogen to test FDA by asking for approval of second Alzheimer's drug</a></h3> <span class="secondary-label">Sept. 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-verdiperstat-msa-study-negative-results/607210/" class="analytics t-editors-bio-article">Biohaven's pipeline takes a hit as drug for rare neurological disease falls short in trial</a></h3> <span class="secondary-label">Sept. 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cdc-pfizer-booster-vaccine-covid-vote/607086/" class="analytics t-editors-bio-article">CDC recommends Pfizer booster shots for many, overruling advisers on broad use</a></h3> <span class="secondary-label">Sept. 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-vaxequity-rna-amplifying-deal/607071/" class="analytics t-editors-bio-article">AstraZeneca strikes deal with university spinoff to turn RNA into drugs</a></h3> <span class="secondary-label">Sept. 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/us-pfizer-vaccine-doses-donation-500-million/606987/" class="analytics t-editors-bio-article">US buying 500M more doses of Pfizer coronavirus vaccine for donation to world</a></h3> <span class="secondary-label">Sept. 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-arctos-medical-gene-therapy-optogenetics/606900/" class="analytics t-editors-bio-article">Novartis pushes further into gene therapy for the eye with deal for Swiss startup</a></h3> <span class="secondary-label">Sept. 21, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/esmo-mirati-kras-astrazeneca-enhertu-keytruda-competition/606830/" class="analytics t-editors-bio-article">ESMO21: Mirati sets new KRAS bar, AstraZeneca's breast cancer data and Keytruda challengers line up</a></h3> <span class="secondary-label">Sept. 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-covid-vaccine-booster-pfizer-advisers/606789/" class="analytics t-editors-bio-article">FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults</a></h3> <span class="secondary-label">Sept. 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-antibody-fda-post-exposure-prevention-authorization/606766/" class="analytics t-editors-bio-article">Lilly's COVID-19 antibody cleared by FDA for post-exposure prevention</a></h3> <span class="secondary-label">Sept. 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-lumakras-colorectal-cancer-combination/606700/" class="analytics t-editors-bio-article">Amgen to advance KRAS drug combination after improved results in colon cancer</a></h3> <span class="secondary-label">Sept. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/covid-antibody-us-supply-deal-lilly-regeneron/606613/" class="analytics t-editors-bio-article">US stocks up on COVID-19 antibody drugs amid shortage concerns</a></h3> <span class="secondary-label">Sept. 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-gene-therapy-trial-death-fourth-audentes/606508/" class="analytics t-editors-bio-article">Fourth trial volunteer dies in Astellas gene therapy study</a></h3> <span class="secondary-label">Sept. 14, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/departing-fda-officials-who-leaders-argue-against-broad-rollout-of-covid-1/606441/" class="analytics t-editors-bio-article">Departing FDA officials, WHO leaders argue against broad rollout of COVID-19 booster shots</a></h3> <span class="secondary-label">Sept. 13, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/apellis-geographic-atrophy-study-results-pegcetacoplan/606278/" class="analytics t-editors-bio-article">Apellis eye drug succeeds in one key study, but falls short in its twin</a></h3> <span class="secondary-label">Sept. 9, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-aav-fda-market-reaction/606134/" class="analytics t-editors-bio-article">'The sky is not falling.' Cautious optimism follows FDA meeting on gene therapy risks</a></h3> <span class="secondary-label">Sept. 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-gene-therapy-meeting-safety-cancer-liver/606088/" class="analytics t-editors-bio-article">At FDA meeting, gene therapy experts wrestle with field's blindspots</a></h3> <span class="secondary-label">Sept. 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-gene-therapy-advisory-meeting-safety-preview/605922/" class="analytics t-editors-bio-article">What to expect at the FDA's two-day meeting on gene therapy safety</a></h3> <span class="secondary-label">Sept. 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ac-immune-tau-alzheimers-semorinemab-positive-study/605842/" class="analytics t-editors-bio-article">Hint of benefit in Alzheimer's drug study fuel stock surge for Swiss biotech</a></h3> <span class="secondary-label">Aug. 31, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-drug-bests-sanofi-regenerons-dupixent-in-head-to-head-study/605776/" class="analytics t-editors-bio-article">Pfizer drug bests Sanofi, Regeneron's Dupixent in head-to-head study</a></h3> <span class="secondary-label">Aug. 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-voxzogo-european-approval-dwarfism/605703/" class="analytics t-editors-bio-article">BioMarin wins European approval to sell drug for dwarfism</a></h3> <span class="secondary-label">Aug. 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-bristol-myers-car-t-patent-reversal-appeal/605644/" class="analytics t-editors-bio-article">Gilead wins reversal of $1.2B penalty in CAR-T patent case</a></h3> <span class="secondary-label">Aug. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-aamir-malik-business-officer-succeed-young/605619/" class="analytics t-editors-bio-article">Pfizer taps McKinsey executive to lead dealmaking efforts</a></h3> <span class="secondary-label">Aug. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-trillium-acquisition-deal-cancer-cd47/605389/" class="analytics t-editors-bio-article">Pfizer stocks cancer drug pipeline with $2.3B deal for Trillium</a></h3> <span class="secondary-label">Aug. 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cell-gene-therapy-record-funding-investment-ipo/605261/" class="analytics t-editors-bio-article">Cell, gene therapy company funding reaches new heights, despite setbacks</a></h3> <span class="secondary-label">Aug. 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-booster-us-biden-pfizer-moderna/605152/" class="analytics t-editors-bio-article">US to offer coronavirus boosters to all Americans in aggressive plan to counter delta's spread</a></h3> <span class="secondary-label">Aug. 18, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-welireg-fda-approval-peloton/605047/" class="analytics t-editors-bio-article">Merck wins approval for cancer drug acquired in 2019 biotech buyout</a></h3> <span class="secondary-label">Aug. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/va-aduhelm-formulary-coverage-alzheimers/604884/" class="analytics t-editors-bio-article">VA leaves Aduhelm off coverage list, recommending against controversial Alzheimer's drug</a></h3> <span class="secondary-label">Aug. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/" class="analytics t-editors-bio-article">Biotech M&A has plateaued. Track the deals that are happening here.</a></h3> <span class="secondary-label">Aug. 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seagen-remegen-antibody-drug-conjugate-china-her2/604644/" class="analytics t-editors-bio-article">SeaGen builds cancer drug pipeline with China biotech deal</a></h3> <span class="secondary-label">Aug. 9, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/startup-eqrx-to-take-drug-price-mission-public-through-18b-spac-deal/604590/" class="analytics t-editors-bio-article">Startup EQRx to take drug price mission public through $1.8B SPAC deal</a></h3> <span class="secondary-label">Aug. 6, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-vaccine-booster-coronavirus-third-dose/604522/" class="analytics t-editors-bio-article">Moderna says vaccine protective through six months, but warns boosters needed this fall</a></h3> <span class="secondary-label">Aug. 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aduhelm-hhs-inspector-general-review-accelerated-approval/604461/" class="analytics t-editors-bio-article">HHS watchdog to review FDA accelerated approval process after Aduhelm controversy</a></h3> <span class="secondary-label">Aug. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-limb-girdle-muscular-dystrophy-nationwide/604440/" class="analytics t-editors-bio-article">Sarepta adds another gene therapy to its ever-expanding pipeline</a></h3> <span class="secondary-label">Aug. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-translate-bio-mrna-acquire-deal/604349/" class="analytics t-editors-bio-article">Sanofi bets $3.2B on mRNA with deal to buy Translate Bio</a></h3> <span class="secondary-label">Aug. 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/caribou-ipo-crispr-gene-editing/603855/" class="analytics t-editors-bio-article">Caribou raises $304M in one of gene editing's most lucrative IPOs</a></h3> <span class="secondary-label">July 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-response-aduhelm-criticism/603726/" class="analytics t-editors-bio-article">Biogen executives attack Aduhelm criticism, blaming 'extensive misinformation'</a></h3> <span class="secondary-label">July 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-predicts-faster-coronavirus-vaccine-sales-amid-debate-over-boosters/603705/" class="analytics t-editors-bio-article">J&J predicts faster coronavirus vaccine sales amid debate over boosters</a></h3> <span class="secondary-label">July 21, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amylyx-faced-with-longer-fda-path-for-promising-als-drug-gets-major-cash/603617/" class="analytics t-editors-bio-article">Amylyx, faced with longer FDA path for promising ALS drug, gets major cash infusion</a></h3> <span class="secondary-label">July 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cytokinetics-heart-drug-redwood-study-results/603545/" class="analytics t-editors-bio-article">Cytokinetics heart drug succeeds in mid-stage study, boosting shares</a></h3> <span class="secondary-label">July 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-biogen-alzheimers-aduhelm-price-access/603453/" class="analytics t-editors-bio-article">Questions on new Alzheimer's drug benefit, price loom large at ICER meeting</a></h3> <span class="secondary-label">July 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/galapagos-shares-sink-as-first-data-from-touted-drug-program-disappoints/603393/" class="analytics t-editors-bio-article">Galapagos shares sink as first data from touted drug program disappoints</a></h3> <span class="secondary-label">July 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-alzheimers-aduhelm-coverage-policy-biogen/603201/" class="analytics t-editors-bio-article">Medicare to weigh nationwide coverage rules for Biogen Alzheimer's drug</a></h3> <span class="secondary-label">July 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-prothena-amyloidosis-drug-heart/603156/" class="analytics t-editors-bio-article">Novo, in rare deal, buys rights to Prothena amyloidosis treatment</a></h3> <span class="secondary-label">July 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-investigation-aduhelm-alzheimers-drug-approval-biogen/603122/" class="analytics t-editors-bio-article">FDA, under fire for Alzheimer's drug approval, seeks investigation of review process</a></h3> <span class="secondary-label">July 9, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-migraine-strong-sales-nurtec/603034/" class="analytics t-editors-bio-article">Biohaven beats expectations with fast sales of migraine drug</a></h3> <span class="secondary-label">July 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-biogen-alzheimers-revise-prescribing-information/603008/" class="analytics t-editors-bio-article">FDA revises labeling of Biogen's Alzheimer's drug to emphasize early treatment</a></h3> <span class="secondary-label">July 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/scorpion-axel-hoos-ceo-gsk-biotech-startup/602966/" class="analytics t-editors-bio-article">A well-funded cancer drug startup brings on GSK's Axel Hoos as CEO</a></h3> <span class="secondary-label">July 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-mrna-vaccine-seasonal-flu-trial/602934/" class="analytics t-editors-bio-article">Moderna puts seasonal flu vaccine ambitions to the test</a></h3> <span class="secondary-label">July 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-jardiance-heart-failure-preserved-first-study/602870/" class="analytics t-editors-bio-article">Lilly, Boehringer say diabetes drug first to succeed in hard-to-treat heart failure</a></h3> <span class="secondary-label">July 6, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-fda-decisions-third-quarter-2021/602786/" class="analytics t-editors-bio-article">5 FDA decisions to watch in the third quarter</a></h3> <span class="secondary-label">July 2, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/curevac-coronavirus-vaccine-final-study-results/602721/" class="analytics t-editors-bio-article">CureVac vows to seek vaccine approval despite low efficacy in COVID-19 study</a></h3> <span class="secondary-label">July 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beam-apellis-base-editing-complement-disease/602668/" class="analytics t-editors-bio-article">Beam, Apellis partner in deal to expand gene editing's reach</a></h3> <span class="secondary-label">June 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-aduhelm-cost-label-revise-biogen/602641/" class="analytics t-editors-bio-article">ICER stands by view on Biogen's Aduhelm, says sharp price cut needed</a></h3> <span class="secondary-label">June 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pardes-bio-spac-gilead-foresite-covid-antiviral-pill/602571/" class="analytics t-editors-bio-article">Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal</a></h3> <span class="secondary-label">June 29, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-kite-yescarta-second-line-car-t-lymphoma/602501/" class="analytics t-editors-bio-article">Gilead matches Bristol Myers in showing benefit to earlier CAR-T treatment</a></h3> <span class="secondary-label">June 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-fda-odac-committee-vote-accelerated-approval/602443/" class="analytics t-editors-bio-article">FDA advisers vote down Incyte cancer drug as agency takes tougher line</a></h3> <span class="secondary-label">June 25, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-alzheimers-seek-accelerated-approval-donanemab/602351/" class="analytics t-editors-bio-article">Reversing course, Lilly to seek fast approval for experimental Alzheimer's drug</a></h3> <span class="secondary-label">June 24, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/third-rock-backed-startup-launches-to-develop-cell-therapies-for-ms-diabet/602233/" class="analytics t-editors-bio-article">Third Rock-backed startup launches to develop cell therapies for MS, diabetes</a></h3> <span class="secondary-label">June 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-alzheimers-drug-approval-documents-disagreement/602241/" class="analytics t-editors-bio-article">FDA documents show how controversial Alzheimer's drug decision was reached</a></h3> <span class="secondary-label">June 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/blackstone-to-invest-250m-in-cell-therapy-startup-backed-by-intellia-cell/602212/" class="analytics t-editors-bio-article">Blackstone to invest $250M in cell therapy startup backed by Intellia, Cellex</a></h3> <span class="secondary-label">June 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-vir-covid-antibody-results-nih-guidelines/602134/" class="analytics t-editors-bio-article">GSK, Vir build case for COVID-19 antibody drug with new study data</a></h3> <span class="secondary-label">June 21, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biden-coronavirus-antiviral-3-billion-funding/602063/" class="analytics t-editors-bio-article">US to invest $3B in research quest for COVID-19 pill</a></h3> <span class="secondary-label">June 18, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-ipo-gene-editing-lyell/601983/" class="analytics t-editors-bio-article">Gene editing biotech Verve to raise $267M in large IPO</a></h3> <span class="secondary-label">June 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-depression-drug-zuranolone-study/601800/" class="analytics t-editors-bio-article">Sage antidepressant succeeds in key study, but data raise questions</a></h3> <span class="secondary-label">June 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novavax-vaccine-covid-coronavirus-phase-3-highly-effective/601719/" class="analytics t-editors-bio-article">Novavax says vaccine 90% effective against COVID-19 in large trial</a></h3> <span class="secondary-label">June 14, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-vertex-gene-editing-blood-data/601685/" class="analytics t-editors-bio-article">Blood disease treatment from CRISPR, Vertex shows promise in more patients</a></h3> <span class="secondary-label">June 11, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-breyanzi-second-line-car-t/601598/" class="analytics t-editors-bio-article">Bristol Myers says CAR-T therapy beat chemo, transplant in lymphoma study</a></h3> <span class="secondary-label">June 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beigene-expands-into-cancer-cell-therapy-with-shoreline-pact/601540/" class="analytics t-editors-bio-article">Beigene expands into cancer cell therapy with Shoreline pact</a></h3> <span class="secondary-label">June 9, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-aduhelm-confirmatory-study-fda-approval/601422/" class="analytics t-editors-bio-article">The FDA approved Biogen's Alzheimer's drug. The company now has years to confirm it works.</a></h3> <span class="secondary-label">June 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-resume-gene-therapy-study-fda-hold/601355/" class="analytics t-editors-bio-article">Bluebird cleared by FDA to resume studies of sickle cell gene therapy</a></h3> <span class="secondary-label">June 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-2021-takeaways-adjuvant-immunotherapy-fate-cullinan/601384/" class="analytics t-editors-bio-article">ASCO21: An immunotherapy debate, an NK cell question and the next precision drugs</a></h3> <span class="secondary-label">June 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-shareholder-lawsuit-car-t/601295/" class="analytics t-editors-bio-article">Bristol Myers sued over delayed approval of cancer cell therapy</a></h3> <span class="secondary-label">June 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-prostate-cancer-drug-extends-survival-in-key-test-of-radiopharmace/601199/" class="analytics t-editors-bio-article">Novartis prostate cancer drug extends survival in key test of radiopharmaceutical therapy</a></h3> <span class="secondary-label">June 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-noria-psma-prostate-cancer/601211/" class="analytics t-editors-bio-article">Bayer buys a biotech and its offshoot in bet on radiopharmaceuticals</a></h3> <span class="secondary-label">June 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/morphosys-to-buy-constellation-in-17b-deal-aided-by-unusual-funding/601112/" class="analytics t-editors-bio-article">MorphoSys to buy Constellation in $1.7B deal, aided by unusual funding</a></h3> <span class="secondary-label">June 2, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-venglustat-study-stopped-kidney-disease/601045/" class="analytics t-editors-bio-article">Sanofi rare disease drug hits another setback</a></h3> <span class="secondary-label">June 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-lumakras-fda-approval-first-kras-lung-cancer/600996/" class="analytics t-editors-bio-article">In first, FDA approves KRAS-blocking cancer drug from Amgen</a></h3> <span class="secondary-label">May 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/centessa-biotech-ipo-330-million/600984/" class="analytics t-editors-bio-article">Centessa raises $330M in third largest biotech IPO this year</a></h3> <span class="secondary-label">May 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-aducanumab-alzheimers-fda-drug-review/600897/" class="analytics t-editors-bio-article">'A hugely consequential decision:' How Biogen's Alzheimer's drug came to face the FDA</a></h3> <span class="secondary-label">May 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-2021-abstracts-allogene-eqrx-serds/600509/" class="analytics t-editors-bio-article">Off-the-shelf CAR-T, a Tagrisso rival and the next breast cancer drugs</a></h3> <span class="secondary-label">May 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-details-data-for-closely-watched-cancer-immunotherapy/600386/" class="analytics t-editors-bio-article">Closely watched Bristol Myers immunotherapy shows benefit in melanoma</a></h3> <span class="secondary-label">May 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-marks-gene-therapy-consistency/600445/" class="analytics t-editors-bio-article">FDA seeking more consistency from cell, gene therapy developers, top official says</a></h3> <span class="secondary-label">May 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-agenus-tigit-cancer-drug/600364/" class="analytics t-editors-bio-article">Bristol Myers pays Agenus $200M for drug aimed at top immunotherapy target</a></h3> <span class="secondary-label">May 18, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-challenge-to-amgens-enbrel-patents-ends-at-supreme-courts-door/600329/" class="analytics t-editors-bio-article">Novartis challenge to Amgen's Enbrel patents ends at Supreme Court's door</a></h3> <span class="secondary-label">May 18, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-gsk-coronavirus-protein-vaccine-phase-2/600243/" class="analytics t-editors-bio-article">Sanofi, GSK say revamped coronavirus vaccine is strong enough for final test</a></h3> <span class="secondary-label">May 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-gene-therapy-eye-study/600204/" class="analytics t-editors-bio-article">Biogen gene therapy misses goal in eye disease study</a></h3> <span class="secondary-label">May 14, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cdc-acip-pfizer-coronavirus-vaccine-adolescents/600049/" class="analytics t-editors-bio-article">CDC panel endorses Pfizer vaccine for 12- to 15-year-olds</a></h3> <span class="secondary-label">May 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gingko-bioworks-spac-public-deal-belldegrun/599966/" class="analytics t-editors-bio-article">Ginkgo Bioworks to go public through $2.5B SPAC deal</a></h3> <span class="secondary-label">May 11, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-authorize-pfizer-vaccine-children-12-15/599926/" class="analytics t-editors-bio-article">FDA authorizes Pfizer's coronavirus vaccine for younger teens</a></h3> <span class="secondary-label">May 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-tezepelumab-fda-submission-asthma/599876/" class="analytics t-editors-bio-article">Amgen asks FDA for approval of key asthma drug</a></h3> <span class="secondary-label">May 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biden-vaccine-patent-waiver-pharma-opposition/599704/" class="analytics t-editors-bio-article">Pharma erupts as Biden administration backs waiver of vaccine patent rights</a></h3> <span class="secondary-label">May 6, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-biogen-aducanumab-price-alzheimers/599612/" class="analytics t-editors-bio-article">ICER, unconvinced by Biogen data, suggests low price for Alzheimer's drug</a></h3> <span class="secondary-label">May 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-coronavirus-vaccine-26-billion-sales/599507/" class="analytics t-editors-bio-article">Pfizer forecasts $26B in coronavirus vaccine revenue this year</a></h3> <span class="secondary-label">May 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/avrobio-fda-fabry-gene-therapy-new-study/599433/" class="analytics t-editors-bio-article">Avrobio changes course after FDA closes path for speedy gene therapy approval</a></h3> <span class="secondary-label">May 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisory-meeting-cancer-immunotherapy-accelerated-approvals/599376/" class="analytics t-editors-bio-article">FDA faces tough choice after panel backs speedy cancer drug approvals</a></h3> <span class="secondary-label">April 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/emergent-kramer-defends-criticism-bayview-vaccine/599360/" class="analytics t-editors-bio-article">Emergent CEO defends company from criticism of error that ruined vaccine doses</a></h3> <span class="secondary-label">April 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-gsk-vaccine-pandemic-hit-gardasil-shingrix/599294/" class="analytics t-editors-bio-article">Merck, GSK vaccine sales hit by pandemic as competitors' business booms</a></h3> <span class="secondary-label">April 29, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-partners-with-allen-institute-to-develop-gene-therapies-for-the-br/599209/" class="analytics t-editors-bio-article">BioMarin partners with Allen Institute to develop gene therapies for the brain</a></h3> <span class="secondary-label">April 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-merck-india-covid-19-antiviral-drugs/599108/" class="analytics t-editors-bio-article">Gilead, Merck to help India access COVID-19 drugs as country's crisis deepens</a></h3> <span class="secondary-label">April 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-deal-moderna-manufacture-coronavirus-vaccine/599022/" class="analytics t-editors-bio-article">Sanofi to aid Moderna on final steps in manufacturing coronavirus vaccine</a></h3> <span class="secondary-label">April 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cdc-acip-johnson-johnson-vaccine-meeting/598969/" class="analytics t-editors-bio-article">FDA, CDC support resuming use of J&J vaccine after advisory panel vote</a></h3> <span class="secondary-label">April 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-jemperli-immunotherapy-fda-approval/598962/" class="analytics t-editors-bio-article">GSK immunotherapy wins FDA approval, joining crowded cancer drug class</a></h3> <span class="secondary-label">April 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-cancer-immunotherapy-advisory-meeting-accelerated-approval/598874/" class="analytics t-editors-bio-article">A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals</a></h3> <span class="secondary-label">April 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-emergent-manufacturing-failures-form-483/598830/" class="analytics t-editors-bio-article">FDA cites Emergent for failings at plant that contaminated J&J doses</a></h3> <span class="secondary-label">April 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-pharma-events-to-watch-second-quarter/598687/" class="analytics t-editors-bio-article">The next 2 months in biotech and pharma will be busy. Here's what to watch.</a></h3> <span class="secondary-label">April 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-withdraw-zynteglo-germany-price/598689/" class="analytics t-editors-bio-article">Bluebird to withdraw gene therapy from Germany after dispute over price</a></h3> <span class="secondary-label">April 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-acquire-zebiai-ai-drug-discovery/598550/" class="analytics t-editors-bio-article">Relay buys AI startup to aid unorthodox drug discovery quest</a></h3> <span class="secondary-label">April 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-stops-studies-testing-closely-watched-cancer-immunotherapy/598472/" class="analytics t-editors-bio-article">GSK stops studies testing closely watched cancer immunotherapy</a></h3> <span class="secondary-label">April 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-vaccine-pause-supply-acip-hesitancy/598335/" class="analytics t-editors-bio-article">The US paused use of J&J's vaccine. What happens next?</a></h3> <span class="secondary-label">April 13, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-fda-cdc-pause-vaccine-blood-clots/598265/" class="analytics t-editors-bio-article">US recommends pause in J&J vaccinations due to concerns over rare blood clots</a></h3> <span class="secondary-label">April 13, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-arch-join-deerfield-in-backing-new-gene-therapy-biotech-jaguar/598246/" class="analytics t-editors-bio-article">Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar</a></h3> <span class="secondary-label">April 13, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-2021-takeaways-immunotherapy-tigit-kras-il2/598189/" class="analytics t-editors-bio-article">5 takeaways from AACR, one of the year's top meetings on cancer drugs</a></h3> <span class="secondary-label">April 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-retevmo-aacr-ret-fusion-cancer/598169/" class="analytics t-editors-bio-article">Lilly gene-targeted drug shows potential for use across cancers</a></h3> <span class="secondary-label">April 11, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-vaccine-blood-clots-hypothesis-heparin-hit/598110/" class="analytics t-editors-bio-article">Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine</a></h3> <span class="secondary-label">April 9, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-barictinib-covid-19-study-failure-silver-lining/598052/" class="analytics t-editors-bio-article">Lilly claims promising finding in failed study of COVID-19 drug</a></h3> <span class="secondary-label">April 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/david-davidson-tessera-bluebird-cmo/597936/" class="analytics t-editors-bio-article">Bluebird executive joins Flagship startup Tessera as CMO</a></h3> <span class="secondary-label">April 7, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-car-t-multiple-myeloma-cost-bristol-johnson/597875/" class="analytics t-editors-bio-article">New CAR-T therapy from Bristol, Bluebird effective but too costly, ICER finds</a></h3> <span class="secondary-label">April 6, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-take-over-emergent-vaccine-factory-astrazeneca/597793/" class="analytics t-editors-bio-article">J&J to oversee vaccine production at Emergent factory that ruined doses</a></h3> <span class="secondary-label">April 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-vaccine-emergent-contaminated-doses/597728/" class="analytics t-editors-bio-article">Manufacturing mix-up could blunt supply boost from J&J vaccine</a></h3> <span class="secondary-label">April 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-gene-therapy-audentes-holles-depart/597703/" class="analytics t-editors-bio-article">Audentes CEO exits as Astellas rebrands a gene therapy buyout</a></h3> <span class="secondary-label">April 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/akebia-fda-application-vadadustat-anemia-ckd/597556/" class="analytics t-editors-bio-article">Akebia tries for FDA approval of anemia drug after mixed data</a></h3> <span class="secondary-label">March 30, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uniqure-cancer-gene-therapy-not-cause-hemophilia/597478/" class="analytics t-editors-bio-article">UniQure says hemophilia gene therapy likely not cause of study volunteer's cancer</a></h3> <span class="secondary-label">March 29, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-car-t-multiple-myeloma-approval-bristol-myers-bluebird/597438/" class="analytics t-editors-bio-article">FDA approves first CAR-T cell therapy for multiple myeloma</a></h3> <span class="secondary-label">March 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/slaoui-step-down-board-vaxcyte-centessa-harassment-claim/597343/" class="analytics t-editors-bio-article">Slaoui steps down from two more biotechs after harassment claim</a></h3> <span class="secondary-label">March 25, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moncef-slaoui-accused-sexual-harassment-galvani-gsk/597251/" class="analytics t-editors-bio-article">Moncef Slaoui, who led US Warp Speed effort, accused of sexual harassment</a></h3> <span class="secondary-label">March 24, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-novo-semaglutide-refuse-file-pushback/597182/" class="analytics t-editors-bio-article">FDA won't review Novo diabetes drug in latest case of regulatory pushback</a></h3> <span class="secondary-label">March 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-may-have-used-outdated-data-to-describe-vaccines-efficacy-n/597165/" class="analytics t-editors-bio-article">AstraZeneca may have used 'outdated' data to describe vaccine's efficacy, NIH says</a></h3> <span class="secondary-label">March 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-cmo-departure-david-davidson/596872/" class="analytics t-editors-bio-article">Bluebird's top doctor to depart as company grapples with safety review</a></h3> <span class="secondary-label">March 17, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-cell-therapy-funding-2020-arm-report/596790/" class="analytics t-editors-bio-article">Record funding flowed into cell, gene therapy companies last year</a></h3> <span class="secondary-label">March 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/elevate-bio-fundraise-525-million-gene-therapy/596716/" class="analytics t-editors-bio-article">Elevate Bio raises half a billion dollars to fuel cell, gene therapy expansion</a></h3> <span class="secondary-label">March 15, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vaccine-factories-churn-out-millions-more-doses-speeding-us-rollout-of-cor/596561/" class="analytics t-editors-bio-article">Vaccine factories churn out millions more doses, speeding US rollout of coronavirus shots</a></h3> <span class="secondary-label">March 11, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-gene-therapy-unlikely-lentiviral-cancer/596463/" class="analytics t-editors-bio-article">Bluebird says gene therapy 'very unlikely' cause of cancer case in trial</a></h3> <span class="secondary-label">March 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-pandion-deal-negotiations-pricey-buyout/596216/" class="analytics t-editors-bio-article">Biotech's deal refusals led to pricey buyout by Merck</a></h3> <span class="secondary-label">March 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-five-prime-cancer-drug-deal-acquisition/596124/" class="analytics t-editors-bio-article">Amgen, with rare buyout, pays $1.9B for cancer biotech Five Prime</a></h3> <span class="secondary-label">March 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fibrogen-shares-sink-as-fda-meeting-decision-suggests-another-delay-for-top/595953/" class="analytics t-editors-bio-article">FibroGen shares sink as FDA meeting decision suggests another delay for top drug</a></h3> <span class="secondary-label">March 2, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-fda-authorization/595843/" class="analytics t-editors-bio-article">J&J's 1-dose coronavirus vaccine becomes third available in US</a></h3> <span class="secondary-label">Feb. 27, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisers-recommend-johnson-johnson-vaccine-meeting/595824/" class="analytics t-editors-bio-article">FDA panel backs J&J's coronavirus vaccine, clearing way for shot's authorization</a></h3> <span class="secondary-label">Feb. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-reveals-new-details-on-cancer-cases-in-gene-therapy-trial/595787/" class="analytics t-editors-bio-article">Bluebird reveals new details on cancer cases in gene therapy trial</a></h3> <span class="secondary-label">Feb. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-johnson-johnson-vaccine-coronavirus-advisory-meeting/595745/" class="analytics t-editors-bio-article">A play-by-play of the FDA meeting on J&J's vaccine</a></h3> <span class="secondary-label">Feb. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/top-moderna-executive-to-leave-company-later-this-year/595721/" class="analytics t-editors-bio-article">Top Moderna executive to leave company later this year</a></h3> <span class="secondary-label">Feb. 25, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jaguar-gene-therapy-startup-former-avexis-executive/595691/" class="analytics t-editors-bio-article">Former AveXis executives launch gene therapy startup with uncommon targets</a></h3> <span class="secondary-label">Feb. 25, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-review-johnson-johnson-coronavirus-vaccine-advisory-meeting/595608/" class="analytics t-editors-bio-article">FDA review supports safety, efficacy of J&J coronavirus vaccine</a></h3> <span class="secondary-label">Feb. 24, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beam-acquire-guide-therapeutics-gene-editing/595534/" class="analytics t-editors-bio-article">Beam, capitalizing on stock surge, buys gene therapy tools developer for $120M</a></h3> <span class="secondary-label">Feb. 23, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-coronavirus-vaccine-update-variant-guidance/595480/" class="analytics t-editors-bio-article">FDA lays out shortened path for testing vaccines against new coronavirus variants</a></h3> <span class="secondary-label">Feb. 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-fda-advisory-meeting/595366/" class="analytics t-editors-bio-article">Why this week's FDA meeting on J&J's coronavirus vaccine will be important</a></h3> <span class="secondary-label">Feb. 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-coronavirus-vaccine-manufacturing-kansas-factory/595407/" class="analytics t-editors-bio-article">Pfizer set to double weekly production of coronavirus vaccine</a></h3> <span class="secondary-label">Feb. 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-pause-gene-therapy-study-leukemia-myelodysplastic/595112/" class="analytics t-editors-bio-article">Bluebird stops studies of sickle cell gene therapy after new cancer cases</a></h3> <span class="secondary-label">Feb. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/centessa-launch-medicxi-saha-slaoui/595097/" class="analytics t-editors-bio-article">10 biotechs become 1: Centessa launches with $250M to prove unorthodox R&D model</a></h3> <span class="secondary-label">Feb. 16, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-lysosomal-storage-disorders-fabry/594991/" class="analytics t-editors-bio-article">A gene therapy pipeline takes shape for a cluster of rare diseases</a></h3> <span class="secondary-label">Feb. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/us-biden-vaccine-doses-moderna-pfizer/595024/" class="analytics t-editors-bio-article">US secures 200 million more vaccine doses from Pfizer, Moderna</a></h3> <span class="secondary-label">Feb. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-covid-antibody-combo-fda-authorization/594857/" class="analytics t-editors-bio-article">FDA clears Lilly's COVID-19 antibody cocktail for emergency use</a></h3> <span class="secondary-label">Feb. 10, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-ceo-replace-collins-jim-mullen/594696/" class="analytics t-editors-bio-article">Editas names new CEO in latest executive shakeup</a></h3> <span class="secondary-label">Feb. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-liso-cel-fda-approval-car-t/594660/" class="analytics t-editors-bio-article">Bristol Myers finally wins FDA approval for cancer cell therapy</a></h3> <span class="secondary-label">Feb. 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-veklury-coronavirus-sales-2021/594628/" class="analytics t-editors-bio-article">Gilead sales propped up by COVID-19 drug Veklury</a></h3> <span class="secondary-label">Feb. 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-submit-fda-coronavirus-vaccine/594582/" class="analytics t-editors-bio-article">J&J asks FDA for emergency clearance of coronavirus vaccine</a></h3> <span class="secondary-label">Feb. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ken-frazier-merck-ceo-retire-rob-davis/594531/" class="analytics t-editors-bio-article">Ken Frazier, veteran pharma leader, to step down as Merck CEO</a></h3> <span class="secondary-label">Feb. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jazz-pharma-acquire-gw-epiodiolex-cannabidiol/594426/" class="analytics t-editors-bio-article">Jazz Pharma to buy GW Pharma, maker of CBD-based epilepsy drug, for $7.2B</a></h3> <span class="secondary-label">Feb. 3, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-coronavirus-vaccine-sales-forecast/594353/" class="analytics t-editors-bio-article">Pfizer forecasts $15B sales boost from coronavirus vaccine orders</a></h3> <span class="secondary-label">Feb. 2, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/curevac-bayer-coronavirus-vaccine-manufacturing/594283/" class="analytics t-editors-bio-article">Bayer agrees to help CureVac produce coronavirus vaccine</a></h3> <span class="secondary-label">Feb. 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-gritstone-hiv-vaccine-immunotherapy/594258/" class="analytics t-editors-bio-article">Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy</a></h3> <span class="secondary-label">Feb. 1, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-vaccine-prevent-covid-study-variants/594192/" class="analytics t-editors-bio-article">J&J says single dose of coronavirus vaccine 66% effective in large trial</a></h3> <span class="secondary-label">Jan. 29, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-kras-sotorasib-phase-2-study-results/594167/" class="analytics t-editors-bio-article">Amgen study data bolster prospects of KRAS-blocking cancer drug</a></h3> <span class="secondary-label">Jan. 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-strikes-deal-to-acquire-drug-for-chronic-pain/594142/" class="analytics t-editors-bio-article">Lilly strikes deal to acquire drug for chronic pain</a></h3> <span class="secondary-label">Jan. 28, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-in-unusual-move-to-help-pfizer-biontech-make-coronavirus-vaccine/594004/" class="analytics t-editors-bio-article">Sanofi, in unusual move, to help Pfizer, BioNTech make coronavirus vaccine doses</a></h3> <span class="secondary-label">Jan. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-results-expected/593984/" class="analytics t-editors-bio-article">J&J says study data on coronavirus vaccine due 'early next week'</a></h3> <span class="secondary-label">Jan. 26, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-variant-booster-study/593889/" class="analytics t-editors-bio-article">Moderna to study vaccine booster aimed at coronavirus variant</a></h3> <span class="secondary-label">Jan. 25, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-inclisiran-cholesterol-cost-novartis/593819/" class="analytics t-editors-bio-article">Pricing challenge looms for Novartis as cholesterol drug's US fate remains unclear</a></h3> <span class="secondary-label">Jan. 22, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-covid-antibody-drug-combination-study/593704/" class="analytics t-editors-bio-article">Lilly's antibody drug prevents COVID-19 in study, but hurdles to use remain</a></h3> <span class="secondary-label">Jan. 20, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verve-gene-editing-venture-funding-clinical-study/593562/" class="analytics t-editors-bio-article">Beam, Verve stockpile cash as investors bank on gene editing progress</a></h3> <span class="secondary-label">Jan. 19, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jp-morgan-2021-verve-sage-lilly-pfizer/593210/" class="analytics t-editors-bio-article">JPM21: Gene editing for heart disease, a new date to watch in Alzheimer's research and Pfizer's deep pockets</a></h3> <span class="secondary-label">Jan. 12, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-split-company-cancer-drug-spin/593152/" class="analytics t-editors-bio-article">Bluebird to split company, spin off cancer drug business</a></h3> <span class="secondary-label">Jan. 11, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-hemophilia-gene-therapy-phase-3-data/593118/" class="analytics t-editors-bio-article">BioMarin tries to get hemophilia gene therapy back on track with positive data</a></h3> <span class="secondary-label">Jan. 11, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-editing-therapy-trends-2021/592951/" class="analytics t-editors-bio-article">5 questions facing gene therapy in 2021</a></h3> <span class="secondary-label">Jan. 8, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approval-decisions-first-quarter-2021/592822/" class="analytics t-editors-bio-article">5 FDA approval decisions to watch in the 1st quarter</a></h3> <span class="secondary-label">Jan. 5, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-cvr-liso-cel-fda-decision/592755/" class="analytics t-editors-bio-article">How an all-or-nothing bet on 3 Bristol Myers drugs came undone</a></h3> <span class="secondary-label">Jan. 4, 2021</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-coronavirus-vaccine-eu-authorization/592635/" class="analytics t-editors-bio-article">Pfizer, BioNTech win EU vaccine approval as UK grapples with new coronavirus variant</a></h3> <span class="secondary-label">Dec. 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-fda-complete-response-inclisiran-inspection/592554/" class="analytics t-editors-bio-article">FDA delays decision on Novartis cholesterol therapy</a></h3> <span class="secondary-label">Dec. 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/agios-servier-deal-cancer-research-pivot/592514/" class="analytics t-editors-bio-article">Changing identity, Agios to sell cancer drug business to Servier</a></h3> <span class="secondary-label">Dec. 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisers-vote-moderna-vaccine-coronavirus/592408/" class="analytics t-editors-bio-article">FDA panel endorses Moderna's coronavirus vaccine</a></h3> <span class="secondary-label">Dec. 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-moderna-advisory-committee-vaccine-coronavirus/592333/" class="analytics t-editors-bio-article">A play-by-play of the FDA meeting on Moderna's coronavirus vaccine</a></h3> <span class="secondary-label">Dec. 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-scientists-back-safety-efficacy-of-modernas-coronavirus-vaccine/592208/" class="analytics t-editors-bio-article">FDA scientists back safety, efficacy of Moderna's coronavirus vaccine</a></h3> <span class="secondary-label">Dec. 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-roche-kras-shp2-cancer-drug-deal/592126/" class="analytics t-editors-bio-article">Relay Therapeutics, fresh off IPO, partners with Roche in cancer drug deal</a></h3> <span class="secondary-label">Dec. 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/viatris-restructuring-layoffs-west-virginia/592054/" class="analytics t-editors-bio-article">Viatris to lay off staff, shutter plants in major restructuring</a></h3> <span class="secondary-label">Dec. 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisers-coronavirus-vaccine-vote-recommend-pfizer/592001/" class="analytics t-editors-bio-article">FDA advisers back Pfizer, BioNTech vaccine, clearing way for emergency approval</a></h3> <span class="secondary-label">Dec. 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisers-pfizer-biontech-vaccine-coronavirus/591919/" class="analytics t-editors-bio-article">A play-by-play of the historic FDA meeting on Pfizer and BioNTech's coronavirus vaccine</a></h3> <span class="secondary-label">Dec. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vaccine-developers-of-year-biontech-moderna-2020/589675/" class="analytics t-editors-bio-article">Vaccine Developers of the Year: BioNTech and Moderna</a></h3> <span class="secondary-label">Dec. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-scientists-appear-supportive-of-pfizer-biontechs-coronavirus-vaccine/591806/" class="analytics t-editors-bio-article">FDA scientists appear supportive of Pfizer, BioNTech's coronavirus vaccine</a></h3> <span class="secondary-label">Dec. 8, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-loxo-305-ash-cll-mcl-imbruvica/591703/" class="analytics t-editors-bio-article">Lilly to pit Loxo cancer drug against top-selling rival after strong study results</a></h3> <span class="secondary-label">Dec. 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vaccine-production-in-focus-as-moderna-pfizer-await-fda-decision/591649/" class="analytics t-editors-bio-article">Vaccine production in focus as Moderna, Pfizer await FDA decision</a></h3> <span class="secondary-label">Dec. 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2020-preview-crispr-bcma-hemophilia/591564/" class="analytics t-editors-bio-article">4 storylines to track at the year's biggest meeting on blood diseases</a></h3> <span class="secondary-label">Dec. 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-oncoimmune-buy-covid-19-drug/589564/" class="analytics t-editors-bio-article">Merck, expanding coronavirus work, buys a small biotech and its COVID-19 drug</a></h3> <span class="secondary-label">Nov. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-administration-pushes-last-ditch-plans-to-lower-drug-prices/589517/" class="analytics t-editors-bio-article">Trump administration pushes last-ditch plans to lower drug prices</a></h3> <span class="secondary-label">Nov. 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-apply-fda-emergency-approval/589471/" class="analytics t-editors-bio-article">Pfizer, BioNTech ask FDA for emergency approval of coronavirus vaccine</a></h3> <span class="secondary-label">Nov. 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uniqure-hemophilia-b-gene-therapy-hope-trial/589336/" class="analytics t-editors-bio-article">UniQure's gene therapy for hemophilia B meets goal in key study</a></h3> <span class="secondary-label">Nov. 19, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-covid-vaccine-full-results-95-effective/589256/" class="analytics t-editors-bio-article">New coronavirus vaccine data bolster Pfizer, BioNTech claims of strongly effective shot</a></h3> <span class="secondary-label">Nov. 18, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-moderna-coronavirus-vaccine-spike-antibody/589140/" class="analytics t-editors-bio-article">Trial success for 2 coronavirus vaccines backs up early research bets</a></h3> <span class="secondary-label">Nov. 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-near-readout/588906/" class="analytics t-editors-bio-article">Moderna close to having results from key coronavirus vaccine trial</a></h3> <span class="secondary-label">Nov. 12, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-coronvirus-vaccine-details-safety/588733/" class="analytics t-editors-bio-article">Pfizer and BioNTech's coronavirus vaccine works. Here's what we still don't know.</a></h3> <span class="secondary-label">Nov. 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-alzheimers-biogen-aducanumab-takeaways/588653/" class="analytics t-editors-bio-article">5 takeaways from the FDA's high-stakes meeting for Biogen's Alzheimer's drug</a></h3> <span class="secondary-label">Nov. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advisory-panel-vote-biogen-alzheimers-aducanumab/588580/" class="analytics t-editors-bio-article">FDA advisers vote against Biogen's Alzheimer's drug, leaving its future in doubt</a></h3> <span class="secondary-label">Nov. 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-fda-roctavian-vosorotide/588549/" class="analytics t-editors-bio-article">BioMarin, stung by FDA rejection, pressed on path forward for 2 key drugs</a></h3> <span class="secondary-label">Nov. 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-surges-as-fda-reviewers-appear-supportive-of-alzheimers-drug-approv/588388/" class="analytics t-editors-bio-article">Biogen surges as FDA reviewers appear supportive of Alzheimer's drug approval</a></h3> <span class="secondary-label">Nov. 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-tyk2-psoriasis-otezla/588288/" class="analytics t-editors-bio-article">Bristol Myers bet pays off as psoriasis drug beats Amgen rival in study</a></h3> <span class="secondary-label">Nov. 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-partners-with-fusion-to-test-radiopharmaceuticals-in-cancer/588201/" class="analytics t-editors-bio-article">AstraZeneca partners with Fusion to test radiopharmaceuticals in cancer</a></h3> <span class="secondary-label">Nov. 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/axovant-shares-sink-on-manufacturing-delay-for-parkinsons-gene-therapy/588130/" class="analytics t-editors-bio-article">Axovant shares sink on manufacturing delay for Parkinson's gene therapy</a></h3> <span class="secondary-label">Oct. 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-veklury-remdesivir-covid-19-drug-sales/587974/" class="analytics t-editors-bio-article">Gilead lifted by fast sales of COVID-19 drug Veklury. Will they last?</a></h3> <span class="secondary-label">Oct. 29, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-coronavirus-antibody-warp-speed-supply-deal/587924/" class="analytics t-editors-bio-article">US to pay Lilly $375M for supply of COVID-19 drug</a></h3> <span class="secondary-label">Oct. 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-coronavirus-vaccine-advisory-meeting-takeaways/587665/" class="analytics t-editors-bio-article">5 takeaways from the FDA's closely watched coronavirus vaccine meeting</a></h3> <span class="secondary-label">Oct. 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-clear-restart-astrazeneca-coronavirus-vaccine-trial/587688/" class="analytics t-editors-bio-article">AstraZeneca, J&J cleared to restart major coronavirus vaccine studies</a></h3> <span class="secondary-label">Oct. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ultragenyx-solid-bio-duchenne-gene-therapy/587639/" class="analytics t-editors-bio-article">Ultragenyx expands into Duchenne gene therapy with Solid Bio deal</a></h3> <span class="secondary-label">Oct. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-meeting-coronavirus-vaccine-approval-impact/587601/" class="analytics t-editors-bio-article">At key meeting, FDA advisors debate if early coronavirus vaccine approvals may compromise trials</a></h3> <span class="secondary-label">Oct. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-trial-enrollment/587547/" class="analytics t-editors-bio-article">Moderna enrolls final volunteers into key coronavirus vaccine study</a></h3> <span class="secondary-label">Oct. 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-pneumococcal-vaccine-study-data/587375/" class="analytics t-editors-bio-article">Merck, with more study data, builds case for pneumonia vaccine successor</a></h3> <span class="secondary-label">Oct. 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intellia-crispr-gene-editing-study-uk/587284/" class="analytics t-editors-bio-article">Intellia cleared to start key CRISPR drug study in UK</a></h3> <span class="secondary-label">Oct. 19, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/remdesivir-gilead-who-study-little-effect-mortality/587187/" class="analytics t-editors-bio-article">Gilead's COVID-19 drug doesn't prevent deaths, large WHO study finds</a></h3> <span class="secondary-label">Oct. 16, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-fujifilm-covid-antibody-drug-manufacturing/587121/" class="analytics t-editors-bio-article">Fujifilm to help Lilly make COVID-19 antibody drug</a></h3> <span class="secondary-label">Oct. 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-ebola-drug-regeneron-first-approval/587066/" class="analytics t-editors-bio-article">FDA approves Regeneron antibody drug as first Ebola virus treatment</a></h3> <span class="secondary-label">Oct. 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nih-study-of-lilly-covid-19-antibody-drug-paused-for-safety-review/586940/" class="analytics t-editors-bio-article">NIH study of Lilly COVID-19 antibody drug paused for safety review</a></h3> <span class="secondary-label">Oct. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-study-pause/586885/" class="analytics t-editors-bio-article">J&J halts studies of coronavirus vaccine due to participant's illness</a></h3> <span class="secondary-label">Oct. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mallinckrodt-bankruptcy-chapter-11-opioids/586836/" class="analytics t-editors-bio-article">Mallinckrodt, beset by opioid drug suits, files for bankruptcy</a></h3> <span class="secondary-label">Oct. 12, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-coronavirus-antibody-barda-phase-3/586795/" class="analytics t-editors-bio-article">US backs AstraZeneca COVID-19 antibody drug with $486M in funding</a></h3> <span class="secondary-label">Oct. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-nih-hyperimmune-plasma-coronavirus-trial/586761/" class="analytics t-editors-bio-article">Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL</a></h3> <span class="secondary-label">Oct. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-cyotkinetics-heart-failure-drug-study/586667/" class="analytics t-editors-bio-article">Amgen and Cytokinetics claim heart drug success, but results widely disappoint</a></h3> <span class="secondary-label">Oct. 8, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-coronavirus-vaccine-guidelines-release-eua/586507/" class="analytics t-editors-bio-article">FDA releases coronavirus vaccine guidelines that White House resisted</a></h3> <span class="secondary-label">Oct. 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-coronavirus-vaccine-authorization-guidelines-election/586481/" class="analytics t-editors-bio-article">FDA told coronavirus vaccine makers of stricter standards for early approval</a></h3> <span class="secondary-label">Oct. 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-coronavirus-regeneron-antibody/586354/" class="analytics t-editors-bio-article">Trump treated for COVID-19 with Regeneron, Gilead drugs</a></h3> <span class="secondary-label">Oct. 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-roger-perlmutter-retire-dean-li/586310/" class="analytics t-editors-bio-article">Merck research chief Roger Perlmutter to retire, leaving immunotherapy legacy</a></h3> <span class="secondary-label">Oct. 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-veklury-supply-us-distribution/586266/" class="analytics t-editors-bio-article">Gilead to distribute COVID-19 drug Veklury in US, taking over from federal government</a></h3> <span class="secondary-label">Oct. 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amag-covis-acquire-deal-ciraparantag/586247/" class="analytics t-editors-bio-article">Private equity-backed Covis to buy AMAG Pharma in $650M deal</a></h3> <span class="secondary-label">Oct. 1, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/house-oversight-drug-pricing-revlimid-copaxone/586173/" class="analytics t-editors-bio-article">Sales targets and bonuses drove Celgene, Teva drug price hikes, lawmakers charge</a></h3> <span class="secondary-label">Oct. 1, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approval-decisions-fourth-quarter-2020/586055/" class="analytics t-editors-bio-article">5 FDA approval decisions to watch in the 4th quarter</a></h3> <span class="secondary-label">Sept. 29, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-first-data/585910/" class="analytics t-editors-bio-article">J&J, beginning final test, shares first data on coronavirus vaccine</a></h3> <span class="secondary-label">Sept. 25, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-manufacturing-industrial-scale/585850/" class="analytics t-editors-bio-article">Drugmakers push forward on large-scale production of coronavirus vaccines</a></h3> <span class="secondary-label">Sept. 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-coronavirus-vaccine-authorization-trump-azar/585830/" class="analytics t-editors-bio-article">Trump undercuts FDA on coronavirus vaccine authorization plans</a></h3> <span class="secondary-label">Sept. 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-phase-3-study-start/585751/" class="analytics t-editors-bio-article">J&J begins largest Phase 3 study of a coronavirus vaccine</a></h3> <span class="secondary-label">Sept. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/blueprint-ayvakit-mastocytosis-study-independent/585666/" class="analytics t-editors-bio-article">Blueprint's bet on itself pays off with rare disease drug data</a></h3> <span class="secondary-label">Sept. 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-esmo-cancer-drug-pipeline-tigit/585586/" class="analytics t-editors-bio-article">Merck matches Roche in search for next cancer immunotherapy</a></h3> <span class="secondary-label">Sept. 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-sotorasib-kras-cancer-esmo/585544/" class="analytics t-editors-bio-article">Amgen's KRAS drug can shrink tumors for months, but new data leave room for improvement</a></h3> <span class="secondary-label">Sept. 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-pfizer-mrna-vaccine-seasonal-flu/585410/" class="analytics t-editors-bio-article">Moderna and Pfizer, having shown speed with coronavirus vaccines, see opportunity in seasonal flu</a></h3> <span class="secondary-label">Sept. 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-study-protocol-november/585386/" class="analytics t-editors-bio-article">Vaccine makers, in bid for transparency, disclose detailed plans of coronavirus vaccine trials</a></h3> <span class="secondary-label">Sept. 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-vaccine-october-results-bourla/585265/" class="analytics t-editors-bio-article">Pfizer says coronavirus vaccine study still on track for October readout</a></h3> <span class="secondary-label">Sept. 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-cell-therapy-manufacturing-site/585237/" class="analytics t-editors-bio-article">Takeda adds to cell therapy push with new manufacturing site</a></h3> <span class="secondary-label">Sept. 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-bariticinib-covid-19-recovery-nih-study/585157/" class="analytics t-editors-bio-article">Lilly says its arthritis drug helps speed COVID-19 recovery</a></h3> <span class="secondary-label">Sept. 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-immunomedics-cancer-drug-deal/585122/" class="analytics t-editors-bio-article">Gilead to buy cancer drugmaker Immunomedics for $21B</a></h3> <span class="secondary-label">Sept. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-pharma-ceo-employee-pay-2019/582851/" class="analytics t-editors-bio-article">How biotech and pharma companies pay their CEOs, and their workers</a></h3> <span class="secondary-label">Sept. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-coronavirus-vaccine-hold-safety-review/584868/" class="analytics t-editors-bio-article">Studies of AstraZeneca coronavirus vaccine put on hold for safety review</a></h3> <span class="secondary-label">Sept. 8, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amarin-loses-appeal-vascepa-patents/584678/" class="analytics t-editors-bio-article">Amarin loses appeal of court ruling on heart drug patents</a></h3> <span class="secondary-label">Sept. 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intercept-layoffs-nash-drug/584586/" class="analytics t-editors-bio-article">Intercept, facing long road ahead for NASH drug, lays off quarter of workforce</a></h3> <span class="secondary-label">Sept. 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nih-guidelines-plasma-covid-19-fda/584542/" class="analytics t-editors-bio-article">NIH panel says data doesn't support plasma use for COVID-19</a></h3> <span class="secondary-label">Sept. 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/relay-protein-motion-drug-discovery-vertex/583431/" class="analytics t-editors-bio-article">Relay Therapeutics set out to change how drugs are designed. Can it continue what Vertex began?</a></h3> <span class="secondary-label">Aug. 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-rejection-biomarin-gilead-roctavian-filgotinib/583776/" class="analytics t-editors-bio-article">In major surprise, FDA rejects high-profile therapies from BioMarin, Gilead</a></h3> <span class="secondary-label">Aug. 19, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-principia-deal-multiple-sclerosis/583612/" class="analytics t-editors-bio-article">Sanofi, seeking control of key drug, to buy Principia for $3.7B</a></h3> <span class="secondary-label">Aug. 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/europe-coronavirus-vaccine-supply-astrazeneca-johnson-johnson/583547/" class="analytics t-editors-bio-article">Europe, trailing US, UK, reaches first coronavirus vaccine deal</a></h3> <span class="secondary-label">Aug. 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cansino-rides-coronavirus-vaccine-progress-to-lucrative-shanghai-market-deb/583464/" class="analytics t-editors-bio-article">CanSino rides coronavirus vaccine progress to lucrative Shanghai market debut</a></h3> <span class="secondary-label">Aug. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-us-vaccine-supply-100-million-doses/583343/" class="analytics t-editors-bio-article">Moderna gets $1.5B from US for coronavirus vaccine supply</a></h3> <span class="secondary-label">Aug. 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/russia-coronavirus-vaccine-approval-gamaleya-institute/583308/" class="analytics t-editors-bio-article">Russia, with scant study data, approves coronavirus vaccine</a></h3> <span class="secondary-label">Aug. 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kodak-drug-loan-on-hold-sec-investigation/583205/" class="analytics t-editors-bio-article">US puts Kodak loan on hold after stock scrutiny</a></h3> <span class="secondary-label">Aug. 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/remdesivir-pfizer-gilead-manufacturing-covid-19/583125/" class="analytics t-editors-bio-article">Pfizer to help Gilead produce COVID-19 drug remdesivir</a></h3> <span class="secondary-label">Aug. 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-blenrep-bcma-multiple-myeloma-fda-approval/583055/" class="analytics t-editors-bio-article">GSK wins US approval for first-of-its-kind blood cancer drug</a></h3> <span class="secondary-label">Aug. 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-price-dose/582947/" class="analytics t-editors-bio-article">Moderna sets high price in early coronavirus vaccine supply deals</a></h3> <span class="secondary-label">Aug. 5, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kymriah-novartis-follicular-lymphoma-car-t/582855/" class="analytics t-editors-bio-article">Novartis says CAR-T cancer therapy works in second lymphoma type</a></h3> <span class="secondary-label">Aug. 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bausch-sec-settlement-valeant-philidor/582780/" class="analytics t-editors-bio-article">Bausch Health to pay $45M to settle US charges over Valeant-era accounting</a></h3> <span class="secondary-label">Aug. 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-coronavirus-vaccine-clinical-study/582699/" class="analytics t-editors-bio-article">Merck nears clinical tests for coronavirus vaccine candidates</a></h3> <span class="secondary-label">July 31, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-gsk-coronavirus-vaccine-warp-speed/582654/" class="analytics t-editors-bio-article">US promises $2.1B to Sanofi, GSK in latest coronavirus vaccine deal</a></h3> <span class="secondary-label">July 31, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cerevel-spac-perceptive-public-neuro-drug/582602/" class="analytics t-editors-bio-article">Pfizer spinoff Cerevel to raise $445M in merger with blank-check company</a></h3> <span class="secondary-label">July 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kodak-fujifilm-drug-vaccine-manufacturing/582434/" class="analytics t-editors-bio-article">US taps camera makers for help manufacturing drugs, vaccines</a></h3> <span class="secondary-label">July 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-daiichi-antibody-drug-conjugate-deal-trop2/582345/" class="analytics t-editors-bio-article">AstraZeneca turns again to Daiichi Sankyo for a major cancer drug deal</a></h3> <span class="secondary-label">July 27, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccines-phase-1-lessons-learned/582140/" class="analytics t-editors-bio-article">Early coronavirus vaccine data leave many questions, but some lessons, too</a></h3> <span class="secondary-label">July 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-coronavirus-vaccine-warp-speed-supply/582093/" class="analytics t-editors-bio-article">US to pay nearly $2B for supply of Pfizer, BioNTech coronavirus vaccine</a></h3> <span class="secondary-label">July 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-to-study-use-of-key-sma-drug-after-novartis-gene-therapy/581996/" class="analytics t-editors-bio-article">Biogen to study use of key SMA drug after Novartis gene therapy</a></h3> <span class="secondary-label">July 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-cansino-china-phase-2/581946/" class="analytics t-editors-bio-article">CanSino coronavirus vaccine clears mid-stage test, but data show its limits</a></h3> <span class="secondary-label">July 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-coronavirus-vaccine-clinical-trial/581752/" class="analytics t-editors-bio-article">J&J, on the cusp of starting coronavirus vaccine trials, sets high bar for success</a></h3> <span class="secondary-label">July 16, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-data-nejm/581602/" class="analytics t-editors-bio-article">Researchers publish long-awaited study data on Moderna coronavirus vaccine</a></h3> <span class="secondary-label">July 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-md-anderson-cancer-drug-clinical-trials/581520/" class="analytics t-editors-bio-article">Sanofi turns to MD Anderson to help fuel cancer drug push</a></h3> <span class="secondary-label">July 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/beigene-amgen-investment-cash-raise/581476/" class="analytics t-editors-bio-article">Beigene, already flush with cash, raising $2B from investors</a></h3> <span class="secondary-label">July 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-recovery-uk-study-dexamethasone/581310/" class="analytics t-editors-bio-article">In the UK, a coronavirus study shows how to get fast, powerful data during a pandemic</a></h3> <span class="secondary-label">July 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approval-decisions-third-quarter-2020/581169/" class="analytics t-editors-bio-article">5 FDA approval decisions to watch in the 3rd quarter</a></h3> <span class="secondary-label">July 8, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/noavavax-coronavirus-vaccine-warp-speed/581123/" class="analytics t-editors-bio-article">Novavax gets $1.6B in US funding for coronavirus vaccine</a></h3> <span class="secondary-label">July 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-emergent-coronavirus-vaccine-manufacturing/581047/" class="analytics t-editors-bio-article">J&J, with new deal, plans for long-term manufacture of coronavirus vaccine</a></h3> <span class="secondary-label">July 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-doctor-kickback-bribe-settlement/580948/" class="analytics t-editors-bio-article">Novartis to pay $678M to settle claims over 'sham' doctor events</a></h3> <span class="secondary-label">July 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-biontech-coronavirus-vaccine-phase-1-results/580877/" class="analytics t-editors-bio-article">Coronavirus vaccine from Pfizer, BioNTech shows early potential</a></h3> <span class="secondary-label">July 1, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-insists-it-will-not-cut-corners-in-coronavirus-vaccine-approvals/580833/" class="analytics t-editors-bio-article">FDA insists it 'will not cut corners' in coronavirus vaccine approvals</a></h3> <span class="secondary-label">June 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/recovery-kaletra-coronavirus-trial-results/580792/" class="analytics t-editors-bio-article">Large UK study finds no benefit to HIV antiviral in COVID-19</a></h3> <span class="secondary-label">June 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-price-covid-19/580701/" class="analytics t-editors-bio-article">Gilead sets price for COVID-19 drug remdesivir</a></h3> <span class="secondary-label">June 29, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-who-2-billion-doses/580637/" class="analytics t-editors-bio-article">WHO lays out ambitious plan to deliver 2 billion coronavirus vaccine doses</a></h3> <span class="secondary-label">June 26, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-translate-coronavirus-vaccine-accelerate-testing/580354/" class="analytics t-editors-bio-article">Trailing leaders, Sanofi speeds coronavirus vaccine plans</a></h3> <span class="secondary-label">June 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-coronavirus-remdesivir-inhaled/580285/" class="analytics t-editors-bio-article">Gilead to launch studies of inhaled version of COVID-19 drug remdesivir</a></h3> <span class="secondary-label">June 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-pneumococcal-vaccine-phase-3-results/580250/" class="analytics t-editors-bio-article">Merck gives 1st look at Phase 3 results for its Prevnar competitor</a></h3> <span class="secondary-label">June 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clover-gsk-dynavax-coronavirus-vaccine-study/580180/" class="analytics t-editors-bio-article">Chinese biotech to test GSK, Dynavax adjuvants in coronavirus vaccine study</a></h3> <span class="secondary-label">June 19, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-price-value-based-trump-medicaid-rule/580099/" class="analytics t-editors-bio-article">With new proposal, Trump administration tries to encourage 'value-based' drug deals</a></h3> <span class="secondary-label">June 18, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/warp-speed-coronavirus-vaccine-benefits/579991/" class="analytics t-editors-bio-article">'Warp Speed' plan for coronavirus vaccines comes into focus</a></h3> <span class="secondary-label">June 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hydroxychloroquine-fda-revoke-emergency-authorization/579826/" class="analytics t-editors-bio-article">FDA revokes emergency clearance for hydroxychloroquine, citing new data, risks</a></h3> <span class="secondary-label">June 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sinovac-coronavirus-vaccine-study-results/579797/" class="analytics t-editors-bio-article">Sinovac claims progress with early coronavirus vaccine study</a></h3> <span class="secondary-label">June 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-vertex-bluebird-sickle-cell-thalassemia-study-update/579692/" class="analytics t-editors-bio-article">New CRISPR, gene therapy results strengthen potential for treatment of blood diseases</a></h3> <span class="secondary-label">June 12, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccines-vials-corning-sio2-barda/579491/" class="analytics t-editors-bio-article">US invests in drug vials to support coronavirus vaccine push</a></h3> <span class="secondary-label">June 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-pipeline-types/579122/" class="analytics t-editors-bio-article">Coronavirus vaccines are rolling out quickly. Here's where the pipeline stands.</a></h3> <span class="secondary-label">June 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-junshi-coronavirus-antibody-study/579374/" class="analytics t-editors-bio-article">Lilly gets a 2nd COVID-19 antibody into clinical trials with Junshi's help</a></h3> <span class="secondary-label">June 8, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hydroxycholoroquine-recovery-uk-study-results/579299/" class="analytics t-editors-bio-article">Case for hydroxychloroquine in COVID-19 fades as key UK study finds no benefit</a></h3> <span class="secondary-label">June 5, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-warp-speed-finalists/579206/" class="analytics t-editors-bio-article">'Warp Speed' push for coronavirus vaccine accelerates as White House reportedly narrows field</a></h3> <span class="secondary-label">June 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hydroxychloroquine-coronavirus-first-placebo-study-minnesota/579154/" class="analytics t-editors-bio-article">Hydroxychloroquine offers no COVID-19 protection after exposure, study shows</a></h3> <span class="secondary-label">June 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/emergent-coronavirus-vaccine-barda-manufacturing/579034/" class="analytics t-editors-bio-article">US government promises Maryland drug manufacturer $628M to make coronavirus vaccines</a></h3> <span class="secondary-label">June 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-cancer-covid-19-nci-sharpless/578898/" class="analytics t-editors-bio-article">COVID-19 could slow progress in reducing cancer death, NCI head warns</a></h3> <span class="secondary-label">June 1, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-vials-supply-bottleneck/578793/" class="analytics t-editors-bio-article">Facing vial shortage, pharmas explore workarounds for coronavirus vaccines</a></h3> <span class="secondary-label">May 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-phase-3-studies-pfizer-astrazeneca-johnson/578765/" class="analytics t-editors-bio-article">Coronavirus vaccine developers plan to enroll tens of thousands in late-stage tests</a></h3> <span class="secondary-label">May 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-coronavirus-vaccine-themis-iavi-ridgeback/578575/" class="analytics t-editors-bio-article">Merck makes COVID-19 drug plans clear with flurry of deals</a></h3> <span class="secondary-label">May 26, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-nejm-nih-results/578545/" class="analytics t-editors-bio-article">New study details show remdesivir speeds COVID-19 recovery, but doesn't help sickest patients</a></h3> <span class="secondary-label">May 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cansino-coronavirus-vaccine-phase-1-results-china/578508/" class="analytics t-editors-bio-article">Coronavirus study in China shows CanSino's vaccine spurs immune responses</a></h3> <span class="secondary-label">May 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-stock-offering-moderna/578223/" class="analytics t-editors-bio-article">Biotech companies raise cash as coronavirus updates lift stocks</a></h3> <span class="secondary-label">May 19, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-vaccine-warp-speed-trump/578057/" class="analytics t-editors-bio-article">'Operation Warp Speed,' unveiled by Trump, aims for coronavirus vaccine by year's end</a></h3> <span class="secondary-label">May 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-abstract-cancer-biotech-allogene/577961/" class="analytics t-editors-bio-article">Cancer biotech stocks shift on glimpse of ASCO data</a></h3> <span class="secondary-label">May 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-first-tigit-data-asco-tiragolumab/577897/" class="analytics t-editors-bio-article">Roche unveils first data for new type of cancer immunotherapy</a></h3> <span class="secondary-label">May 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-bluebird-fda-refuse-cell-therapy-application/577856/" class="analytics t-editors-bio-article">Surprise setback for Bristol, Bluebird as FDA rejects cell therapy application</a></h3> <span class="secondary-label">May 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-distribution-hhs-states/577635/" class="analytics t-editors-bio-article">Trump administration: States to decide which hospitals get Gilead's COVID-19 drug</a></h3> <span class="secondary-label">May 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-retevmo-fda-approval-loxo/577632/" class="analytics t-editors-bio-article">Lilly's Loxo buyout bears fruit as FDA clears cancer drug Retevmo</a></h3> <span class="secondary-label">May 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-vaccine-phase-3-summer/577568/" class="analytics t-editors-bio-article">Moderna plans earlier start to late-stage test of coronavirus vaccine</a></h3> <span class="secondary-label">May 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ousted-barda-director-claims-retaliation-for-pushing-back-on-unproven-coron/577418/" class="analytics t-editors-bio-article">Ousted BARDA director claims retaliation for pushing back on unproven coronavirus drugs</a></h3> <span class="secondary-label">May 5, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alexion-portola-acquire-andexxa-hematology/577369/" class="analytics t-editors-bio-article">Alexion, seeking to broaden business, to buy Portola for $1.4B</a></h3> <span class="secondary-label">May 5, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-icer-coronavirus-drug-price/577282/" class="analytics t-editors-bio-article">With new estimate, ICER sets terms of debate on pricing Gilead's COVID-19 drug</a></h3> <span class="secondary-label">May 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-coronavirus-fda-emergency-authorization/577027/" class="analytics t-editors-bio-article">Gilead's remdesivir, shown to hasten COVID-19 recovery, cleared for emergency use by FDA</a></h3> <span class="secondary-label">May 1, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-coronavirus-drug-profit/577189/" class="analytics t-editors-bio-article">Gilead may have a drug for COVID-19. Wall Street asks whether it will profit</a></h3> <span class="secondary-label">May 1, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-remdesivir-coronavirus-nih-study-win/577066/" class="analytics t-editors-bio-article">'We really did need a win.' Gilead drug no knockout in COVID-19, but results spur optimism</a></h3> <span class="secondary-label">April 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-remdesivir-gilead-nih-study-results/576330/" class="analytics t-editors-bio-article">Gilead drug for COVID-19 clears crucial clinical test</a></h3> <span class="secondary-label">April 29, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-covid-19-business-impact-earnings/576907/" class="analytics t-editors-bio-article">Pharmas boosted by drug stockpiling, but warn of COVID-19 impact</a></h3> <span class="secondary-label">April 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-cemiplimab-lung-cancer-survival-benefit/576800/" class="analytics t-editors-bio-article">Regeneron, Sanofi immunotherapy extends survival in previously untreated lung cancer</a></h3> <span class="secondary-label">April 27, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-sanofi-kevzara-study-results-imminent/576733/" class="analytics t-editors-bio-article">Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'</a></h3> <span class="secondary-label">April 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-remdesivir-gilead-data-china-study/576657/" class="analytics t-editors-bio-article">Leaked data on Gilead's remdesivir suggest drug didn't help patients with COVID-19</a></h3> <span class="secondary-label">April 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/immunomedics-fda-approval-trodelvy-breast-cancer/576563/" class="analytics t-editors-bio-article">Immunomedics wins long-sought FDA approval for breast cancer drug</a></h3> <span class="secondary-label">April 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-pfizer-biontech-vaccine-study-start-germany/576522/" class="analytics t-editors-bio-article">Coronavirus vaccine from BioNTech, Pfizer set to enter testing in Germany</a></h3> <span class="secondary-label">April 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/barda-director-depart-rick-bright-coronavirus/576471/" class="analytics t-editors-bio-article">BARDA director says he was ousted for 'clashes' with HHS over unproven therapies</a></h3> <span class="secondary-label">April 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-hydroxychloroquine-placebo-study/576344/" class="analytics t-editors-bio-article">Novartis, launching COVID-19 trial, seeks to prove hydroxychloroquine's worth</a></h3> <span class="secondary-label">April 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-moderna-barda-vaccine-manufacturing/576217/" class="analytics t-editors-bio-article">US government to back Moderna's coronavirus vaccine with up to $483M</a></h3> <span class="secondary-label">April 16, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-ebola-antibody-fda-review/576175/" class="analytics t-editors-bio-article">As Ebola drug review starts, Regeneron hopes to chart similar path for coronavirus therapy</a></h3> <span class="secondary-label">April 16, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-astrazeneca-calquence-cytokine-storm/576083/" class="analytics t-editors-bio-article">AstraZeneca to study leukemia drug as COVID-19 treatment</a></h3> <span class="secondary-label">April 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-sanofi-gsk-vaccine-partnership/575965/" class="analytics t-editors-bio-article">In rare move, Sanofi and GSK ally on coronavirus vaccine development</a></h3> <span class="secondary-label">April 14, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-remdesivir-gilead-compassionate-use-nejm/575862/" class="analytics t-editors-bio-article">Early data on Gilead coronavirus drug raises hope, but answers few questions</a></h3> <span class="secondary-label">April 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-pfizer-biontech-mrna-vaccine-april/575806/" class="analytics t-editors-bio-article">Pfizer accelerates clinical trial plans for coronavirus drug</a></h3> <span class="secondary-label">April 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-restructuring-layoffs-340-employees/575641/" class="analytics t-editors-bio-article">Sage to lay off half of workforce in cost-cutting retrenchment</a></h3> <span class="secondary-label">April 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-inovio-vaccine-first-dose-human/575607/" class="analytics t-editors-bio-article">Inovio begins first human test of experimental coronavirus vaccine</a></h3> <span class="secondary-label">April 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-remdesivir-gilead-production-donate-doses/575508/" class="analytics t-editors-bio-article">Gilead working to quickly boost production of experimental coronavirus drug</a></h3> <span class="secondary-label">April 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-jakafi-incyte-novartis-cytokine-storm/575450/" class="analytics t-editors-bio-article">Incyte, Novartis to test repurposed cancer drug in COVID-19</a></h3> <span class="secondary-label">April 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-amgen-adaptive-antibody-covid/575363/" class="analytics t-editors-bio-article">Amgen, partnering with Seattle's Adaptive, begins coronavirus drug search</a></h3> <span class="secondary-label">April 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amarin-vascepa-court-defeat-generic/575201/" class="analytics t-editors-bio-article">Amarin shares slump as surprising court defeat puts Vascepa at risk</a></h3> <span class="secondary-label">March 31, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-fda-data-review-form-483/575142/" class="analytics t-editors-bio-article">No sanctions for Novartis as FDA ends review of gene therapy violations</a></h3> <span class="secondary-label">March 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-fda-chloroquine-emergency-use/575097/" class="analytics t-editors-bio-article">FDA clears emergency use of malaria pills to treat COVID-19</a></h3> <span class="secondary-label">March 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-car-t-cancer-therapy-bristol-gilead-novartis/575031/" class="analytics t-editors-bio-article">For CAR-T, coronavirus brings uneven impact to studies, treatment</a></h3> <span class="secondary-label">March 27, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-silence-rnai-deal/574850/" class="analytics t-editors-bio-article">AstraZeneca turns again to UK's Silence in renewed RNAi push</a></h3> <span class="secondary-label">March 25, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-asco-cancel-virtual-online-meeting/574767/" class="analytics t-editors-bio-article">Coronavirus forces ASCO, cancer research's top meeting, to move online</a></h3> <span class="secondary-label">March 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-gilead-pause-compassionate-use-remdesivir/574662/" class="analytics t-editors-bio-article">Gilead, flooded with requests, suspends access to experimental coronavirus drug</a></h3> <span class="secondary-label">March 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-chloroquine-mylan-teva-manufacturing/574572/" class="analytics t-editors-bio-article">Drugmakers boost production of malaria pill touted by Trump as coronavirus treatment</a></h3> <span class="secondary-label">March 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-kaletra-clinical-trial-nejm/574435/" class="analytics t-editors-bio-article">Despite 'heroic' effort, coronavirus study finds little benefit to repurposed HIV drug</a></h3> <span class="secondary-label">March 18, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-redraws-plans-zuranolone-antidepressant-new-studies/574392/" class="analytics t-editors-bio-article">Sage redraws its plans for failed antidepressant drug</a></h3> <span class="secondary-label">March 18, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-pharma-sales-representatives-pause-visits/574241/" class="analytics t-editors-bio-article">Pharma salesforces brought to a halt as coronavirus shutters economy</a></h3> <span class="secondary-label">March 17, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-curevac-trump-access-research-us/574181/" class="analytics t-editors-bio-article">Germany's CureVac, the subject of a reported US overture, thrust into coronavirus spotlight</a></h3> <span class="secondary-label">March 16, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-lilly-abcellera-antibody-treatment/574100/" class="analytics t-editors-bio-article">With AbCellera deal, Lilly becomes latest pharma to start coronavirus program</a></h3> <span class="secondary-label">March 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/curevac-coronavirus-replace-ceo-menichella/574015/" class="analytics t-editors-bio-article">CureVac CEO replaced in midst of biotech's coronavirus push</a></h3> <span class="secondary-label">March 12, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-coronavirus-postpone-annual-meeting/573926/" class="analytics t-editors-bio-article">Facing coronavirus risk, a top cancer group postpones annual meeting</a></h3> <span class="secondary-label">March 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-takeda-multiple-myeloma-drugs-fall-short/573813/" class="analytics t-editors-bio-article">2 newer multiple myeloma drugs fall short in bid for wider market</a></h3> <span class="secondary-label">March 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-biogen-takeda-coronavirus-employees-work-remote/573714/" class="analytics t-editors-bio-article">As US coronavirus cases mount, top drugmakers tell employees to work from home</a></h3> <span class="secondary-label">March 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-medical-meetings-coronavirus-risk-cancelations/573642/" class="analytics t-editors-bio-article">Coronavirus spread threatens spring slate of medical meetings</a></h3> <span class="secondary-label">March 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-remdesivir-gilead-antiviral-drug-covid-19/573261/" class="analytics t-editors-bio-article">A closer look at the Ebola drug that's become the top hope for a coronavirus treatment</a></h3> <span class="secondary-label">March 5, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-editas-first-patient-dose-lca10-blindness/573466/" class="analytics t-editors-bio-article">In a CRISPR first, Editas therapy used to fix genes in the body</a></h3> <span class="secondary-label">March 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-prices-profits-too-high-jama-study/573376/" class="analytics t-editors-bio-article">High prices fuel pharma profits. New research provides more context</a></h3> <span class="secondary-label">March 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-fda-approval-sarclisa-multiple-myeloma/571086/" class="analytics t-editors-bio-article">Sanofi wins US approval for myeloma drug key to its cancer ambitions</a></h3> <span class="secondary-label">March 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/unum-restructures-layoffs-cell-therapy-pivot/573306/" class="analytics t-editors-bio-article">Cell therapy developer Unum restructures, cutting staff in pivot</a></h3> <span class="secondary-label">March 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/karyopharm-xpovio-boston-fda-multiple-myeloma/573277/" class="analytics t-editors-bio-article">Karyopharm shares jump on positive study data for multiple myeloma drug</a></h3> <span class="secondary-label">March 2, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-drug-shortage-coronavirus-first-impact/573190/" class="analytics t-editors-bio-article">FDA reports first drug shortage due to coronavirus impact</a></h3> <span class="secondary-label">Feb. 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-launch-phase-3-studies-remdesivir-coronavirus/573089/" class="analytics t-editors-bio-article">Gilead commits to in-house development of coronavirus treatment hopeful</a></h3> <span class="secondary-label">Feb. 27, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-heart-drug-omecamtiv-interim-check-2020-data/573030/" class="analytics t-editors-bio-article">Amgen heart drug passes interim check, setting up year-end readout</a></h3> <span class="secondary-label">Feb. 26, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coronavirus-us-clinical-trial-remdesivir-gilead/572920/" class="analytics t-editors-bio-article">US begins first study of coronavirus treatment, testing Gilead's remdesivir</a></h3> <span class="secondary-label">Feb. 25, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-spin-out-drug-ingredient-manufacturing-new-company/572842/" class="analytics t-editors-bio-article">As shortages draw spotlight, Sanofi to spin out drug ingredient business</a></h3> <span class="secondary-label">Feb. 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-clover-china-adjuvant-vaccine-coronavirus/572813/" class="analytics t-editors-bio-article">Chinese biotech enlists GSK in coronavirus vaccine effort</a></h3> <span class="secondary-label">Feb. 24, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/zolgensma-manufacturing-durham-novartis/572731/" class="analytics t-editors-bio-article">With supply tight, Novartis readies gene therapy plant for production</a></h3> <span class="secondary-label">Feb. 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/immatics-glaxosmithkline-t-cell-immunotherapy/572649/" class="analytics t-editors-bio-article">GSK taps Immatics' cell therapy science in research deal</a></h3> <span class="secondary-label">Feb. 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tocagen-forte-restructuring-ends-reverse-merger/572635/" class="analytics t-editors-bio-article">Tocagen restructuring leads to reverse merger with Forte</a></h3> <span class="secondary-label">Feb. 20, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/belcher-price-increase-biopharma-executive-criticism-letter/572547/" class="analytics t-editors-bio-article">Biotech executives, having pledged fair pricing, criticize drugmaker for steep hike</a></h3> <span class="secondary-label">Feb. 19, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/audentes-gene-therapy-manufacturing-sanford-north-carolina-plant/572494/" class="analytics t-editors-bio-article">Audentes to spend $110M on new gene therapy plant in North Carolina</a></h3> <span class="secondary-label">Feb. 18, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-coronavirus-vaccine-barda/572449/" class="analytics t-editors-bio-article">Sanofi starts work on coronavirus vaccine, bringing scale to global research effort</a></h3> <span class="secondary-label">Feb. 18, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-liso-cel-car-t-speedy-fda-review/572273/" class="analytics t-editors-bio-article">Bristol-Myers finds FDA receptive to speedy review of key cell therapy</a></h3> <span class="secondary-label">Feb. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-barda-coronavirus-vaccine-research/572189/" class="analytics t-editors-bio-article">J&J bolsters coronavirus vaccine work with BARDA partnership</a></h3> <span class="secondary-label">Feb. 12, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-executives-depart-ameet-nathwani-restructuring/572179/" class="analytics t-editors-bio-article">Sanofi shrinks executive team as new CEO reshapes French drugmaker</a></h3> <span class="secondary-label">Feb. 12, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-coronavirus-mrna-vaccine-cash-raise/572095/" class="analytics t-editors-bio-article">Moderna, raising cash, quickly advances coronavirus candidate</a></h3> <span class="secondary-label">Feb. 11, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biohaven-anxiety-study-troriluzole-study-failure/572001/" class="analytics t-editors-bio-article">Biohaven misses a chance to prove it's more than migraine</a></h3> <span class="secondary-label">Feb. 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-skyrizi-rinvoq-launch-humira-replace/571919/" class="analytics t-editors-bio-article">AbbVie's plan to replace Humira is ahead of schedule</a></h3> <span class="secondary-label">Feb. 7, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cell-therapy-car-nk-md-anderson-takeda-nejm/571827/" class="analytics t-editors-bio-article">In small study, hints of promise for 'natural killer' cell therapy</a></h3> <span class="secondary-label">Feb. 6, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-yescarta-cell-therapy-writedown-deal-pressure/571762/" class="analytics t-editors-bio-article">Kite isn't flying with investors, and Gilead knows it</a></h3> <span class="secondary-label">Feb. 5, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-hhs-coronavirus-antibody-development/571651/" class="analytics t-editors-bio-article">Regeneron partners with US government to develop coronavirus treatment</a></h3> <span class="secondary-label">Feb. 4, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-gsk-coronavirus-antiviral-clinical-trial/571583/" class="analytics t-editors-bio-article">Antiviral drugmakers GSK, Gilead join fight against coronavirus' spread</a></h3> <span class="secondary-label">Feb. 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-diversity-leadership-women-bio-report/571495/" class="analytics t-editors-bio-article">Biotech lacking diverse leadership, top trade group admits</a></h3> <span class="secondary-label">Jan. 31, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-trikafta-launch-cystic-fibrosis-leiden/571452/" class="analytics t-editors-bio-article">Vertex impresses with strong Trikafta launch</a></h3> <span class="secondary-label">Jan. 30, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-discontinue-advair-generic-mylan-glaxosmithkline/571347/" class="analytics t-editors-bio-article">Novartis gives up on Advair generic, leaving Mylan as sole competitor</a></h3> <span class="secondary-label">Jan. 29, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-gene-therapy-sales-momentum/571302/" class="analytics t-editors-bio-article">Zolgensma sales grow, signaling gene therapy momentum</a></h3> <span class="secondary-label">Jan. 29, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-gene-therapy-guidance-sameness-durability/571225/" class="analytics t-editors-bio-article">FDA, expecting a gene therapy boom, firms up policies</a></h3> <span class="secondary-label">Jan. 28, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-wuhan-coronavirus-vaccine-stoffels/571132/" class="analytics t-editors-bio-article">J&J launches vaccine efforts as coronavirus spreads</a></h3> <span class="secondary-label">Jan. 27, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/epizyme-tazverik-fda-approval-epithelioid-sarcoma/571007/" class="analytics t-editors-bio-article">Epizyme drug granted approval by FDA for rare cancer</a></h3> <span class="secondary-label">Jan. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-carbon-negative-2030-climate-inhalers/570958/" class="analytics t-editors-bio-article">AstraZeneca pledges to go 'carbon negative' by 2030</a></h3> <span class="secondary-label">Jan. 23, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ionis-akcea-triglyceride-fcs-phase-2-success-novartis/570865/" class="analytics t-editors-bio-article">Drug trial success a consolation prize for Akcea, Ionis</a></h3> <span class="secondary-label">Jan. 22, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-biopharma-earnings-watch-novartis-biogen-lilly-global-blood-bluebird/570765/" class="analytics t-editors-bio-article">5 biopharmas to watch as the decade's last earnings kick off</a></h3> <span class="secondary-label">Jan. 21, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biontech-buy-neon-cancer-cell-therapy/570584/" class="analytics t-editors-bio-article">BioNTech rescues cancer biotech Neon in bargain buyout</a></h3> <span class="secondary-label">Jan. 16, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-half-price-insulin-humalog/570520/" class="analytics t-editors-bio-article">Lilly expands half-price insulin offerings</a></h3> <span class="secondary-label">Jan. 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nationwide-childrens-gene-therapy-manufacturing-andelyn-launch/570397/" class="analytics t-editors-bio-article">Nationwide Children's, a gene therapy leader, launches manufacturing spinout</a></h3> <span class="secondary-label">Jan. 15, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-morphosys-license-deal-tafasitimab/570297/" class="analytics t-editors-bio-article">Incyte turns to German Morphosys to refresh cancer pipeline</a></h3> <span class="secondary-label">Jan. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eqrx-launch-alexis-borisy-drug-price-competition/570266/" class="analytics t-editors-bio-article">A biotech startup launches with unusual goal: invent new drugs, and sell them for less</a></h3> <span class="secondary-label">Jan. 13, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/blueprint-Ayvakit-FDA-approval-GIST-cancer/570223/" class="analytics t-editors-bio-article">Blueprint wins 1st FDA approval with targeted cancer drug</a></h3> <span class="secondary-label">Jan. 10, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-trends-2020/569957/" class="analytics t-editors-bio-article">5 biotech trends to follow in 2020</a></h3> <span class="secondary-label">Jan. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ardena-cdmo-bought-gho-capital-private-equity/570157/" class="analytics t-editors-bio-article">Belgian CDMO Ardena gets new private equity owners</a></h3> <span class="secondary-label">Jan. 9, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/us-cancer-death-rate-drops-by-most-on-record/570039/" class="analytics t-editors-bio-article">US cancer death rate drops by most on record</a></h3> <span class="secondary-label">Jan. 8, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-trial-setback-itacitinib-gvhd-gravitas/569763/" class="analytics t-editors-bio-article">Trial failure keeps Incyte searching for its next act</a></h3> <span class="secondary-label">Jan. 3, 2020</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/stealth-phase-3-setback-elamipretide-alexion/569521/" class="analytics t-editors-bio-article">Stealth's rare disease drug falls short in study, sinking shares</a></h3> <span class="secondary-label">Dec. 20, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bladder-cancer-approval-gives-seattle-genetics-its-second-drug/569432/" class="analytics t-editors-bio-article">Bladder cancer approval gives Seattle Genetics its second drug</a></h3> <span class="secondary-label">Dec. 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-importation-trump-plan-prices-canada/569323/" class="analytics t-editors-bio-article">Trump administration lays out plans to import drugs from abroad</a></h3> <span class="secondary-label">Dec. 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-advances-blood-cancer-drug-to-fda-but-rivals-threaten/569243/" class="analytics t-editors-bio-article">GSK advances blood cancer drug to FDA, but rivals threaten</a></h3> <span class="secondary-label">Dec. 17, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ftc-clear-roche-spark-gene-therapy-deal/569206/" class="analytics t-editors-bio-article">Roche's $4.8B deal for Spark cleared by FTC after long delay</a></h3> <span class="secondary-label">Dec. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-vosorotide-dwarfism-study-success-fda/569136/" class="analytics t-editors-bio-article">BioMarin drug for dwarfism meets goal in late-stage study</a></h3> <span class="secondary-label">Dec. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-surprise-approval-sarepta-vyondys-53-duchenne-drug/569015/" class="analytics t-editors-bio-article">In stunning twist, FDA approves Sarepta's Duchenne drug it rejected</a></h3> <span class="secondary-label">Dec. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-kymriah-car-t-manufacturing-difficulties-cell-viability/568830/" class="analytics t-editors-bio-article">Novartis still hasn't solved its CAR-T manufacturing issues</a></h3> <span class="secondary-label">Dec. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-kite-car-t-christi-shaw-dealmaking/568767/" class="analytics t-editors-bio-article">For an 'acquisitive' Gilead, 2020 will be key test for CAR-T plans</a></h3> <span class="secondary-label">Dec. 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sickle-cell-new-drugs-excite-more-needed-ash/568690/" class="analytics t-editors-bio-article">New drugs for sickle cell excite but, at ASH, a recognition that more is needed</a></h3> <span class="secondary-label">Dec. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/zolgensma-novartis-drug-launch-dive-awards/566260/" class="analytics t-editors-bio-article">Drug Launch of the Year: Zolgensma</a></h3> <span class="secondary-label">Dec. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/josh-bilenker-loxo-lilly-executive-dive-awards/566261/" class="analytics t-editors-bio-article">Executive of the Year: Josh Bilenker, Loxo Oncology</a></h3> <span class="secondary-label">Dec. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-hemophilia-high-dose-ash-progress/568669/" class="analytics t-editors-bio-article">Sangamo keeps pressure on rivals with updated hemophilia data</a></h3> <span class="secondary-label">Dec. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/car-t-multiple-myeloma-bristol-bluebird-janssen-ash/568666/" class="analytics t-editors-bio-article">Myeloma cell therapies, now in pharma hands, move into spotlight</a></h3> <span class="secondary-label">Dec. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-trial-setback-mountain-antidepressant/568513/" class="analytics t-editors-bio-article">Trial setback strikes blow to Sage antidepressant ambitions</a></h3> <span class="secondary-label">Dec. 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-loxo-cancer-research-development-restructuring-josh-bilenker/568492/" class="analytics t-editors-bio-article">Lilly puts its cancer future in Loxo's hands</a></h3> <span class="secondary-label">Dec. 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-buy-audentes-gene-therapy-xlmtm-duchenne/568306/" class="analytics t-editors-bio-article">Astellas joins gene therapy race with $3B Audentes buy</a></h3> <span class="secondary-label">Dec. 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-deny-lexicon-appeal-zynquista-diabetes-drug-rejection/568255/" class="analytics t-editors-bio-article">FDA denies Lexicon bid to reverse diabetes drug rejection</a></h3> <span class="secondary-label">Dec. 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wave-faces-key-test-in-bid-to-challenge-sarepta-in-dmd/568192/" class="analytics t-editors-bio-article">Wave faces key test in bid to challenge Sarepta in DMD</a></h3> <span class="secondary-label">Nov. 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/karuna-a-ha-moment-stock-swing-antipsychotic-drug/568094/" class="analytics t-editors-bio-article">Karuna's 'A-ha moment': A billion-dollar stock swing and new expectations</a></h3> <span class="secondary-label">Nov. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-buys-back-into-rnai-novartis-medicines-company/567984/" class="analytics t-editors-bio-article">Medicines Co. deal caps pharma's reentry into field it once abandoned</a></h3> <span class="secondary-label">Nov. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-buy-medicines-company-cholesterol-drug-inclisiran/567950/" class="analytics t-editors-bio-article">Novartis buys Medicines Co. in $9.7B bet on cholesterol drug</a></h3> <span class="secondary-label">Nov. 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-al-sandrock-defend-decision-fda-alzheimers-aducanumab/567880/" class="analytics t-editors-bio-article">'I believe the drug works.' Biogen CMO defends decision to submit Alzheimer's drug to FDA</a></h3> <span class="secondary-label">Nov. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-hal-barron-ai-drug-discovery-prediction-daphne-koller/567855/" class="analytics t-editors-bio-article">AI's impact in drug discovery is coming fast, predicts GSK's Hal Barron</a></h3> <span class="secondary-label">Nov. 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-car-t-gene-therapy-research-andy-plump/567640/" class="analytics t-editors-bio-article">Takeda sees cell, gene therapy in its future. Is it too late?</a></h3> <span class="secondary-label">Nov. 20, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-vertex-gene-editing-data-sickle-cell-beta-thalassemia/567557/" class="analytics t-editors-bio-article">First look at CRISPR, Vertex gene-editing therapy hints at treatment potential</a></h3> <span class="secondary-label">Nov. 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-vincristine-restart-production-shortage-pfizer/567284/" class="analytics t-editors-bio-article">Teva to restart production of cancer drug after shortages stressed treatment</a></h3> <span class="secondary-label">Nov. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-zulresso-slow-start-focus-depression-data-mountain/567234/" class="analytics t-editors-bio-article">Sage's new drug starts slow, as Wall Street waits for depression data</a></h3> <span class="secondary-label">Nov. 13, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amarin-fda-documents-vascepa-advisory-committee/567130/" class="analytics t-editors-bio-article">FDA documents appear to clear Amarin path to wider heart drug approval</a></h3> <span class="secondary-label">Nov. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regenxbio-sues-fda-clinical-hold-gene-therapy-wet-amd/567049/" class="analytics t-editors-bio-article">Regenxbio, stung by trial hold on gene therapy, sues FDA</a></h3> <span class="secondary-label">Nov. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-win-fda-approval-luspatercept-reblozyl-beta-thalassemia/566968/" class="analytics t-editors-bio-article">FDA approves first drug for anemia tied to rare blood disorder</a></h3> <span class="secondary-label">Nov. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/anaptysbio-shares-collapse-etokimab-fails-phase-2/566954/" class="analytics t-editors-bio-article">AnaptysBio shares collapse after 'worst case scenario' for key drug</a></h3> <span class="secondary-label">Nov. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-administration-sue-gilead-prep-hiv-patents-truvada/566834/" class="analytics t-editors-bio-article">Trump administration sues Gilead over HIV drug patents</a></h3> <span class="secondary-label">Nov. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-biosimilar-samsung-bioepis-lucentis-eylea/566728/" class="analytics t-editors-bio-article">Biogen broadens biosimilar bet to go after top-selling eye drugs</a></h3> <span class="secondary-label">Nov. 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-libtayo-immunotherapy-challenge-merck-lung-cancer/566643/" class="analytics t-editors-bio-article">Regeneron defends bid to challenge Merck in lung cancer</a></h3> <span class="secondary-label">Nov. 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/china-alzheimers-drug-oligomannate-approval-green-valley/566540/" class="analytics t-editors-bio-article">China approves Alzheimer's drug, inviting fresh debate in field with few successes</a></h3> <span class="secondary-label">Nov. 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/stephen-hahn-nominated-fda-commissioner-trump/566418/" class="analytics t-editors-bio-article">Stephen Hahn, top MD Anderson official, will be next FDA chief</a></h3> <span class="secondary-label">Nov. 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roivant-sumitomo-cystic-fibrosis-unveil-spirovant/566335/" class="analytics t-editors-bio-article">Roivant, Sumitomo alliance to target cystic fibrosis gene therapy</a></h3> <span class="secondary-label">Oct. 31, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amag-makena-fda-advisory-panel-vote-withdrawal-preterm-birth/566159/" class="analytics t-editors-bio-article">FDA panel backs withdrawal of Amag drug to prevent preterm birth</a></h3> <span class="secondary-label">Oct. 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/strong-sales-buoy-pharma-even-as-risks-grow/566056/" class="analytics t-editors-bio-article">Strong sales buoy pharma even as risks grow</a></h3> <span class="secondary-label">Oct. 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mirati-first-kras-cancer-drug-results-keeps-pace-amgen/565967/" class="analytics t-editors-bio-article">Mirati keeps pace with Amgen in hunt for KRAS cancer drug</a></h3> <span class="secondary-label">Oct. 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-yescarta-car-t-sales-slow/565857/" class="analytics t-editors-bio-article">Gilead CAR-T sales slow, renewing growth doubts</a></h3> <span class="secondary-label">Oct. 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-cuts-profits-to-account-for-proposed-opioid-settlement/565768/" class="analytics t-editors-bio-article">J&J cuts profits to account for proposed opioid settlement</a></h3> <span class="secondary-label">Oct. 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-alzheimers-aducanumab-revival-7-questions/565609/" class="analytics t-editors-bio-article">7 questions on Biogen's revival of a failed Alzheimer's drug</a></h3> <span class="secondary-label">Oct. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seattle-genetics-tucatinib-breast-cancer-study-success/565448/" class="analytics t-editors-bio-article">Seattle Genetics stock hits record high on well-placed breast cancer bet</a></h3> <span class="secondary-label">Oct. 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mirati-kras-first-data-challenge-amgen/565352/" class="analytics t-editors-bio-article">Mirati data to test whether biotech can challenge Amgen in KRAS quest</a></h3> <span class="secondary-label">Oct. 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-pegilodeckin-trial-failure-pancreatic-cancer/565125/" class="analytics t-editors-bio-article">Lilly cancer drug pipeline hit by trial setback</a></h3> <span class="secondary-label">Oct. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ichnos-glenmark-spin-out-cancer-bispecific-riva/565010/" class="analytics t-editors-bio-article">Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field</a></h3> <span class="secondary-label">Oct. 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/revance-ceo-step-down-dan-browne-misjudgment/564964/" class="analytics t-editors-bio-article">Revance CEO stepping down over 'misjudgment'</a></h3> <span class="secondary-label">Oct. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-migraine-drug-approval-fda-reyvow-lasmiditan/564906/" class="analytics t-editors-bio-article">Lilly's 1-drug migraine business gets support with new approval</a></h3> <span class="secondary-label">Oct. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-biotechs-manufacturing-challenges/564788/" class="analytics t-editors-bio-article">Gene therapy biotechs caught in manufacturing crunch</a></h3> <span class="secondary-label">Oct. 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/first-fda-approval-light-sensitive-pain-drug-scenesse/564663/" class="analytics t-editors-bio-article">Australian drugmaker's decade-long journey ends in FDA approval</a></h3> <span class="secondary-label">Oct. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-unsupported-drug-price-increases-pharma/564539/" class="analytics t-editors-bio-article">With new report, ICER puts itself at center of drug pricing storm</a></h3> <span class="secondary-label">Oct. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/buttigieg-pharma-drug-pricing-plan/564469/" class="analytics t-editors-bio-article">Buttigieg targets pharma in aggressive plan to lower drug prices</a></h3> <span class="secondary-label">Oct. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/arbutus-stops-hepatitis-b-study-safety-concerns/564374/" class="analytics t-editors-bio-article">Arbutus stops early hepatitis B study on safety concerns</a></h3> <span class="secondary-label">Oct. 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-opioid-settle-20-million-cuyahoga-summit-ohio/564197/" class="analytics t-editors-bio-article">J&J paying $20M to settle Ohio opioid suits</a></h3> <span class="secondary-label">Oct. 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-microsoft-ai-artificial-intelligence-alliance-car-t/564117/" class="analytics t-editors-bio-article">Novartis, Microsoft ink 5-year AI alliance</a></h3> <span class="secondary-label">Oct. 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/paul-hudson-ceo-sanofi-research-story-better-told/564095/" class="analytics t-editors-bio-article">Sanofi's story needs to be 'better told,' new CEO says</a></h3> <span class="secondary-label">Oct. 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seattle-genetics-esmo-data-enfortumab-vedotin-bladder-cancer/563995/" class="analytics t-editors-bio-article">Seattle Genetics makes case it can be more than Adcetris</a></h3> <span class="secondary-label">Sept. 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-novartis-breast-cancer-cdk46-esmo-kisqali-verzenio/563943/" class="analytics t-editors-bio-article">Novartis, Lilly drugs set new survival bar in breast cancer</a></h3> <span class="secondary-label">Sept. 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-kras-510-colorectal-cancer-esmo/563916/" class="analytics t-editors-bio-article">Colon cancer proves tougher target for Amgen's KRAS drug</a></h3> <span class="secondary-label">Sept. 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-immunotherapy-research-growth-drug-study-oncology/563881/" class="analytics t-editors-bio-article">Cancer immunotherapy boom showing no sign of slowdown</a></h3> <span class="secondary-label">Sept. 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-slowed-immunotherapy-use-in-bladder-cancer/563684/" class="analytics t-editors-bio-article">FDA warning slowed immunotherapy use in bladder cancer</a></h3> <span class="secondary-label">Sept. 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-to-speed-avexis-integration-in-wake-of-data-manipulation/563596/" class="analytics t-editors-bio-article">Novartis to speed AveXis integration in wake of data manipulation</a></h3> <span class="secondary-label">Sept. 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/states-drug-pricing-transparency-laws-bills-uncertain-effect/563321/" class="analytics t-editors-bio-article">States pull back curtain on drug prices, to uncertain effect</a></h3> <span class="secondary-label">Sept. 23, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-eye-to-competition-biogen-explores-higher-doses-of-spinraza/563387/" class="analytics t-editors-bio-article">With eye to competition, Biogen explores higher doses of Spinraza</a></h3> <span class="secondary-label">Sept. 20, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-gene-therapy-presymptomatic-early-treatment/563211/" class="analytics t-editors-bio-article">Novartis, shadowed by data scandal, renews case for Zolgensma</a></h3> <span class="secondary-label">Sept. 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-first-cancer-drugs-simultaneously-approved-in-us-canada-australia/563191/" class="analytics t-editors-bio-article">In first, cancer drugs simultaneously approved in US, Canada, Australia</a></h3> <span class="secondary-label">Sept. 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alexions-cfo-steps-down-in-surprise-departure/563141/" class="analytics t-editors-bio-article">Alexion's CFO steps down in surprise departure</a></h3> <span class="secondary-label">Sept. 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-ebola-vaccine-fda-priority-review-v920-pdufa/563087/" class="analytics t-editors-bio-article">Ebola vaccine from Merck takes step toward US approval</a></h3> <span class="secondary-label">Sept. 17, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-questions-esmo-cancer-drug-data-might-answer/562922/" class="analytics t-editors-bio-article">5 questions ESMO cancer drug data might answer</a></h3> <span class="secondary-label">Sept. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-ofatumumab-challenge-roche-ocrevus-ectrims/562884/" class="analytics t-editors-bio-article">Novartis' strong MS results could pose challenge to Roche</a></h3> <span class="secondary-label">Sept. 13, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-marks-progress-toward-goal-of-coaxing-medicine-from-bodys-cells/562743/" class="analytics t-editors-bio-article">Moderna marks progress toward goal of coaxing medicine from body's cells</a></h3> <span class="secondary-label">Sept. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-lexicon-settlement-zynquista-exit-diabetes-partnership/562705/" class="analytics t-editors-bio-article">Sanofi paying Lexicon $260M to exit diabetes alliance</a></h3> <span class="secondary-label">Sept. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarker-data-help-merck-case-for-wide-use-of-keytruda-combo/562598/" class="analytics t-editors-bio-article">Biomarker data help Merck case for wide use of Keytruda combo</a></h3> <span class="secondary-label">Sept. 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-data-integrity-fda-reporting-narasimhan/562506/" class="analytics t-editors-bio-article">After scandal, Novartis pledges faster action on data integrity</a></h3> <span class="secondary-label">Sept. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-loxo-292-ret-wclc-lung-cancer-results/562419/" class="analytics t-editors-bio-article">Cancer drug data back up Lilly's Loxo buyout</a></h3> <span class="secondary-label">Sept. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-kras-lung-cancer-drug-wclc-update/562449/" class="analytics t-editors-bio-article">Amgen update shows promise, limits of KRAS cancer drug</a></h3> <span class="secondary-label">Sept. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-commissioner-stephen-hahn-top-candidate-trump/562395/" class="analytics t-editors-bio-article">MD Anderson official emerges as top choice to run FDA, reports say</a></h3> <span class="secondary-label">Sept. 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ifm-novartis-third-pharma-deal-sting-innate-immune/562239/" class="analytics t-editors-bio-article">With third pharma deal, IFM's unorthodox approach paying off</a></h3> <span class="secondary-label">Sept. 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nice-luxturna-gene-therapy-recommendation-novartis-discount/562211/" class="analytics t-editors-bio-article">Novartis secures NICE nod for Luxturna with discount offer</a></h3> <span class="secondary-label">Sept. 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uniqure-stays-a-step-ahead-in-hemophilia-b/562134/" class="analytics t-editors-bio-article">UniQure stays a step ahead in hemophilia B</a></h3> <span class="secondary-label">Sept. 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alexion-amgen-ipr-patent-challenge-soliris/562039/" class="analytics t-editors-bio-article">Alexion shares slide on Amgen patent challenge to top-seller</a></h3> <span class="secondary-label">Aug. 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-kras-navy-seals-team-lung-cancer-drug/561633/" class="analytics t-editors-bio-article">Amgen puts its KRAS hopes on 'Navy Seals' team of drug hunters</a></h3> <span class="secondary-label">Aug. 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-patents-on-repatha-invalid-judge-rules-in-reversal/561882/" class="analytics t-editors-bio-article">Amgen patents on Repatha invalid, judge rules in reversal</a></h3> <span class="secondary-label">Aug. 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/purdue-offering-as-much-as-12-billion-to-settle-opioid-claims-report/561861/" class="analytics t-editors-bio-article">Purdue offering as much as $12 billion to settle opioid claims: report</a></h3> <span class="secondary-label">Aug. 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-oklahoma-order-pay-572-million-judge-balkman/561715/" class="analytics t-editors-bio-article">Oklahoma judge orders J&J pay $572M in landmark opioid case</a></h3> <span class="secondary-label">Aug. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lillys-case-for-taltz-helped-by-expanded-approval/561673/" class="analytics t-editors-bio-article">Lilly's case for Taltz helped by expanded approval</a></h3> <span class="secondary-label">Aug. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-buy-otezla-celgene-13-billion-enbrel/561657/" class="analytics t-editors-bio-article">Amgen buying Celgene's Otezla in $13B deal</a></h3> <span class="secondary-label">Aug. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moving-quickly-gsk-to-advance-myeloma-drug-on-new-data/561561/" class="analytics t-editors-bio-article">Moving quickly, GSK to advance myeloma drug on new data</a></h3> <span class="secondary-label">Aug. 23, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hhs-to-fund-further-manufacturing-of-merck-ebola-vaccine/561514/" class="analytics t-editors-bio-article">HHS to fund further manufacturing of Merck Ebola vaccine</a></h3> <span class="secondary-label">Aug. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/adma-relaunch-immune-globulin-drug-supply-shortage/561508/" class="analytics t-editors-bio-article">As supply shortages persist, ADMA relaunches immune globulin drug</a></h3> <span class="secondary-label">Aug. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-administration-appeal-court-ruling-drug-prices-tv-ads/561412/" class="analytics t-editors-bio-article">Trump administration not giving up on plan to require prices in TV drug ads</a></h3> <span class="secondary-label">Aug. 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-imfinzi-lung-cancer-miss-merck-gain/561378/" class="analytics t-editors-bio-article">AstraZeneca lung cancer miss is Merck's gain</a></h3> <span class="secondary-label">Aug. 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-biosimilar-debut-boosted-by-unitedhealthcare-coverage-switch/561192/" class="analytics t-editors-bio-article">Amgen biosimilar debut boosted by UnitedHealthcare coverage switch</a></h3> <span class="secondary-label">Aug. 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-wins-approval-for-drug-key-to-bristol-buyout/561100/" class="analytics t-editors-bio-article">Celgene wins approval for drug key to Bristol buyout</a></h3> <span class="secondary-label">Aug. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-faces-shareholder-suit-over-insulin-sales-disclosures/561091/" class="analytics t-editors-bio-article">Novo faces shareholder suit over insulin sales disclosures</a></h3> <span class="secondary-label">Aug. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-rozlytrek-cancer-drug-approval-tumor-agnostic/561027/" class="analytics t-editors-bio-article">Roche cancer drug the 3rd approved for pan-tumor use</a></h3> <span class="secondary-label">Aug. 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/study-success-strengthens-case-for-lynparza-in-ovarian-cancer/560900/" class="analytics t-editors-bio-article">Study success strengthens case for Lynparza in ovarian cancer</a></h3> <span class="secondary-label">Aug. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-replaces-avexis-chief-scientist-research-head-zolgensma/560907/" class="analytics t-editors-bio-article">Novartis replaced AveXis chief scientist, R&D head amid Zolgensma uproar</a></h3> <span class="secondary-label">Aug. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Congress-grassley-pressure-Novartis-data-manipulation-Zolgensma/560809/" class="analytics t-editors-bio-article">Lawmakers up pressure on Novartis in wake of data manipulation</a></h3> <span class="secondary-label">Aug. 13, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-resurgent-as-court-victory-for-top-drug-eases-doubts/560704/" class="analytics t-editors-bio-article">Amgen resurgent as court victory for top drug eases doubts</a></h3> <span class="secondary-label">Aug. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-rebuke-of-novartis-fda-making-statement-for-the-world/560551/" class="analytics t-editors-bio-article">In rebuke of Novartis, FDA making 'statement for the world'</a></h3> <span class="secondary-label">Aug. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-decision-on-amarin-heart-drug-delayed-as-agency-to-hold-expert-review/560559/" class="analytics t-editors-bio-article">FDA decision on Amarin heart drug delayed as agency to hold expert review</a></h3> <span class="secondary-label">Aug. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-car-t-coverage-cancer-therapies-nationwide/560472/" class="analytics t-editors-bio-article">Medicare boosts CAR-T cancer therapies with expanded coverage</a></h3> <span class="secondary-label">Aug. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-ceo-on-defense-as-data-scandal-clouds-gene-therapy-ok/560431/" class="analytics t-editors-bio-article">Novartis CEO on defense as data scandal clouds gene therapy approval</a></h3> <span class="secondary-label">Aug. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-gene-therapy-application-contained-manipulated-data-fda-says/560346/" class="analytics t-editors-bio-article">Novartis used manipulated data in winning Zolgensma approval, FDA says</a></h3> <span class="secondary-label">Aug. 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-buys-north-carolina-plant-purdue-oral-drug/560332/" class="analytics t-editors-bio-article">Novo buys North Carolina plant from Purdue</a></h3> <span class="secondary-label">Aug. 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-reversal-mallinckrodt-puts-split-plans-on-hold/560314/" class="analytics t-editors-bio-article">In reversal, Mallinckrodt puts split plans on hold</a></h3> <span class="secondary-label">Aug. 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-trial-win-for-tecentriq-leaves-questions-unanswered/560226/" class="analytics t-editors-bio-article">Roche trial win for Tecentriq leaves questions unanswered</a></h3> <span class="secondary-label">Aug. 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/congress-is-going-after-drug-prices-pharma-ceos-arent-panicking-yet/559858/" class="analytics t-editors-bio-article">Congress is going after drug prices. Pharma CEOs aren't panicking, yet</a></h3> <span class="secondary-label">Aug. 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/akorn-takes-74-million-charge-to-settle-shareholder-lawsuit/560054/" class="analytics t-editors-bio-article">Akorn takes $74 million charge to settle shareholder lawsuit</a></h3> <span class="secondary-label">Aug. 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sales-gap-merck-keytruda-bristol-opdivo-cancer-immunotherapies/559829/" class="analytics t-editors-bio-article">Sales gap grows between rival Merck, Bristol cancer therapies</a></h3> <span class="secondary-label">July 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-cancer-push-boosted-by-survival-benefit-to-key-drug/559767/" class="analytics t-editors-bio-article">Lilly cancer push boosted by survival benefit to key drug</a></h3> <span class="secondary-label">July 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/big-pharma-deals-show-industrys-weak-spots/559659/" class="analytics t-editors-bio-article">Big pharma deals show industry's weak spots</a></h3> <span class="secondary-label">July 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-hemophilia-write-down-competition-pressure-earnings/559721/" class="analytics t-editors-bio-article">Sanofi writes down hemophilia drug as competitive pressures rise</a></h3> <span class="secondary-label">July 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-advances-ms-drug-candidate-toward-us-eu-markets/559621/" class="analytics t-editors-bio-article">J&J advances MS drug candidate toward US, EU markets</a></h3> <span class="secondary-label">July 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-allergan-launch-first-in-vivo-study-of-crispr-based-medicine/559522/" class="analytics t-editors-bio-article">Editas, Allergan launch first in vivo study of CRISPR-based medicine</a></h3> <span class="secondary-label">July 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-hits-snag-in-plan-to-catch-merck-in-lung-cancer/559466/" class="analytics t-editors-bio-article">Bristol-Myers hits snag in plan to catch Merck in lung cancer</a></h3> <span class="secondary-label">July 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-turns-focus-for-key-drug-to-treatment-resistant-depression/559353/" class="analytics t-editors-bio-article">In pivot, Sage turns focus to treatment-resistant depression</a></h3> <span class="secondary-label">July 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acadia-schizophrenia-trial-misses-goal-setting-back-pipeline-hopes/559303/" class="analytics t-editors-bio-article">Acadia schizophrenia trial misses goal, setting back pipeline hopes</a></h3> <span class="secondary-label">July 23, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-questions-going-into-this-weeks-biopharma-earnings/559239/" class="analytics t-editors-bio-article">5 questions going into this week's biopharma earnings</a></h3> <span class="secondary-label">July 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/viiv-veteran-science-chief-to-step-down/559144/" class="analytics t-editors-bio-article">ViiV veteran science chief to step down</a></h3> <span class="secondary-label">July 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/catalent-to-help-make-novartis-zolgensma-at-maryland-site/559076/" class="analytics t-editors-bio-article">Catalent to help make Novartis' Zolgensma at Maryland site</a></h3> <span class="secondary-label">July 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-gives-first-glimpse-at-zolgensma-launch/559037/" class="analytics t-editors-bio-article">Novartis gives first glimpse at Zolgensma launch</a></h3> <span class="secondary-label">July 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/inovio-cuts-staff-research-to-buy-time/558949/" class="analytics t-editors-bio-article">Inovio cuts staff, research to buy time</a></h3> <span class="secondary-label">July 17, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-sickle-cell-crizanlizumab-fda-priority-review/558850/" class="analytics t-editors-bio-article">Novartis secures speedy review for sickle cell drug</a></h3> <span class="secondary-label">July 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/neon-to-advance-cancer-vaccine-after-early-results-suggest-added-benefit/558748/" class="analytics t-editors-bio-article">Neon to advance cancer vaccine after early results suggest added benefit</a></h3> <span class="secondary-label">July 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-forges-closer-ties-with-galapagos-with-51b-deal/558714/" class="analytics t-editors-bio-article">Gilead forges closer ties with Galapagos in $5.1B deal</a></h3> <span class="secondary-label">July 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lillys-shaw-to-head-gileads-cancer-push-as-new-ceo-of-kite/558605/" class="analytics t-editors-bio-article">Lilly's Shaw to head Gilead's cancer push as new CEO of Kite</a></h3> <span class="secondary-label">July 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/german-court-blocks-sale-of-sanofi-regeneron-cholesterol-drug/558585/" class="analytics t-editors-bio-article">German court blocks sale of Sanofi, Regeneron cholesterol drug</a></h3> <span class="secondary-label">July 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/white-house-pulls-drug-rebate-rule-to-relief-of-payers/558545/" class="analytics t-editors-bio-article">White House pulls drug rebate rule to relief of payers</a></h3> <span class="secondary-label">July 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgens-kras-success-has-other-drugmakers-eager-to-follow/558457/" class="analytics t-editors-bio-article">Amgen's KRAS success has other drugmakers eager to follow</a></h3> <span class="secondary-label">July 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hunting-better-biomarkers-jj-taps-celsius-to-unpack-role-played-by-single/558359/" class="analytics t-editors-bio-article">Hunting better biomarkers, J&J taps Celsius to unpack role played by single cells</a></h3> <span class="secondary-label">July 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-stocks-slide-as-industry-mulls-trump-drug-price-action/558312/" class="analytics t-editors-bio-article">Pharma stocks slide as industry mulls Trump drug price action</a></h3> <span class="secondary-label">July 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/zolgensma-set-a-new-drug-pricing-bar-insurers-show-some-signs-of-pushback/558101/" class="analytics t-editors-bio-article">Zolgensma set a new drug pricing bar. Insurers show some signs of pushback</a></h3> <span class="secondary-label">July 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-firms-up-path-to-market-for-key-arthritis-drug/558064/" class="analytics t-editors-bio-article">Gilead firms up path to market for key arthritis drug</a></h3> <span class="secondary-label">July 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-funding-century-cell-therapy-250-million/557995/" class="analytics t-editors-bio-article">Bayer backs cell therapy startup with $215M in funding</a></h3> <span class="secondary-label">July 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-bone-drug-application-knocked-back-in-europe/557879/" class="analytics t-editors-bio-article">Amgen bone drug application knocked back in Europe</a></h3> <span class="secondary-label">June 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/former-fda-head-gottlieb-to-join-pfizer-board/557825/" class="analytics t-editors-bio-article">Former FDA head Gottlieb joins Pfizer board</a></h3> <span class="secondary-label">June 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/catalent-picks-up-novavax-facilities-100-employees/557784/" class="analytics t-editors-bio-article">Catalent picks up Novavax facilities, 100 employees</a></h3> <span class="secondary-label">June 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samsung-bioepis-ceo-urges-patience-as-us-biosimilar-market-lags/556738/" class="analytics t-editors-bio-article">Samsung Bioepis CEO urges patience as US biosimilar market lags</a></h3> <span class="secondary-label">June 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-buy-allergan-deal-63-billion/557554/" class="analytics t-editors-bio-article">AbbVie buying Allergan in $63B deal for its post-Humira future</a></h3> <span class="secondary-label">June 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-wins-speedy-ok-for-lymphoma-drug-polivy/556575/" class="analytics t-editors-bio-article">Roche wins speedy OK for lymphoma drug Polivy</a></h3> <span class="secondary-label">June 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/experimental-drug-delays-type-1-diabetes-in-research-first/556538/" class="analytics t-editors-bio-article">Experimental drug delays Type 1 diabetes in research first</a></h3> <span class="secondary-label">June 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-crispr-exonics-dmd-research-deal/556431/" class="analytics t-editors-bio-article">Vertex sets sights on DMD gene therapy, joining crowded field</a></h3> <span class="secondary-label">June 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/former-gsk-site-to-be-redeveloped-as-wework-styled-life-sciences-center/556373/" class="analytics t-editors-bio-article">Former GSK site to be redeveloped as WeWork-styled life sciences center</a></h3> <span class="secondary-label">June 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/opioid-maker-insys-to-pay-225m-to-settle-fraud-charges/556350/" class="analytics t-editors-bio-article">Opioid maker Insys to pay $225M to settle fraud charges</a></h3> <span class="secondary-label">June 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-takeaways-cancer-conference/556183/" class="analytics t-editors-bio-article">3 takeaways from cancer's biggest conference</a></h3> <span class="secondary-label">June 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-shuffles-executive-ranks-for-post-celgene-future/556251/" class="analytics t-editors-bio-article">Bristol-Myers shuffles executive ranks for post-Celgene future</a></h3> <span class="secondary-label">June 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-biotech-pharma-stocks-climb-higher-after-cancer-meeting/556146/" class="analytics t-editors-bio-article">Biotech, pharma stocks climb higher after cancer meeting</a></h3> <span class="secondary-label">June 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-gene-therapy-approved-in-eu-in-first-for-severe-blood-disorder/556053/" class="analytics t-editors-bio-article">Bluebird gene therapy approved in Europe in first for severe blood disorder</a></h3> <span class="secondary-label">June 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/blueprint-keeps-pressure-on-lilly-with-ret-targeted-cancer-therapy/556019/" class="analytics t-editors-bio-article">Blueprint keeps pressure on Lilly with RET-targeted cancer therapy</a></h3> <span class="secondary-label">June 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-amgen-crack-kras-code-targeted-cancer-amg-510/555985/" class="analytics t-editors-bio-article">Early cancer drug data give Amgen hope it has 'cracked KRAS code'</a></h3> <span class="secondary-label">June 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-debate-speedy-drug-approvals-spotlight-lilly-lartruvo/556006/" class="analytics t-editors-bio-article">At cancer conference, debate over speedy drug approvals in the spotlight</a></h3> <span class="secondary-label">June 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-merck-keytruda-five-year-lung-cancer-survival/555979/" class="analytics t-editors-bio-article">For some lung cancer patients, Keytruda provides lasting benefit</a></h3> <span class="secondary-label">June 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-novartis-kisqali-breast-cancer-survival-benefit-pfizer-lilly/555946/" class="analytics t-editors-bio-article">Novartis breast cancer drug shows survival benefit in younger women</a></h3> <span class="secondary-label">June 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-19-turning-point-makes-push-to-outdo-pfizer-roche-in-targeted-cancer-therapy/555882/" class="analytics t-editors-bio-article">Turning Point makes push to outdo Pfizer, Roche in targeted cancer therapy</a></h3> <span class="secondary-label">May 31, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/follow-up-studies-often-lacking-for-cancer-drugs-approved-early/555733/" class="analytics t-editors-bio-article">Follow-up studies often lacking for cancer drugs approved early</a></h3> <span class="secondary-label">May 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-gene-therapy-zolgensma-approved-fda/554961/" class="analytics t-editors-bio-article">Novartis gene therapy approved, but will come at cost of more than $2M</a></h3> <span class="secondary-label">May 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nektar-forms-new-biotech-to-sell-under-review-pain-drug/555532/" class="analytics t-editors-bio-article">Nektar forms new biotech to sell under-review pain drug</a></h3> <span class="secondary-label">May 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dynavax-cuts-staff-in-retreat-from-cancer-research/555504/" class="analytics t-editors-bio-article">Dynavax cuts staff in retreat from cancer research</a></h3> <span class="secondary-label">May 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-looking-earlier-for-deals-as-biotech-valuations-stay-high/555441/" class="analytics t-editors-bio-article">Novartis looking earlier for deals as biotech valuations stay high</a></h3> <span class="secondary-label">May 23, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verily-sanofi-pfizer-novartis-clinical-research-pact/555235/" class="analytics t-editors-bio-article">Verily lures major pharmas with promise of speedier clinical research</a></h3> <span class="secondary-label">May 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-seeks-to-make-drug-price-research-more-accessible/555143/" class="analytics t-editors-bio-article">ICER seeks to make drug price research more accessible</a></h3> <span class="secondary-label">May 20, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-ceo-house-hearing-prep-hiv-drug-pricing/555028/" class="analytics t-editors-bio-article">Gilead CEO pressured on PrEP pricing at House hearing</a></h3> <span class="secondary-label">May 17, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aimmune-fda-adcomm-date-ar101-peanut-allergy-drug/554939/" class="analytics t-editors-bio-article">FDA schedules Aimmune's peanut allergy drug for September expert review</a></h3> <span class="secondary-label">May 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-in-the-spotlight-as-pharma-takes-back-seat-at-asco/554809/" class="analytics t-editors-bio-article">Biotech in the spotlight at ASCO as pharma takes back seat</a></h3> <span class="secondary-label">May 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-kymera-research-deal-protein-degradation/554854/" class="analytics t-editors-bio-article">Vertex follows pharma lead in bet on protein degradation</a></h3> <span class="secondary-label">May 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/myovant-phase-3-data-relugolix-uterine-fibroids-abbvie/554753/" class="analytics t-editors-bio-article">Myovant reports a Phase 3 success, but Wall Street isn't cheered</a></h3> <span class="secondary-label">May 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-late-to-digital-game-rushes-to-catch-up/553780/" class="analytics t-editors-bio-article">Pharma, late to digital game, rushes to catch up</a></h3> <span class="secondary-label">May 13, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/catalent-hindered-by-softgel-weakness-sees-stronger-growth-ahead/554479/" class="analytics t-editors-bio-article">Catalent, hindered by Softgel weakness, sees stronger growth ahead</a></h3> <span class="secondary-label">May 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-cautions-gene-therapy-launch-slow-start/554458/" class="analytics t-editors-bio-article">Nearing gene therapy launch, Bluebird cautions a slower start</a></h3> <span class="secondary-label">May 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-prices-tv-ads-trump-hhs-rule-finalize/554329/" class="analytics t-editors-bio-article">Drugmakers will soon be required to disclose prices in TV ads</a></h3> <span class="secondary-label">May 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-blood-cancer-drug-hits-study-goal-early/554253/" class="analytics t-editors-bio-article">AstraZeneca blood cancer drug hits study goal early</a></h3> <span class="secondary-label">May 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pathbreaking-roche-ionis-trial-offers-way-forward-in-huntingtons-diseas/554181/" class="analytics t-editors-bio-article">'Pathbreaking' Ionis trial offers way forward in Huntington's disease</a></h3> <span class="secondary-label">May 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trelegy-success-gives-gsk-some-respiratory-respite/554058/" class="analytics t-editors-bio-article">Trelegy success gives GSK some respiratory respite</a></h3> <span class="secondary-label">May 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/renewable-energy-to-power-all-novo-drug-production-by-next-year/553973/" class="analytics t-editors-bio-article">Renewable energy to power all Novo drug production by next year</a></h3> <span class="secondary-label">May 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-posts-strong-onpattro-sales-as-competition-heats-up/553959/" class="analytics t-editors-bio-article">Alnylam posts strong Onpattro sales as competition heats up</a></h3> <span class="secondary-label">May 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/longtime-gilead-finance-chief-robin-washington-to-step-down-next-year/553845/" class="analytics t-editors-bio-article">Longtime Gilead finance chief Robin Washington to step down next year</a></h3> <span class="secondary-label">May 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-insurance-coverage-cost-challenges/553699/" class="analytics t-editors-bio-article">At gene therapy meeting, insurance execs grapple with expected cost</a></h3> <span class="secondary-label">April 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/keytruda-powers-merck-to-another-strong-quarter/553764/" class="analytics t-editors-bio-article">Keytruda powers Merck to another strong quarter</a></h3> <span class="secondary-label">April 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/praluent-cardiovascular-approval-label-amgen-pcsk9/553611/" class="analytics t-editors-bio-article">Praluent scores heart label, matching Amgen's rival Repatha</a></h3> <span class="secondary-label">April 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-drugs-lift-astrazeneca-aiding-turnaround/553555/" class="analytics t-editors-bio-article">Cancer drugs lift AstraZeneca, aiding turnaround</a></h3> <span class="secondary-label">April 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-chief-defends-cell-gene-therapy-push/553354/" class="analytics t-editors-bio-article">Novartis chief defends cell, gene therapy push</a></h3> <span class="secondary-label">April 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-rd-small-biotechs-hold-their-own-against-big-pharma/553260/" class="analytics t-editors-bio-article">In R&D, small biotechs hold their own against big pharma</a></h3> <span class="secondary-label">April 23, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/keytruda-approved-in-kidney-cancer-challenging-bristol-myers/553143/" class="analytics t-editors-bio-article">Keytruda approved in kidney cancer, challenging Bristol-Myers</a></h3> <span class="secondary-label">April 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-pharma-business-is-booming-for-now/552938/" class="analytics t-editors-bio-article">Roche's pharma business is booming, for now</a></h3> <span class="secondary-label">April 17, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-zolgensma-sma-strive-data-gene-therapy-patient-deaths/552873/" class="analytics t-editors-bio-article">With FDA decision near, Novartis bolsters SMA gene therapy case</a></h3> <span class="secondary-label">April 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-q1-earnings-sales-outperform-zytiga-generic-hit/552842/" class="analytics t-editors-bio-article">J&J drugs sales outperform despite generic hit</a></h3> <span class="secondary-label">April 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-wins-support-of-influential-advisory-firms-in-shareholder-fight/552742/" class="analytics t-editors-bio-article">Allergan wins support of influential advisory firms in shareholder fight</a></h3> <span class="secondary-label">April 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-wins-fda-ok-for-first-targeted-therapy-in-bladder-cancer/552666/" class="analytics t-editors-bio-article">J&J wins FDA OK for first targeted therapy in bladder cancer</a></h3> <span class="secondary-label">April 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-shareholder-backing-celgene-deal/552620/" class="analytics t-editors-bio-article">Bristol-Myers wins shareholder backing for Celgene buyout</a></h3> <span class="secondary-label">April 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lonzas-ceo-on-keeping-up-with-microbiome-gene-therapy-boom/552555/" class="analytics t-editors-bio-article">Lonza's CEO on keeping up with microbiome, gene therapy boom</a></h3> <span class="secondary-label">April 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/unblinded-herve-hoppenot-incyte-single-asset-syndrome/551546/" class="analytics t-editors-bio-article">Unblinded: Hervé Hoppenot on solving Incyte's 'single asset syndrome'</a></h3> <span class="secondary-label">April 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alcon-spin-out-marks-step-in-novartis-plan-to-remake-business/552341/" class="analytics t-editors-bio-article">Alcon spin-out marks step in Novartis plan to remake business</a></h3> <span class="secondary-label">April 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coherus-neulasta-biosimilar-surprises-with-strong-early-uptake/552244/" class="analytics t-editors-bio-article">Coherus' Neulasta biosimilar surprises with strong early uptake</a></h3> <span class="secondary-label">April 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-wins-expanded-ibrance-approval-using-real-world-data/552135/" class="analytics t-editors-bio-article">Pfizer wins expanded Ibrance approval using real world data</a></h3> <span class="secondary-label">April 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-novartis-aimovig-partnership-lawsuits/552059/" class="analytics t-editors-bio-article">Amgen, Novartis clash in dispute over Aimovig partnership</a></h3> <span class="secondary-label">April 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aarp-generic-drugs-challenges-price-cost/552037/" class="analytics t-editors-bio-article">AARP report offers window into generic drugmaker pain</a></h3> <span class="secondary-label">April 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-hemophilia-a-gene-therapy-data/551836/" class="analytics t-editors-bio-article">Sangamo hemophilia A progress boosts shares</a></h3> <span class="secondary-label">April 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-research-boom-few-immunotherapy-studies-targeting-pancreatic-cance/551737/" class="analytics t-editors-bio-article">Despite research boom, few immunotherapy studies targeting pancreatic cancer</a></h3> <span class="secondary-label">April 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/early-studies-hint-at-some-potential-for-car-t-therapy-in-solid-tumors/551664/" class="analytics t-editors-bio-article">Early studies hint at some potential for CAR-T therapy in solid tumors</a></h3> <span class="secondary-label">March 31, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-daiichi-cancer-therapy-deal/551622/" class="analytics t-editors-bio-article">AstraZeneca inks ambitious $6.9B deal for Daiichi cancer therapy</a></h3> <span class="secondary-label">March 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-filgotinib-finch-trials-positive-arthritis-drug-jak/551571/" class="analytics t-editors-bio-article">Gilead earns needed trial win as arthritis drug succeeds in 2 studies</a></h3> <span class="secondary-label">March 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-to-seek-speedy-approval-of-third-dmd-drug/551522/" class="analytics t-editors-bio-article">Sarepta to seek speedy approval of third DMD drug</a></h3> <span class="secondary-label">March 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-mayzent-multiple-sclerosis-approval-secondary-progressive/551419/" class="analytics t-editors-bio-article">Novartis wins key US approval for multiple sclerosis drug Mayzent</a></h3> <span class="secondary-label">March 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/a-year-after-fda-refusal-celgene-resubmits-ozanimod-for-review/551311/" class="analytics t-editors-bio-article">A year after FDA refusal, Celgene resubmits ozanimod for review</a></h3> <span class="secondary-label">March 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/activist-investor-escalates-pressure-on-allergan/551219/" class="analytics t-editors-bio-article">Activist investor escalates pressure on Allergan</a></h3> <span class="secondary-label">March 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aducanumabs-failure-puts-pressure-on-field-to-look-beyond-amyloid/551071/" class="analytics t-editors-bio-article">Aducanumab's failure puts pressure on field to look beyond amyloid</a></h3> <span class="secondary-label">March 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fdas-gottlieb-defends-agency-response-to-valsartan-contamination/551037/" class="analytics t-editors-bio-article">FDA's Gottlieb defends agency response to valsartan contamination</a></h3> <span class="secondary-label">March 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/soon-to-depart-scott-gottlieb-keeps-focus-on-greater-drug-competition/550903/" class="analytics t-editors-bio-article">Soon to depart, Scott Gottlieb keeps focus on greater drug competition</a></h3> <span class="secondary-label">March 20, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-tecentriq-secures-another-immunotherapy-first/550813/" class="analytics t-editors-bio-article">Roche's Tecentriq secures another immunotherapy first</a></h3> <span class="secondary-label">March 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-nightstar-gene-therapy-competition-biotech-buyouts-deal-value/550747/" class="analytics t-editors-bio-article">Gene therapy progress spurs competition in biotech buyouts</a></h3> <span class="secondary-label">March 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/farxiga-astrazeneca-heart-benefits-diabetes-clinical-trial/550715/" class="analytics t-editors-bio-article">Heart benefits to AstraZeneca's Farxiga detailed in new findings</a></h3> <span class="secondary-label">March 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fdas-gottlieb-calls-for-greater-adoption-of-new-clinical-trial-tools/550598/" class="analytics t-editors-bio-article">FDA's Gottlieb calls for greater adoption of new clinical trial tools</a></h3> <span class="secondary-label">March 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-dodges-alvogen-bid-to-overturn-revlimid-patent/550505/" class="analytics t-editors-bio-article">Celgene dodges Alvogen bid to overturn Revlimid patent</a></h3> <span class="secondary-label">March 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-enbrel-court-ruling-biosimilar-novartis-sandoz/550405/" class="analytics t-editors-bio-article">Amgen's top-selling Enbrel in balance as key court ruling nears</a></h3> <span class="secondary-label">March 13, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nci-director-ned-sharpless-to-become-acting-fda-commissioner/550318/" class="analytics t-editors-bio-article">NCI Director Ned Sharpless to become acting FDA commissioner</a></h3> <span class="secondary-label">March 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-sells-biologics-plant-to-fujifilm-in-890m-deal/550299/" class="analytics t-editors-bio-article">Biogen sells biologics plant to Fujifilm in $890M deal</a></h3> <span class="secondary-label">March 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-wins-first-immunotherapy-approval-for-triple-negative-breast-cancer/550109/" class="analytics t-editors-bio-article">Roche wins first immunotherapy approval for triple-negative breast cancer</a></h3> <span class="secondary-label">March 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-advair-generic-gsk-strong-launch/550093/" class="analytics t-editors-bio-article">Mylan's Advair generic pressures GSK with strong launch</a></h3> <span class="secondary-label">March 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-walks-back-plan-to-alter-generic-names-of-already-approved-biologics/549991/" class="analytics t-editors-bio-article">FDA walks back plan to alter generic names of already approved biologics</a></h3> <span class="secondary-label">March 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-rapastinel-depression-drug-fails-phase-3-setback/549942/" class="analytics t-editors-bio-article">Allergan depression drug fails in setback for turnaround</a></h3> <span class="secondary-label">March 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-esketamine-approval-faster-acting-depression-drug/549848/" class="analytics t-editors-bio-article">FDA approves J&J's esketamine as faster-acting depression treatment</a></h3> <span class="secondary-label">March 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-oncology-chief-departing-to-head-up-glenmark-spin-out/549814/" class="analytics t-editors-bio-article">Gilead oncology chief departing to head up Glenmark spin-out</a></h3> <span class="secondary-label">March 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-commissioner-scott-gottlieb-resigning-to-leave-in-one-month/549790/" class="analytics t-editors-bio-article">FDA Commissioner Scott Gottlieb resigning, to leave in one month</a></h3> <span class="secondary-label">March 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-fedratinib-filing-regulatory-fda-bristol-myers-deal/549759/" class="analytics t-editors-bio-article">Celgene checks regulatory box for key drug in Bristol-Myers deal</a></h3> <span class="secondary-label">March 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-to-launch-generic-of-its-insulin-humalog-cutting-list-price-in-half/549656/" class="analytics t-editors-bio-article">Lilly to launch generic of its insulin Humalog, cutting list price in half</a></h3> <span class="secondary-label">March 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aimmune-answer-peanut-drug-status-fda-review/549497/" class="analytics t-editors-bio-article">Aimmune has its answer on peanut drug's status, but how FDA proceeds still unclear</a></h3> <span class="secondary-label">March 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-fda-approval-more-convenient-herceptin-subcutaneous/549507/" class="analytics t-editors-bio-article">Roche wins US approval of more convenient Herceptin</a></h3> <span class="secondary-label">March 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/at-senate-hearing-pharma-shows-split-on-biosimilars/549366/" class="analytics t-editors-bio-article">At Senate hearing, pharma shows split on biosimilars</a></h3> <span class="secondary-label">Feb. 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-progress-spurs-sarepta-buy-of-myonexus/549324/" class="analytics t-editors-bio-article">Gene therapy progress spurs Sarepta buy of Myonexus</a></h3> <span class="secondary-label">Feb. 27, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharmas-day-in-congress-a-hearing-not-a-show/549279/" class="analytics t-editors-bio-article">Pharma's day in Congress: 'A hearing not a show'</a></h3> <span class="secondary-label">Feb. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-front-of-congress-pharma-execs-blame-broken-system/549226/" class="analytics t-editors-bio-article">In front of Congress, pharma execs blame 'broken' system</a></h3> <span class="secondary-label">Feb. 26, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-wins-jury-verdict-in-pcsk9-court-battle-with-sanofi-regeneron/549188/" class="analytics t-editors-bio-article">Amgen wins jury verdict in PCSK9 court battle with Sanofi, Regeneron</a></h3> <span class="secondary-label">Feb. 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-gene-editing-milestone-first-patient-treated-in-vertex-crispr-therapeu/549127/" class="analytics t-editors-bio-article">In gene editing milestone, first patient treated in Vertex, CRISPR Therapeutics study</a></h3> <span class="secondary-label">Feb. 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lawmakers-pressure-pharma-execs-senate-hearing-drug-pricing/549067/" class="analytics t-editors-bio-article">How lawmakers could pressure top pharma execs in Senate hearing</a></h3> <span class="secondary-label">Feb. 25, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/insulin-drugmakers-again-come-under-senate-scrutiny/549046/" class="analytics t-editors-bio-article">Insulin drugmakers again come under Senate scrutiny</a></h3> <span class="secondary-label">Feb. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-unusual-step-fda-pushes-back-against-reports-on-questionable-generic-dr/548999/" class="analytics t-editors-bio-article">In unusual step, FDA pushes back against reports on questionable generic drug quality</a></h3> <span class="secondary-label">Feb. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-drug-plant-inspections-poland-slovenia/548919/" class="analytics t-editors-bio-article">FDA to accept drug plant inspections by Poland, Slovenia</a></h3> <span class="secondary-label">Feb. 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-handed-payers-nearly-12b-in-drug-rebates-last-year/548865/" class="analytics t-editors-bio-article">Sanofi handed payers nearly $12B in drug rebates last year</a></h3> <span class="secondary-label">Feb. 21, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-activist-split-ceo-chairman-roles/548799/" class="analytics t-editors-bio-article">Allergan rebuffs activist call to split CEO, chairman roles</a></h3> <span class="secondary-label">Feb. 20, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intercept-nash-drug-succeeds-in-fields-first-positive-phase-3-trial/548678/" class="analytics t-editors-bio-article">Intercept NASH drug succeeds in field's first positive Phase 3 trial</a></h3> <span class="secondary-label">Feb. 19, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hunt-for-immunotherapy-combinations-turns-up-success-in-kidney-cancer/548613/" class="analytics t-editors-bio-article">Hunt for immunotherapy combinations turns up success in kidney cancer</a></h3> <span class="secondary-label">Feb. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-lilly-deal-closes-bayer-secures-full-rights-to-loxos-vitrakvi/548584/" class="analytics t-editors-bio-article">As Lilly deal closes, Bayer secures full rights to Loxo's Vitrakvi</a></h3> <span class="secondary-label">Feb. 15, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-set-to-shed-11-manufacturing-sites-in-2019/548503/" class="analytics t-editors-bio-article">Teva set to shed 11 manufacturing sites in 2019</a></h3> <span class="secondary-label">Feb. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dbv-sets-sights-on-fda-resubmission-for-peanut-allergy-treatment/548481/" class="analytics t-editors-bio-article">DBV sets sights on FDA resubmission for peanut allergy treatment</a></h3> <span class="secondary-label">Feb. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-predicts-bleak-year-ahead-as-generic-copaxone-sales-drop/548358/" class="analytics t-editors-bio-article">Teva predicts bleak year ahead as generic, Copaxone sales drop</a></h3> <span class="secondary-label">Feb. 13, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jjs-esketamine-wins-backing-of-key-advisory-panel/548274/" class="analytics t-editors-bio-article">J&J's esketamine wins backing of key advisory panel</a></h3> <span class="secondary-label">Feb. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-kidney-cancer-data-impresses-putting-pressure-on-bristol-myers/548251/" class="analytics t-editors-bio-article">Merck kidney cancer data impresses, putting pressure on Bristol-Myers</a></h3> <span class="secondary-label">Feb. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-revlimid-patent-challenge-dr-reddys-ptab/548172/" class="analytics t-editors-bio-article">Celgene's Revlimid defenses withstand another challenge</a></h3> <span class="secondary-label">Feb. 12, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-sanofi-cut-pcsk9-list-price-matching-earlier-move-by-rival-amge/548147/" class="analytics t-editors-bio-article">Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen</a></h3> <span class="secondary-label">Feb. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-setback-pulls-down-gene-editing-biotech-peers/548024/" class="analytics t-editors-bio-article">Sangamo setback pulls down gene editing biotech peers</a></h3> <span class="secondary-label">Feb. 8, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-turns-rd-focus-inward-amid-cuts-to-drug-pipeline/547927/" class="analytics t-editors-bio-article">Sanofi turns R&D focus inward amid cuts to drug pipeline</a></h3> <span class="secondary-label">Feb. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-merck-ceo-testify-senate-drug-pricing-hearing/547808/" class="analytics t-editors-bio-article">Pharma CEOs to testify in Senate drug pricing hearing</a></h3> <span class="secondary-label">Feb. 6, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-earnings-q4-investors-trial-readouts/547697/" class="analytics t-editors-bio-article">Gilead investors hold their breath as trial readouts near</a></h3> <span class="secondary-label">Feb. 5, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/strategic-fit-bristol-myers-celgene-deal-net/547435/" class="analytics t-editors-bio-article">'Strategic fit' with Bristol-Myers kept Celgene from casting wider net in deal negotiations</a></h3> <span class="secondary-label">Feb. 1, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-administration-proposal-takes-aim-at-drug-rebates/547375/" class="analytics t-editors-bio-article">Trump administration proposal takes aim at drug rebates</a></h3> <span class="secondary-label">Jan. 31, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lonza-new-ceo-biopharma/547350/" class="analytics t-editors-bio-article">Lonza promotes biopharma head to CEO spot</a></h3> <span class="secondary-label">Jan. 31, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-misses-its-prescription-for-growth/547183/" class="analytics t-editors-bio-article">Pharma misses its prescription for growth</a></h3> <span class="secondary-label">Jan. 31, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-alzheimers-setback-puts-biogen-in-lonely-spot/547209/" class="analytics t-editors-bio-article">Roche Alzheimer's setback puts Biogen in lonely spot</a></h3> <span class="secondary-label">Jan. 30, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-faces-2019-burdened-by-competitive-challenges/547106/" class="analytics t-editors-bio-article">Pfizer faces 2019 burdened by competitive challenges</a></h3> <span class="secondary-label">Jan. 29, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgens-migraine-lead-faces-early-test-in-cvs-decision/546989/" class="analytics t-editors-bio-article">Amgen's migraine lead faces early test in CVS decision</a></h3> <span class="secondary-label">Jan. 28, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lonza-begins-second-gen-supply-of-portolas-andexxa/546785/" class="analytics t-editors-bio-article">Lonza begins second-gen supply of Portola's Andexxa</a></h3> <span class="secondary-label">Jan. 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/opdivo-questions-hang-over-bristol-myers-amid-sales-miss/546756/" class="analytics t-editors-bio-article">Opdivo questions hang over Bristol-Myers amid sales miss</a></h3> <span class="secondary-label">Jan. 24, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/high-ranking-vertex-exec-fired-over-code-of-conduct-violations/546711/" class="analytics t-editors-bio-article">High-ranking Vertex exec fired over code of conduct violations</a></h3> <span class="secondary-label">Jan. 23, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-ceo-exit-sparks-investor-fears/546566/" class="analytics t-editors-bio-article">Editas' CEO exit sparks investor fears</a></h3> <span class="secondary-label">Jan. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-sales-forecast-disappoints-as-generic-pricing-headwinds-rise/546531/" class="analytics t-editors-bio-article">J&J sales forecast disappoints as generic, pricing headwinds rise</a></h3> <span class="secondary-label">Jan. 22, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aimmune-drug-application-confusion-leaves-investors-searching-for-answers/546348/" class="analytics t-editors-bio-article">Aimmune drug application confusion leaves investors searching for answers</a></h3> <span class="secondary-label">Jan. 18, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/7-biopharma-trends-to-watch-in-2019/546011/" class="analytics t-editors-bio-article">7 biopharma trends to watch in 2019</a></h3> <span class="secondary-label">Jan. 17, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-mohawk-tribe-restasis-supreme-court-patent-case/546180/" class="analytics t-editors-bio-article">Allergan, Mohawk tribe ask for Supreme Court review of scrutinized patent case</a></h3> <span class="secondary-label">Jan. 16, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aimmune-ar101-fda-review-hold-government-shutdown/546016/" class="analytics t-editors-bio-article">FDA review of Aimmune drug put on hold due to government shutdown</a></h3> <span class="secondary-label">Jan. 14, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hunting-productivity-drugmakers-pitch-new-pillars-of-rd/545839/" class="analytics t-editors-bio-article">Hunting productivity, drugmakers pitch new 'pillars' of R&D</a></h3> <span class="secondary-label">Jan. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jp-morgan-biotech-winners-losers-2019/545818/" class="analytics t-editors-bio-article">The winners and losers from JPM 2019</a></h3> <span class="secondary-label">Jan. 11, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm19-a-biotechs-ma-invitation-editas-next-crispr-step-and-more-from-d/545705/" class="analytics t-editors-bio-article">A biotech's M&A invitation and Editas' next CRISPR step</a></h3> <span class="secondary-label">Jan. 10, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm19-modernas-defense-biosimilar-battles-and-other-updates-you-may-have/545591/" class="analytics t-editors-bio-article">Moderna's defense, biosimilar battles and other updates</a></h3> <span class="secondary-label">Jan. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm19-shire-deal-done-takeda-turns-to-task-of-forging-top-pharma/545499/" class="analytics t-editors-bio-article">Shire deal done, Takeda turns to task of forging top pharma</a></h3> <span class="secondary-label">Jan. 9, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm19-novartis-cell-therapy-ambitions-outpace-early-returns/545463/" class="analytics t-editors-bio-article">Novartis' cell therapy ambitions outpace early returns</a></h3> <span class="secondary-label">Jan. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm19-sanofi-zeroes-in-on-bispecifics-in-reworked-regeneron-deal/545387/" class="analytics t-editors-bio-article">Sanofi zeroes in on bispecifics in reworked Regeneron deal</a></h3> <span class="secondary-label">Jan. 7, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-gamble-on-celgene-pipeline-prospects/545244/" class="analytics t-editors-bio-article">Bristol-Myers' gamble on Celgene pipeline prospects</a></h3> <span class="secondary-label">Jan. 4, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-buy-celgene-74-billion-pharma-deal/545184/" class="analytics t-editors-bio-article">Bristol-Myers to buy Celgene in industry-shaking $74B deal</a></h3> <span class="secondary-label">Jan. 3, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-price-hikes-new-year-2019/545091/" class="analytics t-editors-bio-article">Drugmakers open new year with price increases on dozens of medicines</a></h3> <span class="secondary-label">Jan. 2, 2019</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acorda-inbrija-approval-parkinsons/545015/" class="analytics t-editors-bio-article">Acorda wins FDA nod for Parkinson's drug</a></h3> <span class="secondary-label">Dec. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/our-10-best-stories-of-2018/544999/" class="analytics t-editors-bio-article">Our 10 best stories of 2018</a></h3> <span class="secondary-label">Dec. 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-could-be-cost-effective-in-sma-but-not-at-4m/544969/" class="analytics t-editors-bio-article">Gene therapy could be cost effective in SMA, but not at $4M</a></h3> <span class="secondary-label">Dec. 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-seeks-to-acquire-french-car-t-contract-manufacturer/544911/" class="analytics t-editors-bio-article">Novartis seeks to acquire French CAR-T contract manufacturer</a></h3> <span class="secondary-label">Dec. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-returns-on-rd-ebb-to-new-low-deloitte-finds/544862/" class="analytics t-editors-bio-article">Pharma returns on R&D ebb to new low, Deloitte finds</a></h3> <span class="secondary-label">Dec. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-drug-ad-proposal-earns-support-from-insurers-medical-groups/544794/" class="analytics t-editors-bio-article">Trump drug ad proposal earns support from insurers, medical groups</a></h3> <span class="secondary-label">Dec. 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-pfizer-consumer-joint-venture-market-partnership/544751/" class="analytics t-editors-bio-article">GSK, Pfizer to launch consumer joint venture in market-shifting partnership</a></h3> <span class="secondary-label">Dec. 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazenecas-china-push-boosted-by-anemia-drug-ok/544634/" class="analytics t-editors-bio-article">AstraZeneca's China push boosted by anemia drug OK</a></h3> <span class="secondary-label">Dec. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-shows-allure-of-pharma-stock-buybacks/544411/" class="analytics t-editors-bio-article">AbbVie shows allure of pharma stock buybacks</a></h3> <span class="secondary-label">Dec. 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-lantus-sanofi-patent-insulin-copycat-market-entry/544306/" class="analytics t-editors-bio-article">Mylan patent win for Lantus copy looks unlikely to speed market entry</a></h3> <span class="secondary-label">Dec. 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kaleo-facing-criticism-launches-generic-overdose-treatment-at-cut-price/544237/" class="analytics t-editors-bio-article">Kaléo, facing criticism, launches generic overdose treatment at cut price</a></h3> <span class="secondary-label">Dec. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bausch-synergy-bid-bankruptcy-asset-sale/544212/" class="analytics t-editors-bio-article">Bausch bids $200M for Synergy gut drug, eyeing turnaround opportunity</a></h3> <span class="secondary-label">Dec. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-wins-key-cancer-drug-approval-but-taking-on-merck-remains-a-challeng/544082/" class="analytics t-editors-bio-article">Roche wins key cancer drug approval, but taking on Merck remains a challenge</a></h3> <span class="secondary-label">Dec. 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-names-roche-veteran-oday-as-ceo/543976/" class="analytics t-editors-bio-article">Gilead names Roche veteran O'Day as CEO</a></h3> <span class="secondary-label">Dec. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-imbruvica-chronic-lymphocytic-leukemia-abbvie-johnson/543758/" class="analytics t-editors-bio-article">ASH successes set to lift Imbruvica in CLL</a></h3> <span class="secondary-label">Dec. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-car-t-manufacturing-a-hurdle-novartis-has-yet-to-clear/543624/" class="analytics t-editors-bio-article">In CAR-T, manufacturing a hurdle Novartis has yet to clear</a></h3> <span class="secondary-label">Dec. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/at-ash-bispecific-cancer-therapies-make-a-mark/543461/" class="analytics t-editors-bio-article">At ASH, bispecific cancer therapies make a mark</a></h3> <span class="secondary-label">Dec. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-gene-therapy-mds-ash-sickle-cell-beta-thalassemia/543488/" class="analytics t-editors-bio-article">ASH18: Bluebird's gene therapy progress shadowed by MDS case</a></h3> <span class="secondary-label">Dec. 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dive-awards-pharma-of-the-year-merck/539651/" class="analytics t-editors-bio-article">Pharma of the Year: Merck & Co.</a></h3> <span class="secondary-label">Dec. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dive-awards-innovation-rna-targeting-therapies/539750/" class="analytics t-editors-bio-article">Innovation of the Year: RNA-targeting therapies</a></h3> <span class="secondary-label">Dec. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dive-awards-executive-emma-walmsley-gsk/539751/" class="analytics t-editors-bio-article">Executive of the Year: Emma Walmsley, GlaxoSmithKline</a></h3> <span class="secondary-label">Dec. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash18-car-t-shows-up-in-early-cll-test/543414/" class="analytics t-editors-bio-article">ASH18: CAR-T shows up in early CLL test</a></h3> <span class="secondary-label">Dec. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash18-cancer-drug-trials-in-need-of-modernization-nci-director-says/543400/" class="analytics t-editors-bio-article">ASH18: Cancer drug trials in need of modernization, NCI director says</a></h3> <span class="secondary-label">Dec. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-luspatercept-ash18-trial-successes/543395/" class="analytics t-editors-bio-article">ASH18: Trial successes back Celgene belief in luspatercept</a></h3> <span class="secondary-label">Dec. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/changing-markets-a-look-at-rheumatoid-arthritis/543054/" class="analytics t-editors-bio-article">Changing markets: A look at rheumatoid arthritis</a></h3> <span class="secondary-label">Nov. 30, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-cut-12000-jobs-business-overhaul-restructuring/543297/" class="analytics t-editors-bio-article">Bayer to cut 12,000 jobs in overhaul of business</a></h3> <span class="secondary-label">Nov. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alkermes-schizophrenia-drug-succeeds-in-needed-trial-win/543227/" class="analytics t-editors-bio-article">Alkermes' schizophrenia drug succeeds in needed trial win</a></h3> <span class="secondary-label">Nov. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/outcry-over-gene-edited-babies-grows-as-chinese-researcher-defends-work/543152/" class="analytics t-editors-bio-article">Outcry over gene-edited babies grows as Chinese researcher defends work</a></h3> <span class="secondary-label">Nov. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/loxo-cancer-drug-approval-targeted-therapy/542896/" class="analytics t-editors-bio-article">Loxo cancer drug wins US approval in advance for targeted therapy</a></h3> <span class="secondary-label">Nov. 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-drugmakers-rheumatoid-arthritis-market-tnf-jak-biosimilars/542802/" class="analytics t-editors-bio-article">Drugmakers vie to capture slice of rheumatoid arthritis market</a></h3> <span class="secondary-label">Nov. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-edited-babies-born-in-china-chinese-researcher-claims/542915/" class="analytics t-editors-bio-article">Gene-edited babies born in China, Chinese researcher claims</a></h3> <span class="secondary-label">Nov. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-taken-to-task-for-manufacturing-failings-at-key-plant/542821/" class="analytics t-editors-bio-article">Mylan taken to task for manufacturing failings at key plant</a></h3> <span class="secondary-label">Nov. 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/-sage-zulresso-fda-delay-approval-decision-postpartum-depression-rems/542705/" class="analytics t-editors-bio-article">Sage faces delayed decision on postpartum depression drug</a></h3> <span class="secondary-label">Nov. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-tests-trump-with-plans-to-hike-prices-on-41-drugs/542517/" class="analytics t-editors-bio-article">Pfizer tests Trump with plans to hike prices on 41 drugs</a></h3> <span class="secondary-label">Nov. 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sitc-key-takeaways-immuno-oncology/541987/" class="analytics t-editors-bio-article">At SITC, clear wins for immunotherapy combos remain elusive</a></h3> <span class="secondary-label">Nov. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nash-drugs-come-into-focus-as-field-awaits-late-stage-data/541779/" class="analytics t-editors-bio-article">NASH drugs come into focus as field awaits late-stage data</a></h3> <span class="secondary-label">Nov. 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-at-inflection-point-in-turnaround-predicts-ceo/541756/" class="analytics t-editors-bio-article">AstraZeneca at 'inflection point' in turnaround, predicts CEO</a></h3> <span class="secondary-label">Nov. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-election-takeaways-for-pharma/541635/" class="analytics t-editors-bio-article">5 election takeaways for pharma</a></h3> <span class="secondary-label">Nov. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nektar-lures-pfizer-with-promise-of-combo-immunotherapy/541512/" class="analytics t-editors-bio-article">Nektar lures Pfizer with promise of combo immunotherapy</a></h3> <span class="secondary-label">Nov. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/humira-biosimilar-discounting-aggressive-as-competition-enters-in-europe/541282/" class="analytics t-editors-bio-article">Humira biosimilar discounting 'aggressive' as competition enters in Europe</a></h3> <span class="secondary-label">Nov. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alkermes-depression-5461-chances-slim-negative-panel-vote/541257/" class="analytics t-editors-bio-article">Alkermes depression drug approval odds slim after negative FDA panel vote</a></h3> <span class="secondary-label">Nov. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gileads-stock-wobbles-on-hiv-pricing-concerns/541162/" class="analytics t-editors-bio-article">Gilead's stock wobbles on HIV pricing concerns</a></h3> <span class="secondary-label">Nov. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/shingrix-gives-glaxosmithkline-near-term-boost-earnings/541121/" class="analytics t-editors-bio-article">Shingrix gives GSK a near-term boost</a></h3> <span class="secondary-label">Nov. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-wins-us-nod-for-humira-biosimilar-but-focus-now-on-europe/541089/" class="analytics t-editors-bio-article">Novartis wins US nod for Humira biosimilar, but focus now on Europe</a></h3> <span class="secondary-label">Oct. 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/come-january-will-pharma-pricing-pledges-hold/541071/" class="analytics t-editors-bio-article">Come January, will pharma pricing pledges hold?</a></h3> <span class="secondary-label">Oct. 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-secures-broader-lung-cancer-approval/541050/" class="analytics t-editors-bio-article">Merck's Keytruda secures broader lung cancer approval</a></h3> <span class="secondary-label">Oct. 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alkermes-depression-drug-set-to-test-flexibility-of-fda/540860/" class="analytics t-editors-bio-article">Alkermes' depression drug set to test flexibility of FDA</a></h3> <span class="secondary-label">Oct. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-novartis-partner-in-hunt-to-find-drugs-for-nash/540819/" class="analytics t-editors-bio-article">Pfizer, Novartis partner in hunt to find drugs for NASH</a></h3> <span class="secondary-label">Oct. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/esperion-clears-final-trial-hurdle-in-bid-to-shake-up-cholesterol-market/540752/" class="analytics t-editors-bio-article">Esperion clears final trial hurdle in bid to shake up cholesterol market</a></h3> <span class="secondary-label">Oct. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-regeneron-appear-most-at-risk-from-trumps-latest-pricing-plan/540700/" class="analytics t-editors-bio-article">Amgen, Regeneron appear most at risk from Trump's latest pricing plan</a></h3> <span class="secondary-label">Oct. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-pitches-new-plan-to-bring-us-drug-prices-down/540610/" class="analytics t-editors-bio-article">Trump pitches new plan to bring US drug prices down</a></h3> <span class="secondary-label">Oct. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/keytruda-growth-fuels-merck-investment/540586/" class="analytics t-editors-bio-article">Keytruda growth fuels Merck investment</a></h3> <span class="secondary-label">Oct. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-dips-as-ban2401-data-bring-more-questions-than-answers/540600/" class="analytics t-editors-bio-article">Biogen dips as BAN2401 data bring more questions than answers</a></h3> <span class="secondary-label">Oct. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-cuts-us-repatha-price-60-amid-market-pressure/540517/" class="analytics t-editors-bio-article">Amgen cuts US Repatha price 60% amid market pressure</a></h3> <span class="secondary-label">Oct. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dtcs-big-issues-trump-cancer-drugs-and-the-first-amendment/540375/" class="analytics t-editors-bio-article">DTC's big issues: Trump, cancer drugs and the First Amendment</a></h3> <span class="secondary-label">Oct. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/reimbursement-cancer-drug-approvals-europe-esmo/540501/" class="analytics t-editors-bio-article">Reimbursement lags cancer drug approvals, but some European countries wait longer</a></h3> <span class="secondary-label">Oct. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-lilly-safety-tanezumab-Phase-3/540465/" class="analytics t-editors-bio-article">Pfizer, Lilly avoid safety red flags in late-stage tanezumab trial</a></h3> <span class="secondary-label">Oct. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-says-advair-copy-approval-imminent-but-investors-jittery/540355/" class="analytics t-editors-bio-article">Advair copy approval 'imminent,' Mylan says, but investors jittery</a></h3> <span class="secondary-label">Oct. 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-ads-tv-pharma-changing-face-dtc-advertising/539982/" class="analytics t-editors-bio-article">Viagra no more: The changing face of drug ads on TV</a></h3> <span class="secondary-label">Oct. 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/esmo-2018-bavencio-pfizer-rcc-merck-sting-novartis-alpelisib/540263/" class="analytics t-editors-bio-article">ESMO 2018: What you missed over the weekend</a></h3> <span class="secondary-label">Oct. 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/loxo-targeted-larotrectinib-hold-up-roche-challenge-entrectinib/540177/" class="analytics t-editors-bio-article">Loxo's targeted therapy holds up to Roche challenge</a></h3> <span class="secondary-label">Oct. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/benefit-of-roches-tecentriq-looks-limited-in-breast-cancer/540176/" class="analytics t-editors-bio-article">Benefit of Roche's Tecentriq looks limited in breast cancer</a></h3> <span class="secondary-label">Oct. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clovis-rubraca-prostate-cancer-clinical-results/540128/" class="analytics t-editors-bio-article">Clovis aims at new market for cancer drug Rubraca</a></h3> <span class="secondary-label">Oct. 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-buys-endocyte-for-21b-in-latest-deal-under-ceo-narasimhan/540015/" class="analytics t-editors-bio-article">Novartis buys Endocyte for $2.1B in latest deal under CEO Narasimhan</a></h3> <span class="secondary-label">Oct. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-humira-biosimilars-launch-europe/539938/" class="analytics t-editors-bio-article">Humira biosimilars launch in Europe, testing AbbVie</a></h3> <span class="secondary-label">Oct. 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-herceptin-biosimilars-europe-q3-earnings/539917/" class="analytics t-editors-bio-article">Biosimilars bite into Herceptin in Europe</a></h3> <span class="secondary-label">Oct. 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-prices-tv-ads-unanswered-questions/539789/" class="analytics t-editors-bio-article">5 questions on the Trump admin's bid to mandate prices in drug ads</a></h3> <span class="secondary-label">Oct. 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/breaking-trump-administration-seeks-to-require-drugmakers-include-list-pri/539714/" class="analytics t-editors-bio-article">Confronting pharma, Trump admin seeks price disclosure in drug ads</a></h3> <span class="secondary-label">Oct. 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/under-pressure-drugmakers-give-an-inch-on-dtc-drug-ads/539669/" class="analytics t-editors-bio-article">Under pressure, drugmakers give an inch on DTC drug ads</a></h3> <span class="secondary-label">Oct. 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/opdivo-misses-survival-goal-in-small-cell-lung-cancer-study/539562/" class="analytics t-editors-bio-article">Opdivo misses survival goal in small-cell lung cancer study</a></h3> <span class="secondary-label">Oct. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/expansion-gives-almac-room-to-grow-in-north-carolina/539479/" class="analytics t-editors-bio-article">Expansion gives Almac room to grow in North Carolina</a></h3> <span class="secondary-label">Oct. 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/us-tightens-scrutiny-of-foreign-investment-into-biotech-sector/539437/" class="analytics t-editors-bio-article">US tightens scrutiny of foreign investment into biotech sector</a></h3> <span class="secondary-label">Oct. 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/price-increases-on-top-drugs-drove-majority-of-recent-growth-analysis-find/539337/" class="analytics t-editors-bio-article">Price increases on top drugs drove majority of recent growth, analysis finds</a></h3> <span class="secondary-label">Oct. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trevena-shares-sink-on-fda-concerns-ahead-of-key-panel-meeting/539229/" class="analytics t-editors-bio-article">Trevena shares sink on FDA concerns ahead of key panel meeting</a></h3> <span class="secondary-label">Oct. 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/loxo-blueprint-drive-forward-with-ret-targeting-cancer-therapies/539109/" class="analytics t-editors-bio-article">Loxo, Blueprint drive forward with RET-targeting cancer therapies</a></h3> <span class="secondary-label">Oct. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-rare-disease-therapy-akcea-ionis/539021/" class="analytics t-editors-bio-article">FDA clears rare disease therapy from Akcea, Ionis</a></h3> <span class="secondary-label">Oct. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-yescarta-coverage-nhs-england-cancer-drugs-fund/538999/" class="analytics t-editors-bio-article">Gilead reaches deal for Yescarta coverage in England</a></h3> <span class="secondary-label">Oct. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-gene-therapy-for-dmd-takes-another-step-forward/538886/" class="analytics t-editors-bio-article">Sarepta gene therapy for DMD takes another step forward</a></h3> <span class="secondary-label">Oct. 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-risdiplam-spinal-muscular-atrophy-sma-durable-benefit/538781/" class="analytics t-editors-bio-article">Roche drug shows benefit in spinal muscular atrophy</a></h3> <span class="secondary-label">Oct. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-reversal-gsk-to-restart-limited-payments-to-doctors/538751/" class="analytics t-editors-bio-article">In reversal, GSK to restart limited payments to doctors</a></h3> <span class="secondary-label">Oct. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/rare-case-of-car-t-resistance-underscores-manufacturing-hurdles/538643/" class="analytics t-editors-bio-article">Rare case of CAR-T resistance underscores manufacturing hurdles</a></h3> <span class="secondary-label">Oct. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/10-biotechs-set-to-shake-up-the-industrys-top-ranks/538470/" class="analytics t-editors-bio-article">10 biotechs set to shake up the industry's top ranks</a></h3> <span class="secondary-label">Oct. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizers-bourla-to-succeed-read-as-ceo/538513/" class="analytics t-editors-bio-article">Pfizer's Bourla to succeed Read as CEO</a></h3> <span class="secondary-label">Oct. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/what-you-need-to-know-about-continuous-manufacturing/533309/" class="analytics t-editors-bio-article">What you need to know about continuous manufacturing</a></h3> <span class="secondary-label">Oct. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-sanofi-win-fda-approval-cancer-immunotherapy-cemiplimab/538429/" class="analytics t-editors-bio-article">Regeneron wins early approval for cancer immunotherapy</a></h3> <span class="secondary-label">Sept. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-puts-chips-on-speedy-ok-givosiran-rare-disease-drug/533439/" class="analytics t-editors-bio-article">Alnylam puts its chips on speedy OK for rare disease drug</a></h3> <span class="secondary-label">Sept. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-drug-approval-expands-pfizers-targeted-therapy-ambition/533506/" class="analytics t-editors-bio-article">Cancer drug approval expands Pfizer's targeted therapy ambition</a></h3> <span class="secondary-label">Sept. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-migraine-emgality-us-approval-cgrp-pressuring-amgen-teva/533349/" class="analytics t-editors-bio-article">Lilly's migraine drug wins US approval, pressuring rivals Amgen, Teva</a></h3> <span class="secondary-label">Sept. 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-ceo-to-stay-on-through-2019/533275/" class="analytics t-editors-bio-article">Merck CEO to stay on through 2019</a></h3> <span class="secondary-label">Sept. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazenecas-imfinzi-shows-its-strength-in-stage-3-lung-cancer/533149/" class="analytics t-editors-bio-article">AstraZeneca's Imfinzi shows its strength in Stage 3 lung cancer</a></h3> <span class="secondary-label">Sept. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tecentriq-sets-the-bar-in-small-cell-lung-cancer/533156/" class="analytics t-editors-bio-article">Tecentriq sets the bar in small-cell lung cancer</a></h3> <span class="secondary-label">Sept. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharmas-slow-embrace-of-continuous-manufacturing/532811/" class="analytics t-editors-bio-article">Pharma's slow embrace of continuous manufacturing</a></h3> <span class="secondary-label">Sept. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/foundation-med-advances-liquid-biopsy-ambition-with-new-test/533038/" class="analytics t-editors-bio-article">Foundation Med advances liquid biopsy ambition with new test</a></h3> <span class="secondary-label">Sept. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amicus-expands-into-gene-therapy-with-100m-deal/532834/" class="analytics t-editors-bio-article">Amicus expands into gene therapy with $100M deal</a></h3> <span class="secondary-label">Sept. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-accused-of-far-reaching-kickback-scheme-for-humira/532654/" class="analytics t-editors-bio-article">AbbVie accused of 'far-reaching' kickback scheme for Humira</a></h3> <span class="secondary-label">Sept. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/viking-shares-soar-as-nash-drug-impresses/532614/" class="analytics t-editors-bio-article">Viking shares soar as NASH drug impresses</a></h3> <span class="secondary-label">Sept. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/will-ajovy-lead-tevas-turnaround/532486/" class="analytics t-editors-bio-article">Will Ajovy lead Teva's turnaround?</a></h3> <span class="secondary-label">Sept. 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-wins-much-needed-us-approval-migraine-drug-ajovy/532422/" class="analytics t-editors-bio-article">Teva wins much-needed US approval of migraine drug</a></h3> <span class="secondary-label">Sept. 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-fills-out-medical-aesthetics-pipeline-195-million-bonti-deal/532387/" class="analytics t-editors-bio-article">Allergan's Bonti buy part of plan to double medical aesthetics business</a></h3> <span class="secondary-label">Sept. 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-looks-to-china-in-business-restructure/532335/" class="analytics t-editors-bio-article">Sanofi looks to China in business restructure</a></h3> <span class="secondary-label">Sept. 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-viratherapeutics-oncolytic-virus-deal/532274/" class="analytics t-editors-bio-article">Boehringer bets on oncolytic viruses in ViraTherapeutics deal</a></h3> <span class="secondary-label">Sept. 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gottlieb-rebuffs-pharma-ceo-nostrum-labs-price-hikes-moral-imperative/532194/" class="analytics t-editors-bio-article">Gottlieb rebuffs pharma CEO who claimed price hikes were 'moral requirement'</a></h3> <span class="secondary-label">Sept. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-tyk-plaque-psoriasis-data/532182/" class="analytics t-editors-bio-article">Bristol-Myers' psoriasis drug proves itself in mid-stage study</a></h3> <span class="secondary-label">Sept. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alcon-to-shift-hq-to-switzerland-after-novartis-spinoff/532057/" class="analytics t-editors-bio-article">Alcon to shift HQ to Switzerland after Novartis spinoff</a></h3> <span class="secondary-label">Sept. 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/appeals-court-upholds-crispr-patent-ruling-win-broad-institute/531968/" class="analytics t-editors-bio-article">Appeals court upholds CRISPR patent ruling in win for Broad Institute</a></h3> <span class="secondary-label">Sept. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-closes-door-to-speedy-ok-for-amicus-rare-disease-drug/531950/" class="analytics t-editors-bio-article">FDA closes door to speedy OK for Amicus rare disease drug</a></h3> <span class="secondary-label">Sept. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-glaxo-pitch-for-nucala-copd-turned-down-crl-fda/531874/" class="analytics t-editors-bio-article">GSK's pitch for Nucala in COPD turned down by FDA</a></h3> <span class="secondary-label">Sept. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/j-and-j-invokana-gains-cardioprotective-labeling-in-europe/531843/" class="analytics t-editors-bio-article">Invokana gains heart labeling in Europe</a></h3> <span class="secondary-label">Sept. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-eliminates-650-jobs-amid-rd-revamp/531779/" class="analytics t-editors-bio-article">GSK eliminates 650 jobs amid R&D revamp</a></h3> <span class="secondary-label">Sept. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/portola-andexxa-second-generation-manufacturing-lonza/531765/" class="analytics t-editors-bio-article">Portola inches closer to large-scale Andexxa production</a></h3> <span class="secondary-label">Sept. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-investment-manufacturing-shanbally-ireland-drug-plant/531763/" class="analytics t-editors-bio-article">BioMarin pumps $43M into Ireland drug plant</a></h3> <span class="secondary-label">Sept. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-delays-key-tecentriq-decision-by-3-months/531744/" class="analytics t-editors-bio-article">FDA delays key Tecentriq decision by 3 months</a></h3> <span class="secondary-label">Sept. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-gene-therapy-progress-stock-investors/531671/" class="analytics t-editors-bio-article">Sangamo pitches gene therapy progress, yet investors stay skeptical</a></h3> <span class="secondary-label">Sept. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chi-med-wins-landmark-china-approval-cancer-drug-fruquintinib/531612/" class="analytics t-editors-bio-article">Chi-Med wins landmark cancer drug approval in China</a></h3> <span class="secondary-label">Sept. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mannkind-stays-afloat-united-licensing-deal-treprostinil/531515/" class="analytics t-editors-bio-article">Mannkind stays afloat with United licensing deal</a></h3> <span class="secondary-label">Sept. 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-calls-out-pharma-peers-biosimilar-scare-tactics-fda-guidance/531214/" class="analytics t-editors-bio-article">Pfizer calls out pharma peers for 'scare tactics' on biosimilars</a></h3> <span class="secondary-label">Aug. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-nice-judges-car-t-yescarta-too-pricey-blow-gilead/531109/" class="analytics t-editors-bio-article">UK's NICE judges Yescarta too pricey, dealing blow to Gilead</a></h3> <span class="secondary-label">Aug. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-scott-gottlieb-confronts-limits-drug-pricing-push/530724/" class="analytics t-editors-bio-article">FDA confronts its limits in push on drug pricing</a></h3> <span class="secondary-label">Aug. 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizers-tafamidis-cuts-risk-of-death-in-rare-disease-study/530974/" class="analytics t-editors-bio-article">Pfizer's tafamidis cuts risk of death in rare disease study</a></h3> <span class="secondary-label">Aug. 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/esperion-bempedoic-acid-combo-clears-phase-3-win/530961/" class="analytics t-editors-bio-article">Esperion clears another milestone in bet on cholesterol pill</a></h3> <span class="secondary-label">Aug. 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/congress-dtc-ad-price-requirement-drug-commercial/530898/" class="analytics t-editors-bio-article">Lawmakers push to require price disclosure in DTC drug ads</a></h3> <span class="secondary-label">Aug. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-breast-cancer-trial-success-alpelisib-pi3k-inhibitor/530792/" class="analytics t-editors-bio-article">Novartis' trial success revives PI3K potential in breast cancer</a></h3> <span class="secondary-label">Aug. 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-argenx-immuno-oncology-licensing-cancer/530682/" class="analytics t-editors-bio-article">AbbVie brings Argenx drug onboard amid immuno-oncology push</a></h3> <span class="secondary-label">Aug. 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hhs-drug-pricing-100-days-report/530579/" class="analytics t-editors-bio-article">HHS touts drug pricing 'wins,' but true tests still to come</a></h3> <span class="secondary-label">Aug. 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aimovig-launch-bolsters-hopes-for-blockbuster-sales/530466/" class="analytics t-editors-bio-article">Aimovig launch bolsters hopes for blockbuster sales</a></h3> <span class="secondary-label">Aug. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amicus-secures-us-approval-galafold-fabry-disease-drug/529863/" class="analytics t-editors-bio-article">Amicus secures US approval for Fabry disease drug</a></h3> <span class="secondary-label">Aug. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-onpattro-patisiran-approval-fda-rna-interference/529700/" class="analytics t-editors-bio-article">In first, FDA approves RNA interference drug from Alnylam</a></h3> <span class="secondary-label">Aug. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cvs-rejects-pharma-claim-that-rebates-push-up-drug-prices/529749/" class="analytics t-editors-bio-article">CVS rejects pharma claim that rebates push up drug prices</a></h3> <span class="secondary-label">Aug. 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-settles-texas-suits-claiming-it-mismarketed-crestor-seroquel/529669/" class="analytics t-editors-bio-article">AstraZeneca settles Texas suits claiming it mismarketed Crestor, Seroquel</a></h3> <span class="secondary-label">Aug. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-to-explore-its-options-as-north-american-business-struggles/529632/" class="analytics t-editors-bio-article">Mylan to explore its options as North American business struggles</a></h3> <span class="secondary-label">Aug. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-drops-abbvie-mavyret-48-drugs-2019-formulary/529553/" class="analytics t-editors-bio-article">Express Scripts drops Mavyret from 2019 formulary in blow to AbbVie</a></h3> <span class="secondary-label">Aug. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spark-gene-therapy-hemophilia-data-stock/529526/" class="analytics t-editors-bio-article">Spark sheds $1B in value on hemophilia gene therapy data</a></h3> <span class="secondary-label">Aug. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-expands-immuno-oncology-push-with-bluebird-pact/529425/" class="analytics t-editors-bio-article">Regeneron expands immuno-oncology push with Bluebird pact</a></h3> <span class="secondary-label">Aug. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drugs-account-15-percent-total-us-healthcare-spending-health-affairs/529325/" class="analytics t-editors-bio-article">Drugs make up more US health spending than thought, report suggests</a></h3> <span class="secondary-label">Aug. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvies-surprised-investors-mavyret-hepatitis-c-success-will-it-last/529158/" class="analytics t-editors-bio-article">AbbVie surprised investors with its hepatitis C success. Will it last?</a></h3> <span class="secondary-label">Aug. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ultragenyx-prv-sale-value-regulation-fast-pass/529221/" class="analytics t-editors-bio-article">Latest PRV sale further evidence of sliding value</a></h3> <span class="secondary-label">Aug. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-spotlights-truvada-ads-as-prep-preventive-use-grows/529127/" class="analytics t-editors-bio-article">Gilead spotlights Truvada ads as preventive use grows</a></h3> <span class="secondary-label">Aug. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-read-drug-rebates-trump-earnings-pricing-plan/529015/" class="analytics t-editors-bio-article">Pfizer CEO sees drug rebates 'going away' in US</a></h3> <span class="secondary-label">July 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/redhill-drug-rhb-104-crohns-clears-first-phase-3-hurdle/528896/" class="analytics t-editors-bio-article">RedHill drug for Crohn's clears first Phase 3 hurdle</a></h3> <span class="secondary-label">July 30, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-earnings-faith-humira-future-growth-remains-ironclad/528795/" class="analytics t-editors-bio-article">AbbVie faith in Humira, future growth remains ironclad</a></h3> <span class="secondary-label">July 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-new-drug-sales-surge-ocrevus-quarter-earnings/528689/" class="analytics t-editors-bio-article">Sales of Roche new drugs are surging. Will that be enough?</a></h3> <span class="secondary-label">July 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-eisai-positive-alzheimers-results-ban2401-spark-cautious-optimism/528551/" class="analytics t-editors-bio-article">Positive Alzheimer's results from Biogen, Eisai spark 'cautious optimism' </a></h3> <span class="secondary-label">July 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-secures-us-approval-of-new-malaria-drug/528617/" class="analytics t-editors-bio-article">GSK secures US approval of new malaria drug</a></h3> <span class="secondary-label">July 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-case-two-drug-hiv-regimen-bolstered-gemini-phase-3/528486/" class="analytics t-editors-bio-article">Two-drug HIV regimen from GSK bolstered by Phase 3 data</a></h3> <span class="secondary-label">July 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-AI-pharma-talent-artificial-intelligence-recruitment/528132/" class="analytics t-editors-bio-article">Seeking to adopt AI, drugmakers search for right mix of talent</a></h3> <span class="secondary-label">July 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sangamo-buys-txcell-cell-therapy-tech-in-84m-deal/528368/" class="analytics t-editors-bio-article">Sangamo to buy TxCell, cell therapy tech in $84M deal</a></h3> <span class="secondary-label">July 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/7-companies-to-watch-during-q2-earnings/528213/" class="analytics t-editors-bio-article">7 companies to watch during Q2 earnings</a></h3> <span class="secondary-label">July 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-hits-car-t-manufacturing-snag-as-kymriah-sales-disappoint/528202/" class="analytics t-editors-bio-article">Novartis hits CAR-T manufacturing snag as Kymriah sales disappoint</a></h3> <span class="secondary-label">July 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-tecentriq-misses-chance-catch-merck-keytruda-impower-132/528171/" class="analytics t-editors-bio-article">Tecentriq misses another chance to catch Keytruda</a></h3> <span class="secondary-label">July 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phrma-drug-lobby-proposes-shake-up-rebate-system-drugs/528084/" class="analytics t-editors-bio-article">Drug lobby aims to shake up how medicines are paid for</a></h3> <span class="secondary-label">July 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-sales-beat-expectations-earnings-price-hike-pause/528059/" class="analytics t-editors-bio-article">Novartis points to price hike pause, potentially dodging Pfizer fate</a></h3> <span class="secondary-label">July 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-experimental-flu-drug-clears-second-phase-3/527954/" class="analytics t-editors-bio-article">Roche experimental flu drug clears second Phase 3</a></h3> <span class="secondary-label">July 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cassiopea-prospects-fill-in-hair-loss-drug-breezula-shows-promise/527855/" class="analytics t-editors-bio-article">Cassiopea prospects fill in as hair loss drug shows promise</a></h3> <span class="secondary-label">July 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-contacts-with-trump-lawyer-broader-than-company-let-on-us-senato/527745/" class="analytics t-editors-bio-article">Novartis' contacts with Trump lawyer broader than company let on, US senators charge</a></h3> <span class="secondary-label">July 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-partners-cell-for-cure-car-t-manufacturing-france/527663/" class="analytics t-editors-bio-article">Novartis partners with French CDMO to bolster CAR-T supply</a></h3> <span class="secondary-label">July 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/glaxosmithkline-dermavant-out-license-tapinarof-psoriasis-pipeline/527652/" class="analytics t-editors-bio-article">Dermavant finds 'cornerstone' drug in GSK's pipeline</a></h3> <span class="secondary-label">July 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-price-hikes-on-pause-after-ceo-sitdown-with-trump/527529/" class="analytics t-editors-bio-article">Pfizer price hikes on pause after Trump pressure</a></h3> <span class="secondary-label">July 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aquinox-cuts-staff-by-50-in-wake-of-late-stage-miss/527440/" class="analytics t-editors-bio-article">Aquinox cuts staff by 50% in wake of late-stage miss</a></h3> <span class="secondary-label">July 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cti-biopharma-cancer-drug-pixuvri-faces-clouded-future/527339/" class="analytics t-editors-bio-article">CTI cancer drug faces clouded future after study failure</a></h3> <span class="secondary-label">July 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-alzheimers-drug-ban2401-shows-unexpected-glimmer-of-promise/527219/" class="analytics t-editors-bio-article">Biogen Alzheimer's drug shows unexpected signs of promise</a></h3> <span class="secondary-label">July 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/prior-authorization-limits-would-be-reasonable-for-cgrp-drugs-icer-says/527133/" class="analytics t-editors-bio-article">Prior authorization limits would be 'reasonable' for CGRP drugs, ICER says</a></h3> <span class="secondary-label">July 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/catalent-expands-with-133m-deal-for-juniper/527049/" class="analytics t-editors-bio-article">Catalent expands with $133M deal for Juniper</a></h3> <span class="secondary-label">July 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-expands-china-presence-with-new-rd-hub/526975/" class="analytics t-editors-bio-article">Sanofi expands China presence with new R&D hub</a></h3> <span class="secondary-label">July 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tecentriq-extends-streak-with-win-in-breast-cancer-trial/526957/" class="analytics t-editors-bio-article">Tecentriq extends streak with win in breast cancer trial </a></h3> <span class="secondary-label">July 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/galapagos-posts-underwhelming-cystic-fibrosis-results-boosting-vertex/526880/" class="analytics t-editors-bio-article">Galapagos posts 'underwhelming' cystic fibrosis results, boosting Vertex </a></h3> <span class="secondary-label">June 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-pays-700m-to-up-stake-in-samsung-bioepis/526858/" class="analytics t-editors-bio-article">Biogen pays $700M to up stake in Samsung Bioepis</a></h3> <span class="secondary-label">June 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/akebia-keryx-to-merge-creating-1b-kidney-disease-company/526761/" class="analytics t-editors-bio-article">Akebia, Keryx to merge, creating $1B kidney disease company</a></h3> <span class="secondary-label">June 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gottlieb-calls-out-perrigo-for-missed-postmarket-study-deadline/526686/" class="analytics t-editors-bio-article">Gottlieb calls out Perrigo for missed postmarket study deadline</a></h3> <span class="secondary-label">June 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/global-blood-bets-sickle-cell-success-volexotor-will-convince-fda/526663/" class="analytics t-editors-bio-article">Global Blood bets sickle cell drug success will convince FDA</a></h3> <span class="secondary-label">June 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-to-pub-surrogate-endpoints-used-in-cancer-drug-approvals/526555/" class="analytics t-editors-bio-article">FDA to pub surrogate endpoints used in cancer drug approvals</a></h3> <span class="secondary-label">June 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jardiance-shows-potential-in-type-1-diabetes-clearing-phase-3-tests/526531/" class="analytics t-editors-bio-article">Jardiance shows potential in type 1 diabetes, clearing Phase 3 tests</a></h3> <span class="secondary-label">June 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-immunotherapy-advances-cancer-vaccines/526290/" class="analytics t-editors-bio-article">Immunotherapy advances spur new look at cancer vaccines</a></h3> <span class="secondary-label">June 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-tecentriq-takes-aim-first-mover-edge-small-cell-lung-cancer/526447/" class="analytics t-editors-bio-article">Roche aims for first-mover edge in small cell lung cancer</a></h3> <span class="secondary-label">June 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novos-case-for-oral-semaglutide-bolstered-by-phase-3-trial-wins/526248/" class="analytics t-editors-bio-article">Novo's case for oral semaglutide bolstered by Phase 3 trial wins</a></h3> <span class="secondary-label">June 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/purdue-pharma-lays-off-350-cutting-remainder-of-sales-force/526161/" class="analytics t-editors-bio-article">Purdue Pharma lays off 350, cutting remainder of sales force</a></h3> <span class="secondary-label">June 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/anika-shares-slump-on-phase-3-miss/526135/" class="analytics t-editors-bio-article">Anika shares slump on Phase 3 miss</a></h3> <span class="secondary-label">June 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-buys-out-foundation-med-in-24b-bet-on-targeted-cancer-treatment/526029/" class="analytics t-editors-bio-article">Roche buys out Foundation Med in $2.4B bet on targeted cancer treatment</a></h3> <span class="secondary-label">June 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/solid-biosciences-fda-lifts-clinical-hold-dmd-gene-therapy/525952/" class="analytics t-editors-bio-article">Solid finds its footing as FDA lifts trial hold</a></h3> <span class="secondary-label">June 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-hit-crl-fda-rejection-psoriasis-drug-duobrii/525923/" class="analytics t-editors-bio-article">Valeant hit with CRL for key dermatology drug</a></h3> <span class="secondary-label">June 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebirds-changes-to-lentiglobin-begin-to-pay-off/525809/" class="analytics t-editors-bio-article">Bluebird's changes to LentiGlobin begin to pay off</a></h3> <span class="secondary-label">June 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/recipharm-to-pay-60m-for-sanofi-manufacturing-plant/525743/" class="analytics t-editors-bio-article">Recipharm to pay $60M for Sanofi manufacturing plant</a></h3> <span class="secondary-label">June 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-license-deal-Shionogi-depression-drug-asia-capital/525734/" class="analytics t-editors-bio-article">Sage licenses out depression drug in Asia, adding to cash warchest</a></h3> <span class="secondary-label">June 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biosimilars-could-still-pack-revenue-busting-punch-analyst-suggests/525635/" class="analytics t-editors-bio-article">Biosimilars could still pack revenue-busting punch, analyst suggests</a></h3> <span class="secondary-label">June 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-guidance-drugmakers-payers-communication-value-based-contracts/525547/" class="analytics t-editors-bio-article">FDA permits more expansive communication between drugmakers, payers</a></h3> <span class="secondary-label">June 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sun-pharma-gets-reprieve-as-fda-clears-key-halol-plant/525504/" class="analytics t-editors-bio-article">Sun Pharma gets reprieve as FDA clears key Halol plant</a></h3> <span class="secondary-label">June 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergans-atogepant-clears-phase-3-migraine-test/525461/" class="analytics t-editors-bio-article">Allergan notches another CGRP success, but faces changing migraine market</a></h3> <span class="secondary-label">June 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-roche-win-key-us-approval-for-blood-cancer-drug/525412/" class="analytics t-editors-bio-article">AbbVie, Roche win key US approval for blood cancer drug</a></h3> <span class="secondary-label">June 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Sanofi-partner-translate-bio-mrna-vaccines-infectious-disease/525394/" class="analytics t-editors-bio-article">Sanofi partners with Translate Bio on mRNA vaccines</a></h3> <span class="secondary-label">June 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-swiss-criminal-probe-trump-lawyer-payments/525223/" class="analytics t-editors-bio-article">Novartis won't face Swiss criminal probe over payments to Trump lawyer</a></h3> <span class="secondary-label">June 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/unanswered-questions-immunotherapy-asco-cancer-conference/525018/" class="analytics t-editors-bio-article">ASCO18: 3 unanswered questions from oncology's largest conference</a></h3> <span class="secondary-label">June 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco18-who-were-the-big-winners-and-losers/525008/" class="analytics t-editors-bio-article">ASCO18: Who were the big winners and losers?</a></h3> <span class="secondary-label">June 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco18-bristol-myers-fights-for-its-place-in-first-line-lung-cancer/524928/" class="analytics t-editors-bio-article">ASCO18: Bristol-Myers fights for its place in first-line lung cancer</a></h3> <span class="secondary-label">June 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-celgene-car-t-juno-liso-cel-lymphoma-competition/524845/" class="analytics t-editors-bio-article">ASCO18: Celgene makes its case as CAR-T rival in lymphoma</a></h3> <span class="secondary-label">June 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco18-merck-raises-the-bar-in-lung-cancer-with-keytruda-data/524835/" class="analytics t-editors-bio-article">ASCO18: Merck raises the bar in lung cancer with Keytruda data</a></h3> <span class="secondary-label">June 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco18-bristol-myers-nektar-forge-ahead-with-phase-3-tests-for-cancer-com/524838/" class="analytics t-editors-bio-article">ASCO18: Bristol-Myers, Nektar forge ahead with Phase 3 tests for cancer combo</a></h3> <span class="secondary-label">June 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco18-positive-readout-marks-step-forward-for-bluebirds-car-t/524826/" class="analytics t-editors-bio-article">ASCO18: Positive readout marks step forward for Bluebird's CAR-T</a></h3> <span class="secondary-label">June 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gileads-filgotinib-clears-mid-stage-test-in-arthritis/524726/" class="analytics t-editors-bio-article">Gilead's filgotinib clears mid-stage test in arthritis</a></h3> <span class="secondary-label">May 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phrma-icer-drug-cost-effectiveness-value-price-feud/524688/" class="analytics t-editors-bio-article">PhRMA criticizes ICER in latest skirmish over valuing drugs</a></h3> <span class="secondary-label">May 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-to-sell-off-womens-health-anti-infective-businesses/524610/" class="analytics t-editors-bio-article">Allergan to sell off women's health, anti-infective businesses</a></h3> <span class="secondary-label">May 30, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-wont-submit-fasenra-copd-second-study-failure/524575/" class="analytics t-editors-bio-article">AstraZeneca won't submit lung drug for COPD after 2nd study miss</a></h3> <span class="secondary-label">May 30, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Roche-tecentriq-improve-survival-os-lung-cancer-impower-130/524486/" class="analytics t-editors-bio-article">Tecentriq trial wins boost Roche bid to compete with Merck</a></h3> <span class="secondary-label">May 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-imfinzi-improve-survival-stage-3-lung-cancer-pacific/524387/" class="analytics t-editors-bio-article">AstraZeneca's Imfinzi delivers survival benefit in Stage 3 lung cancer</a></h3> <span class="secondary-label">May 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-drug-spending-climbs-with-top-winners-earning-lions-share/524289/" class="analytics t-editors-bio-article">Cancer drug spending climbs, with top winners earning lion's share</a></h3> <span class="secondary-label">May 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/momentum-grows-for-hemophilia-gene-therapies/524062/" class="analytics t-editors-bio-article">Momentum grows for hemophilia gene therapies</a></h3> <span class="secondary-label">May 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-qa-baras-regeneron-genome-nash/523596/" class="analytics t-editors-bio-article">Regeneron's Aris Baras on probing the genome to find drugs for NASH</a></h3> <span class="secondary-label">May 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-turn-to-nash-unlikely-to-mirror-meteoric-rise-of-hep-c/523746/" class="analytics t-editors-bio-article">Pharma turn to NASH unlikely to mirror meteoric rise of hep C</a></h3> <span class="secondary-label">May 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warns-of-decreased-survival-in-2-studies-of-keytruda-tecentriq/523966/" class="analytics t-editors-bio-article">FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq</a></h3> <span class="secondary-label">May 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-johnson-fda-anticompetitive-generic-list/523871/" class="analytics t-editors-bio-article">Celgene, J&J top complaint list to FDA for blocking generics</a></h3> <span class="secondary-label">May 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/5-takeaways-from-the-first-look-at-cancers-biggest-conference/523763/" class="analytics t-editors-bio-article">5 takeaways from the first look at cancer's biggest conference</a></h3> <span class="secondary-label">May 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/to-shame-drugmakers-cms-publicizes-price-hikes/523693/" class="analytics t-editors-bio-article">To shame drugmakers, CMS publicizes price hikes</a></h3> <span class="secondary-label">May 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/top-novartis-lawyer-to-exit-over-deal-with-trump-insider/523661/" class="analytics t-editors-bio-article">Top Novartis lawyer to exit over deal with Trump insider</a></h3> <span class="secondary-label">May 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-europe-car-t-manufacturing-site-facility-yescarta/523552/" class="analytics t-editors-bio-article">Gilead finds new home in Europe for CAR-T manufacturing</a></h3> <span class="secondary-label">May 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-widens-hunt-for-tcr-therapies-in-revised-medigene-deal/523467/" class="analytics t-editors-bio-article">Bluebird widens hunt for TCR therapies in revised Medigene deal</a></h3> <span class="secondary-label">May 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-fasenra-fails-copd-phase-3-study/523352/" class="analytics t-editors-bio-article">AstraZeneca lung drug comes up short in COPD</a></h3> <span class="secondary-label">May 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-tecentriq-cotellic-combo-stumbles-phase-3-colorectal/523271/" class="analytics t-editors-bio-article">Tecentriq stumbles in Phase 3 colon cancer study</a></h3> <span class="secondary-label">May 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/walmart-opioid-prescriptions-7-day-supply/523194/" class="analytics t-editors-bio-article">Walmart to limit opioid prescriptions to 7-day supply</a></h3> <span class="secondary-label">May 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-trump-attorney-stormy-daniels-lawyer/523169/" class="analytics t-editors-bio-article">Novartis paid $1.2M to firm linked to Trump attorney</a></h3> <span class="secondary-label">May 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-shire-takeover-62-billion-deal/523066/" class="analytics t-editors-bio-article">Takeda secures Shire takeover with $62B deal</a></h3> <span class="secondary-label">May 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-esketamine-antidepressant-mixed-results-phase-3/522942/" class="analytics t-editors-bio-article">J&J's ketamine-based antidepressant sees mixed results in Phase 3</a></h3> <span class="secondary-label">May 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-moderna-mrna-tech-kras-deal/522868/" class="analytics t-editors-bio-article">Merck bets Moderna's mRNA tech can unlock KRAS puzzle</a></h3> <span class="secondary-label">May 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approves-andexxa-in-major-boost-to-portola/522849/" class="analytics t-editors-bio-article">FDA approves Andexxa in major boost to Portola</a></h3> <span class="secondary-label">May 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fremanezumab-approval-by-mid-june-unlikely-teva-says/522776/" class="analytics t-editors-bio-article">Fremanezumab approval by mid-June unlikely, Teva says</a></h3> <span class="secondary-label">May 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-sanofi-praluent-pcsk9-price-deal-express-scripts/522670/" class="analytics t-editors-bio-article">Regeneron, Sanofi drop PCSK9 price in deal with Express Scripts</a></h3> <span class="secondary-label">May 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incye-ido-drug-development-scaled-back/522635/" class="analytics t-editors-bio-article">IDO drug development scaled back in wake of Incyte trial miss</a></h3> <span class="secondary-label">May 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-immunotherapy-lead-q1-earnings-pipeline/522513/" class="analytics t-editors-bio-article">Merck, riding clinical success, eyes cancer immunotherapy lead</a></h3> <span class="secondary-label">May 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/q1-earnings-preview-gilead-merck-co-highlight-the-week/522511/" class="analytics t-editors-bio-article">Q1 earnings preview: Novo, Celgene still to come</a></h3> <span class="secondary-label">May 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/saunders-all-options-remain-on-the-table-for-allergan/522433/" class="analytics t-editors-bio-article">Saunders: All options remain on the table for Allergan</a></h3> <span class="secondary-label">April 30, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/opdivo-q1-sales-opdivo-eliquis-analysts-question-whats-next/522269/" class="analytics t-editors-bio-article">Opdivo sales rise again, but analysts question what's next</a></h3> <span class="secondary-label">April 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ocrevus-fuels-fast-start-to-year-for-roche/522245/" class="analytics t-editors-bio-article">Ocrevus fuels fast start to year for Roche</a></h3> <span class="secondary-label">April 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-increase-stake-biosimilar-samsung-bioepis/522169/" class="analytics t-editors-bio-article">Biogen to increase stake in biosimilar developer Samsung Bioepis</a></h3> <span class="secondary-label">April 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-advair-slump-respiratory-earnings-q1/522149/" class="analytics t-editors-bio-article">GSK new drug success eclipsed by currency, Advair slump</a></h3> <span class="secondary-label">April 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/immunotherapies-biosimilars-to-dominate-next-week-of-earnings/522076/" class="analytics t-editors-bio-article">Immunotherapies, biosimilars to dominate next week of earnings</a></h3> <span class="secondary-label">April 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/setback-for-astrazeneca-cancer-combo-raises-mystic-stakes/522060/" class="analytics t-editors-bio-article">Setback for AstraZeneca cancer combo raises MYSTIC stakes</a></h3> <span class="secondary-label">April 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-raises-sales-forecasts-as-diabetes-drugs-outperform/522033/" class="analytics t-editors-bio-article">Lilly raises sales forecasts as diabetes drugs outperform</a></h3> <span class="secondary-label">April 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-india-china-drug-industries-mature-fda-scrutiny-an-overhang/521719/" class="analytics t-editors-bio-article">As India, China drug industries mature, FDA scrutiny an overhang</a></h3> <span class="secondary-label">April 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/top-challenges-facing-drug-supply-chains/521876/" class="analytics t-editors-bio-article">Top challenges facing drug supply chains</a></h3> <span class="secondary-label">April 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizers-herceptin-copy-hits-fda-roadblock/521933/" class="analytics t-editors-bio-article">Pfizer's Herceptin copy hits FDA roadblock</a></h3> <span class="secondary-label">April 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-ionis-billion-dollar-research-deal/521841/" class="analytics t-editors-bio-article">Biogen, facing questions, turns again to Ionis in $1B research deal</a></h3> <span class="secondary-label">April 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-agensys--manufacturing-facilities-gilead-deal/521767/" class="analytics t-editors-bio-article">Astellas sells Agensys facilities to Gilead</a></h3> <span class="secondary-label">April 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cosentyx-jitters-weigh-on-novartis/521720/" class="analytics t-editors-bio-article">Cosentyx jitters weigh on Novartis</a></h3> <span class="secondary-label">April 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/harvard-pilgrim-astrazeneca-symbicort-value-contract/521659/" class="analytics t-editors-bio-article">Pushing 'value,' Harvard Pilgrim tests outcomes deals</a></h3> <span class="secondary-label">April 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dea-proposed-rule-strictly-manage-opioid-manufacturing/521618/" class="analytics t-editors-bio-article">DEA seeks to more strictly manage opioid manufacturing</a></h3> <span class="secondary-label">April 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-advent-deal-european-generics/521525/" class="analytics t-editors-bio-article">Sanofi nears deal to sell EU generics unit for $2.4B </a></h3> <span class="secondary-label">April 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-bet-tumor-mutation-burden-checkmate-227/521411/" class="analytics t-editors-bio-article">Two years after cancer setback, Bristol-Myers' new biomarker bet pays off</a></h3> <span class="secondary-label">April 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/immunotherapy-combos-aacr-merck-keytruda-bristol-myers-opdivo/521373/" class="analytics t-editors-bio-article">I/O combos inch forward in pharma's lung cancer quest</a></h3> <span class="secondary-label">April 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/q1-kicks-off-with-jj-novartis-glaxo-results/521255/" class="analytics t-editors-bio-article">Q1 kicks off with J&J, Novartis, Glaxo results</a></h3> <span class="secondary-label">April 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lonza-gene-therapy-texas-plant-opening/521230/" class="analytics t-editors-bio-article">Lonza makes gene therapy ambitions clear with Texas plant</a></h3> <span class="secondary-label">April 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-offloads-gene-therapy-drugs-to-uks-orchard/521196/" class="analytics t-editors-bio-article">GSK offloads gene therapy drugs to UK's Orchard</a></h3> <span class="secondary-label">April 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cvs-hands-pharmacists-tool-to-compare-drug-prices/521132/" class="analytics t-editors-bio-article">CVS hands pharmacists tool to compare drug prices</a></h3> <span class="secondary-label">April 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-inlyta-phase-3-kidney-failure/521120/" class="analytics t-editors-bio-article">Pfizer's Inlyta misses mark in Phase 3 kidney cancer study</a></h3> <span class="secondary-label">April 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-study-success-abbvies-arthritis-hopeful-looks-to-be-a-safer-bet/520974/" class="analytics t-editors-bio-article">With study success, AbbVie's arthritis hopeful looks to be a safer bet</a></h3> <span class="secondary-label">April 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-avexis-gene-therapy-deal-aquisition/520880/" class="analytics t-editors-bio-article">Novartis buys AveXis for $8.7B, broadening gene therapy bet</a></h3> <span class="secondary-label">April 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-humira-biosimilar-settlement-samsung-bioepis/520763/" class="analytics t-editors-bio-article">AbbVie staves off another biosimilar challenge to Humira</a></h3> <span class="secondary-label">April 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-cancer-study-fails-setting-back-drug-combo-hopes/520781/" class="analytics t-editors-bio-article">Incyte cancer study fails, setting back drug combo hopes</a></h3> <span class="secondary-label">April 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/corning-to-build-nc-facility-in-pharma-packaging-expansion/520713/" class="analytics t-editors-bio-article">Corning to build NC facility in pharma packaging expansion</a></h3> <span class="secondary-label">April 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-ose-buys-cd47-checkpoint-inhibitor/520693/" class="analytics t-editors-bio-article">Boehringer joins checkpoint inhibitor race with OSE deal</a></h3> <span class="secondary-label">April 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-agilent-commercial-api-supply-patisiran/520659/" class="analytics t-editors-bio-article">Alnylam taps Agilent for commercial API supply</a></h3> <span class="secondary-label">April 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-repatha-pcsk9-cost-effective-cholesterol/520609/" class="analytics t-editors-bio-article">Amgen's money-back offer on Repatha isn't all that meaningful, researchers find</a></h3> <span class="secondary-label">April 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/proposed-china-tariffs-target-dozens-of-medical-products/520575/" class="analytics t-editors-bio-article">Proposed China tariffs target dozens of medical products</a></h3> <span class="secondary-label">April 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/rigel-fostamatinib-phase-2-fail-stock/520479/" class="analytics t-editors-bio-article">Rigel's fostamatinib falls short in Phase 2</a></h3> <span class="secondary-label">April 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-tafamidis-phase-3-attr-success-competition-alnylam/520378/" class="analytics t-editors-bio-article">Pfizer surprises ATTR rivals with tafamidis success</a></h3> <span class="secondary-label">April 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eisai-partners-with-nichi-iko-in-generics-pact/520293/" class="analytics t-editors-bio-article">Eisai partners with Nichi-Iko in generics pact</a></h3> <span class="secondary-label">March 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/indivior-inks-deal-for-preclinical-addiction-treatment-candidate/520272/" class="analytics t-editors-bio-article">Indivior inks deal for preclinical addiction treatment candidate</a></h3> <span class="secondary-label">March 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phrma-goes-after-drug-middlemen-in-new-ad-attack/520198/" class="analytics t-editors-bio-article">PhRMA goes after drug 'middlemen' in new ad attack</a></h3> <span class="secondary-label">March 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-hemlibra-hemophilia-patient-deaths-safety-worries/520177/" class="analytics t-editors-bio-article">Roche reports deaths of patients taking Hemlibra</a></h3> <span class="secondary-label">March 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-novartis-consumer-deal-asset-swap/520056/" class="analytics t-editors-bio-article">GSK buys Novartis stake in consumer business for $13B</a></h3> <span class="secondary-label">March 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-lilly-bet-pain-drugs-bare-pharma-pipeline/519592/" class="analytics t-editors-bio-article">Lilly's bet on pain stands out amid bare pharma pipeline</a></h3> <span class="secondary-label">March 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-momentum-grows-as-tecentriq-combo-delivers-survival-benefit/519944/" class="analytics t-editors-bio-article">Roche's momentum grows as Tecentriq combo delivers survival benefit</a></h3> <span class="secondary-label">March 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-pfizer-consumer-business-bid/519860/" class="analytics t-editors-bio-article">GSK drops bid to acquire Pfizer's consumer business</a></h3> <span class="secondary-label">March 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-multiple-sclerosis-siponimod-data-filing/519822/" class="analytics t-editors-bio-article">Novartis readies MS drug for speedy US filing</a></h3> <span class="secondary-label">March 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warns-indian-drugamker-malladi-open-air-api-production/519772/" class="analytics t-editors-bio-article">FDA warns Indian drugmaker over open-air API production</a></h3> <span class="secondary-label">March 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-alnylam-partner-to-turn-discovery-into-new-drugs-for-nash/519742/" class="analytics t-editors-bio-article">Regeneron, Alnylam partner to turn discovery into new drugs for NASH</a></h3> <span class="secondary-label">March 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seattle-genetics-adcetris-label-expansion-approval/519628/" class="analytics t-editors-bio-article">Seattle Genetics secures key label expansion for Adcetris</a></h3> <span class="secondary-label">March 21, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Roche-tecentriq-chemo-combo-success-impower-131/519531/" class="analytics t-editors-bio-article">Tecentriq combo success boosts Roche in lung cancer</a></h3> <span class="secondary-label">March 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/herons-non-opioid-pain-drug-succeeds-in-phase-3-lifting-shares/519418/" class="analytics t-editors-bio-article">Heron's non-opioid pain drug succeeds in Phase 3, lifting shares</a></h3> <span class="secondary-label">March 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ionis-taps-majority-owned-akcea-to-launch-inotersen/519315/" class="analytics t-editors-bio-article">Ionis taps majority-owned Akcea to launch inotersen</a></h3> <span class="secondary-label">March 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-splits-operations-unit-as-part-of-leadership-reshuffle/519247/" class="analytics t-editors-bio-article">Novartis splits operations unit as part of leadership reshuffle</a></h3> <span class="secondary-label">March 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sec-charges-against-theranos-holmes-dispel-last-shreds-of-unicorn-myth/519217/" class="analytics t-editors-bio-article">SEC charges against Theranos, Holmes dispel last shreds of unicorn myth</a></h3> <span class="secondary-label">March 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/president-cancer-panel-call-urgent-action-drug-prices/519149/" class="analytics t-editors-bio-article">Federal panel calls for 'urgent action' on cancer drug prices</a></h3> <span class="secondary-label">March 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-merck-echo-301-cancer-immunotherapy-epacadostat-ido/519040/" class="analytics t-editors-bio-article">Incyte study could bring lessons for cancer immunotherapy</a></h3> <span class="secondary-label">March 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-returns-rights-sosei-cgrp-inhibitor-ends-discovery-pact/519006/" class="analytics t-editors-bio-article">Teva hands back rights to preclinical CGRP blocker</a></h3> <span class="secondary-label">March 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-delays-readout-mystic-imfinzi-lung-cancer-study/518897/" class="analytics t-editors-bio-article">AstraZeneca pushes back readout of key lung cancer study</a></h3> <span class="secondary-label">March 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-sanofi-praluent-cut-cardiovascular-heart-risk-odyssey-study/518854/" class="analytics t-editors-bio-article">Regeneron-Sanofi cholesterol drug cuts heart risk in major study</a></h3> <span class="secondary-label">March 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-crowded-io-field-pharma-vcs-still-eager-to-invest/518795/" class="analytics t-editors-bio-article">Despite crowded I/O field, pharma, VCs still eager to invest</a></h3> <span class="secondary-label">March 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-recognizes-gmp-inspections-by-4-more-eu-states/518730/" class="analytics t-editors-bio-article">FDA recognizes GMP inspections by 4 more EU states</a></h3> <span class="secondary-label">March 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-eisai-keytruda-combo-partnership/518714/" class="analytics t-editors-bio-article">Merck partners with Eisai in sweeping bet on Keytruda combo</a></h3> <span class="secondary-label">March 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/unitedhealthcare-to-use-rebates-to-lower-drug-costs-for-patients/518485/" class="analytics t-editors-bio-article">UnitedHealthcare to use rebates to lower drug costs for patients</a></h3> <span class="secondary-label">March 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/santhera-shares-slide-as-raxone-fails-in-ms-study/518455/" class="analytics t-editors-bio-article">Santhera shares slide as Raxone fails in MS study</a></h3> <span class="secondary-label">March 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dermira-acne-drug-misses-the-mark-surprising-investors/518385/" class="analytics t-editors-bio-article">Dermira acne drug misses the mark, surprising investors</a></h3> <span class="secondary-label">March 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-ionis-showcase-potential-of-huntingtons-disease-drug/518272/" class="analytics t-editors-bio-article">Roche, Ionis showcase potential of Huntington's disease drug</a></h3> <span class="secondary-label">March 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-links-rise-in-eylea-safety-reports-to-syringes/518193/" class="analytics t-editors-bio-article">Regeneron links rise in Eylea safety reports to syringes</a></h3> <span class="secondary-label">March 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-partners-with-revance-to-develop-a-botox-biosimilar/518183/" class="analytics t-editors-bio-article">Mylan partners with Revance to develop a Botox biosimilar</a></h3> <span class="secondary-label">March 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/benzo-overprescribing-risk-may-be-overlooked-amid-opioid-crisis/518088/" class="analytics t-editors-bio-article">Benzo overprescribing risk may be overlooked amid opioid crisis</a></h3> <span class="secondary-label">Feb. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-medimmune-spins-out-autoimmune-drugs-launches-viela-bio/518058/" class="analytics t-editors-bio-article">AstraZeneca spins out new biotech, shedding autoimmune drugs</a></h3> <span class="secondary-label">Feb. 28, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-verzenio-approved-first-line-breast-cancer-pfizer-novartis/517955/" class="analytics t-editors-bio-article">Lilly wins broader Verzenio approval, drawing even with rivals</a></h3> <span class="secondary-label">Feb. 27, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/messy-phase-2-data-for-arcas-heart-drug-leave-investors-unimpressed/517882/" class="analytics t-editors-bio-article">Messy Phase 2 data for Arca's heart drug leave investors unimpressed</a></h3> <span class="secondary-label">Feb. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-microbiome-gut-bacteria-cancer-immuno-oncology/517247/" class="analytics t-editors-bio-article">Cancer and the microbiome: What's old is new again</a></h3> <span class="secondary-label">Feb. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/patent-board-ptab-denies-mohawk-tribe-restasis-patents-allergan/517841/" class="analytics t-editors-bio-article">Patent board ruling undermines Allergan effort to defend Restasis patents</a></h3> <span class="secondary-label">Feb. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bellicum-restart-cell-therapy-trials-clinical-hold/517735/" class="analytics t-editors-bio-article">Bellicum outlines path to restart US studies of cell therapy</a></h3> <span class="secondary-label">Feb. 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/car-t-growing-up-with-big-pharmas-big-bet/517135/" class="analytics t-editors-bio-article">CAR-T growing up with big pharma's big bet</a></h3> <span class="secondary-label">Feb. 20, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/charles-river-mpi-cro-cmo-deal-consolidation/517204/" class="analytics t-editors-bio-article">Charles River boosts CRO chops with $800M deal for MPI</a></h3> <span class="secondary-label">Feb. 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-shares-fall-after-unexpected-variability-in-alzheimers-studies/517193/" class="analytics t-editors-bio-article">Biogen shares fall after unexpected 'variability' in Alzheimer's studies</a></h3> <span class="secondary-label">Feb. 15, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-nektar-combination-cancer-therapy-opdivo-214/517063/" class="analytics t-editors-bio-article">Bristol-Myers bets $1.85B on combo potential of Nektar cancer drug</a></h3> <span class="secondary-label">Feb. 14, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tevas-copaxone-sales-hit-hastened-with-ok-of-novartis-copy/516969/" class="analytics t-editors-bio-article">Teva's Copaxone sales hit hastened with OK of Novartis copy</a></h3> <span class="secondary-label">Feb. 13, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/maker-of-oxycontin-to-halt-opioid-promotion-to-doctors/516863/" class="analytics t-editors-bio-article">Maker of Oxycontin to halt opioid promotion to doctors</a></h3> <span class="secondary-label">Feb. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-ends-alzheimers-research-for-pde9-blocker/516762/" class="analytics t-editors-bio-article">Boehringer ends Alzheimer's research for PDE9 blocker</a></h3> <span class="secondary-label">Feb. 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-letter-details-violations-at-celltrion-plant/516684/" class="analytics t-editors-bio-article">FDA warning letter details violations at Celltrion plant</a></h3> <span class="secondary-label">Feb. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-manufacturing-tax-code-biologic-plant/516677/" class="analytics t-editors-bio-article">Citing lower tax rate, Amgen plans new biomanufacturing plant</a></h3> <span class="secondary-label">Feb. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-gsk-crl-advair-copy-rejection/516652/" class="analytics t-editors-bio-article">FDA knocks back Novartis' Advair copy</a></h3> <span class="secondary-label">Feb. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-plan-drug-spending-rose-at-slowest-rate-in-24-years/516563/" class="analytics t-editors-bio-article">Express Scripts: Plan drug spending rose at slowest rate in 24 years</a></h3> <span class="secondary-label">Feb. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mixed-results-muddy-sanofis-plans-for-2018-growth/516534/" class="analytics t-editors-bio-article">Mixed results muddy Sanofi's plans for 2018 growth</a></h3> <span class="secondary-label">Feb. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-hepatitis-c-revenues-slide-fourth-quarter-earnings/516494/" class="analytics t-editors-bio-article">Gilead forecasts steep slide in 2018 hepatitis C revenues</a></h3> <span class="secondary-label">Feb. 6, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/strong-data-lift-profile-of-jjs-cancer-drug-apalutamide/516340/" class="analytics t-editors-bio-article">Strong data lift profile of J&J's cancer drug apalutamide</a></h3> <span class="secondary-label">Feb. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biopharma-in-charts-key-takeaways-from-q4-earnings/516321/" class="analytics t-editors-bio-article">Biopharma in charts: Key takeaways from Q4 earnings</a></h3> <span class="secondary-label">Feb. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/keytruda-boosts-merck-yet-2018-will-be-crucial-year/516200/" class="analytics t-editors-bio-article">Keytruda boosts Merck, yet 2018 will be crucial year</a></h3> <span class="secondary-label">Feb. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celltrion-biosimilars-plant-hit-with-fda-warning-letter-inflectra/516149/" class="analytics t-editors-bio-article">Celltrion biosimilars plant hit with FDA warning letter</a></h3> <span class="secondary-label">Feb. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-tees-up-us-capital-spending-yet-details-remain-vague/516141/" class="analytics t-editors-bio-article">Pharma tees up US capital spending, yet details remain vague</a></h3> <span class="secondary-label">Feb. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-adds-black-box-warning-to-intercepts-ocaliva/516115/" class="analytics t-editors-bio-article">FDA adds black box warning to Intercept's Ocaliva</a></h3> <span class="secondary-label">Feb. 1, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aegerion-sentenced-for-mismarketing-of-cholesterol-drug/516027/" class="analytics t-editors-bio-article">Aegerion sentenced for mismarketing of cholesterol drug</a></h3> <span class="secondary-label">Jan. 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-tax-reform-q4-earnings-deal/516010/" class="analytics t-editors-bio-article">Boosted by tax reform, Lilly looking for ways to spend $9B</a></h3> <span class="secondary-label">Jan. 31, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-eliquis-noac-real-world-data-unseat-warfarin/515516/" class="analytics t-editors-bio-article">How Bristol-Myers and Pfizer are using real-world data to unseat warfarin </a></h3> <span class="secondary-label">Jan. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-real-world-data-drug-evidence-drivers-value/515692/" class="analytics t-editors-bio-article">5 Drivers spurring use of real-world evidence</a></h3> <span class="secondary-label">Jan. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aradigm-stung-fda-rejection-crl-inhaled-antibiotic-linhaliq/515774/" class="analytics t-editors-bio-article">Aradigm stung by FDA rejection of inhaled antibiotic</a></h3> <span class="secondary-label">Jan. 29, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-tax-rate-mavyret-stock-humira-2018/515664/" class="analytics t-editors-bio-article">AbbVie shares boom on rosy outlook</a></h3> <span class="secondary-label">Jan. 26, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ge-china-clover-flexfactory-manufacturing/515586/" class="analytics t-editors-bio-article">Chinese drugmakers tap GE tech, seeing biologic boom ahead</a></h3> <span class="secondary-label">Jan. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spark-licenses-luxturna-gene-therapy-novartis-outside-us/515575/" class="analytics t-editors-bio-article">Spark deals Novartis ex-US rights to gene therapy for $105M</a></h3> <span class="secondary-label">Jan. 25, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/us-in-desperate-need-of-biosimilars-novartis-narasimhan/515489/" class="analytics t-editors-bio-article">US in 'desperate need' of biosimilars: Novartis' Narasimhan</a></h3> <span class="secondary-label">Jan. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-pulls-arzerra-ex-us-markets-cll-competition-genmab/515480/" class="analytics t-editors-bio-article">Novartis pulls Arzerra outside US markets amid rising CLL competition</a></h3> <span class="secondary-label">Jan. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-predicts-growth-pick-up-on-back-of-cosentyx-entresto/515443/" class="analytics t-editors-bio-article">Novartis predicts growth pick-up on back of Cosentyx, Entresto</a></h3> <span class="secondary-label">Jan. 24, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astellas-vicals-cmv-vaccine-phase-3-failure-miss/515347/" class="analytics t-editors-bio-article">Astellas, Vical's CMV vaccine comes up short in Phase 3</a></h3> <span class="secondary-label">Jan. 23, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-buys-juno-9-billion-deepening-bet-car-t/515226/" class="analytics t-editors-bio-article">Celgene buys Juno for $9B, deepening bet on CAR-T</a></h3> <span class="secondary-label">Jan. 22, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-to-speed-public-notification-of-product-recalls/515155/" class="analytics t-editors-bio-article">FDA to speed public notification of product recalls</a></h3> <span class="secondary-label">Jan. 19, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ipca-labs-buys-pisgah-labs-manufacturer-for-9-million/515076/" class="analytics t-editors-bio-article">Ipca Labs buys North Carolina manufacturer for $9.7M </a></h3> <span class="secondary-label">Jan. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-eye-to-brexit-almac-to-invest-42m-in-ireland-site/515070/" class="analytics t-editors-bio-article">With eye to Brexit, Almac to invest $42M in Ireland site</a></h3> <span class="secondary-label">Jan. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ptab-invalidate-jnj-patent-zytiga-generic-competition-pfizer/515039/" class="analytics t-editors-bio-article">Patent setback could sting J&J prostate cancer franchise</a></h3> <span class="secondary-label">Jan. 18, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/exelixis-cabozantinib-celestial-study-results-liver-cancer-survival/514935/" class="analytics t-editors-bio-article">Exelixis details Phase 3 cabozantinib results</a></h3> <span class="secondary-label">Jan. 17, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-finds-spark-luxturna-gene-therapy-too-expensive-price/514821/" class="analytics t-editors-bio-article">Price for Spark gene therapy too high, ICER says</a></h3> <span class="secondary-label">Jan. 16, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biopharma-dives-3-predictions-for-2018-and-beyond/514712/" class="analytics t-editors-bio-article">BioPharma Dive's 3 predictions for 2018 and beyond</a></h3> <span class="secondary-label">Jan. 12, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/closing-jpm18-winners-and-losers-brighter-days-for-neuroscience/514622/" class="analytics t-editors-bio-article">Closing JPM18: Winners and losers, brighter days for neuroscience</a></h3> <span class="secondary-label">Jan. 11, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm18-day-3-valeant-and-acorda-make-plans-promises-of-ma/514522/" class="analytics t-editors-bio-article">JPM18 Day 3: Valeant and Acorda make plans, promises of M&A</a></h3> <span class="secondary-label">Jan. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/price-competition-to-hit-oncology-next-biopharma-dives-2018-predictions/513221/" class="analytics t-editors-bio-article"> Price competition to hit oncology next: BioPharma Dive's 2018 predictions</a></h3> <span class="secondary-label">Jan. 10, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jp-morgan-bluebird-bio-file-2019-gene-therapy-price-value/514426/" class="analytics t-editors-bio-article">JPM18: Bluebird set to file 3 drugs for approval by 2019</a></h3> <span class="secondary-label">Jan. 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm18-day-2-roche-on-gene-therapy-aimmune-nears-key-readout-and-outpatien/514406/" class="analytics t-editors-bio-article">JPM18 Day 2: Roche on gene therapy, Aimmune nears key readout and outpatient CAR-T</a></h3> <span class="secondary-label">Jan. 9, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm18-day-1-celgene-bullish-alnylam-tempers-expectations-jj-on-diabetes/514311/" class="analytics t-editors-bio-article">JPM18 Day 1: Celgene bullish, Alnylam tempers hopes, Axovant shocks</a></h3> <span class="secondary-label">Jan. 8, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-buy-impact-biomedicines-7-billion-fedratinib-jp-morgan/514243/" class="analytics t-editors-bio-article">Celgene aims to quell growth worries with $7B Impact deal</a></h3> <span class="secondary-label">Jan. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-ends-neuroscience-alzheimers-research-cuts-300-jobs/514210/" class="analytics t-editors-bio-article">Pfizer pulls back from neuroscience, ending research </a></h3> <span class="secondary-label">Jan. 7, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-rejects-allergan-citizen-petition-block-restasis-generic-copies/514170/" class="analytics t-editors-bio-article">FDA rejects Allergan's latest bid to block Restasis copies</a></h3> <span class="secondary-label">Jan. 5, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-strengthen-oversight-compounded-drug-manufacturing-nejm/514097/" class="analytics t-editors-bio-article">FDA aims to strengthen oversight of compounded drug manufacturing</a></h3> <span class="secondary-label">Jan. 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/macrogenics-finds-new-pharma-partner-in-roche/514081/" class="analytics t-editors-bio-article">MacroGenics finds new pharma partner in Roche</a></h3> <span class="secondary-label">Jan. 4, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-approvals-surged-in-2017-what-does-that-mean-for-pharma/513995/" class="analytics t-editors-bio-article">Drug approvals surged in 2017. What does that mean for pharma?</a></h3> <span class="secondary-label">Jan. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-to-cut-1000-jobs-as-generic-competition-threatens/513991/" class="analytics t-editors-bio-article">Allergan to cut 1,000 jobs as generic competition threatens</a></h3> <span class="secondary-label">Jan. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-sangamo-partner-develop-gene-therapy-ALS-zinc-fingers/513965/" class="analytics t-editors-bio-article">Pfizer teams up with Sangamo to develop ALS gene therapy</a></h3> <span class="secondary-label">Jan. 3, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-builds-case-for-ketamine-based-depression-drug/513866/" class="analytics t-editors-bio-article">J&J builds case for ketamine-based depression drug</a></h3> <span class="secondary-label">Jan. 2, 2018</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mallinckrodt-buy-sucampo-deal-new-drugs-pipeline/513759/" class="analytics t-editors-bio-article">Mallinckrodt builds pipeline through $1.2B Sucampo deal</a></h3> <span class="secondary-label">Dec. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/janssen-china-legend-biotech-car-t-deal-multiple-myeloma/513713/" class="analytics t-editors-bio-article">J&J enters CAR-T field with $350M Legend deal</a></h3> <span class="secondary-label">Dec. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biopharma-trends-to-watch-in-2018/513714/" class="analytics t-editors-bio-article">Biopharma trends to watch in 2018</a></h3> <span class="secondary-label">Dec. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-draft-car-t-cost-effective-kymriah-yescarta-price/513625/" class="analytics t-editors-bio-article">Kymriah, Yescarta could be cost-effective, ICER finds</a></h3> <span class="secondary-label">Dec. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-car-t-manufacturing-partnership-thermo-scientific/513588/" class="analytics t-editors-bio-article">Juno inks CAR-T supply deal with Thermo Fisher</a></h3> <span class="secondary-label">Dec. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/galera-scores-trial-win-for-cancer-side-effect-treatment/513526/" class="analytics t-editors-bio-article">Galera scores trial win for cancer side effect treatment</a></h3> <span class="secondary-label">Dec. 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-spark-blindness-treatment-gene-therapy-luxturna/513431/" class="analytics t-editors-bio-article">FDA approves Spark blindness drug in gene therapy first</a></h3> <span class="secondary-label">Dec. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aerie-eyes-glaucoma-market-after-early-fda-win/513415/" class="analytics t-editors-bio-article">Aerie eyes glaucoma market after early FDA win</a></h3> <span class="secondary-label">Dec. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-ultragenyx-priority-review-voucher-sale-130-million/513303/" class="analytics t-editors-bio-article">Novartis buys regulatory fast pass for $130M</a></h3> <span class="secondary-label">Dec. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-gastric-cancer-trial-miss-failure/513170/" class="analytics t-editors-bio-article">Trial miss sets back Merck's Keytruda plans in stomach cancer</a></h3> <span class="secondary-label">Dec. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samsung-biologics-ema-approval-production-plant/513090/" class="analytics t-editors-bio-article">EMA signs off on Samsung BioLogics manufacturing plant</a></h3> <span class="secondary-label">Dec. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-letter-seindni-korean-drugmaker/513087/" class="analytics t-editors-bio-article">FDA warns Korean OTC manufacturer for GMP violations</a></h3> <span class="secondary-label">Dec. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-sanofi-cemiplimab-pd1-inhibitor-cutaneous-carcinoma-submit-bla/513065/" class="analytics t-editors-bio-article">Regeneron's play for a stake in the I/O market boosted by study success</a></h3> <span class="secondary-label">Dec. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-2017-what-you-missed/512936/" class="analytics t-editors-bio-article">ASH 2017: What you missed</a></h3> <span class="secondary-label">Dec. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash17-jjs-darzalex-delivers-combo-win/512799/" class="analytics t-editors-bio-article">ASH17: J&J's Darzalex delivers combo win</a></h3> <span class="secondary-label">Dec. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spark-hemophilia-gene-therapy-disappoints-biomarin/512785/" class="analytics t-editors-bio-article">ASH17: Spark gene therapy falls behind BioMarin in hemophilia</a></h3> <span class="secondary-label">Dec. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/shire-ornskov-hemophilia-roche-gene-therapy-competition/512683/" class="analytics t-editors-bio-article">Shire CEO: Hemophilia will remain a core business</a></h3> <span class="secondary-label">Dec. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash17-benefit-of-gileads-car-t-remains-durable-over-longer-term/512666/" class="analytics t-editors-bio-article">ASH17: Benefit of Gilead's CAR-T remains durable over longer term</a></h3> <span class="secondary-label">Dec. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash17-seattle-genetics-sees-market-opportunity-in-cancer-combo-success/512667/" class="analytics t-editors-bio-article">ASH17: Seattle Genetics sees market opportunity in cancer combo success</a></h3> <span class="secondary-label">Dec. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-makes-strides-car-t-bb2121-multiple-myeloma/512660/" class="analytics t-editors-bio-article">ASH17: bluebird bio makes strides in CAR-T, gene therapy</a></h3> <span class="secondary-label">Dec. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-gene-therapy-cuts-bleeding-hemophilia-a-ash-2017/512659/" class="analytics t-editors-bio-article">ASH17: BioMarin's gene therapy promises one-time treatment of hemophilia</a></h3> <span class="secondary-label">Dec. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-buys-cell-design-car-t-567-million/512580/" class="analytics t-editors-bio-article">Gilead deepens CAR-T push with deal for Cell Design</a></h3> <span class="secondary-label">Dec. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chasing-leaders-juno-rides-car-t-momentum-into-ash/512555/" class="analytics t-editors-bio-article">Chasing leaders, Juno rides CAR-T momentum into ASH</a></h3> <span class="secondary-label">Dec. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wuxi-preps-for-biologics-manufacturing-surge-in-china/512526/" class="analytics t-editors-bio-article">Wuxi preps for biologics manufacturing surge in China</a></h3> <span class="secondary-label">Dec. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-tecentriq-combo-cuts-risk-of-lung-cancer-progression/512512/" class="analytics t-editors-bio-article">Roche's Tecentriq combo cuts risk of lung cancer progression</a></h3> <span class="secondary-label">Dec. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-outcomes-based-contract-prime-multiple-sclerosis/512422/" class="analytics t-editors-bio-article">Biogen inks outcomes-based contract for MS meds</a></h3> <span class="secondary-label">Dec. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-lifts-clinical-hold-checkpoint-inhibitors-multiple-myeloma/512404/" class="analytics t-editors-bio-article">FDA cautiously lifts holds on combo studies of checkpoint inhibitors</a></h3> <span class="secondary-label">Dec. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-shut-down-end-c-difficile-vaccine/512233/" class="analytics t-editors-bio-article">Updated: Sanofi discontinues C. diff candidate in blow to vaccine unit</a></h3> <span class="secondary-label">Dec. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/7-biopharmas-to-watch-at-ash-2017/512206/" class="analytics t-editors-bio-article">7 Biopharmas to watch at ASH 2017</a></h3> <span class="secondary-label">Dec. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-first-us-approval-herceptin-biosimilar-roche/512187/" class="analytics t-editors-bio-article">Mylan wins first US approval of Herceptin biosimilar</a></h3> <span class="secondary-label">Dec. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/deal-of-the-year-gilead-buys-kite-pharma-2017/510812/" class="analytics t-editors-bio-article">Deal of the Year: Gilead Buys Kite Pharma</a></h3> <span class="secondary-label">Dec. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/most-impressive-drug-launch-roche-ocrevus-2017/510814/" class="analytics t-editors-bio-article">Most Impressive Drug Launch: Roche's Ocrevus</a></h3> <span class="secondary-label">Dec. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/the-biopharma-dive-awards-for-2017/511023/" class="analytics t-editors-bio-article">The BioPharma Dive Awards for 2017</a></h3> <span class="secondary-label">Dec. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-xofigo-study-unblinding-patient-deaths-prostate-cancer/512102/" class="analytics t-editors-bio-article">Bayer unblinds cancer drug study early to investigate patient deaths</a></h3> <span class="secondary-label">Dec. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/corning-185-jobs-valor-glass-pharma-packaging-production/512006/" class="analytics t-editors-bio-article">Corning adds 185 jobs to support pharma packaging production</a></h3> <span class="secondary-label">Nov. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-dengue-vaccine-limit-use-label-change-100-million-charge/511997/" class="analytics t-editors-bio-article">Sanofi to propose limits on use of dengue vaccine after safety signal</a></h3> <span class="secondary-label">Nov. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-opdp-third-warning-letter-magna-misleading-drug-promotion/511892/" class="analytics t-editors-bio-article">FDA knocks generic maker for misbranding sleep aid</a></h3> <span class="secondary-label">Nov. 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/industry-pulse-new-drugs-and-the-search-for-growth/511833/" class="analytics t-editors-bio-article">Biopharma in charts: New drugs and the search for growth</a></h3> <span class="secondary-label">Nov. 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-merck-kgaas-bavencio-falls-short-in-gastric-cancer-study/511769/" class="analytics t-editors-bio-article">Pfizer, Merck KGaA's Bavencio falls short in gastric cancer study</a></h3> <span class="secondary-label">Nov. 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-china-joint-venture-dizal-pharma-drug-development/511642/" class="analytics t-editors-bio-article">AstraZeneca launches JV, furthering play for China market</a></h3> <span class="secondary-label">Nov. 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-restructures-to-stabilize-struggling-business/511617/" class="analytics t-editors-bio-article">Teva restructures to stabilize struggling business</a></h3> <span class="secondary-label">Nov. 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-janssen-darzalex-multiple-myeloma-first-line/511563/" class="analytics t-editors-bio-article">J&J eyes broader market for blood cancer med Darzalex</a></h3> <span class="secondary-label">Nov. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-boosted-by-us-approval-of-two-drug-hiv-pill/511550/" class="analytics t-editors-bio-article">GSK boosted by US approval of two-drug HIV pill</a></h3> <span class="secondary-label">Nov. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cytokinetics-als-tirasemtiv-end-development-study-failure/511447/" class="analytics t-editors-bio-article">Cytokinetics to discontinue ALS drug after Phase 3 miss</a></h3> <span class="secondary-label">Nov. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-lung-cancer-tecentriq-impower150/511326/" class="analytics t-editors-bio-article">Roche lung cancer results boost Tecentriq versus I/O rivals</a></h3> <span class="secondary-label">Nov. 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/proposed-medicare-policy-could-shift-drug-rebates-to-consumers/511221/" class="analytics t-editors-bio-article">Proposed Medicare policy could shift drug rebates to consumers</a></h3> <span class="secondary-label">Nov. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/recipharm-to-shutter-two-plants-cutting-225-jobs/511136/" class="analytics t-editors-bio-article">Recipharm to shutter two plants, cutting 225 jobs</a></h3> <span class="secondary-label">Nov. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/avista-doubles-api-manufacturing-capacity-at-co-facility/511132/" class="analytics t-editors-bio-article">Avista doubles API manufacturing capacity at CO facility</a></h3> <span class="secondary-label">Nov. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/quotient-sciences-pharmaterials-cdmo-deal/511123/" class="analytics t-editors-bio-article">Quotient Sciences buys UK CDMO in third acquisition of year</a></h3> <span class="secondary-label">Nov. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/janssen-johnson-licenses-gi-antisense-drug-ionis/511106/" class="analytics t-editors-bio-article">Janssen picks up second GI drug from Ionis</a></h3> <span class="secondary-label">Nov. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-cosentyx-growth-immunology-tnf/511013/" class="analytics t-editors-bio-article">Novartis sets Cosentyx hopes higher</a></h3> <span class="secondary-label">Nov. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-wins-fda-approval-fasenra-benralizumab-asthma/510991/" class="analytics t-editors-bio-article">AstraZeneca wins US approval for asthma biologic</a></h3> <span class="secondary-label">Nov. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/loxo-parlays-cancer-drug-success-into-15b-deal-with-bayer/510873/" class="analytics t-editors-bio-article">Loxo parlays cancer drug success into $1.5B deal with Bayer</a></h3> <span class="secondary-label">Nov. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/homology-medicine-novartis-gene-editing-collaboration/510822/" class="analytics t-editors-bio-article">Novartis turns to startup to boost gene editing efforts</a></h3> <span class="secondary-label">Nov. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/zymeworks-adds-6th-pharma-partner-jj-janssen-deal/510744/" class="analytics t-editors-bio-article">Zymeworks adds 6th pharma partner with J&J deal</a></h3> <span class="secondary-label">Nov. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-analysis-of-shuttered-study-offers-clues-for-car-t/510634/" class="analytics t-editors-bio-article">Juno analysis of shuttered study offers clues for CAR-T</a></h3> <span class="secondary-label">Nov. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-shares-boom-Phase-3-success-postpartum-depression-drug/510505/" class="analytics t-editors-bio-article">Sage shares boom on success of postpartum depression drug</a></h3> <span class="secondary-label">Nov. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hard-brexit-uk-eu-risks-disruption-drug-supply-efpia/510464/" class="analytics t-editors-bio-article">'Hard' Brexit risks disrupting supply of thousands of drugs</a></h3> <span class="secondary-label">Nov. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-to-shift-packaging-operations-trimming-235-jobs/510462/" class="analytics t-editors-bio-article">Roche to shift packaging operations, trimming 235 jobs</a></h3> <span class="secondary-label">Nov. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spark-gene-therapy-blindness-luxturna-steep-cost-price/510414/" class="analytics t-editors-bio-article">Spark gene therapy for blindness could come at steep cost</a></h3> <span class="secondary-label">Nov. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-third-quarter-eylea-sales-rise-dupixent/510387/" class="analytics t-editors-bio-article">Regeneron boosted by Eylea strength</a></h3> <span class="secondary-label">Nov. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cellectis-car-t-fda-lifts-clinical-hold-restart-study/510269/" class="analytics t-editors-bio-article">FDA lifts clinical hold on Cellectis CAR-T</a></h3> <span class="secondary-label">Nov. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/therapeuticsmd-fda-flexibility-resubmission-TX-004HR/510144/" class="analytics t-editors-bio-article">FDA agrees to review TherapeuticsMD drug, dropping safety demands</a></h3> <span class="secondary-label">Nov. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-reduce-revenue-forecast-copaxone-generic-price/510014/" class="analytics t-editors-bio-article">One-two punch hits Teva, sparking worries about debt</a></h3> <span class="secondary-label">Nov. 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-recognize-8-eu-regulators-gmp-inspections-ema/509914/" class="analytics t-editors-bio-article">FDA to recognize GMP inspections by 8 EU drug regulators</a></h3> <span class="secondary-label">Nov. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/diabetes-drags-on-sanofi-even-as-dupixent-shines/509897/" class="analytics t-editors-bio-article">Diabetes drags on Sanofi, even as Dupixent shines</a></h3> <span class="secondary-label">Nov. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-drug-pricing-watchdog-funding/509814/" class="analytics t-editors-bio-article">ICER looks to expand watchdog role with new funding</a></h3> <span class="secondary-label">Nov. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-secures-us-approval-for-cornerstone-cancer-drug/509773/" class="analytics t-editors-bio-article">AstraZeneca secures US approval for 'cornerstone' cancer drug</a></h3> <span class="secondary-label">Nov. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-lentiglobin-sickle-cell-manufacturing-changes-ash/509737/" class="analytics t-editors-bio-article">Bluebird marks progress on Lentiglobin gene therapy</a></h3> <span class="secondary-label">Nov. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-incyte-imfinzi-epacadostat-combo-study-pacific/508562/" class="analytics t-editors-bio-article">AstraZeneca looks to build edge in early-stage lung cancer</a></h3> <span class="secondary-label">Oct. 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spotlight-globalization-china-reform-novartis/508180/" class="analytics t-editors-bio-article">Pharma's betting big on China, but R&D boom still to come</a></h3> <span class="secondary-label">Oct. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-buy-advanced-accelerator-4-billion-acquisition-radiopharmaceuticals/508446/" class="analytics t-editors-bio-article">Novartis bolsters oncology with $3.9B Advanced Accelerator buy</a></h3> <span class="secondary-label">Oct. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-sales-lung-cancer-third-quarter-earnings/508350/" class="analytics t-editors-bio-article">Merck sales slip, even as Keytruda gains ground</a></h3> <span class="secondary-label">Oct. 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/q3-third-quarter-earnings-pfizer-allergan-novo/508295/" class="analytics t-editors-bio-article">What to expect from the rest of pharma's earnings</a></h3> <span class="secondary-label">Oct. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-hepatitis-c-sales-fall-further-abbvie-mavyret/508289/" class="analytics t-editors-bio-article">Gilead warns hep C sales could fall further</a></h3> <span class="secondary-label">Oct. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/puerto-rico-gottlieb-manufacturing-drug-production-disruptions/508263/" class="analytics t-editors-bio-article">Drug production in Puerto Rico still disrupted, FDA says</a></h3> <span class="secondary-label">Oct. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-manufacturing-insulin-production-upgrade/508247/" class="analytics t-editors-bio-article">Lilly to spend $72M on upgrading insulin production</a></h3> <span class="secondary-label">Oct. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-boosts-sales-forecasts-cystic-fibrosis-drugs-outperform/508227/" class="analytics t-editors-bio-article">Vertex grows CF franchise as combos move forward</a></h3> <span class="secondary-label">Oct. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-advair-copies-looming-gsk-keeps-focus-on-new-drugs/508116/" class="analytics t-editors-bio-article">With Advair copies looming, GSK keeps focus on new drugs</a></h3> <span class="secondary-label">Oct. 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eyes-on-alcon-as-novartis-notches-modest-growth/508005/" class="analytics t-editors-bio-article">Eyes on Alcon as Novartis notches modest growth</a></h3> <span class="secondary-label">Oct. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/glaxosmithkline-gsk-shingrix-fda-approval-shingles-vaccine/507887/" class="analytics t-editors-bio-article">Vaccine approval buoys GSK new drug push</a></h3> <span class="secondary-label">Oct. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/whats-next-for-biopharma-q3-earnings/507703/" class="analytics t-editors-bio-article">What's next for biopharma Q3 earnings</a></h3> <span class="secondary-label">Oct. 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gritstone-arbutus-technology-rna-based-drugs/507706/" class="analytics t-editors-bio-article">Gritstone taps Arbutus' LNP tech for RNA-based therapies</a></h3> <span class="secondary-label">Oct. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-and-johnson-puerto-rico-plants-full-operations-hurricane-maria/507702/" class="analytics t-editors-bio-article">J&J says Puerto Rico plants returning to full operations</a></h3> <span class="secondary-label">Oct. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-car-t-approval-kite-yescarta-fda/507623/" class="analytics t-editors-bio-article">Gilead wins US approval for CAR-T cancer therapy</a></h3> <span class="secondary-label">Oct. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-increased-spending-orphan-drugs-still-small-piece-of-us-medicines/507597/" class="analytics t-editors-bio-article">Despite increased spending, orphan drugs still small piece of US medicines market</a></h3> <span class="secondary-label">Oct. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-congressional-spotlight-drug-industry-groups-blame-each-other/507578/" class="analytics t-editors-bio-article">In Congressional spotlight, drug industry groups blame each other</a></h3> <span class="secondary-label">Oct. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amneal-impax-combine-amid-generics-crunch/507464/" class="analytics t-editors-bio-article">Amneal, Impax combine amid generics crunch</a></h3> <span class="secondary-label">Oct. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/district-judge-invalidates-allergan-restasis-patents-generic-competition/507390/" class="analytics t-editors-bio-article">Federal judge invalidates Restasis patents in blow to Allergan</a></h3> <span class="secondary-label">Oct. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/exelixis-cabometyx-hcc-cancer-phase-3-celestial-success/507349/" class="analytics t-editors-bio-article">Exelixis continues to gain momentum with positive data</a></h3> <span class="secondary-label">Oct. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-jnj-roche-biogen-lilly-novartis-Q3-earnings/507176/" class="analytics t-editors-bio-article">What Q3 earnings will look like for 5 pharma giants</a></h3> <span class="secondary-label">Oct. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sparks-gene-therapy-for-blindness-takes-major-step-toward-approval/507157/" class="analytics t-editors-bio-article">Spark's gene therapy for blindness takes major step toward approval</a></h3> <span class="secondary-label">Oct. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-sells-boulder-colorado-api-facility-cordenpharma/507172/" class="analytics t-editors-bio-article">Pfizer sells off Colorado facility to CordenPharma</a></h3> <span class="secondary-label">Oct. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-expands-vaccine-production-facility-170-million/507136/" class="analytics t-editors-bio-article">Sanofi commits €170M to expand flu vaccines production</a></h3> <span class="secondary-label">Oct. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharmaceutical-advertising-side-effects-risky-marketing/507056/" class="analytics t-editors-bio-article">Long rundowns of side effects can make drugs seem less risky, study finds</a></h3> <span class="secondary-label">Oct. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lupin-symbiomix-expands-us-business-deal/507026/" class="analytics t-editors-bio-article">Lupin expands US presence with $150M Symbiomix deal</a></h3> <span class="secondary-label">Oct. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-abemaciclib-lung-cancer-failure-trial-miss/506903/" class="analytics t-editors-bio-article">Lilly's plans for abemaciclib dented by lung trial miss</a></h3> <span class="secondary-label">Oct. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/flexion-osteoarthritis-FDA-approval-zilretta/506810/" class="analytics t-editors-bio-article">Flexion secures US approval for osteoarthritis drug</a></h3> <span class="secondary-label">Oct. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/strong-data-for-pompe-therapy-boosts-amicus/506388/" class="analytics t-editors-bio-article">Strong data for Pompe therapy boosts Amicus</a></h3> <span class="secondary-label">Oct. 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/rigel-blood-drug-fostamatinib-hits-mark-study-aiha/506357/" class="analytics t-editors-bio-article">Rigel blood drug hits mark in mid-stage study</a></h3> <span class="secondary-label">Oct. 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-/506290/" class="analytics t-editors-bio-article">Express Scripts: Specialty meds driving up US drug spend</a></h3> <span class="secondary-label">Oct. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/arbutus-roivant-invest-116-million-hepatitis-b-lnp/506265/" class="analytics t-editors-bio-article">Arbutus boosted by $116M investment from Roivant </a></h3> <span class="secondary-label">Oct. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/zogenix-epilepsy-dravet-drug-succeeds-shares-surge/506124/" class="analytics t-editors-bio-article">Zogenix looks to filing after epilepsy trial success</a></h3> <span class="secondary-label">Sept. 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/a-drug-15-years-in-the-making-alnylams-quest-to-prove-rnai/505971/" class="analytics t-editors-bio-article">A drug 15 years in the making: Alnylam's quest to prove RNAi</a></h3> <span class="secondary-label">Sept. 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abeona-partners-brammer-bio-gene-therapy-manufacturing/506054/" class="analytics t-editors-bio-article">Abeona taps Brammer Bio for gene therapy manufacturing support</a></h3> <span class="secondary-label">Sept. 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-single-digit-limit-price-hikes-2018-blowback/505929/" class="analytics t-editors-bio-article">AbbVie to keep limits on price hikes next year, denying backtrack</a></h3> <span class="secondary-label">Sept. 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/axovants-closely-watched-alzheimers-drug-fails-late-stage-trial/505817/" class="analytics t-editors-bio-article">Axovant's closely watched Alzheimer's drug fails late-stage trial</a></h3> <span class="secondary-label">Sept. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/without-power-puerto-ricos-drug-manufacturing-left-battered-by-maria/505783/" class="analytics t-editors-bio-article">Without power, Puerto Rico's drug manufacturing left battered by Maria</a></h3> <span class="secondary-label">Sept. 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/car-t-price-kymriah-express-scripts-new-payment-model/505732/" class="analytics t-editors-bio-article">Premium price for Novartis' CAR-T sparks pushback from top PBM</a></h3> <span class="secondary-label">Sept. 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/versartis-crashes-after-phase-3-miss/505634/" class="analytics t-editors-bio-article">Versartis crashes after Phase 3 miss</a></h3> <span class="secondary-label">Sept. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/brammer-bio-florida-expansion-cell-gene-therapy/505558/" class="analytics t-editors-bio-article">Brammer Bio doubles manufacturing capacity at Florida site</a></h3> <span class="secondary-label">Sept. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/provention-bio-licenses-two-candidates-janssen-immunology/505443/" class="analytics t-editors-bio-article">Provention builds pipeline with Janssen licensing deal</a></h3> <span class="secondary-label">Sept. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-soars-apollo-trial-success-patisiran-rnai/505308/" class="analytics t-editors-bio-article">Alnylam soars on trial win for RNAi drug</a></h3> <span class="secondary-label">Sept. 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-ends-sales-essure-contraceptive-implant-outside-us/505278/" class="analytics t-editors-bio-article">Bayer ends sales of Essure implant outside of US</a></h3> <span class="secondary-label">Sept. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/glaxosmithkline-triple-therapy-inhaler-win-fda-approval-copd/505224/" class="analytics t-editors-bio-article">GSK's respiratory business boosted by lung drug approval</a></h3> <span class="secondary-label">Sept. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-roche-to-seek-broader-market-for-leukemia-drug-after-trial-success/505161/" class="analytics t-editors-bio-article">AbbVie, Roche to seek broader market for leukemia drug after trial success</a></h3> <span class="secondary-label">Sept. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/smaller-sales-forces-get-the-job-done-in-rare-disease/504809/" class="analytics t-editors-bio-article">Smaller sales forces get the job done in rare disease</a></h3> <span class="secondary-label">Sept. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nabriva-antibiotic-phase-3-success-lefamulin-cabp/505130/" class="analytics t-editors-bio-article">Nabriva shares leap higher on antibiotic trial success</a></h3> <span class="secondary-label">Sept. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samsung-bioepis-first-ema-backing-herceptin-biosimilar/505052/" class="analytics t-editors-bio-article">Samsung Bioepis first to secure EMA backing for Herceptin biosimilar</a></h3> <span class="secondary-label">Sept. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-biosimilar-avastin-win-fda-approval-first-cancer-us/504990/" class="analytics t-editors-bio-article">Amgen, Allergan win first approval of cancer biosimilar in US</a></h3> <span class="secondary-label">Sept. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-continuous-manufacturing-drafting-framework-comment/504971/" class="analytics t-editors-bio-article">FDA calls for industry input on continuous manufacturing guidelines</a></h3> <span class="secondary-label">Sept. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-xtandi-trial-success-expand-approval-prostate-cancer/504937/" class="analytics t-editors-bio-article">Pfizer, Astellas eye wider market for prostate cancer drug</a></h3> <span class="secondary-label">Sept. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amicus-trial-failure-butterfly-disease-epidermolysis-bullosa/504838/" class="analytics t-editors-bio-article">Amicus drops wound drug after trial miss</a></h3> <span class="secondary-label">Sept. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-repatha-cost-effectiveness-lower-price-pcsk9/504776/" class="analytics t-editors-bio-article">ICER analysis latest salvo in debate over Repatha price</a></h3> <span class="secondary-label">Sept. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-trial-failure-brexanolone-epilepsy-srse/504739/" class="analytics t-editors-bio-article">Sage stock sinks after epilepsy drug fails to beat placebo</a></h3> <span class="secondary-label">Sept. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-dupixent-severe-asthma-clinical-success-tezepelumab/504669/" class="analytics t-editors-bio-article">Blockbuster hopeful Dupixent succeeds in asthma study </a></h3> <span class="secondary-label">Sept. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-pacific-imfinzi-flaura-tagrisso-results-esmo/504656/" class="analytics t-editors-bio-article">ESMO: New momentum for AstraZeneca as lung cancer studies impress</a></h3> <span class="secondary-label">Sept. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-abemaciclib-monarch-3-esmo-results-ibrance-kisqali/504594/" class="analytics t-editors-bio-article">ESMO: Lilly breast cancer drug keeps pace with Pfizer, Novartis rivals</a></h3> <span class="secondary-label">Sept. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tumor-mutation-burden-blood-foundation-tecentriq-esmo/504555/" class="analytics t-editors-bio-article">ESMO: Foundation biomarker test could help boost immunotherapy</a></h3> <span class="secondary-label">Sept. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-trial-stopped-early-OS-kidney-cancer/504495/" class="analytics t-editors-bio-article">Opdivo combo shows early survival benefit in kidney cancer</a></h3> <span class="secondary-label">Sept. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cell-therapy-emergence-opens-up-new-markets-for-shippers-logistic-companie/504476/" class="analytics t-editors-bio-article">Cell therapy emergence opens up new markets for shippers, logistic companies</a></h3> <span class="secondary-label">Sept. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-sees-first-in-class-potential-for-asthma-biologic/504454/" class="analytics t-editors-bio-article">AstraZeneca sees first-in-class potential for asthma biologic</a></h3> <span class="secondary-label">Sept. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-letter-opioid-cipher-pharma-misbranding/504373/" class="analytics t-editors-bio-article">FDA warns drugmaker over misleading marketing of opioid</a></h3> <span class="secondary-label">Sept. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/verastem-duvelisib-phase-3-duo-study-cll-seek-approval/504342/" class="analytics t-editors-bio-article">Verastem bet on blood cancer drug pays off with trial success</a></h3> <span class="secondary-label">Sept. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/industry-pulse-10-charts-on-ma-io-and-biosimilar-threats/504115/" class="analytics t-editors-bio-article">Industry Pulse: 10 charts on M&A, I/O and biosimilar threats</a></h3> <span class="secondary-label">Sept. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/macrogenics-janssen-terminates-development-deal-mgd011/504089/" class="analytics t-editors-bio-article">Janssen drops MacroGenics cancer candidate over safety concerns</a></h3> <span class="secondary-label">Sept. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-car-t-kymriah-manufacturing-production-challenges/504017/" class="analytics t-editors-bio-article">Landmark approval won, Novartis' next test is scaling CAR-T manufacturing</a></h3> <span class="secondary-label">Aug. 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-epacadostat-esmo-echo-202-updated-results-merck/503984/" class="analytics t-editors-bio-article">Incyte, Merck build case for skin cancer combo</a></h3> <span class="secondary-label">Aug. 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-cart-fda-approval-kymriah-gene-therapy/503888/" class="analytics t-editors-bio-article">In historic first, FDA approves Novartis CAR-T therapy</a></h3> <span class="secondary-label">Aug. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-baricitinib-earlier-resubmission-2018-fda/503876/" class="analytics t-editors-bio-article">Lilly speeds up timeline for refiling of baricitinib</a></h3> <span class="secondary-label">Aug. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-takeda-parkinons-externalization-deal/503764/" class="analytics t-editors-bio-article">AstraZeneca strikes $400M deal with Takeda for Parkinson's drug</a></h3> <span class="secondary-label">Aug. 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eliquis-emanate-bristol-myers-pfizer-cardioversion-afib/503673/" class="analytics t-editors-bio-article">Bristol-Myers, Pfizer continue to build case for Eliquis</a></h3> <span class="secondary-label">Aug. 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-canakinumab-ilaris-cantos-heart-disease-inflammation/503628/" class="analytics t-editors-bio-article">Novartis rare disease drug opens up new way to treat heart disease</a></h3> <span class="secondary-label">Aug. 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regenxbio-dimension-acquisition-stock-deal-gene-therapy/503519/" class="analytics t-editors-bio-article">Regenxbio picks up Dimension in $86M stock deal </a></h3> <span class="secondary-label">Aug. 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samsung-bioepis-humira-biosimilar-eu-approval-imraldi/503462/" class="analytics t-editors-bio-article">Samsung Bioepis locks down EU approval for Humira biosimilar</a></h3> <span class="secondary-label">Aug. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/imprimis-rx-fda-warning-letter-wood-compounding/503441/" class="analytics t-editors-bio-article">FDA warns compounding pharmacy of wood contamination</a></h3> <span class="secondary-label">Aug. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-emicizumab-february-23-pdufa-hemophilia-novo-shire/503405/" class="analytics t-editors-bio-article">Roche lines up February decision date for hemophilia prospect</a></h3> <span class="secondary-label">Aug. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-patent-prevnar-india-pneumonia-vaccine-msf/503323/" class="analytics t-editors-bio-article">Pfizer secures patent in India for pneumonia vaccine</a></h3> <span class="secondary-label">Aug. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-repatha-study-pcsk9-value-cost-price/503302/" class="analytics t-editors-bio-article">In cost debate, Amgen stands by Repatha's value</a></h3> <span class="secondary-label">Aug. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-repatha-pcsk9-cost-effectiveness-jama-study/503201/" class="analytics t-editors-bio-article">PCSK9 inhibitors still too pricey, study finds</a></h3> <span class="secondary-label">Aug. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ironwood-duzallo-approval-gout-drug-hyperuricemia/503096/" class="analytics t-editors-bio-article">Ironwood wins FDA approval for combo gout drug</a></h3> <span class="secondary-label">Aug. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samsung-bioepis-new-biologics-takeda-partnership-biosimilars/503048/" class="analytics t-editors-bio-article">Samsung Bioepis partners with Takeda to break into novel biologics</a></h3> <span class="secondary-label">Aug. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-lynparza-approval-broader-label-maintenance/449651/" class="analytics t-editors-bio-article">Expanded label boosts AstraZeneca and Merck's Lynparza</a></h3> <span class="secondary-label">Aug. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/democrat-investigation-multiple-sclerosis-drugmakers-price/449592/" class="analytics t-editors-bio-article">House Democrats to probe 'skyrocketing' prices for MS meds</a></h3> <span class="secondary-label">Aug. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-tampa-facility-fda-vai-resolve-submission-aerie/449577/" class="analytics t-editors-bio-article">Valeant says FDA to reclassify troubled Tampa plant</a></h3> <span class="secondary-label">Aug. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-ends-business-councils-CEOs-manufacturing-frazier-gorsky/449539/" class="analytics t-editors-bio-article">CEOs break with Trump amid disintegration of business councils </a></h3> <span class="secondary-label">Aug. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-rcc-trial-setback-kidney-cancer/449463/" class="analytics t-editors-bio-article">Bristol-Myers' Opdivo comes up short in kidney cancer study</a></h3> <span class="secondary-label">Aug. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amid-ceo-exits-jj-chief-to-stay-on-trump-manufacturing-council/449391/" class="analytics t-editors-bio-article">Amid CEO exits, J&J chief to stay on Trump manufacturing council </a></h3> <span class="secondary-label">Aug. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mundipharma-cellact-250-million-chemo-deal-etoposide/449358/" class="analytics t-editors-bio-article">Mundipharma picks up chemo prodrug in $250M deal</a></h3> <span class="secondary-label">Aug. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-federal-efforts-slow-states-take-up-drug-pricing-pushback/449010/" class="analytics t-editors-bio-article">As federal efforts slow, states take up drug pricing pushback</a></h3> <span class="secondary-label">Aug. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-ceo-resigns-from-trumps-manufacturing-council/449253/" class="analytics t-editors-bio-article">Merck CEO resigns from Trump's manufacturing council </a></h3> <span class="secondary-label">Aug. 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-pharmatech-warning-bacteria-contamination-recall/449092/" class="analytics t-editors-bio-article">PharmaTech liquid drugs possibly contaminated, FDA says</a></h3> <span class="secondary-label">Aug. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aerie-contract-manufacturer-rhopressa-tampa-CRL/449086/" class="analytics t-editors-bio-article">Manufacturing issues threaten delay for Aerie eye drug</a></h3> <span class="secondary-label">Aug. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-revusiran-investigation-patient-deaths-imbalance/449067/" class="analytics t-editors-bio-article">Alnylam review turns up no clear answers on revusiran deaths</a></h3> <span class="secondary-label">Aug. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-delays-launch-advair-copaxone-cuts-guidance/448962/" class="analytics t-editors-bio-article">Mylan cuts sales forecast as pricing pressure grows</a></h3> <span class="secondary-label">Aug. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dermira-roche-lebrikizumab-atopic-dermatitis-sell-divest-deal/448871/" class="analytics t-editors-bio-article">Roche sells off dermatitis drug to Dermira</a></h3> <span class="secondary-label">Aug. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-lasmiditan-migraine-pain-spartan-study/448755/" class="analytics t-editors-bio-article">Lilly's turn to pain gathers momentum</a></h3> <span class="secondary-label">Aug. 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/radius-tymlos-payer-coverage-express-scripts-launch/448671/" class="analytics t-editors-bio-article">Payer coverage boosts Radius' Tymlos</a></h3> <span class="secondary-label">Aug. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-sirukumab-fda-advisory-committee-adcom/448547/" class="analytics t-editors-bio-article">J&J set back by negative panel vote for sirukumab </a></h3> <span class="secondary-label">Aug. 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cytokinetics-inches-forward-with-heart-failure-program/448439/" class="analytics t-editors-bio-article">Cytokinetics inches forward with heart failure program</a></h3> <span class="secondary-label">Aug. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-kalydeco-fda-approval-guidance-raise/448341/" class="analytics t-editors-bio-article">Vertex wins new Kalydeco approval, ups sales forecast</a></h3> <span class="secondary-label">Aug. 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-2018-formulary-excluded-drug-radius-synergy/448254/" class="analytics t-editors-bio-article">Express Scripts shuts out 64 branded drugs from 2018 formulary</a></h3> <span class="secondary-label">July 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-cgrp-migraine-competition/448180/" class="analytics t-editors-bio-article">Unfazed by competition, Allergan sees room at CGRP table</a></h3> <span class="secondary-label">July 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-humira-q2-immunology-leadership-jak1-biosimilars/448156/" class="analytics t-editors-bio-article">AbbVie confident in strategy as Humira mints money</a></h3> <span class="secondary-label">July 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/glaxosmithkline-gsk-rare-disease-sell-divest-strimvelis/448087/" class="analytics t-editors-bio-article">GSK looks to exit rare diseases</a></h3> <span class="secondary-label">July 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-cryoport-car-t-logistics-shipping-cryopreservation/448060/" class="analytics t-editors-bio-article">Novartis taps Cryoport for CAR-T logistics support</a></h3> <span class="secondary-label">July 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/corning-merck-pfizer-valor-glass-pharmaceutical-packaging-trump/448057/" class="analytics t-editors-bio-article">Corning invests $500M to build better glass packaging for pharma</a></h3> <span class="secondary-label">July 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-mystic-failure-imfinzi-pfs-setback-miss/448010/" class="analytics t-editors-bio-article">MYSTIC flop a major blow to AstraZeneca's I/O hopes</a></h3> <span class="secondary-label">July 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-launch-remicade-biosimilar-discount-jnj-pfizer/447939/" class="analytics t-editors-bio-article">Merck undercuts Pfizer on Remicade biosimilar price</a></h3> <span class="secondary-label">July 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/glaxosmithkline-gsk-rd-pipeline-restructuring-cut-q2-earnings/447924/" class="analytics t-editors-bio-article">GSK overhauls R&D, axes 30 programs to regain edge</a></h3> <span class="secondary-label">July 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-oncology-cancer-restructure-rd-focus-q2-earnings/447836/" class="analytics t-editors-bio-article">Lilly maps out new approach to cancer R&D</a></h3> <span class="secondary-label">July 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nektar-eli-lilly-deal-collaboration-150-million-autoimmune/447732/" class="analytics t-editors-bio-article">Nektar secures $400M deal with Lilly for Phase 1 drug</a></h3> <span class="secondary-label">July 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alzheimers-disease-trends-drug-development-amyloid-biomarkers/447068/" class="analytics t-editors-bio-article">5 trends shaping Alzheimer's drug development</a></h3> <span class="secondary-label">July 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/athenex-import-sodium-bicarbonate-fda-clearance-pfizer/447049/" class="analytics t-editors-bio-article">Amid supply shortage, FDA clears import of in-demand drug</a></h3> <span class="secondary-label">July 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-cialis-patent-generic-copycat-settlement-2018/447020/" class="analytics t-editors-bio-article">Lilly extends patent runway for Cialis</a></h3> <span class="secondary-label">July 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-car-t-ctl019-fda-adcomm-support/446925/" class="analytics t-editors-bio-article">FDA panel unanimously backs approval of Novartis CAR-T</a></h3> <span class="secondary-label">July 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amicus-fda-drop-phase-3-study-migalastat-nda-application/446807/" class="analytics t-editors-bio-article">FDA changes tune on Amicus Fabry disease drug</a></h3> <span class="secondary-label">July 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-car-t-fda-adcomm-advisory-committee-ctl019/446707/" class="analytics t-editors-bio-article">Safety issues for Novartis CAR-T therapy main focus of FDA</a></h3> <span class="secondary-label">July 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/generic-association-lawsuit-maryland-drug-price-law-aam/446615/" class="analytics t-editors-bio-article">Generic drug association sues to stop state price-gouging law</a></h3> <span class="secondary-label">July 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-recall-novopen-echo-faulty-insulin-cartridge-holder/446512/" class="analytics t-editors-bio-article">Novo Nordisk recalls six batches of insulin cartridge holders</a></h3> <span class="secondary-label">July 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-clinical-hold-fda-deaths-keynote/446482/" class="analytics t-editors-bio-article">3 Keytruda studies put on clinical hold after deaths</a></h3> <span class="secondary-label">July 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-open-payments-doctors-cms-research-drugs/446394/" class="analytics t-editors-bio-article">Industry paid $8.2B to docs, hospitals last year</a></h3> <span class="secondary-label">July 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coherus-enbrel-biosimilar-daiichi-sankyo-discontinue-development/446357/" class="analytics t-editors-bio-article">Daiichi Sankyo pulls plug on Coherus biosimilar</a></h3> <span class="secondary-label">July 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cgrp-inhibitors-migraine-drugs-alder-amgen-lilly-teva/446199/" class="analytics t-editors-bio-article">A head above the rest? Drugmakers face off in migraine market</a></h3> <span class="secondary-label">June 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/patheon-45-million-investment-expand-contract-development/446177/" class="analytics t-editors-bio-article">Patheon maps out $45M investment in services network</a></h3> <span class="secondary-label">June 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/basf-ibuprofen-production-200-million-investment/446176/" class="analytics t-editors-bio-article">Chemicals giant BASF builds out ibuprofen API production</a></h3> <span class="secondary-label">June 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/exelexis-repayment-debt-deerfield-cabometyx-/446154/" class="analytics t-editors-bio-article">Exelixis clears debt, turning eye to future growth</a></h3> <span class="secondary-label">June 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ariad-insider-trading-sec-former-employees-iclusig/446047/" class="analytics t-editors-bio-article">SEC charges ex-Ariad employees with insider trading</a></h3> <span class="secondary-label">June 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alder-cgrp-migrane-phase-3-eptinezumab/445926/" class="analytics t-editors-bio-article">Alder scores CGRP win but investors not impressed</a></h3> <span class="secondary-label">June 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-givosiran-acute-porphyria-rnai-study/445852/" class="analytics t-editors-bio-article">Alnylam lines up Phase 3 for another RNAi drug</a></h3> <span class="secondary-label">June 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seattle-genetics-adcetris-echelon-study-lymphoma-frontline/445828/" class="analytics t-editors-bio-article">Seattle Genetics' Adcetris succeeds in study but shares slide</a></h3> <span class="secondary-label">June 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-kisqali-ema-chmp-recommendation-aveo-tivozanib/445745/" class="analytics t-editors-bio-article">CHMP decisions: Novartis locks up backing for Kisqali</a></h3> <span class="secondary-label">June 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-board-executive-pay-shareholder-challenge-epipen/445733/" class="analytics t-editors-bio-article">Mylan board weathers shareholder challenge</a></h3> <span class="secondary-label">June 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-epogen-biosimilar-rejection-crl-fda/445724/" class="analytics t-editors-bio-article">FDA surprises with rejection of Pfizer's Epogen biosimilar</a></h3> <span class="secondary-label">June 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-manufacturing-facility-germany-oranienburg/445629/" class="analytics t-editors-bio-article">Takeda set to open new German manufacturing facilities</a></h3> <span class="secondary-label">June 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gottlieb-generic-competition-drug-price-fda-action-plan/445530/" class="analytics t-editors-bio-article">FDA targets regulatory 'gaming' to boost generic competition </a></h3> <span class="secondary-label">June 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-pharma-deals-inventiv-dealmaking-report-ma/445493/" class="analytics t-editors-bio-article">Report: Biopharma dealmaking set to level off</a></h3> <span class="secondary-label">June 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-antibiotic-approval-melinta-baxdela-absssi/445395/" class="analytics t-editors-bio-article">FDA approves new antibiotic for skin infections</a></h3> <span class="secondary-label">June 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clovis-rucaparib-parp-inhibitor-ovarian-ariel/445303/" class="analytics t-editors-bio-article">Clovis soars on strong results for PARP inhibitor</a></h3> <span class="secondary-label">June 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-shanbally-ireland-manufacturing-vimizim-facility/445123/" class="analytics t-editors-bio-article">BioMarin secures FDA approval for Ireland production facility</a></h3> <span class="secondary-label">June 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-biologics-manufacturing-production-600-million/445121/" class="analytics t-editors-bio-article">Sanofi continues biologics push, building on recent approvals</a></h3> <span class="secondary-label">June 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-verily-venture-medicxi-european-biotech/445084/" class="analytics t-editors-bio-article">Novartis, Verily back new $300M fund for European biotechs</a></h3> <span class="secondary-label">June 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-price-rebate-pcma-report-payers-pharma/444998/" class="analytics t-editors-bio-article">Rebates not to blame for rising drug costs, says PBM trade group </a></h3> <span class="secondary-label">June 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/how-merck-hopes-to-win-in-io-combos-qa-with-roy-baynes/444919/" class="analytics t-editors-bio-article">How Merck hopes to win in I/O combos: Q&A with Roy Baynes</a></h3> <span class="secondary-label">June 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/supreme-court-biosimilars-amgen-sandoz-bpcia-ruling/444864/" class="analytics t-editors-bio-article">Supreme Court ruling gives biosimilar makers a boost</a></h3> <span class="secondary-label">June 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-therapy-by-the-numbers/444592/" class="analytics t-editors-bio-article">Gene therapy by the numbers</a></h3> <span class="secondary-label">June 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-pfizer-sglt2-ertugliflozin-diabetes-ada/444763/" class="analytics t-editors-bio-article">ADA: Merck, Pfizer notch success, but late with SGLT-2 data</a></h3> <span class="secondary-label">June 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-car-t-juliet-lymphoma-ctl-019/444447/" class="analytics t-editors-bio-article">Novartis' CAR-T stacks up to Kite in lymphoma</a></h3> <span class="secondary-label">June 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-legend-car-t-bcma-multiple-myeloma-asco/444279/" class="analytics t-editors-bio-article">ASCO17: CAR-Ts steal the show</a></h3> <span class="secondary-label">June 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco17-juno-marks-progress-with-second-gen-car-t/444241/" class="analytics t-editors-bio-article">ASCO17: Juno marks progress with second-gen CAR-T</a></h3> <span class="secondary-label">June 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-2017-what-you-missed/444212/" class="analytics t-editors-bio-article">ASCO 2017: What you missed</a></h3> <span class="secondary-label">June 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-aphinity-perjeta-herceptin-breast-cancer/444162/" class="analytics t-editors-bio-article">ASCO17: Roche's Perjeta cuts risk in Aphinity, but is it enough? </a></h3> <span class="secondary-label">June 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco17-roches-alecensa-bests-xalkori-in-lung-study/444176/" class="analytics t-editors-bio-article">ASCO17: Roche's Alecensa bests Xalkori in lung study </a></h3> <span class="secondary-label">June 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco17-astrazenecas-lynparza-stays-step-ahead-of-parp-rivals/444152/" class="analytics t-editors-bio-article">ASCO17: AstraZeneca's Lynparza stays step ahead of PARP rivals</a></h3> <span class="secondary-label">June 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/asco-incyte-ido-epacadostat-market-value/444151/" class="analytics t-editors-bio-article">ASCO17: Incyte pads its IDO numbers</a></h3> <span class="secondary-label">June 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/loxo-oncology-asco-trk-fusion-biomarker-larotrectinib/444148/" class="analytics t-editors-bio-article">ASCO17: Loxo shows promise of biomarker approach to cancer</a></h3> <span class="secondary-label">June 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-cites-braun-medical-for-repeat-gmp-violations/444043/" class="analytics t-editors-bio-article">FDA cites Braun Medical for repeat GMP violations</a></h3> <span class="secondary-label">June 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chiltern-japan-ida-clinical-cro-asia-pharma/444038/" class="analytics t-editors-bio-article">Chiltern acquires Japanese CRO in Asia expansion bid</a></h3> <span class="secondary-label">June 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-overcharge-epipen-billion-medicaid-us/444017/" class="analytics t-editors-bio-article">US may have overpaid $1.3B for Mylan's EpiPen, HHS watchdog says</a></h3> <span class="secondary-label">June 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-drug-rebate-cost-part-d-price/443909/" class="analytics t-editors-bio-article">Drug rebates may shift costs to Medicare, study finds</a></h3> <span class="secondary-label">May 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-harvard-pilgrim-value-outcomes-brilinta-bydureon/443891/" class="analytics t-editors-bio-article">AstraZeneca taps outcomes deals to boost CV, diabetes meds</a></h3> <span class="secondary-label">May 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-hiv-triple-combo-bictegravir-phase-3/443787/" class="analytics t-editors-bio-article">Gilead tees up filing for HIV triple combo after Phase 3 wins</a></h3> <span class="secondary-label">May 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/industry-pulse-biopharma-research-development-spending/443506/" class="analytics t-editors-bio-article">Industry Pulse: R&D spending in charts</a></h3> <span class="secondary-label">May 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/industry-pulse-bestseller-drug-percent-revenue-blockbusters/443502/" class="analytics t-editors-bio-article">Industry Pulse: Aging blockbusters tax bottom lines</a></h3> <span class="secondary-label">May 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sun-pharma-sparc-fda-rejection-halol-manufacturing/443602/" class="analytics t-editors-bio-article">Problems at Sun Pharma plant trip up drug approval </a></h3> <span class="secondary-label">May 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-settles-otc-manufacturing-issue-for-33m/443592/" class="analytics t-editors-bio-article">J&J settles OTC manufacturing issue for $33M</a></h3> <span class="secondary-label">May 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aerie-shares-Roclatan-trial-success/443578/" class="analytics t-editors-bio-article">Aerie shares rise on trial success for eye drug</a></h3> <span class="secondary-label">May 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/under-new-ceo-alexion-continues-overhaul-of-leadership/443459/" class="analytics t-editors-bio-article">Under new CEO, Alexion continues overhaul of leadership</a></h3> <span class="secondary-label">May 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-benralizumab-asthma-biologic-reduce-steroid/443374/" class="analytics t-editors-bio-article">Trial success buoys AstraZeneca's hopes for asthma biologic</a></h3> <span class="secondary-label">May 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kevzara-sarilumab-fda-approval-sanofi-regeneron/443308/" class="analytics t-editors-bio-article">Overcoming delay, Sanofi, Regeneron win US approval for RA drug</a></h3> <span class="secondary-label">May 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/celgene-ozanimod-multiple-sclerosis-trial-fda-submission/443272/" class="analytics t-editors-bio-article">Celgene MS drug succeeds in second Phase 3 study</a></h3> <span class="secondary-label">May 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-romosuzumab-safety-signal-derail-approval-radius/443249/" class="analytics t-editors-bio-article">Safety signal derails expected approval of Amgen bone drug</a></h3> <span class="secondary-label">May 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/thermo-fisher-to-buy-patheon-in-72b-deal-accelerating-cdmo-consolidation/443066/" class="analytics t-editors-bio-article">Thermo Fisher to buy Patheon in $7.2B deal, accelerating CDMO consolidation</a></h3> <span class="secondary-label">May 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-highlights-asco-abstracts-ido-incyte/443046/" class="analytics t-editors-bio-article">7 Areas to watch from the ASCO abstracts</a></h3> <span class="secondary-label">May 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warns-of-higher-amputation-risk-for-jjs-invokana/442958/" class="analytics t-editors-bio-article">FDA warns of higher amputation risk for J&J's Invokana</a></h3> <span class="secondary-label">May 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/coherus-humira-patent-abbvie-ipr-biosimilar/442950/" class="analytics t-editors-bio-article">Coherus wins Humira patent ruling, chipping away at AbbVie's defenses</a></h3> <span class="secondary-label">May 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gottlieb-fda-drug-prices-generics-lower-cost/442824/" class="analytics t-editors-bio-article">Taking office, Gottlieb keeps drug pricing front and center</a></h3> <span class="secondary-label">May 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aspen-pharma-antitrust-generic-drugs-EC-europe-investigation/442722/" class="analytics t-editors-bio-article">EU investigating generic drugmaker over cancer drug price hikes</a></h3> <span class="secondary-label">May 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/adherence-value-based-deal-payment-patient-outcomes/442449/" class="analytics t-editors-bio-article">Can value-based deals work if patients don't take the drug?</a></h3> <span class="secondary-label">May 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-rises-after-positive-lung-cancer-results-for-key-drug/442624/" class="analytics t-editors-bio-article">AstraZeneca rises after positive lung cancer results for key drug</a></h3> <span class="secondary-label">May 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-inspection-vikshara-fake-strike-manufacturing/442541/" class="analytics t-editors-bio-article">Indian drugmaker stages worker strike to avoid FDA inspection</a></h3> <span class="secondary-label">May 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hikma-advair-generic-fda-rejection-gsk/442528/" class="analytics t-editors-bio-article">Second Advair copy rejected, giving GSK short-term respite</a></h3> <span class="secondary-label">May 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-bolsters-io-edge-with-keytruda-combo-approval/442513/" class="analytics t-editors-bio-article">Merck bolsters I/O edge with Keytruda combo approval </a></h3> <span class="secondary-label">May 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gottlieb-fda-senate-confirmation-vote/442428/" class="analytics t-editors-bio-article">Senate confirms Scott Gottlieb as FDA chief</a></h3> <span class="secondary-label">May 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phrma-membership-changes-22-drugmakers-research/442402/" class="analytics t-editors-bio-article">PhRMA ousts 22 drugmakers from ranks in membership change</a></h3> <span class="secondary-label">May 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-quarter-earnings-debt-xifaxan/442301/" class="analytics t-editors-bio-article">Valeant pitches a turnaround but new roadblocks complicate story</a></h3> <span class="secondary-label">May 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kite-patient-death-cerebral-edema-car-t/442193/" class="analytics t-editors-bio-article">Kite discloses patient death in CAR-T trial, sparking safety worries</a></h3> <span class="secondary-label">May 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-hospira-manufacturing-progress/441999/" class="analytics t-editors-bio-article">Pfizer making progress on Hospira manufacturing issues, execs say</a></h3> <span class="secondary-label">May 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bio-drug-price-increase-blue-cross-blame/441971/" class="analytics t-editors-bio-article">BIO accuses insurer report of shifting blame on drug prices</a></h3> <span class="secondary-label">May 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-xtandi-slow-sales-patient-assistance/441893/" class="analytics t-editors-bio-article">Weak Xtandi sales spur questions on Pfizer's $14B Medivation takeover</a></h3> <span class="secondary-label">May 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pieris-astrazeneca-collaboration-respiratory-anticalin/441851/" class="analytics t-editors-bio-article">Pieris teams up with AstraZeneca on respiratory drug development</a></h3> <span class="secondary-label">May 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-repatha-refund-contract-harvard-pilgrim/441777/" class="analytics t-editors-bio-article">Amgen inks first money-back guarantee for Repatha</a></h3> <span class="secondary-label">May 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-lung-cancer-earnings-first-quarter/441760/" class="analytics t-editors-bio-article">Merck sees Keytruda gains, offsetting generic hits to sales</a></h3> <span class="secondary-label">May 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/q1-earnings-preview-gilead-merck-pfizer-allergan/441449/" class="analytics t-editors-bio-article">Q1 Earnings Preview: Gilead, Merck, Pfizer, Allergan</a></h3> <span class="secondary-label">May 1, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Radius-Health-Tymlos-fda-approval-price/441584/" class="analytics t-editors-bio-article">Radius targets quick ramp up for newly approved osteoporosis drug</a></h3> <span class="secondary-label">April 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-quarter-earnings-diabetes-dupixent/441531/" class="analytics t-editors-bio-article">Diabetes decline hangs over Sanofi's growth in specialty care, immunology</a></h3> <span class="secondary-label">April 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sun-pharma-form-483-dadra-fda-inspection/441452/" class="analytics t-editors-bio-article">Sun Pharma tripped up by Form 483 at Dadra unit</a></h3> <span class="secondary-label">April 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/daiichi-sankyo-antibody-drug-conjugate-adc-manufacturing-expansion/441440/" class="analytics t-editors-bio-article">Daiichi Sankyo to invest $135M in ADC manufacturing expansion</a></h3> <span class="secondary-label">April 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amid-sales-growth-roche-plans-defense-from-biosimilar-threats/441402/" class="analytics t-editors-bio-article">Amid sales growth, Roche plans defense from biosimilar threats</a></h3> <span class="secondary-label">April 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/q1-earnings-preview-abbvie-astrazeneca-bms-celgene-roche-sanofi/441223/" class="analytics t-editors-bio-article">Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi</a></h3> <span class="secondary-label">April 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicines-co-inclisiran-phase-3-cardiovascular-outcomes/441306/" class="analytics t-editors-bio-article">Medicines Co. charts ambitious late-stage tests for heart drug</a></h3> <span class="secondary-label">April 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-letter-fake-cancer-cures-14-drugmakers/441241/" class="analytics t-editors-bio-article">FDA busts 14 companies for selling bogus cancer cures</a></h3> <span class="secondary-label">April 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-baricitinib-Q1-earnings-new-drugs/441195/" class="analytics t-editors-bio-article">Lilly gets lift from new drugs, but baricitinib setback hangs over revenue growth</a></h3> <span class="secondary-label">April 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-immunotherapy-works-but-how-to-find-which-patients-will-benefit/440721/" class="analytics t-editors-bio-article">Cancer immunotherapy works, but how to find which patients will benefit?</a></h3> <span class="secondary-label">April 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-recommend-approval-biogen-biomarin-biosimilars/441087/" class="analytics t-editors-bio-article">Biogen, BioMarin secure orphan drug endorsements in Europe</a></h3> <span class="secondary-label">April 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/q1-earnings-preview-novartis-lilly-biogen-gsk-amgen/441007/" class="analytics t-editors-bio-article">Q1 Earnings Preview: Novartis, Lilly, Biogen, GSK, Amgen</a></h3> <span class="secondary-label">April 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biopharma-partnerships-research-discovery-deloitte-report/440914/" class="analytics t-editors-bio-article">Biopharma opening up to new ways of partnering on R&D</a></h3> <span class="secondary-label">April 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-settlement-fine-arizona-refund-CMS/440807/" class="analytics t-editors-bio-article">Theranos pays $4.65M to refund cost of blood tests in Arizona</a></h3> <span class="secondary-label">April 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alpine-immune-nivalis-merger-mitch-gold/440612/" class="analytics t-editors-bio-article">Former Dendreon CEO debuts new public company in reverse merger</a></h3> <span class="secondary-label">April 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-earnings-q1-remicade-biosimilar/440646/" class="analytics t-editors-bio-article">Pharma bellwether J&J not worried about drug pricing for specialty meds</a></h3> <span class="secondary-label">April 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-nash-bavarian-nordic-biomarkers/440564/" class="analytics t-editors-bio-article">Bristol-Myers taps Danish biotech in NASH biomarker deal</a></h3> <span class="secondary-label">April 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ge-asymptote-cell-therapy-manufacturing-deal/440480/" class="analytics t-editors-bio-article">GE acquires British cold chain specialist, deepening cell therapy push</a></h3> <span class="secondary-label">April 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-fda-warning-letter-china/440475/" class="analytics t-editors-bio-article">FDA warns Teva over violations at China plant</a></h3> <span class="secondary-label">April 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-patent-uc-appeal-broad-gene-editing/440445/" class="analytics t-editors-bio-article">University of California appeals patent setback, extending CRISPR fight</a></h3> <span class="secondary-label">April 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-calls-on-poop-troop-to-drive-constipation-awareness/440362/" class="analytics t-editors-bio-article">Biotech calls on 'Poop Troop' to drive constipation awareness</a></h3> <span class="secondary-label">April 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sv-health-venture-fund-400-million-biotech/440354/" class="analytics t-editors-bio-article">SV Health secures $400M for new life sciences venture fund</a></h3> <span class="secondary-label">April 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-cancer-combination-Immuno-oncology/440255/" class="analytics t-editors-bio-article">Cancer combos key to AstraZeneca success, but rivals have long lead</a></h3> <span class="secondary-label">April 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-arthritis-drugs-price-report/440145/" class="analytics t-editors-bio-article">In familiar routine, ICER finds rheumatoid arthritis drugs overpriced</a></h3> <span class="secondary-label">April 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trends-rare-disease-orphan-drug-development/439866/" class="analytics t-editors-bio-article">5 trends shaping rare disease drug development</a></h3> <span class="secondary-label">April 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-januvia-crl-fda-cardiovascular-outcomes-tecos/440034/" class="analytics t-editors-bio-article">FDA shoots down Merck's bid to expand Januvia label</a></h3> <span class="secondary-label">April 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/indoco-remedies-fda-warning-letter/439946/" class="analytics t-editors-bio-article">Indoco Remedies handed FDA warning letter</a></h3> <span class="secondary-label">April 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phrma-payers-ad-campaign-discounts-drug/439917/" class="analytics t-editors-bio-article">PhRMA takes shot at payers in drug pricing war</a></h3> <span class="secondary-label">April 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/scott-gottlieb-commits-to-defend-fdas-gold-standard-for-drug-reviews/439825/" class="analytics t-editors-bio-article">Scott Gottlieb commits to defend FDA's 'gold standard' for drug reviews</a></h3> <span class="secondary-label">April 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-recap-idos-under-the-microscope/439821/" class="analytics t-editors-bio-article">AACR recap: IDOs under the microscope</a></h3> <span class="secondary-label">April 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-newlinks-ido-data-shows-promise-but-is-it-enough/439709/" class="analytics t-editors-bio-article">AACR: NewLink's IDO data shows promise, but is it enough? </a></h3> <span class="secondary-label">April 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-epacadostat-combos-opdivo-keytruda/439630/" class="analytics t-editors-bio-article">AACR: Incyte hedges bet on combo strategy</a></h3> <span class="secondary-label">April 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-bristol-myers-opdivo-overall-survival/439603/" class="analytics t-editors-bio-article">AACR: Busy start for Bristol-Myers Squibb's Opdivo</a></h3> <span class="secondary-label">April 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/car-t-race-heats-up-as-kite-novartis-complete-filings-to-fda/439525/" class="analytics t-editors-bio-article">CAR-T race heats up as Kite, Novartis complete filings to FDA</a></h3> <span class="secondary-label">April 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/warp-drive-bio-gsk-druggable-collaboration/439380/" class="analytics t-editors-bio-article">Warp Drive Bio teams up with GSK, taking aim at 'undruggable' targets</a></h3> <span class="secondary-label">March 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/agenus-restructuring-staff-reduction-biotech/439372/" class="analytics t-editors-bio-article">Agenus trims staff, narrows focus in restructuring</a></h3> <span class="secondary-label">March 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-prices-phrma-payers-report-blame/439349/" class="analytics t-editors-bio-article">Drug prices continue to climb, but who's to blame? </a></h3> <span class="secondary-label">March 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-mylan-advair-crl-rejected-generic/439186/" class="analytics t-editors-bio-article">GSK breathes sigh of relief as Mylan Advair copy rejected</a></h3> <span class="secondary-label">March 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-cystic-fibrosis-trial-combination-success-tezacaftor/439259/" class="analytics t-editors-bio-article">Vertex boosted by strong trial data for next-gen CF drug </a></h3> <span class="secondary-label">March 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aacr-preview-ido1-cdk-46-and-cancer-combos/438961/" class="analytics t-editors-bio-article">AACR preview: IDO1, CDK 4/6 and cancer combos</a></h3> <span class="secondary-label">March 29, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-europe-patent-office-charpentier-broad-editas/439137/" class="analytics t-editors-bio-article">In twisting patent fight, CRISPR Therapeutics scores win in Europe</a></h3> <span class="secondary-label">March 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alexion-new-ceo-ludwig-hantson-soliris/439038/" class="analytics t-editors-bio-article">Alexion taps ex-Baxalta chief as new CEO</a></h3> <span class="secondary-label">March 27, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-850m-manufacturing-US-tax-reform-trump/438889/" class="analytics t-editors-bio-article">Lilly touts $850M manufacturing investment as CEO stumps for tax reform </a></h3> <span class="secondary-label">March 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/control-over-production-data-still-tripping-up-foreign-drug-manufacturers-w/438810/" class="analytics t-editors-bio-article">Control over production data still tripping up foreign drug manufacturers with FDA</a></h3> <span class="secondary-label">March 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-approval-eye-drug/438808/" class="analytics t-editors-bio-article">Valeant hopes for August approval of eye drug</a></h3> <span class="secondary-label">March 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnson-gsk-stop-advertising-google-youtube/438795/" class="analytics t-editors-bio-article">J&J, GSK pull ads from YouTube amid display concerns</a></h3> <span class="secondary-label">March 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-patent-challenge-blockbuster-tecfidera/438691/" class="analytics t-editors-bio-article">Biogen staves off patent challenge to blockbuster MS drug</a></h3> <span class="secondary-label">March 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eliquis-anticoagulants-noac-medicare-study-bristol-myers/438480/" class="analytics t-editors-bio-article">Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin</a></h3> <span class="secondary-label">March 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phase-3-win-moves-lillys-breast-cancer-drug-closer-to-market/438472/" class="analytics t-editors-bio-article">Phase 3 win moves Lilly's breast cancer drug closer to market</a></h3> <span class="secondary-label">March 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-cvd-real-sglt2-diabetes-farxiga/438425/" class="analytics t-editors-bio-article">Real world study shows cardiovascular benefit to SGLT2 drugs</a></h3> <span class="secondary-label">March 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicines-co-hits-mark-in-orion-plans-pcsk9-phase-3/438387/" class="analytics t-editors-bio-article">Medicines Co. hits mark in ORION, plans PCSK9 Phase 3</a></h3> <span class="secondary-label">March 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-fourier-repatha-pcsk9-cardiovascular-outcomes/438362/" class="analytics t-editors-bio-article">Amgen's Repatha shows CV benefit, but falls short of expectations</a></h3> <span class="secondary-label">March 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-letter-lumis-gmp-violations/438286/" class="analytics t-editors-bio-article">FDA warns two manufacturers from China, India for GMP lapses</a></h3> <span class="secondary-label">March 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-joint-venture-scohia-pharma-restructuring/438279/" class="analytics t-editors-bio-article">Takeda teams up with venture firm on drug discovery unit</a></h3> <span class="secondary-label">March 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ptc-marathon-emflaza-dmd-drug-140-million/438260/" class="analytics t-editors-bio-article">Under fire, Marathon offloads Duchenne drug to PTC for $140M</a></h3> <span class="secondary-label">March 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-lynparza-ovarican-cancer-tesaro-clovis/438078/" class="analytics t-editors-bio-article">AstraZeneca staves off Tesaro threat to PARP crown</a></h3> <span class="secondary-label">March 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-taps-crispr-biotech-editas-in-eye-care-deal/438051/" class="analytics t-editors-bio-article">Allergan taps CRISPR biotech Editas in eye care deal</a></h3> <span class="secondary-label">March 14, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-locks-up-kisqali-approval-eyes-pfizers-lead/437982/" class="analytics t-editors-bio-article">Novartis locks up Kisqali approval, eyes Pfizer's lead</a></h3> <span class="secondary-label">March 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mylan-herceptin-roche-license-settlement-trastuzumab/437963/" class="analytics t-editors-bio-article">Mylan clears way for biosimilar Herceptin launch in US </a></h3> <span class="secondary-label">March 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gottlieb-trump-fda-commissioner-nominate/437882/" class="analytics t-editors-bio-article">Trump taps Scott Gottlieb to head FDA</a></h3> <span class="secondary-label">March 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/radius-fda-abaloparatide-pdufa-delay-extension/437870/" class="analytics t-editors-bio-article">Radius shares slide after FDA delays decision on bone drug</a></h3> <span class="secondary-label">March 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nicox-resubmits-eye-drug-fda-manufacturing/437788/" class="analytics t-editors-bio-article">Nicox resubmits eye drug to FDA after manufacturing setback</a></h3> <span class="secondary-label">March 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/wockhardt-fda-manufacturing-gmp-oversight/437779/" class="analytics t-editors-bio-article">Indian drugmaker slammed for repeated GMP failures</a></h3> <span class="secondary-label">March 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-cummings-meeting-drug-prices-medicare/437763/" class="analytics t-editors-bio-article">Trump 'enthusiastic' about drug price negotiation, lawmakers say</a></h3> <span class="secondary-label">March 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-hype-still-much-to-uncover-about-immunotherapy/437696/" class="analytics t-editors-bio-article">Despite hype, still much to uncover about immunotherapy</a></h3> <span class="secondary-label">March 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/icer-multiple-sclerosis-drug-price-expensive/437618/" class="analytics t-editors-bio-article">MS drugs too expensive, ICER says</a></h3> <span class="secondary-label">March 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/marathon-congress-letter-emflaza-drug-price-scrutiny/437560/" class="analytics t-editors-bio-article">Pressure builds on Marathon over orphan drug price</a></h3> <span class="secondary-label">March 7, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-mystic-biomarkers-durvalumab-trial-design/436885/" class="analytics t-editors-bio-article">Changes to MYSTIC could set AstraZeneca up for success</a></h3> <span class="secondary-label">March 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-fine-tunes-cf-portfolio-with-concert-deal/437469/" class="analytics t-editors-bio-article">Vertex fine tunes CF portfolio with Concert deal</a></h3> <span class="secondary-label">March 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-biotech-research-development-bestsellers-percent-revenue/433169/" class="analytics t-editors-bio-article">Industry Pulse: Who's spending on R&D?</a></h3> <span class="secondary-label">Feb. 28, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-idenix-hep-c-compounds-value-accounting-charge/436872/" class="analytics t-editors-bio-article">Merck writes off $2.9B as new hep C reality blooms</a></h3> <span class="secondary-label">Feb. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-manufacturing-congress-tax-reform-trump/436781/" class="analytics t-editors-bio-article">Pharma CEOs sign on to letter urging tax reform</a></h3> <span class="secondary-label">Feb. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-emicizumab-patient-death-hemophilia/436772/" class="analytics t-editors-bio-article">Safety concerns reemerge for Roche hemophilia drug</a></h3> <span class="secondary-label">Feb. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/harvard-pilgrim-value-based-amgen-eli-lilly/436673/" class="analytics t-editors-bio-article">Harvard Pilgrim bets on value-based drug payments with new deals</a></h3> <span class="secondary-label">Feb. 22, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-priority-review-voucher-gilead-sale-125/436572/" class="analytics t-editors-bio-article">Gilead snaps up Sarepta's priority review voucher for $125M</a></h3> <span class="secondary-label">Feb. 21, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warning-letter-gmp-manufacturing-japan-sato/436389/" class="analytics t-editors-bio-article">FDA warns another Japanese drug manufacturer over GMP flaws</a></h3> <span class="secondary-label">Feb. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-brodalumab-siliq-fda-approval/436348/" class="analytics t-editors-bio-article">Are commercial prospects limited for Valeant's Siliq?</a></h3> <span class="secondary-label">Feb. 16, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-patent-ruling-broad-university-california-biotechs/436290/" class="analytics t-editors-bio-article">Broad Institute notches win in CRISPR patent battle</a></h3> <span class="secondary-label">Feb. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-verubecestat-alzheimers-failure-phase-3/436264/" class="analytics t-editors-bio-article">Merck scraps late-stage study of Alzheimer's candidate</a></h3> <span class="secondary-label">Feb. 15, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/marathon-deflazacort-sanders-cummings-price-letter/436080/" class="analytics t-editors-bio-article">Marathon presses pause on Emflaza launch after pricing pushback</a></h3> <span class="secondary-label">Feb. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarkers-trends-precision-medicine-diagnostics/435952/" class="analytics t-editors-bio-article">5 trends being impacted by biomarkers</a></h3> <span class="secondary-label">Feb. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/liquid-biopsy-cancer-screening-blood-test/435886/" class="analytics t-editors-bio-article">Liquid biopsies: The next frontier in cancer?</a></h3> <span class="secondary-label">Feb. 13, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-praluent-appeal-ban-amgen-court-injunction/435975/" class="analytics t-editors-bio-article">Sanofi confident in case to overturn Praluent ban</a></h3> <span class="secondary-label">Feb. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-sanofi-win-reprieve-from-court-ban-on-praluent/435827/" class="analytics t-editors-bio-article">Regeneron, Sanofi win reprieve from court ban on Praluent</a></h3> <span class="secondary-label">Feb. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-earnings-diabetes-lantus-dupixent/435716/" class="analytics t-editors-bio-article">Sanofi pins hopes on immunology as Lantus sales fade</a></h3> <span class="secondary-label">Feb. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-ceo-out-erez-vigodman-exit-successor/435574/" class="analytics t-editors-bio-article">Teva CEO out, board chairman steps in as interim chief</a></h3> <span class="secondary-label">Feb. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/innate-bristol-myers-lirilumab-trial-failure/435552/" class="analytics t-editors-bio-article">Innate's cancer immunotherapy falls short in Phase 2</a></h3> <span class="secondary-label">Feb. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warns-italian-drug-manufacturer-for-quality-lapses/435379/" class="analytics t-editors-bio-article">FDA warns Italian drug manufacturer for quality lapses</a></h3> <span class="secondary-label">Feb. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trump-pharma-manufactuing-us-jobs/435372/" class="analytics t-editors-bio-article">Trump pushes pharma to boost drug production in US</a></h3> <span class="secondary-label">Feb. 2, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-ibrance-sales-cdk-ribociclib-abemaciclib/435186/" class="analytics t-editors-bio-article">Pfizer counts on Ibrance as Prevnar sales slip</a></h3> <span class="secondary-label">Jan. 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-read-trump-tax-reform-earnings-q4/435160/" class="analytics t-editors-bio-article">Pfizer's Read sees positives for industry under Trump </a></h3> <span class="secondary-label">Jan. 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/insulin-lawsuit-lilly-novo-nordisk-sanofi-prices/435133/" class="analytics t-editors-bio-article">Insulin drugmakers sued for inflating prices</a></h3> <span class="secondary-label">Jan. 31, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-ups-pricing-transparency-amid-industry-ad-blitz/435040/" class="analytics t-editors-bio-article">Merck ups pricing transparency amid industry ad blitz</a></h3> <span class="secondary-label">Jan. 30, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/earnings-preview-merck-set-to-solidify-io-lead-sanofi-still-looking-for/434875/" class="analytics t-editors-bio-article">Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more</a></h3> <span class="secondary-label">Jan. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intrexon-genvec-acquisition-gene-delivery/434871/" class="analytics t-editors-bio-article">Intrexon picks up struggling GenVec to build delivery tech</a></h3> <span class="secondary-label">Jan. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-earnings-guidance-merck/434854/" class="analytics t-editors-bio-article">On the defensive, Bristol faces down I/O competition</a></h3> <span class="secondary-label">Jan. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jnj-actelion-acquire-deal-30-billion-PAH/434839/" class="analytics t-editors-bio-article">J&J seals $30B deal for Actelion</a></h3> <span class="secondary-label">Jan. 26, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-car-t-fda-filing-ctl019-immuno-oncology/434757/" class="analytics t-editors-bio-article">Novartis aims to gain ground on I/O leaders</a></h3> <span class="secondary-label">Jan. 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-and-johnson-aca-repeal-healthcare-tax-jnj/434739/" class="analytics t-editors-bio-article">As Trump moves to repeal, J&J says preserve some of ACA</a></h3> <span class="secondary-label">Jan. 25, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/anthem-coverage-spinraza-biogen-sma/434666/" class="analytics t-editors-bio-article">Anthem limits coverage for Biogen's new SMA drug</a></h3> <span class="secondary-label">Jan. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jnj-quarter-earnings-drug-pricing-remicade/434623/" class="analytics t-editors-bio-article">J&J earnings disappoint, with no word on Actelion deal</a></h3> <span class="secondary-label">Jan. 24, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/endo-ftc-pay-for-delay-allergan-opana-generic/434576/" class="analytics t-editors-bio-article">Endo reaches deal with FTC over pay-for-delay allegations</a></h3> <span class="secondary-label">Jan. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/7-companies-to-know-in-the-emerging-biosimilars-field/433539/" class="analytics t-editors-bio-article">7 companies to know in the emerging biosimilars field</a></h3> <span class="secondary-label">Jan. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/actelion-opsumit-trial-failure-JNJ-takeover/434538/" class="analytics t-editors-bio-article">Actelion misses goal in study, but takeover talks likely unaffected</a></h3> <span class="secondary-label">Jan. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biosimilar-name-suffix-interchangeable-fda/434401/" class="analytics t-editors-bio-article">Biosimilars: What's in a name?</a></h3> <span class="secondary-label">Jan. 23, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-nixes-hopes-of-early-filing-for-opdivo-combo/434446/" class="analytics t-editors-bio-article">Bristol-Myers nixes hopes of early filing for Opdivo combo</a></h3> <span class="secondary-label">Jan. 20, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/earnings-preview-7-biopharmas-to-watch/434395/" class="analytics t-editors-bio-article">Earnings preview: 7 biopharmas to watch</a></h3> <span class="secondary-label">Jan. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-off-label-communications-guidance/434337/" class="analytics t-editors-bio-article">FDA details thinking on off-label communications</a></h3> <span class="secondary-label">Jan. 19, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chinese-api-supplier-lands-in-hot-water-with-fda/434287/" class="analytics t-editors-bio-article">Chinese API supplier lands in hot water with FDA</a></h3> <span class="secondary-label">Jan. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cellceutix-short-seller-mako-seeking-alpha/434248/" class="analytics t-editors-bio-article">Cellceutix fires back against short-seller accusations</a></h3> <span class="secondary-label">Jan. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-spells-out-expectations-on-biosimilar-interchangeability/434231/" class="analytics t-editors-bio-article">FDA spells out expectations on biosimilar interchangeability</a></h3> <span class="secondary-label">Jan. 18, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jay-bradner-novartis-nibr-drug-discovery-cancer/434146/" class="analytics t-editors-bio-article">Why Jay Bradner thinks Novartis can recharge drug discovery</a></h3> <span class="secondary-label">Jan. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/supreme-court-biosimilar-cert-amgen-sandoz/434115/" class="analytics t-editors-bio-article">Supreme Court to review key biosimilar dispute</a></h3> <span class="secondary-label">Jan. 17, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-biosimilar-naming-guidance/433965/" class="analytics t-editors-bio-article">FDA issues long-awaited guidance on biosimilar naming</a></h3> <span class="secondary-label">Jan. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kite-car-t-readout-nears/433958/" class="analytics t-editors-bio-article">Kite confident as CAR-T readout nears</a></h3> <span class="secondary-label">Jan. 12, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nci-cancer-drug-formulary-combo-trials/433837/" class="analytics t-editors-bio-article">NCI launches new cancer drug formulary to speed combo trials</a></h3> <span class="secondary-label">Jan. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-day-2-roundup/433796/" class="analytics t-editors-bio-article">JPM: Day 2 round-up</a></h3> <span class="secondary-label">Jan. 11, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jpm-valeant-dendreon-sanpower/433682/" class="analytics t-editors-bio-article">JPM: Valeant sells off Dendreon, skincare brands for $2.1B</a></h3> <span class="secondary-label">Jan. 10, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vertex-orkambi-guidance-2017-kalydeco/433616/" class="analytics t-editors-bio-article">JPM: Vertex stakes out cautious 2017 forecasts</a></h3> <span class="secondary-label">Jan. 9, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ipsen-merrimack-onivyde-sale-restructuring/433578/" class="analytics t-editors-bio-article">JPM: Ipsen snatches up Merrimack's Onivyde for $575M</a></h3> <span class="secondary-label">Jan. 8, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-repatha-ban-injunction-praluent-regeneron/433523/" class="analytics t-editors-bio-article">Judge hands Amgen major patent victory over PCSK9 rivals</a></h3> <span class="secondary-label">Jan. 6, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-to-drugmakers-dont-let-manufacturing-lead-to-rejection/433438/" class="analytics t-editors-bio-article">FDA to drugmakers: Don't let manufacturing lead to rejection</a></h3> <span class="secondary-label">Jan. 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alexion-pressure-soliris-investigation/433410/" class="analytics t-editors-bio-article">Alexion faults tone at top, management pressure in Soliris investigation</a></h3> <span class="secondary-label">Jan. 5, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-notches-another-win-in-patent-dispute-with-sanofi-regeneron/433334/" class="analytics t-editors-bio-article">Amgen notches another win in patent dispute with Sanofi, Regeneron</a></h3> <span class="secondary-label">Jan. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/rana-mrna-shire-deal/433313/" class="analytics t-editors-bio-article">Tiny Rana makes a play for mRNA with Shire deal</a></h3> <span class="secondary-label">Jan. 4, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gates-foundation-invests-50m-in-intarcia-for-anti-hiv-work/433222/" class="analytics t-editors-bio-article">Gates Foundation invests $50M in Intarcia for anti-HIV work</a></h3> <span class="secondary-label">Jan. 3, 2017</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-biosimilars-take-root-threat-grows-for-biologics-makers/433097/" class="analytics t-editors-bio-article">Threat grows for biologics makers as biosimilars take root</a></h3> <span class="secondary-label">Dec. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-rd-returns-take-a-hit-some-pharmas-are-ramping-up-spending/433063/" class="analytics t-editors-bio-article">As R&D returns take a hit, some pharmas are ramping up spending</a></h3> <span class="secondary-label">Dec. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-pays-up-520m-to-settle-bribery-charges/432977/" class="analytics t-editors-bio-article">Teva pays up $520M to settle bribery charges</a></h3> <span class="secondary-label">Dec. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/vitality-secures-approvals-for-cannabinoid-facility/432972/" class="analytics t-editors-bio-article">Vitality secures approvals for cannabinoid facility</a></h3> <span class="secondary-label">Dec. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/a-rough-year-for-biotech-ipos/432964/" class="analytics t-editors-bio-article">A rough year for biotech IPOs</a></h3> <span class="secondary-label">Dec. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warns-drugmakers-on-misleading-marketing/432869/" class="analytics t-editors-bio-article">FDA warns drugmakers on misleading marketing</a></h3> <span class="secondary-label">Dec. 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/incyte-puts-up-200m-in-bispecifics-deal-with-merus/432856/" class="analytics t-editors-bio-article">Incyte puts up $200M in bispecifics deal with Merus</a></h3> <span class="secondary-label">Dec. 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-picks-up-regenerative-med-company-for-29b/432762/" class="analytics t-editors-bio-article">Allergan picks up regenerative med company for $2.9B</a></h3> <span class="secondary-label">Dec. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/conatus-soars-on-novartis-deal/432757/" class="analytics t-editors-bio-article">Conatus soars on Novartis deal</a></h3> <span class="secondary-label">Dec. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-locks-down-rights-to-add-on-crispr-tech/432662/" class="analytics t-editors-bio-article">Editas locks down rights to add-on CRISPR tech</a></h3> <span class="secondary-label">Dec. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nasdaq-biotech-index-reranking-stock/432648/" class="analytics t-editors-bio-article">Nasdaq shuffles biotech index ranks, highlighting 2016 hits, misses</a></h3> <span class="secondary-label">Dec. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ophthotech-job-cuts-fovista-trial/432570/" class="analytics t-editors-bio-article">Ophthotech shrinks staff in wake of Fovista setback</a></h3> <span class="secondary-label">Dec. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-biotechs-band-together-in-ip-pact/432557/" class="analytics t-editors-bio-article">CRISPR biotechs band together in IP pact</a></h3> <span class="secondary-label">Dec. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/20-states-sue-6-generic-drugmakers-over-price-fixing/432473/" class="analytics t-editors-bio-article">20 states sue 6 generic drugmakers over price fixing</a></h3> <span class="secondary-label">Dec. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-cuts-jobs-in-ma-manufacturing-slimdown/432470/" class="analytics t-editors-bio-article">Biogen cuts jobs in MA manufacturing slimdown</a></h3> <span class="secondary-label">Dec. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/first-charges-come-in-generic-price-fixing-probe/432382/" class="analytics t-editors-bio-article">First charges come in generic price-fixing probe</a></h3> <span class="secondary-label">Dec. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-celgene-flagged-for-misleading-dtc-ads/432375/" class="analytics t-editors-bio-article">Sanofi, Celgene flagged for misleading DTC ads</a></h3> <span class="secondary-label">Dec. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-plans-rd-overhaul-site-shutdowns/432273/" class="analytics t-editors-bio-article">Bristol-Myers plans R&D overhaul, site shutdowns</a></h3> <span class="secondary-label">Dec. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cempra-makes-ceo-change-ahead-of-fda-decision/432256/" class="analytics t-editors-bio-article">Cempra makes CEO change ahead of FDA decision</a></h3> <span class="secondary-label">Dec. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-intellia-editas-IPO-gene-editing/431688/" class="analytics t-editors-bio-article">Armed with IPO cash, CRISPR biotechs grow gene-editing tech</a></h3> <span class="secondary-label">Dec. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alexion-ceo-cfo-out-amid-soliris-investigation/432177/" class="analytics t-editors-bio-article">Alexion CEO, CFO out amid Soliris investigation</a></h3> <span class="secondary-label">Dec. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/purdue-pharma-exicure-psoriasis-diversify/432168/" class="analytics t-editors-bio-article">Purdue lands rights to psoriasis drug in diversification deal</a></h3> <span class="secondary-label">Dec. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-boosted-by-early-alzheimers-data/432084/" class="analytics t-editors-bio-article">Biogen boosted by early Alzheimer's data</a></h3> <span class="secondary-label">Dec. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Insys-execs-arrest-fentanyl-subsys/431995/" class="analytics t-editors-bio-article">Former pharma execs arrested in bribery scheme</a></h3> <span class="secondary-label">Dec. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sun-pharma-faces-new-worries-at-key-halol-plant/431990/" class="analytics t-editors-bio-article">Sun Pharma faces new worries at key Halol plant</a></h3> <span class="secondary-label">Dec. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cures-clears-senate-in-94-5-vote/431980/" class="analytics t-editors-bio-article">'Cures' clears Senate in 94-5 vote</a></h3> <span class="secondary-label">Dec. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-hit-with-record-fine-in-uk-for-drug-price-hike/431888/" class="analytics t-editors-bio-article">Pfizer hit with record fine in UK for drug price hike</a></h3> <span class="secondary-label">Dec. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-breast-cancer-drug-falls-short-in-phase-2/431880/" class="analytics t-editors-bio-article">AbbVie breast cancer drug falls short in Phase 2</a></h3> <span class="secondary-label">Dec. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-locks-in-regulatory-path-for-postpartum-depression-drug/431791/" class="analytics t-editors-bio-article">Sage locks in regulatory path for postpartum depression drug</a></h3> <span class="secondary-label">Dec. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kite-car-t-ash-approval-KTE-C19/431773/" class="analytics t-editors-bio-article">Kite begins march to market</a></h3> <span class="secondary-label">Dec. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-jcar017-rocket-setback-car-t/431704/" class="analytics t-editors-bio-article">Juno turns to JCAR017 amid Rocket setback</a></h3> <span class="secondary-label">Dec. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-scores-ash-win-in-hemophilia/431672/" class="analytics t-editors-bio-article">Alnylam scores ASH win in hemophilia</a></h3> <span class="secondary-label">Dec. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-forges-ahead-with-lead-car-t/431657/" class="analytics t-editors-bio-article">Novartis forges ahead with lead CAR-T</a></h3> <span class="secondary-label">Dec. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-boehringer-secure-cv-label-for-jardiance/431587/" class="analytics t-editors-bio-article">Eli Lilly, Boehringer secure CV label for Jardiance</a></h3> <span class="secondary-label">Dec. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/house-passes-cures-in-overwhelming-vote/431462/" class="analytics t-editors-bio-article">House passes 'Cures' in overwhelming vote</a></h3> <span class="secondary-label">Dec. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alnylam-touts-hemophilia-drugs-edge-over-roche-rival/431404/" class="analytics t-editors-bio-article">Alnylam touts hemophilia drug's edge over Roche rival</a></h3> <span class="secondary-label">Nov. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/arrowhead-nixes-clinical-pipeline-trims-staff/431364/" class="analytics t-editors-bio-article">Arrowhead nixes clinical pipeline, trims staff</a></h3> <span class="secondary-label">Nov. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ash-preview-car-ts-mixed-results-and-pipeline-progress/431187/" class="analytics t-editors-bio-article">ASH preview: CAR-Ts, mixed results and pipeline progress</a></h3> <span class="secondary-label">Nov. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/recro-pharma-notches-second-phase-3-win-for-pain-drug/431179/" class="analytics t-editors-bio-article">Recro Pharma notches second Phase 3 win for pain drug</a></h3> <span class="secondary-label">Nov. 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-patient-death-jcar015-cart/431092/" class="analytics t-editors-bio-article">Juno halts CAR-T trial after new patient deaths</a></h3> <span class="secondary-label">Nov. 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-durvalumab-hold-restart-enrollment/430952/" class="analytics t-editors-bio-article">AstraZeneca restarts halted durvalumab trials</a></h3> <span class="secondary-label">Nov. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/halozyme-abbvie-collaboration-discontinue-end/430878/" class="analytics t-editors-bio-article">Halozyme falls after AbbVie nixes partnered program</a></h3> <span class="secondary-label">Nov. 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ex-valeant-exec-arrested-in-philidor-kickback-scheme/430684/" class="analytics t-editors-bio-article">Ex-Valeant exec arrested in Philidor kickback scheme</a></h3> <span class="secondary-label">Nov. 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-insider-trading-johnston-visium/430598/" class="analytics t-editors-bio-article">Ex-FDA official settles insider trading charges</a></h3> <span class="secondary-label">Nov. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-essure-fda-black-box-warning/430583/" class="analytics t-editors-bio-article">Boxed warning added to label of Bayer's Essure </a></h3> <span class="secondary-label">Nov. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/data-in-hand-the-medicines-co-speeds-pcsk9-plans/430481/" class="analytics t-editors-bio-article">Data in hand, The Medicines Co. speeds PCSK9 plans</a></h3> <span class="secondary-label">Nov. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicare-drug-prices-rebate-cost/430451/" class="analytics t-editors-bio-article">Costs for many Medicare drugs continue steady rise</a></h3> <span class="secondary-label">Nov. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dynavax-fda-rejection-hepatitis-b-crl/430354/" class="analytics t-editors-bio-article">Dynavax drops on FDA rejection of hep B vaccine</a></h3> <span class="secondary-label">Nov. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-ptc-gilead-approval/430278/" class="analytics t-editors-bio-article">CHMP decision round-up; PTC wins reprieve</a></h3> <span class="secondary-label">Nov. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-fda-warning-manufacturing-rochester/430189/" class="analytics t-editors-bio-article">Valeant hit with another FDA warning letter</a></h3> <span class="secondary-label">Nov. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-rival-surges-forward-juno-touts-car-t-pipeline/430175/" class="analytics t-editors-bio-article">As rival surges forward, Juno touts CAR-T pipeline</a></h3> <span class="secondary-label">Nov. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-off-label-drug-promotion/430089/" class="analytics t-editors-bio-article">FDA invites pharma input in off-label debate</a></h3> <span class="secondary-label">Nov. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/the-medicines-company-discontinue-heart-drug-pcsk9si/429997/" class="analytics t-editors-bio-article">The Medicines Co. abandons heart drug, focus all on PCSK9si</a></h3> <span class="secondary-label">Nov. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-nusinersen-sma-phase3-fda/429867/" class="analytics t-editors-bio-article">Biogen eyes quick launch for SMA drug</a></h3> <span class="secondary-label">Nov. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-incubators-trends-drug-development/429616/" class="analytics t-editors-bio-article">5 trends turning biotech toward incubators</a></h3> <span class="secondary-label">Nov. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-incubator-advice-start-up-emerging/429701/" class="analytics t-editors-bio-article">Advice to an emerging biotech</a></h3> <span class="secondary-label">Nov. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-incubator-key-people-drug-development/429703/" class="analytics t-editors-bio-article">Key people to know in early drug development</a></h3> <span class="secondary-label">Nov. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/portola-broadens-andexxa-partnership-with-daiichi/429696/" class="analytics t-editors-bio-article">Portola broadens AndexXa partnership with Daiichi </a></h3> <span class="secondary-label">Nov. 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/doctors-biosimilars-prescription-survey/429603/" class="analytics t-editors-bio-article">Doctors willing to prescribe biosimilars, survey shows</a></h3> <span class="secondary-label">Nov. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-salix-sale-xifaxan-debt/429575/" class="analytics t-editors-bio-article">What would a Salix sale do for Valeant?</a></h3> <span class="secondary-label">Nov. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/shire-hemophilia-price-drug-pbm/429481/" class="analytics t-editors-bio-article">Shire confident in hemophilia despite looming pricing challenge</a></h3> <span class="secondary-label">Nov. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-value-based-contract/429394/" class="analytics t-editors-bio-article">Amid pricing scrutiny, Amgen CEO predicts more value-based contracts</a></h3> <span class="secondary-label">Oct. 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/third-rock-ventures-secures-616m-in-new-biotech-fund/429391/" class="analytics t-editors-bio-article">Third Rock Ventures secures $616M in new biotech fund</a></h3> <span class="secondary-label">Oct. 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/interpharm-fda-warning-letter/429212/" class="analytics t-editors-bio-article">Czech drugmaker hit with FDA warning letter</a></h3> <span class="secondary-label">Oct. 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-motus-200m-deal/429199/" class="analytics t-editors-bio-article">Continuing M&A spree, Allergan picks up Motus for $200M</a></h3> <span class="secondary-label">Oct. 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/the-medicines-co-moves-cholesterol-drug-forward-as-sales-fall/429122/" class="analytics t-editors-bio-article">The Medicines Co. moves cholesterol drug forward as sales fall</a></h3> <span class="secondary-label">Oct. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/humana-to-cover-sareptas-dmd-drug-with-caveats/429085/" class="analytics t-editors-bio-article">Humana to cover Sarepta's DMD drug with caveats</a></h3> <span class="secondary-label">Oct. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-says-complete-sola-failure-unlikely/428991/" class="analytics t-editors-bio-article">Lilly says complete Sola failure unlikely</a></h3> <span class="secondary-label">Oct. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-keytruda-first-line-lung-cancer/428934/" class="analytics t-editors-bio-article">Merck cements advantage in I/O with first-line approval</a></h3> <span class="secondary-label">Oct. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aduro-hit-with-partial-hold-sending-shares-spiraling/428903/" class="analytics t-editors-bio-article">Aduro hit with partial hold, sending shares spiraling </a></h3> <span class="secondary-label">Oct. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alkermes-antidepressant-alks-5461-fda/428799/" class="analytics t-editors-bio-article">Alkermes surges on antidepressant success</a></h3> <span class="secondary-label">Oct. 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dimension-beefs-up-aav-manufacturing/428739/" class="analytics t-editors-bio-article">Dimension beefs up AAV manufacturing</a></h3> <span class="secondary-label">Oct. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/single-placebo-response-derails-rigel-study/428722/" class="analytics t-editors-bio-article">Single placebo response derails Rigel study</a></h3> <span class="secondary-label">Oct. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-lays-groundwork-for-biosimilar-push/428637/" class="analytics t-editors-bio-article">Merck lays groundwork for biosimilar push</a></h3> <span class="secondary-label">Oct. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/car-t-ready-for-flight-says-kite/428629/" class="analytics t-editors-bio-article">CAR-T ready for flight, says Kite</a></h3> <span class="secondary-label">Oct. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/earnings-guide-a-preview-of-9-big-pharmas-in-q3/428562/" class="analytics t-editors-bio-article">Earnings guide: A preview of 9 big pharmas in Q3</a></h3> <span class="secondary-label">Oct. 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicines-co-pcsk9-cholesterol/428519/" class="analytics t-editors-bio-article">Medicines Co. scores positive results for PCSK9 drug</a></h3> <span class="secondary-label">Oct. 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-snubs-ptc-appeal-for-duchenne-drug/428417/" class="analytics t-editors-bio-article">FDA snubs PTC appeal for Duchenne drug</a></h3> <span class="secondary-label">Oct. 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-touts-upgrades-to-gene-therapy-but-shares-slip/428358/" class="analytics t-editors-bio-article">Bluebird touts upgrades to gene therapy</a></h3> <span class="secondary-label">Oct. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/insulin-market-novo-lilly-sanofi/427602/" class="analytics t-editors-bio-article">Insulin makers become casualties of pricing war</a></h3> <span class="secondary-label">Oct. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-asthma-study-synairgen/428133/" class="analytics t-editors-bio-article">AstraZeneca halts asthma study in blow to Synairgen</a></h3> <span class="secondary-label">Oct. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-aetna-januvia-pay-for-performance/428045/" class="analytics t-editors-bio-article">Merck inks pay-for-performance deal to boost diabetes drugs</a></h3> <span class="secondary-label">Oct. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-broadens-oncology-pipeline-with-crescendo-deal/427962/" class="analytics t-editors-bio-article">Takeda broadens oncology pipeline with Crescendo deal</a></h3> <span class="secondary-label">Oct. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/downfall-of-a-unicorn-how-theranos-fell-apart/427937/" class="analytics t-editors-bio-article">Downfall of a unicorn: How Theranos fell apart</a></h3> <span class="secondary-label">Oct. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/major-us-insurer-snubs-sareptas-duchenne-drug/427894/" class="analytics t-editors-bio-article">Major US insurer snubs Sarepta's Duchenne drug</a></h3> <span class="secondary-label">Oct. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-shuts-down-labs-lays-off-340/427762/" class="analytics t-editors-bio-article">Theranos shuts down labs, lays off 340 </a></h3> <span class="secondary-label">Oct. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-shakes-up-rd-closing-down-two-biologics-units/427660/" class="analytics t-editors-bio-article">Novartis shakes up R&D, closing down two biologics units</a></h3> <span class="secondary-label">Oct. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-steps-up-dmd-dealmaking/427566/" class="analytics t-editors-bio-article">Sarepta steps up DMD dealmaking</a></h3> <span class="secondary-label">Oct. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biosimilars-whats-in-a-name/427493/" class="analytics t-editors-bio-article">Biosimilars emerge in US, but what to call them? </a></h3> <span class="secondary-label">Oct. 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-furthers-sell-off-strategy-with-new-deal/427470/" class="analytics t-editors-bio-article">AstraZeneca furthers sell-off strategy with new deal</a></h3> <span class="secondary-label">Oct. 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regeneron-slips-on-trial-setback-for-eylea-combo/427388/" class="analytics t-editors-bio-article">Regeneron slips on trial setback for Eylea combo</a></h3> <span class="secondary-label">Sept. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-cites-chinese-manufacturers-for-gmp-lapses/427303/" class="analytics t-editors-bio-article">FDA cites Chinese manufacturers for GMP lapses</a></h3> <span class="secondary-label">Sept. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-amgen-score-phase-3-win-for-migraine-drug/427293/" class="analytics t-editors-bio-article">Novartis, Amgen score Phase 3 win for migraine drug</a></h3> <span class="secondary-label">Sept. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/will-staff-cuts-help-novo-stay-competitive/427290/" class="analytics t-editors-bio-article">Will staff cuts help Novo stay competitive?</a></h3> <span class="secondary-label">Sept. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boehringer-gets-option-to-buy-in-io-deal/427192/" class="analytics t-editors-bio-article">Boehringer gets option to buy in I/O deal</a></h3> <span class="secondary-label">Sept. 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kite-bolsters-lead-with-positive-car-t-data/427086/" class="analytics t-editors-bio-article">Kite bolsters lead with positive CAR-T data</a></h3> <span class="secondary-label">Sept. 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-nixes-split-plans-opts-to-remain-one-company/426992/" class="analytics t-editors-bio-article">Pfizer nixes split plans, opts to remain one company</a></h3> <span class="secondary-label">Sept. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/indivior-stumbles-as-us-states-file-antitrust-suit/426932/" class="analytics t-editors-bio-article">Indivior stumbles as US states file antitrust suit</a></h3> <span class="secondary-label">Sept. 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-approval-in-hand-sarepta-plans-for-future-studies/426860/" class="analytics t-editors-bio-article">FDA approval in hand, Sarepta plans for future studies</a></h3> <span class="secondary-label">Sept. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-lifts-curtain-on-manufacturing-plant-plans/426853/" class="analytics t-editors-bio-article">Moderna lifts curtain on manufacturing plant plans</a></h3> <span class="secondary-label">Sept. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-shutters-study-for-anti-mmp9-drug/426828/" class="analytics t-editors-bio-article">Gilead shutters study for anti-MMP9 drug</a></h3> <span class="secondary-label">Sept. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-pays-steep-premium-for-tobira-and-nash-drugs/426650/" class="analytics t-editors-bio-article">Allergan pays steep premium for Tobira and NASH drugs</a></h3> <span class="secondary-label">Sept. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drama-at-fda-5-things-to-know-about-the-sarepta-approval/426568/" class="analytics t-editors-bio-article">Drama at FDA: 5 things to know about the Sarepta approval </a></h3> <span class="secondary-label">Sept. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-skyrockets-as-fda-approves-dmd-drug/426562/" class="analytics t-editors-bio-article">Sarepta skyrockets as FDA approves DMD drug</a></h3> <span class="secondary-label">Sept. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-rebates-on-heart-drugs-are-coming/426544/" class="analytics t-editors-bio-article">Valeant: rebates on heart drugs are coming</a></h3> <span class="secondary-label">Sept. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novavax-short-on-options-after-vaccine-fails-trial/426474/" class="analytics t-editors-bio-article">Novavax short on options after vaccine fails trial</a></h3> <span class="secondary-label">Sept. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eisai-ramps-up-precision-med-efforts-with-new-unit/426408/" class="analytics t-editors-bio-article">Eisai ramps up precision med efforts with new unit</a></h3> <span class="secondary-label">Sept. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lonza-builds-out-gene-therapy-offerings/426399/" class="analytics t-editors-bio-article">Lonza builds out gene therapy offerings</a></h3> <span class="secondary-label">Sept. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-pulls-71000-kits-of-glucagon-med-from-us-market/426397/" class="analytics t-editors-bio-article">Novo pulls 71,000 kits of glucagon med from US market</a></h3> <span class="secondary-label">Sept. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acelrx-stock-jumps-after-trial-success/426388/" class="analytics t-editors-bio-article">AcelRx stock jumps after trial success</a></h3> <span class="secondary-label">Sept. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/un-panel-drug-prices-rd-costs-delink/426329/" class="analytics t-editors-bio-article">UN group urges 'de-linkage' of R&D costs from drug prices</a></h3> <span class="secondary-label">Sept. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bio-blames-insurers-in-pushback-on-drug-pricing/426290/" class="analytics t-editors-bio-article">BIO blames insurers in pushback on drug pricing</a></h3> <span class="secondary-label">Sept. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-bolsters-evidence-for-ms-drug-ocrevus/426283/" class="analytics t-editors-bio-article">Roche bolsters evidence for MS drug Ocrevus</a></h3> <span class="secondary-label">Sept. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/irish-startup-secures-17m-series-a/426188/" class="analytics t-editors-bio-article">Irish startup secures $17M Series A</a></h3> <span class="secondary-label">Sept. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/generic-drugmaker-under-federal-pricing-probe/426133/" class="analytics t-editors-bio-article">Generic drugmaker under federal pricing probe</a></h3> <span class="secondary-label">Sept. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aveo-halts-study-of-lung-cancer-drug/426107/" class="analytics t-editors-bio-article">Aveo halts study of lung cancer drug</a></h3> <span class="secondary-label">Sept. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/horizon-adds-rare-disease-drugs-in-800m-raptor-deal/426103/" class="analytics t-editors-bio-article">Horizon adds rare disease drugs in $800M Raptor deal</a></h3> <span class="secondary-label">Sept. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-closes-in-on-90m-ipo/426100/" class="analytics t-editors-bio-article">CRISPR closes in on $90M IPO </a></h3> <span class="secondary-label">Sept. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jj-pushes-forward-with-hep-c-triple-combo/426029/" class="analytics t-editors-bio-article">J&J pushes forward with hep C triple-combo</a></h3> <span class="secondary-label">Sept. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-highlights-new-drug-potential/426024/" class="analytics t-editors-bio-article">Allergan highlights new drug potential </a></h3> <span class="secondary-label">Sept. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fresh-off-new-funding-moderna-plans-new-manufacturing-plant/425960/" class="analytics t-editors-bio-article">Fresh off new funding, Moderna plans new manufacturing plant</a></h3> <span class="secondary-label">Sept. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-renews-ban-on-indian-drugmaker-after-fresh-violations/425958/" class="analytics t-editors-bio-article">FDA renews ban on Indian drugmaker after fresh violations</a></h3> <span class="secondary-label">Sept. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-proceeds-with-late-stage-trial-after-key-improvement/425948/" class="analytics t-editors-bio-article">Bluebird proceeds with late-stage trial after key improvement</a></h3> <span class="secondary-label">Sept. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-comments-on-split-rumors/425943/" class="analytics t-editors-bio-article">Gilead comments on split rumors</a></h3> <span class="secondary-label">Sept. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tonix-shelves-fibromyalgia-plans-after-phase-3-miss/425868/" class="analytics t-editors-bio-article">Tonix shelves fibromyalgia plans after Phase 3 miss</a></h3> <span class="secondary-label">Sept. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/karyopharm-tees-up-filing-for-multiple-myeloma-drug/425860/" class="analytics t-editors-bio-article">Karyopharm tees up filing for multiple myeloma drug </a></h3> <span class="secondary-label">Sept. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jazz-subsidiary-warned-over-misbranding-of-cancer-drug/425795/" class="analytics t-editors-bio-article">Jazz subsidiary warned over misbranding of cancer drug</a></h3> <span class="secondary-label">Sept. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-brent-saunders-drug-predatory-pricing/425780/" class="analytics t-editors-bio-article">Allergan CEO disavows 'predatory pricing'</a></h3> <span class="secondary-label">Sept. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/flush-from-pfizer-deal-medivation-execs-set-to-cash-in/425768/" class="analytics t-editors-bio-article">Flush from Pfizer deal, Medivation execs set to cash in</a></h3> <span class="secondary-label">Sept. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/momenta-pulls-the-plug-on-pancreatic-cancer-drug/425689/" class="analytics t-editors-bio-article">Momenta pulls the plug on pancreatic cancer drug</a></h3> <span class="secondary-label">Sept. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sunovion-snaps-up-cynapsus-in-624m-deal/425628/" class="analytics t-editors-bio-article">Sunovion snaps up Cynapsus in $624M deal</a></h3> <span class="secondary-label">Sept. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-wake-of-generics-deal-teva-to-close-new-york-plant/425617/" class="analytics t-editors-bio-article">In wake of generics deal, Teva to close New York plant</a></h3> <span class="secondary-label">Sept. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-zika-fda-inspection-minilab/425610/" class="analytics t-editors-bio-article">Theranos stumbles in efforts to sell Zika test: report</a></h3> <span class="secondary-label">Sept. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-hit-with-patent-suit-over-hepatitis-c-drugs/425603/" class="analytics t-editors-bio-article">Gilead hit with patent suit over hepatitis C drugs</a></h3> <span class="secondary-label">Sept. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-tecentriq-ready-to-compete-in-lung-cancer/425584/" class="analytics t-editors-bio-article">Roche's Tecentriq ready to compete in lung cancer</a></h3> <span class="secondary-label">Sept. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/weighing-in-on-epipen-phrma-calls-for-reforms-at-fda/425517/" class="analytics t-editors-bio-article">Weighing in on EpiPen, PhRMA calls for reforms at FDA</a></h3> <span class="secondary-label">Aug. 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-dissolve-cell-gene-therapy-car-t/425494/" class="analytics t-editors-bio-article">Novartis breaks up CAR-T unit in major shift</a></h3> <span class="secondary-label">Aug. 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-biosimilar-enbrel-amgen-fda/425434/" class="analytics t-editors-bio-article">Novartis wins US approval for biosimilar Enbrel</a></h3> <span class="secondary-label">Aug. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/looking-past-fda-snub-portola-touts-new-andexxa-data/425433/" class="analytics t-editors-bio-article">Looking past FDA snub, Portola touts new Andexxa data</a></h3> <span class="secondary-label">Aug. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/trial-failure-dashes-vecturas-hopes-for-wider-use-of-asthma-drug/425408/" class="analytics t-editors-bio-article">Trial failure dashes Vectura's hopes for wider use of asthma drug </a></h3> <span class="secondary-label">Aug. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/stada-elects-new-chairman-after-activist-pressure/425400/" class="analytics t-editors-bio-article">Stada elects new chairman after activist pressure</a></h3> <span class="secondary-label">Aug. 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moderna-reels-in-450m-in-new-funding/425317/" class="analytics t-editors-bio-article">Moderna reels in $450M in new funding</a></h3> <span class="secondary-label">Aug. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biosim-threat-stiffens-for-roches-herceptin/425287/" class="analytics t-editors-bio-article">Biosim threat stiffens for Roche's Herceptin</a></h3> <span class="secondary-label">Aug. 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mallinckrodt-sharpens-specialty-pharma-focus/425247/" class="analytics t-editors-bio-article">Mallinckrodt sharpens specialty pharma focus</a></h3> <span class="secondary-label">Aug. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-planning-appeal-of-federal-penalties/425242/" class="analytics t-editors-bio-article">Theranos planning appeal of federal penalties</a></h3> <span class="secondary-label">Aug. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sagent-recalls-injectable-antibiotic/425174/" class="analytics t-editors-bio-article">Sagent recalls injectable antibiotic</a></h3> <span class="secondary-label">Aug. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/denali-secures-130m-in-new-funding-reveals-rd-plans/425153/" class="analytics t-editors-bio-article">Denali secures $130M in new funding, reveals R&D plans</a></h3> <span class="secondary-label">Aug. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-FDA-rejection-crl-parsabiv/425141/" class="analytics t-editors-bio-article">FDA unexpectedly snubs Amgen drug </a></h3> <span class="secondary-label">Aug. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-astrazeneca-antibiotics-acquisition/425060/" class="analytics t-editors-bio-article">Pfizer continues dealmaking with antibiotics buy</a></h3> <span class="secondary-label">Aug. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-pdufa-date-for-rucaparib-set-clovis-eyes-rebound/425052/" class="analytics t-editors-bio-article">With PDUFA date for rucaparib set, Clovis eyes rebound</a></h3> <span class="secondary-label">Aug. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mi-labs-to-biotechs-call-us-home/424591/" class="analytics t-editors-bio-article">MI Labs to biotechs: Call us home</a></h3> <span class="secondary-label">Aug. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/oncogenex-scrambles-after-trial-fail/424542/" class="analytics t-editors-bio-article">OncoGenex scrambles after trial fail</a></h3> <span class="secondary-label">Aug. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aurinia-succeeds-but-safety-concerns-loom/424531/" class="analytics t-editors-bio-article">Aurinia succeeds, but safety concerns loom</a></h3> <span class="secondary-label">Aug. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/veteran-ceo-of-german-drugmaker-stada-resigns/424490/" class="analytics t-editors-bio-article">Veteran CEO of German drugmaker Stada resigns</a></h3> <span class="secondary-label">Aug. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chinese-regulators-advance-overhaul-of-drug-manufacturing/424474/" class="analytics t-editors-bio-article">Chinese regulators advance overhaul of drug manufacturing</a></h3> <span class="secondary-label">Aug. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/acelrx-meets-goal-in-phase-3-but-stock-slips/424472/" class="analytics t-editors-bio-article">AcelRx meets goal in Phase 3, but stock slips</a></h3> <span class="secondary-label">Aug. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-merck-court-fees-hepatitis-c-patent/424459/" class="analytics t-editors-bio-article">Gilead can recoup legal fees from Merck, judge says</a></h3> <span class="secondary-label">Aug. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drug-pricing-studies-anger-industry-icer-pushes-back/424377/" class="analytics t-editors-bio-article">Drug pricing studies anger industry, ICER pushes back </a></h3> <span class="secondary-label">Aug. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-tumbles-on-report-of-fraud-investigation/424293/" class="analytics t-editors-bio-article">Valeant tumbles on report of fraud investigation</a></h3> <span class="secondary-label">Aug. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nih-shuts-down-facility-used-to-produce-drugs-for-clinical-trials/424223/" class="analytics t-editors-bio-article">NIH shuts down facility used to produce drugs for clinical trials</a></h3> <span class="secondary-label">Aug. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-temporarily-shutters-indian-facility-after-inspections/424139/" class="analytics t-editors-bio-article">Pfizer temporarily shutters Indian facility after inspections</a></h3> <span class="secondary-label">Aug. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seizing-car-t-lead-kite-readies-commercial-scale-manufacturing/424136/" class="analytics t-editors-bio-article">Seizing CAR-T lead, Kite readies commercial-scale manufacturing</a></h3> <span class="secondary-label">Aug. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/editas-continues-to-expand-crispr-capabilities-with-new-deal/424119/" class="analytics t-editors-bio-article">Editas continues to expand CRISPR capabilities with new deal</a></h3> <span class="secondary-label">Aug. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kite-steps-up-plans-for-leading-car-t-putting-pressure-on-juno/424070/" class="analytics t-editors-bio-article">Kite steps up plans for leading CAR-T, putting pressure on Juno</a></h3> <span class="secondary-label">Aug. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novo-nordisk-sees-pricing-challenges-intensifying/424029/" class="analytics t-editors-bio-article">Novo Nordisk sees pricing challenges 'intensifying'</a></h3> <span class="secondary-label">Aug. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-trial-restart-juno-pushes-back-launch-timeline-for-car-t-therapy/423957/" class="analytics t-editors-bio-article">Despite trial restart, Juno pushes back launch timeline for CAR-T therapy</a></h3> <span class="secondary-label">Aug. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-fails-key-lung-cancer-study-stocks-ricochet/423954/" class="analytics t-editors-bio-article">Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet</a></h3> <span class="secondary-label">Aug. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-cuts-151-jobs-at-new-york-plant/423886/" class="analytics t-editors-bio-article">Pfizer cuts 151 jobs at New York plant</a></h3> <span class="secondary-label">Aug. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/FDA-Xiamen-Chinese-supplier-ban-warning/423883/" class="analytics t-editors-bio-article">Chinese drug manufacturer lies to FDA, promptly gets banned</a></h3> <span class="secondary-label">Aug. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-we-stand-behind-the-pricing-of-our-therapies/423859/" class="analytics t-editors-bio-article">Gilead: 'We stand behind the pricing of our therapies'</a></h3> <span class="secondary-label">Aug. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeover-rumors-juice-biogen-stock-but-fade-fast/423786/" class="analytics t-editors-bio-article">Takeover rumors juice Biogen stock, but fade fast</a></h3> <span class="secondary-label">Aug. 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-secures-rights-to-cancer-immunotherapy-from-biotech-advaxis/423715/" class="analytics t-editors-bio-article">Amgen secures rights to cancer immunotherapy from biotech Advaxis</a></h3> <span class="secondary-label">Aug. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-holmes-technology-minilab-criticism/423686/" class="analytics t-editors-bio-article">Theranos founder Holmes touts new tech despite unanswered questions </a></h3> <span class="secondary-label">Aug. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-snaps-up-rights-to-neuromuscular-disease-drug-after-trial-success/423632/" class="analytics t-editors-bio-article">Biogen snaps up rights to neuromuscular disease drug after trial success</a></h3> <span class="secondary-label">Aug. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-verily-launch-715-million-bet-on-bioelectronic-medicines/423611/" class="analytics t-editors-bio-article">GSK, Verily launch $715 million bet on bioelectronic medicines </a></h3> <span class="secondary-label">Aug. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/higher-humira-sales-lift-abbvie-in-q2/423553/" class="analytics t-editors-bio-article">Higher Humira sales lift AbbVie in Q2</a></h3> <span class="secondary-label">July 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mercks-keytruda-continues-gains-driving-q2-revenues-higher/423542/" class="analytics t-editors-bio-article">Merck's Keytruda continues gains, driving Q2 revenues higher</a></h3> <span class="secondary-label">July 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-revenues-climb-on-strong-opdivo-performance/423473/" class="analytics t-editors-bio-article">Bristol-Myers revenues climb on strong Opdivo performance</a></h3> <span class="secondary-label">July 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-boosts-sales-forecast-as-q2-profits-jump/423416/" class="analytics t-editors-bio-article">Amgen boosts sales forecast as Q2 profits jump</a></h3> <span class="secondary-label">July 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ftc-approve-teva-allergan-generics-deal/423382/" class="analytics t-editors-bio-article">US regulators clear Teva, Allergan generics deal </a></h3> <span class="secondary-label">July 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/taurx-alzheimers-drug-flunks-late-stage-study/423370/" class="analytics t-editors-bio-article">TauRx Alzheimer's drug flunks late-stage study</a></h3> <span class="secondary-label">July 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lilly-ceo-retire-john-lechleiter/423363/" class="analytics t-editors-bio-article">Lilly CEO John Lechleiter to retire by year-end</a></h3> <span class="secondary-label">July 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/health-plans-slow-to-adopt-new-drug-value-assessments-survey/423309/" class="analytics t-editors-bio-article">Health plans slow to adopt new drug value assessments: survey</a></h3> <span class="secondary-label">July 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-blames-stiff-competition-for-lower-us-sales-of-lung-cancer-drugs/423294/" class="analytics t-editors-bio-article">Lilly blames stiff competition for lower US sales of lung cancer drugs</a></h3> <span class="secondary-label">July 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-trims-guidance-as-hepatitis-c-drug-sales-slip/423224/" class="analytics t-editors-bio-article">Gilead trims guidance as Hepatitis C drug sales slip</a></h3> <span class="secondary-label">July 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/alzheon-readies-phase-3-study-of-alzheimers-drug/423212/" class="analytics t-editors-bio-article">Alzheon readies Phase 3 study of Alzheimer's drug</a></h3> <span class="secondary-label">July 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-bristol-myers-rova-t-combo-trial/423193/" class="analytics t-editors-bio-article">AbbVie partners with Bristol-Myers in combo study of cancer drugs</a></h3> <span class="secondary-label">July 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fresh-off-relistor-win-valeant-hits-fda-roadblock-for-eye-drug/423128/" class="analytics t-editors-bio-article">Fresh off Relistor win, Valeant hits FDA roadblock for eye drug</a></h3> <span class="secondary-label">July 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chinese-team-to-test-crispr-in-humans-jumping-ahead-of-planned-us-study/423110/" class="analytics t-editors-bio-article">Chinese team to test CRISPR in humans, jumping ahead of planned US study</a></h3> <span class="secondary-label">July 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/swiss-group-galencia-buys-us-biotech-relypsa-for-15-billion/423055/" class="analytics t-editors-bio-article">Swiss group Galencia buys US biotech Relypsa for $1.5 billion</a></h3> <span class="secondary-label">July 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-ceo-george-scangos-to-step-down/423031/" class="analytics t-editors-bio-article">Biogen CEO George Scangos to step down</a></h3> <span class="secondary-label">July 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-sales-buoyed-by-cancer-drugs/423032/" class="analytics t-editors-bio-article">Roche sales buoyed by cancer drugs</a></h3> <span class="secondary-label">July 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/federal-court-thwarts-astrazeneca-efforts-to-block-crestor-copies/422965/" class="analytics t-editors-bio-article">Federal court thwarts AstraZeneca efforts to block Crestor copies</a></h3> <span class="secondary-label">July 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-wins-backing-of-fda-panel-for-psoriasis-drug/422941/" class="analytics t-editors-bio-article">Valeant wins backing of FDA panel for psoriasis drug</a></h3> <span class="secondary-label">July 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-settles-for-30-million-over-california-kickback-claims/422890/" class="analytics t-editors-bio-article">Bristol-Myers settles for $30 million over California kickback claims</a></h3> <span class="secondary-label">July 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ziopharm-says-patient-death-unrelated-to-gene-therapy/422885/" class="analytics t-editors-bio-article">Ziopharm says patient death unrelated to gene therapy</a></h3> <span class="secondary-label">July 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-quarter-q2-sales-entresto-gleevec/422845/" class="analytics t-editors-bio-article">Novartis doubles down on new drugs as sales slump for top cancer med</a></h3> <span class="secondary-label">July 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-flood-of-orphan-drug-applications-slowing-review-process/422833/" class="analytics t-editors-bio-article">FDA: Flood of orphan drug applications slowing review process</a></h3> <span class="secondary-label">July 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-blood-cancer-drug-falls-short-in-late-stage-study/422799/" class="analytics t-editors-bio-article">Roche blood cancer drug falls short in late-stage study</a></h3> <span class="secondary-label">July 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-new-additions-phrma-opens-door-to-generics-drugmaker-teva/422720/" class="analytics t-editors-bio-article">With new additions, PhRMA opens door to generics drugmaker Teva</a></h3> <span class="secondary-label">July 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-staff-raises-safety-concerns-for-valeant-psoriasis-drug/422717/" class="analytics t-editors-bio-article">FDA staff raises safety concerns for Valeant psoriasis drug</a></h3> <span class="secondary-label">July 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-antibiotics-resistance-amr-open-science/422664/" class="analytics t-editors-bio-article">Why Allergan thinks an 'open science' approach can help it develop new antibiotics</a></h3> <span class="secondary-label">July 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-partners-with-daiichi-to-market-biosimilars-in-japan/422634/" class="analytics t-editors-bio-article">Amgen partners with Daiichi to market biosimilars in Japan</a></h3> <span class="secondary-label">July 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-sequoia-fund-sell-exit-stake/422548/" class="analytics t-editors-bio-article">Large Valeant investor sold off remaining stake last quarter</a></h3> <span class="secondary-label">July 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-FDA-clinical-hold-lift-car-t/422483/" class="analytics t-editors-bio-article">Juno restarts suspended CAR-T trial after FDA lifts clinical hold</a></h3> <span class="secondary-label">July 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-job-cuts-research-new-jersey/422477/" class="analytics t-editors-bio-article">Merck trims research jobs at three sites, shifts drug discovery focus</a></h3> <span class="secondary-label">July 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sage-postpartum-depression-remission-stock/422466/" class="analytics t-editors-bio-article">Sage soars after small study of postpartum depression drug shows benefit</a></h3> <span class="secondary-label">July 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cancer-drug-Parkinsons-disease-nilotinib-georgetown/422393/" class="analytics t-editors-bio-article">Cancer drug could benefit Parkinson's patients, study shows</a></h3> <span class="secondary-label">July 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/facing-major-penalties-theranos-could-be-forced-to-change-business/422358/" class="analytics t-editors-bio-article">Facing major penalties, Theranos could be forced to change business</a></h3> <span class="secondary-label">July 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-staff-backs-amgen-biosim-of-abbvies-humira/422306/" class="analytics t-editors-bio-article">FDA staff backs Amgen biosim of AbbVie's Humira</a></h3> <span class="secondary-label">July 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-elizabeth-holmes-ban-cms/422290/" class="analytics t-editors-bio-article">Theranos founder banned from blood-testing business</a></h3> <span class="secondary-label">July 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-car-t-trial-fda-patient-deaths/422254/" class="analytics t-editors-bio-article">Juno CAR-T trial halted by FDA after three patient deaths</a></h3> <span class="secondary-label">July 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-ablynx-arthritis-trial-actemra/422214/" class="analytics t-editors-bio-article">AbbVie bet on Ablynx gets boost after arthritis drug shows promise</a></h3> <span class="secondary-label">July 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-pledges-to-disclose-risks-of-opioid-addiction/422130/" class="analytics t-editors-bio-article">Pfizer pledges to disclose risks of opioid addiction </a></h3> <span class="secondary-label">July 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/federal-appeals-court-reaffirms-biosimilar-launch-rules/422091/" class="analytics t-editors-bio-article">Federal appeals court reaffirms biosimilar launch rules</a></h3> <span class="secondary-label">July 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanof-medivation-confidentiality-sale-talks/422079/" class="analytics t-editors-bio-article">Medivation enters takeover talks with Sanofi after rejecting new bid</a></h3> <span class="secondary-label">July 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-cost-agency-knocks-back-bristol-myers-opdivo-in-kidney-cancer/422058/" class="analytics t-editors-bio-article">UK cost agency knocks back Bristol-Myers' Opdivo in kidney cancer</a></h3> <span class="secondary-label">July 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-buys-cormorant-pharma-eyes-cancer-combo-potential/422041/" class="analytics t-editors-bio-article">Bristol-Myers buys Cormorant Pharma, eyes cancer combo potential</a></h3> <span class="secondary-label">July 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-sells-off-dermatology-drug-rights-to-leo-pharma/421967/" class="analytics t-editors-bio-article">AstraZeneca sells off dermatology drug rights to LEO Pharma</a></h3> <span class="secondary-label">July 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/major-trade-group-slams-misleading-analysis-of-drug-prices/421885/" class="analytics t-editors-bio-article">Major trade group slams 'misleading' analysis of drug prices</a></h3> <span class="secondary-label">June 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tesaro-soars-after-ovarian-cancer-drug-meets-phase-3-goal/421795/" class="analytics t-editors-bio-article">Tesaro soars after ovarian cancer drug meets Phase 3 goal</a></h3> <span class="secondary-label">June 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-narrow-vote-fda-panel-supports-heart-benefit-claim-for-lilly-diabetes-d/421790/" class="analytics t-editors-bio-article">In narrow vote, FDA panel supports heart benefit claim for Lilly diabetes drug</a></h3> <span class="secondary-label">June 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/veterans-affairs-IBM-Watson-precision-cancer/421751/" class="analytics t-editors-bio-article">VA teams up with IBM's supercomputer Watson to expand precision medicine</a></h3> <span class="secondary-label">June 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/harvard-pilgrim-inks-pay-for-performance-deals-with-novartis-eli-lilly/421740/" class="analytics t-editors-bio-article">Harvard Pilgrim inks pay-for-performance deals with Novartis, Eli Lilly</a></h3> <span class="secondary-label">June 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-wins-fda-nod-for-pan-genotypic-hep-c-drug/421723/" class="analytics t-editors-bio-article">Gilead wins FDA nod for pan-genotypic Hep C drug</a></h3> <span class="secondary-label">June 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-to-open-first-asia-biotech-center-in-china/421716/" class="analytics t-editors-bio-article">Pfizer to open first Asia biotech center in China</a></h3> <span class="secondary-label">June 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-jumps-into-bi-specific-antibody-space-with-150-million-xencor-dea/421703/" class="analytics t-editors-bio-article">Novartis jumps into bi-specific antibody space with $150 million Xencor deal</a></h3> <span class="secondary-label">June 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-halts-testing-of-regulus-hep-c-drug-sending-shares-into-tailspin/421664/" class="analytics t-editors-bio-article">FDA halts testing of Regulus' Hep C drug, sending shares into tailspin</a></h3> <span class="secondary-label">June 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gw-pharma-shares-jump-on-phase-3-data-for-cannabis-based-drug/421624/" class="analytics t-editors-bio-article">GW Pharma shares jump on Phase 3 data for cannabis-based drug</a></h3> <span class="secondary-label">June 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-boehringer-trade-business-units-in-25-billion-swap/421619/" class="analytics t-editors-bio-article">Sanofi, Boehringer trade business units in $25 billion swap</a></h3> <span class="secondary-label">June 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-seals-deal-to-market-copy-of-astrazeneca-diabetes-drug/421553/" class="analytics t-editors-bio-article">Teva seals deal to market copy of AstraZeneca diabetes drug</a></h3> <span class="secondary-label">June 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/britain-europe-pharmaceuticals-brexit/421528/" class="analytics t-editors-bio-article">Brexit vote creates new uncertainty for UK, EU pharma industry</a></h3> <span class="secondary-label">June 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/epizyme-roche-cancer-combo-tecentriq/421487/" class="analytics t-editors-bio-article">Epizyme partners with Roche to test cancer drug combo</a></h3> <span class="secondary-label">June 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-plans-to-close-colorado-production-facility/421471/" class="analytics t-editors-bio-article">Pfizer plans to close Colorado production facility</a></h3> <span class="secondary-label">June 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-writes-off-80-million-after-us-authorities-say-nasal-flu-vacci/421457/" class="analytics t-editors-bio-article">AstraZeneca writes off $80 million after US authorities say nasal flu vaccine ineffective</a></h3> <span class="secondary-label">June 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/first-human-study-of-crispr-approved-by-federal-panel/421375/" class="analytics t-editors-bio-article">First human study of CRISPR approved by federal panel </a></h3> <span class="secondary-label">June 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/startup-biotech-homology-med-aims-to-leapfrog-crispr-competitors/421310/" class="analytics t-editors-bio-article">Startup biotech Homology Med aims to 'leapfrog' CRISPR competitors</a></h3> <span class="secondary-label">June 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/teva-impax-generic-drugs-586million/421302/" class="analytics t-editors-bio-article">Teva, Allergan continue to shed assets with $586 million sale to Impax</a></h3> <span class="secondary-label">June 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/takeda-begins-field-testing-norovirus-vaccine/421296/" class="analytics t-editors-bio-article">Takeda begins field testing norovirus vaccine</a></h3> <span class="secondary-label">June 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nih-denies-xtandi-patent-override/421231/" class="analytics t-editors-bio-article">NIH turns down request to override cancer drug patent</a></h3> <span class="secondary-label">June 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-biosimilar-market-launch-2020/421218/" class="analytics t-editors-bio-article">Doubling down on biosimilars, Novartis plans five launches by 2020</a></h3> <span class="secondary-label">June 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nih-panel-to-review-proposal-for-first-in-human-test-of-crispr/421139/" class="analytics t-editors-bio-article">NIH panel to review proposal for first in human test of CRISPR</a></h3> <span class="secondary-label">June 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-begins-construction-on-200-million-biologics-plant-in-ma/421064/" class="analytics t-editors-bio-article">Pfizer begins construction on $200 million biologics plant in MA</a></h3> <span class="secondary-label">June 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mercks-keytruda-beats-out-chemotherapy-in-lung-cancer-study/421055/" class="analytics t-editors-bio-article">Merck's Keytruda beats out chemotherapy in lung cancer study</a></h3> <span class="secondary-label">June 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/facing-legal-troubles-and-declining-sales-aegerion-to-merge-with-canadian/420972/" class="analytics t-editors-bio-article">Facing legal troubles and declining sales, Aegerion to merge with Canadian QLT</a></h3> <span class="secondary-label">June 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/marathon-pharma-latest-company-to-try-for-approval-of-duchenne-drug/420971/" class="analytics t-editors-bio-article"> Marathon Pharma latest company to try for approval of Duchenne drug</a></h3> <span class="secondary-label">June 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/shire-buys-rights-to-pfizer-bowel-disease-drug/420915/" class="analytics t-editors-bio-article">Shire buys rights to Pfizer bowel disease drug</a></h3> <span class="secondary-label">June 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda_warning_diabetes_invokana_farxiga/420912/" class="analytics t-editors-bio-article">FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca</a></h3> <span class="secondary-label">June 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/former-dendreon-ceo-leads-alpine-immune-to-48-million-financing/420889/" class="analytics t-editors-bio-article">Former Dendreon CEO leads Alpine Immune to $48 million financing </a></h3> <span class="secondary-label">June 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/report-oncology-drove-record-pharma-dealmaking-in-2015/420684/" class="analytics t-editors-bio-article">Report: Oncology drove record pharma dealmaking in 2015</a></h3> <span class="secondary-label">June 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/small-biotech-accera-reinvents-itself-takes-aim-at-alzheimers-treatment/420531/" class="analytics t-editors-bio-article">Small biotech Accera reinvents itself, takes aim at Alzheimer's treatment</a></h3> <span class="secondary-label">June 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-asks-sarepta-for-more-data-on-muscular-dystrophy-drug/420441/" class="analytics t-editors-bio-article">FDA asks Sarepta for more data on muscular dystrophy drug</a></h3> <span class="secondary-label">June 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-lung-cancer-drug-shows-promise-but-has-high-expectations-to-meet/420356/" class="analytics t-editors-bio-article">AbbVie lung cancer drug shows promise, but has high expectations to meet</a></h3> <span class="secondary-label">June 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-opens-rd-center-shanghai/420249/" class="analytics t-editors-bio-article">With eye to growing Chinese market, Novartis opens major R&D hub in Shanghai</a></h3> <span class="secondary-label">June 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/global-cancer-drug-spending-rises-set-to-surpass-150-billion-by-2020/420238/" class="analytics t-editors-bio-article">Global cancer drug spending rises, set to surpass $150 billion by 2020</a></h3> <span class="secondary-label">June 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-warns-another-indian-api-supplier-on-manufacturing-lapses/420184/" class="analytics t-editors-bio-article">FDA warns another Indian API supplier on manufacturing lapses</a></h3> <span class="secondary-label">June 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/activist-investor-icahn-acquires-large-stake-in-allergan/420151/" class="analytics t-editors-bio-article">Activist investor Icahn acquires large stake in Allergan</a></h3> <span class="secondary-label">June 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-stock-plunge-former-valeant-ceo-to-collect-9-million-in-severance/420148/" class="analytics t-editors-bio-article">Despite stock plunge, former Valeant CEO to collect $9 million in severance pay</a></h3> <span class="secondary-label">June 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biomarin-ends-duchenne-program-withdraws-eu-application-for-drisapersen/420094/" class="analytics t-editors-bio-article">BioMarin ends Duchenne program, withdraws EU application for drisapersen</a></h3> <span class="secondary-label">May 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/intercept-shares-climb-on-fda-approval-of-liver-drug/420077/" class="analytics t-editors-bio-article">Intercept shares climb on FDA approval of liver drug </a></h3> <span class="secondary-label">May 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jazz-pharma-snaps-up-leukemia-drug-with-15-billion-deal-for-celator/420060/" class="analytics t-editors-bio-article">Jazz Pharma snaps up leukemia drug with $1.5 billion deal for Celator</a></h3> <span class="secondary-label">May 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-knocks-back-multiple-myeloma-drug-from-takeda/419988/" class="analytics t-editors-bio-article">EMA knocks back multiple myeloma drug from Takeda</a></h3> <span class="secondary-label">May 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-gazyva-notches-early-trial-success/419981/" class="analytics t-editors-bio-article">Roche's Gazyva notches early trial success</a></h3> <span class="secondary-label">May 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-rejects-astrazeneca-hyperkalemia-drug-boosting-competitor-relypsa/419977/" class="analytics t-editors-bio-article">FDA rejects AstraZeneca hyperkalemia drug, boosting competitor Relypsa</a></h3> <span class="secondary-label">May 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-attacks-cost-effectiveness-study-of-cancer-drug/419938/" class="analytics t-editors-bio-article">Bristol-Myers attacks cost-effectiveness study of cancer drug</a></h3> <span class="secondary-label">May 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-diabetes-drug-wins-adcomm-support-keeping-pace-with-novo/419901/" class="analytics t-editors-bio-article">Sanofi diabetes drug wins adcomm support, keeping pace with Novo</a></h3> <span class="secondary-label">May 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-hit-with-class-action-lawsuit-over-blood-testing-claims/419860/" class="analytics t-editors-bio-article">Theranos hit with class-action lawsuit over blood-testing claims</a></h3> <span class="secondary-label">May 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sarepta-fda-delays-decision-duchenne-dmd/419824/" class="analytics t-editors-bio-article">Sarepta shares jump after FDA delays decision on Duchenne drug</a></h3> <span class="secondary-label">May 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-recent-rd-setbacks-lilly-aims-to-launch-20-new-drugs-by-2023/419760/" class="analytics t-editors-bio-article">Despite recent R&D setbacks, Lilly aims to launch 20 new drugs by 2023</a></h3> <span class="secondary-label">May 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/janssens-multiple-myeloma-drug-passes-muster-in-europe/419757/" class="analytics t-editors-bio-article">Janssen's multiple myeloma drug passes muster in Europe</a></h3> <span class="secondary-label">May 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/after-setback-gsks-breo-gets-boost-from-real-world-data/419754/" class="analytics t-editors-bio-article">After setback, GSK's Breo gets boost from real-world data</a></h3> <span class="secondary-label">May 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eyeing-us-market-samsung-applies-for-approval-of-biosimilar-remicade/419742/" class="analytics t-editors-bio-article">Eyeing US market, Samsung applies for approval of biosimilar Remicade</a></h3> <span class="secondary-label">May 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-removes-warning-from-pfizer-smoking-cessation-drug/419665/" class="analytics t-editors-bio-article">EMA removes warning from Pfizer smoking cessation drug</a></h3> <span class="secondary-label">May 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ahead-of-key-panel-vote-fda-staff-raises-concerns-over-novo-diabetes-drug/419632/" class="analytics t-editors-bio-article">Ahead of key panel vote, FDA staff raises concerns over Novo diabetes drug</a></h3> <span class="secondary-label">May 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/immunotherapies-from-merck-and-bristol-myers-help-extend-life-new-data-sho/419551/" class="analytics t-editors-bio-article">Immunotherapies from Merck and Bristol-Myers help extend life, new data shows</a></h3> <span class="secondary-label">May 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-corrects-two-years-of-test-results-wsj/419550/" class="analytics t-editors-bio-article">Theranos corrects two years of test results: WSJ</a></h3> <span class="secondary-label">May 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-to-shutter-clarecastle-plant-after-it-cant-find-buyer/419526/" class="analytics t-editors-bio-article">Roche to shutter Clarecastle plant after it can't find buyer</a></h3> <span class="secondary-label">May 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-much-anticipated-immontherapy-wins-early-approval-for-bladder-cance/419477/" class="analytics t-editors-bio-article">Roche's much-anticipated immontherapy wins early approval for bladder cancer</a></h3> <span class="secondary-label">May 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/-AbbVie-Humira-patent-challenge-Coherus/419435/" class="analytics t-editors-bio-article">New patent threat looms for AbbVie's blockbuster Humira</a></h3> <span class="secondary-label">May 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-extends-lead-with-new-opdivo-indication/419360/" class="analytics t-editors-bio-article">Bristol-Myers extends lead with new Opdivo indication</a></h3> <span class="secondary-label">May 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-split-oncology-pharma-epstein/419355/" class="analytics t-editors-bio-article">Novartis splits drugs unit, pharma chief to depart </a></h3> <span class="secondary-label">May 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-asthma-drug-clears-phase-3-studies-boosting-respiratory-pipeli/419350/" class="analytics t-editors-bio-article">AstraZeneca asthma drug clears phase 3 studies, boosting respiratory pipeline</a></h3> <span class="secondary-label">May 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-unveils-gene-therapy-collaboration-with-upenn-experts/419286/" class="analytics t-editors-bio-article">Biogen unveils gene therapy collaboration with UPenn experts</a></h3> <span class="secondary-label">May 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/after-criticism-valeant-details-plans-for-hospital-discounts-on-heart-drug/419267/" class="analytics t-editors-bio-article">After criticism, Valeant details plans for hospital discounts on heart drugs</a></h3> <span class="secondary-label">May 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-generics-deal-pending-tevas-europe-portfolio-attracts-buyers/419261/" class="analytics t-editors-bio-article">With generics deal pending, Teva's Europe portfolio attracts buyers</a></h3> <span class="secondary-label">May 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-adds-eczema-drug-in-52-billion-deal-for-anacor/419256/" class="analytics t-editors-bio-article">Pfizer adds eczema drug in $5.2 billion deal for Anacor</a></h3> <span class="secondary-label">May 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/aegerion-to-plead-guilty-to-misbranding-cholesterol-drug-will-pay-40-mill/419148/" class="analytics t-editors-bio-article">Aegerion to plead guilty to misbranding cholesterol drug, will pay $40 million</a></h3> <span class="secondary-label">May 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/after-shutting-down-cancer-drug-clovis-now-facing-government-investigation/419130/" class="analytics t-editors-bio-article">After shutting down cancer drug, Clovis now facing government investigations</a></h3> <span class="secondary-label">May 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/baxter-reportedly-top-suitor-for-indian-injectables-maker/419119/" class="analytics t-editors-bio-article">Baxter reportedly top suitor for Indian injectables maker</a></h3> <span class="secondary-label">May 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amid-losses-endo-plans-cutbacks-at-par-manufacturing-facilities/419114/" class="analytics t-editors-bio-article">Amid losses, Endo plans cutbacks at Par manufacturing facilities</a></h3> <span class="secondary-label">May 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-cost-agency-rejects-bristol-myers-opdivo-for-lung-cancer/419108/" class="analytics t-editors-bio-article">U.K. cost agency rejects Bristol-Myer's Opdivo for lung cancer</a></h3> <span class="secondary-label">May 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-president-to-leave-company-as-federal-scrutiny-continues/419104/" class="analytics t-editors-bio-article">Theranos president to leave company as federal scrutiny continues</a></h3> <span class="secondary-label">May 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/colombian-diplomat-warns-of-fallout-from-novartis-patent-battle/419063/" class="analytics t-editors-bio-article">Colombian diplomat warns of fallout from Novartis patent battle</a></h3> <span class="secondary-label">May 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/drugmakers-hit-with-federal-investigations-of-pbm-contracts/418975/" class="analytics t-editors-bio-article">Drugmakers hit with federal investigations of PBM contracts</a></h3> <span class="secondary-label">May 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/india-awards-patent-to-gileads-sovaldi/418960/" class="analytics t-editors-bio-article">India awards patent to Gilead's Sovaldi</a></h3> <span class="secondary-label">May 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-plans-10-billion-stock-buyback-as-it-waits-for-teva-cash/418949/" class="analytics t-editors-bio-article">Allergan plans $10 billion stock buyback as it waits for Teva cash</a></h3> <span class="secondary-label">May 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-flags-potential-safety-risk-for-lilly-antipsychotic-drug/418944/" class="analytics t-editors-bio-article">FDA flags potential safety risk for Lilly antipsychotic drug </a></h3> <span class="secondary-label">May 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/the-sharks-are-circling-5-insights-from-the-valeant-documents/418922/" class="analytics t-editors-bio-article">'The sharks are circling:' 5 insights from the Valeant documents</a></h3> <span class="secondary-label">May 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/medicines-co-sells-off-cardiovascular-drugs-to-italys-chiesi/418860/" class="analytics t-editors-bio-article">Medicines Co. sells off cardiovascular drugs to Italy's Chiesi</a></h3> <span class="secondary-label">May 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lower-sales-of-generic-drugs-weigh-on-tevas-first-quarter-revenue/418852/" class="analytics t-editors-bio-article">Lower sales of generic drugs weigh on Teva's first-quarter revenue</a></h3> <span class="secondary-label">May 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-new-ceo-takes-over-valeant-forms-committee-to-oversee-drug-pricing/418789/" class="analytics t-editors-bio-article">As new CEO takes over, Valeant forms committee to oversee drug pricing</a></h3> <span class="secondary-label">May 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-big-pharma-circles-medivation-makes-case-for-independence/418786/" class="analytics t-editors-bio-article">As Big Pharma circles, Medivation makes case for independence </a></h3> <span class="secondary-label">May 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-reaches-agreement-with-xellia-on-troubled-manufacturing-plant/418715/" class="analytics t-editors-bio-article">FDA reaches agreement with Xellia on troubled manufacturing plant</a></h3> <span class="secondary-label">May 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biogen-spinoff-set-to-build-out-hemophilia-pipeline/418710/" class="analytics t-editors-bio-article">Biogen spinoff set to build out hemophilia pipeline</a></h3> <span class="secondary-label">May 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-threatens-medivation-board-with-hostile-bid/418704/" class="analytics t-editors-bio-article">Sanofi threatens Medivation board with hostile bid</a></h3> <span class="secondary-label">May 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Merck-Q1-sales-generic-competition-Keytruda/418697/" class="analytics t-editors-bio-article">Merck sales hit by generic competition in US, Europe</a></h3> <span class="secondary-label">May 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-medivation-acquisition-offer-xtandi/418614/" class="analytics t-editors-bio-article">Report: Pfizer considering takeover offer for sought-after Medivation </a></h3> <span class="secondary-label">May 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/Taro-keveyis-free-rare-disease-drug/418564/" class="analytics t-editors-bio-article">Israeli pharma company provides rare disease drug for free after it can't find patients</a></h3> <span class="secondary-label">May 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-revenues-surge-as-vaccines-new-drugs-rack-up-sales/418557/" class="analytics t-editors-bio-article">Pfizer revenues surge as vaccines, new drugs rack up sales</a></h3> <span class="secondary-label">May 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/boosting-focus-on-neurology-biogen-to-spin-off-hemophilia-business/418536/" class="analytics t-editors-bio-article">Boosting focus on neurology, Biogen to spin off hemophilia business</a></h3> <span class="secondary-label">May 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eagle-pharma-hits-fda-with-lawsuit-after-cancer-drug-denied-orphan-exclusiv/418474/" class="analytics t-editors-bio-article">Eagle Pharma hits FDA with lawsuit after cancer drug denied orphan exclusivity</a></h3> <span class="secondary-label">May 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gene-editing-biotech-homology-med-launches-with-44-million-in-financing/418450/" class="analytics t-editors-bio-article">Gene editing biotech Homology Med launches with $44 million in financing</a></h3> <span class="secondary-label">May 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/federal-judge-reopens-high-stakes-patent-case-between-merck-and-gilead/418389/" class="analytics t-editors-bio-article">Federal judge reopens high-stakes patent case between Merck and Gilead</a></h3> <span class="secondary-label">May 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-profits-drop-astrazeneca-trims-costs-and-sharpens-focus-on-rd/418380/" class="analytics t-editors-bio-article">As profits drop, AstraZeneca trims costs and sharpens focus on R&D</a></h3> <span class="secondary-label">April 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-ceo-pearson-set-to-bow-out-valeant-files-much-delayed-annual-report/418358/" class="analytics t-editors-bio-article">With CEO Pearson set to bow out, Valeant files much-delayed annual report</a></h3> <span class="secondary-label">April 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-new-drugs-take-hold-lilly-ramps-up-rd-spend/418305/" class="analytics t-editors-bio-article">As new drugs take hold, Lilly ramps up R&D spend</a></h3> <span class="secondary-label">April 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-board-changes-ackman/418298/" class="analytics t-editors-bio-article">Adding to changes at top, Valeant reportedly set to turn over board</a></h3> <span class="secondary-label">April 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-pressures-medivation-to-take-93-billion-bid/418287/" class="analytics t-editors-bio-article">Sanofi pressures Medivation to take $9.3 billion bid</a></h3> <span class="secondary-label">April 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-senate-hearing-pearson-ackman/418239/" class="analytics t-editors-bio-article">Valeant officials apologize to Senate panel for steep price hikes</a></h3> <span class="secondary-label">April 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-increased-prices-too-aggressively-ceo-expected-to-tell-senate-pane/418202/" class="analytics t-editors-bio-article">Valeant increased prices too aggressively, CEO expected to tell Senate panel</a></h3> <span class="secondary-label">April 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-demands-additional-studies-for-catalysts-firdapse/418145/" class="analytics t-editors-bio-article">FDA demands additional studies for Catalyst's firdapse</a></h3> <span class="secondary-label">April 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/seven-new-york-insurers-end-restrictions-on-coverage-for-hepatitis-c-drugs/418130/" class="analytics t-editors-bio-article">Seven New York insurers end restrictions on coverage for hepatitis C drugs</a></h3> <span class="secondary-label">April 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/new-drug-sales-boost-lilly-revenue-yet-profits-tumble/418125/" class="analytics t-editors-bio-article">New drug sales boost Lilly revenue, yet profits tumble</a></h3> <span class="secondary-label">April 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/despite-efforts-of-advocates-fda-panel-votes-against-sareptas-duchenne-dr/418061/" class="analytics t-editors-bio-article">Despite efforts of advocates, FDA panel votes against Sarepta's Duchenne drug</a></h3> <span class="secondary-label">April 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-names-ex-perrigo-chief-joseph-papa-as-ceo/418032/" class="analytics t-editors-bio-article">Valeant names ex-Perrigo chief Joseph Papa as CEO</a></h3> <span class="secondary-label">April 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/inside-the-development-of-venclexta-abbvies-new-leukemia-drug/417965/" class="analytics t-editors-bio-article">Inside the development of Venclexta, AbbVie's new leukemia drug </a></h3> <span class="secondary-label">April 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/adding-to-cosmetic-portfolio-allergan-buys-topokine-for-85-million/417957/" class="analytics t-editors-bio-article">Adding to cosmetic portfolio, Allergan buys Topokine for $85 million </a></h3> <span class="secondary-label">April 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazeneca-launches-massive-drug-discovery-effort-aims-to-sequence-2-mill/417939/" class="analytics t-editors-bio-article">AstraZeneca launches massive drug discovery effort, aims to sequence 2 million genomes</a></h3> <span class="secondary-label">April 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/continuing-scrutiny-fda-hits-sri-krishna-with-warning-over-serious-data/417885/" class="analytics t-editors-bio-article">Continuing scrutiny, FDA hits Sri Krishna with warning over 'serious' data violations</a></h3> <span class="secondary-label">April 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/china-investigates-3-drugmakers-for-manufacturing-violations-orders-recall/417882/" class="analytics t-editors-bio-article">China investigates 3 drugmakers for manufacturing violations, orders recall</a></h3> <span class="secondary-label">April 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-income-falls-as-key-cancer-drug-battles-generic-competition/417876/" class="analytics t-editors-bio-article">Novartis income falls as key cancer drug battles generic competition</a></h3> <span class="secondary-label">April 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bluebird-bio-gene-therapy-sees-encouraging-early-results-in-treatment-of-ra/417864/" class="analytics t-editors-bio-article">Bluebird Bio gene therapy sees encouraging early results in treatment of rare brain disease</a></h3> <span class="secondary-label">April 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/nih-suspends-work-at-two-facilities-including-t-cell-research/417745/" class="analytics t-editors-bio-article">NIH suspends work at two facilities, including T-cell research</a></h3> <span class="secondary-label">April 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-shows-promise-in-head-neck-cancers/417723/" class="analytics t-editors-bio-article">Bristol-Myers' Opdivo shows promise in head, neck cancers</a></h3> <span class="secondary-label">April 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-beats-q1-expectations-on-strong-oncology-sales/417717/" class="analytics t-editors-bio-article">Roche beats Q1 expectations on strong oncology sales</a></h3> <span class="secondary-label">April 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-new-studies-boehringer-and-lilly-to-pit-diabetes-drug-against-heart-f/417709/" class="analytics t-editors-bio-article">With new studies, Boehringer and Lilly to pit diabetes drug against heart failure</a></h3> <span class="secondary-label">April 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/theranos-reportedly-facing-new-federal-investigations/417695/" class="analytics t-editors-bio-article">Theranos reportedly facing new federal investigations</a></h3> <span class="secondary-label">April 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-gets-boost-from-long-term-survival-data/417614/" class="analytics t-editors-bio-article">Bristol-Myers' Opdivo gets boost from long-term survival data</a></h3> <span class="secondary-label">April 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/review-of-nci-facilities-halts-patient-enrollment-in-kite-t-cell-studies-1/417568/" class="analytics t-editors-bio-article">Review of NCI facilities halts patient enrollment in Kite T-cell studies</a></h3> <span class="secondary-label">April 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/report-astrazeneca-considering-bid-for-cancer-biotech-medivation-1/417563/" class="analytics t-editors-bio-article">Report: AstraZeneca considering bid for cancer biotech Medivation</a></h3> <span class="secondary-label">April 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/further-downgrade-to-valeant-ratings-reportedly-could-trigger-forced-sellin/417533/" class="analytics t-editors-bio-article">Further downgrade to Valeant ratings reportedly could trigger forced selling</a></h3> <span class="secondary-label">April 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/swiss-company-lonza-group-seeking-to-acquire-cro-catalent-report/417469/" class="analytics t-editors-bio-article">Swiss company Lonza Group seeking to acquire CRO Catalent: report</a></h3> <span class="secondary-label">April 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-advocates-for-adoption-of-speedier-drug-manufacturing-technique/417464/" class="analytics t-editors-bio-article">FDA advocates for adoption of speedier drug manufacturing technique </a></h3> <span class="secondary-label">April 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/report-us-drug-spending-hit-310-billion-last-year/417449/" class="analytics t-editors-bio-article">Report: U.S. drug spending hit $310 billion last year </a></h3> <span class="secondary-label">April 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/regulator-proposes-2-year-ban-of-theranos-founder-elizabeth-holmes/417375/" class="analytics t-editors-bio-article">Regulator proposes 2-year ban of Theranos founder Elizabeth Holmes</a></h3> <span class="secondary-label">April 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biosimilars-gain-momentum-and-pharma-leaders-are-noticing-1/417366/" class="analytics t-editors-bio-article">Biosimilars gain momentum — and pharma leaders are noticing</a></h3> <span class="secondary-label">April 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/large-bondholder-hits-valeant-with-default-notice/417299/" class="analytics t-editors-bio-article">Large bondholder hits Valeant with default notice</a></h3> <span class="secondary-label">April 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clovis-lung-cancer-drug-fails-to-impress-fda-panel/417297/" class="analytics t-editors-bio-article">Clovis' lung cancer drug fails to impress FDA panel</a></h3> <span class="secondary-label">April 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/japanese-genomic-analysis-characterizes-liver-cancer-into-six-types-1/417288/" class="analytics t-editors-bio-article">Japanese genomic analysis characterizes liver cancer into six types</a></h3> <span class="secondary-label">April 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/crispr-biotech-intellia-strikes-licensing-deal-with-regeneron-readies-ipo-1/417229/" class="analytics t-editors-bio-article">CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO</a></h3> <span class="secondary-label">April 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/life-after-shkreli-kalobios-promises-affordable-drugs-no-price-gouging-1/417210/" class="analytics t-editors-bio-article">Life after Shkreli: KaloBios promises affordable drugs, no 'price gouging'</a></h3> <span class="secondary-label">April 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-and-roche-team-wins-fda-approval-for-leukemia-drug/417203/" class="analytics t-editors-bio-article">AbbVie and Roche team wins FDA approval for leukemia drug</a></h3> <span class="secondary-label">April 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roches-anti-pdl1-immunotherapy-granted-fast-track-status-1/417195/" class="analytics t-editors-bio-article">Roche's anti-PDL1 immunotherapy granted fast track status</a></h3> <span class="secondary-label">April 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-board-asks-ceo-pearson-to-cooperate-with-senate-panel-subpoena/417162/" class="analytics t-editors-bio-article">Valeant board asks CEO Pearson to cooperate with Senate panel subpoena</a></h3> <span class="secondary-label">April 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amid-questions-on-accuracy-of-blood-tests-theranos-bulks-up-its-medical-bo/417125/" class="analytics t-editors-bio-article">Amid questions on accuracy of blood tests, Theranos bulks up its medical board</a></h3> <span class="secondary-label">April 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/after-alzheimers-drug-passes-safety-review-astrazeneca-and-lilly-push-int-1/417117/" class="analytics t-editors-bio-article">After Alzheimer's drug passes safety review, AstraZeneca and Lilly push into Phase 3</a></h3> <span class="secondary-label">April 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/inspections-by-fda-hurting-indian-drug-exports-says-dr-reddys-chairman/417052/" class="analytics t-editors-bio-article">Inspections by FDA hurting Indian drug exports, says Dr. Reddy's chairman</a></h3> <span class="secondary-label">April 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/why-partnerships-are-crucial-for-pushing-vaccine-rd-forward/417050/" class="analytics t-editors-bio-article">Why partnerships are crucial for pushing vaccine R&D forward</a></h3> <span class="secondary-label">April 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/allergan-snaps-up-rights-to-alzheimers-drugs-in-deal-with-heptares/417035/" class="analytics t-editors-bio-article">Allergan snaps up rights to Alzheimer's drugs in deal with Heptares</a></h3> <span class="secondary-label">April 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lenders-give-valeant-a-reprieve-agree-to-extend-deadline-for-filing-annual-1/417032/" class="analytics t-editors-bio-article">Lenders give Valeant a reprieve, agree to extend deadline for filing annual report</a></h3> <span class="secondary-label">April 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/after-merger-with-pfizer-implodes-allergans-acquisition-options-open-up/416967/" class="analytics t-editors-bio-article">After merger with Pfizer implodes, Allergan's acquisition options open up</a></h3> <span class="secondary-label">April 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-calls-off-160-billion-merger-with-allergan/416924/" class="analytics t-editors-bio-article">Pfizer calls off $160 billion merger with Allergan</a></h3> <span class="secondary-label">April 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/remicade-copy-clears-fda-becomes-second-biosim-to-win-approval-in-us/416879/" class="analytics t-editors-bio-article">Remicade copy clears FDA, becomes second biosim to win approval in U.S.</a></h3> <span class="secondary-label">April 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-phase-3-collaboration-merck-and-pfizer-testing-pdl1tki-combo/416870/" class="analytics t-editors-bio-article">In phase 3 collaboration, Merck and Pfizer testing PDL1/TKI combo</a></h3> <span class="secondary-label">April 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-panel-concludes-philidor-investigation-finds-no-more-misstatements/416863/" class="analytics t-editors-bio-article">Valeant panel concludes Philidor investigation, finds no more misstatements</a></h3> <span class="secondary-label">April 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/new-us-inversion-rules-could-wreck-pfizer-allergan-deal/416861/" class="analytics t-editors-bio-article">New US inversion rules could wreck Pfizer-Allergan deal</a></h3> <span class="secondary-label">April 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/report-valeant-cuts-sales-force-for-female-libido-drug/416821/" class="analytics t-editors-bio-article">Report: Valeant cuts sales force for female libido drug</a></h3> <span class="secondary-label">April 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gileads-new-hiv-formulation-continues-success-with-fda-approval-of-descovy/416797/" class="analytics t-editors-bio-article">Gilead's new HIV formulation continues success with FDA approval of Descovy</a></h3> <span class="secondary-label">April 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/study-shows-no-clinical-benefit-from-lillys-failed-cholesterol-drug/416753/" class="analytics t-editors-bio-article">Study shows no clinical benefit from Lilly's failed cholesterol drug</a></h3> <span class="secondary-label">April 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-gene-therapy-for-rare-immune-disorder-wins-ema-approval/416749/" class="analytics t-editors-bio-article">GSK gene therapy for rare immune disorder wins EMA approval</a></h3> <span class="secondary-label">April 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/samsung-bioepis-biosim-of-remicade-clears-regulatory-hurdle-in-eu/416713/" class="analytics t-editors-bio-article">Samsung Bioepis' biosim of Remicade clears regulatory hurdle in EU</a></h3> <span class="secondary-label">April 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ftc-alleges-endo-struck-illegal-deals-to-delay-release-of-generic-drugs/416709/" class="analytics t-editors-bio-article">FTC alleges Endo struck illegal deals to delay release of generic drugs</a></h3> <span class="secondary-label">April 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/canadian-securities-regulator-issues-cease-trade-orders-to-valeant-manageme/416704/" class="analytics t-editors-bio-article">Canadian securities regulator issues cease trade orders to Valeant management</a></h3> <span class="secondary-label">April 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-aging-blockbusters-come-off-patent-new-opportunities-emerge-for-biosim/416639/" class="analytics t-editors-bio-article">As aging blockbusters come off patent, new opportunities emerge for biosim manufacturers</a></h3> <span class="secondary-label">March 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-quest-to-expand-diabetes-market-share-novo-breaks-ground-on-18b-us/416634/" class="analytics t-editors-bio-article">In quest to expand diabetes market share, Novo breaks ground on $1.8b U.S. plant </a></h3> <span class="secondary-label">March 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-wont-file-drug-patents-in-low-income-countries/416631/" class="analytics t-editors-bio-article">GSK won't file drug patents in low-income countries</a></h3> <span class="secondary-label">March 31, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/indian-drug-regulator-to-begin-surprise-inspections-at-manufacturing-sites/416556/" class="analytics t-editors-bio-article">Indian drug regulator to begin surprise inspections at manufacturing sites</a></h3> <span class="secondary-label">March 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ftc-asks-pfizer-allergan-for-more-details-on-proposed-mega-merger/416555/" class="analytics t-editors-bio-article">FTC asks Pfizer, Allergan for more details on proposed mega-merger </a></h3> <span class="secondary-label">March 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/with-deadline-looming-valeant-asks-lenders-for-more-time-to-file-report/416538/" class="analytics t-editors-bio-article">With deadline looming, Valeant asks lenders for more time to file report</a></h3> <span class="secondary-label">March 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cambridge-based-aveo-settles-fraud-charges-with-sec-for-4-million/416488/" class="analytics t-editors-bio-article">Cambridge-based Aveo settles fraud charges with SEC for $4 million </a></h3> <span class="secondary-label">March 30, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-panel-says-benefits-outweigh-risks-for-acadias-parkinsons-drug/416485/" class="analytics t-editors-bio-article">FDA panel says benefits outweigh risks for Acadia's Parkinson's drug</a></h3> <span class="secondary-label">March 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sun-pharma-expands-presence-in-japan-with-293-million-deal-for-novartis-dr/416480/" class="analytics t-editors-bio-article">Sun Pharma expands presence in Japan with $293 million deal for Novartis drugs</a></h3> <span class="secondary-label">March 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanders-other-lawmakers-urge-nih-to-consider-patent-override-on-cancer-dru/416397/" class="analytics t-editors-bio-article">Sanders, other lawmakers urge NIH to consider patent override on cancer drug</a></h3> <span class="secondary-label">March 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/new-phase-2-data-boosts-prospects-for-alders-migraine-drug/416371/" class="analytics t-editors-bio-article">New phase 2 data boosts prospects for Alder's migraine drug</a></h3> <span class="secondary-label">March 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/spending-on-vertexs-kalydeco-consumed-86-of-scottish-rare-disease-funds/416362/" class="analytics t-editors-bio-article">Spending on Vertex's Kalydeco consumed 86% of Scottish rare disease fund's budget</a></h3> <span class="secondary-label">March 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sprout-investors-reportedly-allege-valeant-overpriced-addyi/416317/" class="analytics t-editors-bio-article">Sprout investors reportedly allege Valeant overpriced Addyi</a></h3> <span class="secondary-label">March 27, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-to-pay-merck-200-million-in-damages-for-hep-c-patents/416288/" class="analytics t-editors-bio-article">Gilead to pay Merck $200 million in damages for Hep C patents</a></h3> <span class="secondary-label">March 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/patent-case-in-india-highlights-tensions-between-public-health-protecting/416279/" class="analytics t-editors-bio-article">Patent case in India highlights tensions between public health, protecting innovation</a></h3> <span class="secondary-label">March 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/head-of-valeants-largest-investor-retires-as-drugmakers-troubles-hit-fund/416224/" class="analytics t-editors-bio-article">Head of Valeant's largest investor retires as drugmaker's troubles hit fund</a></h3> <span class="secondary-label">March 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/a-month-after-fda-spurned-dmd-drug-ptc-laying-off-18-of-workforce/416195/" class="analytics t-editors-bio-article">A month after FDA spurned DMD drug, PTC laying off 18% of workforce</a></h3> <span class="secondary-label">March 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-major-stroke-study-astrazenecas-brilinta-fails-to-beat-aspirin/416183/" class="analytics t-editors-bio-article">In major stroke study, AstraZeneca's Brilinta fails to beat aspirin</a></h3> <span class="secondary-label">March 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/merck-wins-major-victory-in-hep-c-patent-case-against-gilead/416118/" class="analytics t-editors-bio-article">Merck wins major victory in hep C patent case against Gilead</a></h3> <span class="secondary-label">March 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/eli-lillys-ixekizumab-gets-green-light-from-fda/416113/" class="analytics t-editors-bio-article">Eli Lilly's ixekizumab gets green light from FDA</a></h3> <span class="secondary-label">March 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-stock-crashed-valeants-largest-shareholder-reportedly-sold-15m-shares/416105/" class="analytics t-editors-bio-article">As stock crashed, Valeant's largest shareholder reportedly sold 1.5m shares</a></h3> <span class="secondary-label">March 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-response-to-crisis-fda-mandates-new-warnings-for-opioid-painkillers/416095/" class="analytics t-editors-bio-article">In response to crisis, FDA mandates new warnings for opioid painkillers</a></h3> <span class="secondary-label">March 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/citing-improper-conduct-valeant-attempts-to-oust-former-cfo-from-board/416026/" class="analytics t-editors-bio-article">Citing 'improper conduct,' Valeant attempts to oust former CFO from board</a></h3> <span class="secondary-label">March 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeants-pearson-will-step-down-as-ceo-ackman-joins-board/416000/" class="analytics t-editors-bio-article">Valeant's Pearson will step down as CEO; Ackman joins Board</a></h3> <span class="secondary-label">March 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-cost-regulator-confirms-final-approval-for-novartis-entresto/415953/" class="analytics t-editors-bio-article">U.K. cost regulator confirms final approval for Novartis' Entresto </a></h3> <span class="secondary-label">March 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/johnson-johnsons-psoriasis-drug-stelara-succeeds-in-phase-3/415923/" class="analytics t-editors-bio-article">Johnson & Johnson's psoriasis drug Stelara succeeds in Phase 3 </a></h3> <span class="secondary-label">March 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-new-deal-kite-pharma-partnering-with-roche-on-cancer-immunotherapy/415921/" class="analytics t-editors-bio-article">In new deal, Kite Pharma partnering with Roche on cancer immunotherapy </a></h3> <span class="secondary-label">March 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mckesson-laying-off-1600-employees/415857/" class="analytics t-editors-bio-article">McKesson laying off 1,600 employees</a></h3> <span class="secondary-label">March 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/scientists-develop-new-type-of-stem-cell-with-only-half-a-genome/415852/" class="analytics t-editors-bio-article">Scientists develop new type of stem cell with only half a genome</a></h3> <span class="secondary-label">March 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amgen-signs-flexible-manufacturing-agreement-with-cmo-patheon/415850/" class="analytics t-editors-bio-article">Amgen signs 'flexible manufacturing agreement' with CMO Patheon </a></h3> <span class="secondary-label">March 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gsk-head-andrew-witty-to-step-down-in-spring-2017/415841/" class="analytics t-editors-bio-article">GSK head Andrew Witty to step down in spring 2017</a></h3> <span class="secondary-label">March 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/jury-rules-in-favor-of-amgen-in-pcsk9-patent-fight/415761/" class="analytics t-editors-bio-article">Jury rules in favor of Amgen in PCSK9 patent fight</a></h3> <span class="secondary-label">March 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/after-forecast-cut-valeant-stock-collapses-as-investors-head-for-the-exits/415750/" class="analytics t-editors-bio-article">After forecast cut, Valeant stock collapses as investors head for the exits</a></h3> <span class="secondary-label">March 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/as-ema-investigates-gilead-halts-six-clinical-trials-of-cancer-drug/415703/" class="analytics t-editors-bio-article">As EMA investigates, Gilead halts six clinical trials of cancer drug</a></h3> <span class="secondary-label">March 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-growth-in-overall-us-drug-spending-slowed-in-2015/415673/" class="analytics t-editors-bio-article">Express Scripts: Growth in overall U.S. drug spending slowed in 2015</a></h3> <span class="secondary-label">March 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/tevas-405-billion-generics-deal-with-allergan-hits-ftc-snag/415670/" class="analytics t-editors-bio-article">Teva's $40.5 billion generics deal with Allergan hits FTC snag</a></h3> <span class="secondary-label">March 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/roche-signs-potential-1-billion-cancer-immunotherapy-deal-with-cambridge-b/415668/" class="analytics t-editors-bio-article">Roche signs potential $1 billion cancer immunotherapy deal with Cambridge biotech</a></h3> <span class="secondary-label">March 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-cuts-2016-revenue-projections-by-15-billion/415656/" class="analytics t-editors-bio-article">Valeant cuts 2016 revenue projections by $1.5 billion</a></h3> <span class="secondary-label">March 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amid-investor-criticism-astrazeneca-considers-link-between-executive-pay-a/415580/" class="analytics t-editors-bio-article">Amid investor criticism, AstraZeneca considers link between executive pay and revenue goal</a></h3> <span class="secondary-label">March 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/doctors-without-borders-moves-to-block-pfizer-patent-in-india/415508/" class="analytics t-editors-bio-article">Doctors Without Borders moves to block Pfizer patent in India</a></h3> <span class="secondary-label">March 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofis-sarilumab-bests-blockbuster-humira-in-phase-3-study/415507/" class="analytics t-editors-bio-article">Sanofi's sarilumab bests blockbuster Humira in Phase 3 study </a></h3> <span class="secondary-label">March 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ec-approves-tevas-405b-deal-for-allergan-generics-arm/415354/" class="analytics t-editors-bio-article">EC approves Teva's $40.5B deal for Allergan generics arm</a></h3> <span class="secondary-label">March 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/house-oversight-committee-presses-valeant-on-details-of-withheld-documents/415446/" class="analytics t-editors-bio-article">House Oversight committee presses Valeant on details of withheld documents</a></h3> <span class="secondary-label">March 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/first-generic-version-of-viagra-in-the-us-approved-by-fda/415432/" class="analytics t-editors-bio-article">First generic version of Viagra in the U.S. approved by FDA</a></h3> <span class="secondary-label">March 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/death-from-french-drug-trial-likely-due-to-high-doses-of-compound/415428/" class="analytics t-editors-bio-article">Death from French drug trial likely due to high doses of compound </a></h3> <span class="secondary-label">March 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/senate-bill-adding-zika-to-priority-review-program-highlights-rd-incentive/415419/" class="analytics t-editors-bio-article">Senate bill adding Zika to priority review program highlights R&D incentives</a></h3> <span class="secondary-label">March 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/va-broadens-hep-c-coverage-to-all-veterans-not-just-the-sickest/415412/" class="analytics t-editors-bio-article">VA broadens Hep C coverage to all veterans, not just the sickest</a></h3> <span class="secondary-label">March 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-accepts-new-keytruda-data-opening-door-for-wider-indication/415324/" class="analytics t-editors-bio-article">FDA accepts new Keytruda data, opening door for wider indication</a></h3> <span class="secondary-label">March 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/report-theranos-continued-blood-tests-even-as-quality-checks-revealed-flaw/415323/" class="analytics t-editors-bio-article">Report: Theranos continued blood tests even as quality checks revealed flaws</a></h3> <span class="secondary-label">March 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hoping-for-rebound-valeant-adds-three-new-members-to-board/415319/" class="analytics t-editors-bio-article">Hoping for rebound, Valeant adds three new members to board</a></h3> <span class="secondary-label">March 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/us-prescription-drug-spending-increases-to-an-estimated-457-billion-in-201/415315/" class="analytics t-editors-bio-article">US prescription drug spending increases to an estimated $457 billion in 2015 </a></h3> <span class="secondary-label">March 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cms-proposes-overhaul-to-part-b-drug-reimbursement/415247/" class="analytics t-editors-bio-article">CMS proposes overhaul to Part B drug reimbursement </a></h3> <span class="secondary-label">March 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/india-will-reportedly-refrain-from-issuing-compulsory-drug-licenses/415245/" class="analytics t-editors-bio-article">India will reportedly refrain from issuing compulsory drug licenses</a></h3> <span class="secondary-label">March 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ending-20-year-partnership-sanofi-and-merck-close-down-joint-vaccines-vent/415233/" class="analytics t-editors-bio-article">Ending 20-year partnership, Sanofi and Merck close down joint vaccines venture</a></h3> <span class="secondary-label">March 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-novartis-sanofi-lose-big-on-venezuelan-bonds/415171/" class="analytics t-editors-bio-article">Bayer, Novartis, Sanofi lose big on Venezuelan bonds</a></h3> <span class="secondary-label">March 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ema-debuts-new-program-to-speed-up-review-of-innovative-drugs/415165/" class="analytics t-editors-bio-article">EMA debuts new program to speed up review of innovative drugs</a></h3> <span class="secondary-label">March 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/in-high-profile-failure-celldexs-cancer-vaccine-crashes-in-phase-3/415158/" class="analytics t-editors-bio-article">In high-profile failure, Celldex's cancer vaccine crashes in phase 3</a></h3> <span class="secondary-label">March 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/abbvie-paying-boehringer-595m-upfront-to-gain-access-to-psoriasis-drug/415153/" class="analytics t-editors-bio-article">AbbVie paying Boehringer $595M upfront to gain access to psoriasis drug </a></h3> <span class="secondary-label">March 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/janssen-abbvies-imbruvica-approved-by-fda-for-first-line-treatment-of-cll/415079/" class="analytics t-editors-bio-article">Janssen, AbbVie's Imbruvica approved by FDA for first line treatment of CLL </a></h3> <span class="secondary-label">March 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/moodys-downgrades-pharma-industry-outlook-cites-lower-pricing/415074/" class="analytics t-editors-bio-article">Moody's downgrades pharma industry outlook, cites lower pricing</a></h3> <span class="secondary-label">March 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-autolus-reels-in-40-million-for-car-t-development/415068/" class="analytics t-editors-bio-article">UK Autolus reels in £40 million for CAR-T development</a></h3> <span class="secondary-label">March 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/much-anticipated-trial-shows-novos-victoza-reduces-cv-risk/415064/" class="analytics t-editors-bio-article">Much-anticipated trial shows Novo's Victoza reduces CV risk </a></h3> <span class="secondary-label">March 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kite-juno-ramping-up-commercial-manufacturing-capacity-for-car-t/414994/" class="analytics t-editors-bio-article">Kite, Juno ramping up commercial manufacturing capacity for CAR-T</a></h3> <span class="secondary-label">March 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-dermatology-exec-resigns-company-cites-personal-reasons/414988/" class="analytics t-editors-bio-article">Valeant dermatology exec resigns, company cites 'personal reasons' </a></h3> <span class="secondary-label">March 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-unimpressed-by-insulin-data-on-novos-tresiba/414981/" class="analytics t-editors-bio-article">Express Scripts unimpressed by insulin data on Novo's Tresiba</a></h3> <span class="secondary-label">March 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-opposes-re-authorization-of-pediatric-priority-review-program-gao-repo/414977/" class="analytics t-editors-bio-article">FDA opposes re-authorization of pediatric priority review program: GAO report</a></h3> <span class="secondary-label">March 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/animated-drug-ads-prompt-fda-study-into-effect-on-consumer-behavior/414896/" class="analytics t-editors-bio-article">Animated drug ads prompt FDA study into effect on consumer behavior</a></h3> <span class="secondary-label">March 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-cost-regulator-rejects-promising-cancer-med-imbruvica/414889/" class="analytics t-editors-bio-article">UK cost regulator rejects promising cancer med Imbruvica</a></h3> <span class="secondary-label">March 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/second-taf-based-hiv-treatment-from-gilead-wins-fda-approval/414820/" class="analytics t-editors-bio-article">Second TAF-based HIV treatment from Gilead wins FDA approval </a></h3> <span class="secondary-label">March 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/phrma-sues-to-challenge-ohio-ballot-initiative-limiting-drug-prices/414817/" class="analytics t-editors-bio-article">PhRMA sues to challenge Ohio ballot initiative limiting drug prices</a></h3> <span class="secondary-label">March 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-exelixis-scores-200m-from-ipsen-for-cancer-drug-rights/414809/" class="analytics t-editors-bio-article">Biotech Exelixis scores $200M from Ipsen for cancer drug rights</a></h3> <span class="secondary-label">March 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/hearings-begin-in-india-on-validity-of-gilead-patent-for-hep-c-med/414745/" class="analytics t-editors-bio-article">Hearings begin in India on validity of Gilead patent for hep C med</a></h3> <span class="secondary-label">Feb. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/on-the-heels-of-ceos-return-valeant-under-new-investigation-by-the-sec/414727/" class="analytics t-editors-bio-article">On the heels of CEO's return, Valeant under new investigation by the SEC</a></h3> <span class="secondary-label">Feb. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amid-calls-for-breakup-glaxo-reportedly-begins-search-for-successor-to-ceo/414715/" class="analytics t-editors-bio-article">Amid calls for breakup, Glaxo reportedly begins search for successor to CEO Witty</a></h3> <span class="secondary-label">Feb. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeants-pearson-returns-from-medical-leave-resumes-post-as-ceo/414709/" class="analytics t-editors-bio-article">Valeant's Pearson returns from medical leave, resumes post as CEO</a></h3> <span class="secondary-label">Feb. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gileads-new-hiv-combo-drug-inches-closer-to-eu-approval/414635/" class="analytics t-editors-bio-article">Gilead's new HIV combo drug inches closer to EU approval</a></h3> <span class="secondary-label">Feb. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/dna-sequencer-illumina-sues-competitor-over-nanopore-patents/414572/" class="analytics t-editors-bio-article">DNA sequencer Illumina sues competitor over nanopore patents</a></h3> <span class="secondary-label">Feb. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/european-pharma-industry-warns-against-brexit-urges-britain-to-remain-in/414562/" class="analytics t-editors-bio-article">European pharma industry warns against 'Brexit,' urges Britain to remain in EU</a></h3> <span class="secondary-label">Feb. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/first-human-trial-of-optogenetics-to-treat-blindness-set-to-launch/414561/" class="analytics t-editors-bio-article">First human trial of optogenetics to treat blindness set to launch</a></h3> <span class="secondary-label">Feb. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kalobios-asking-bankruptcy-court-approval-to-buy-rights-to-chagas-drug/414546/" class="analytics t-editors-bio-article">KaloBios asking bankruptcy court approval to buy rights to Chagas drug</a></h3> <span class="secondary-label">Feb. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/senate-confirms-califf-as-fda-commissioner-by-an-89-4-vote/414456/" class="analytics t-editors-bio-article">Senate confirms Califf as FDA commissioner by an 89-4 vote</a></h3> <span class="secondary-label">Feb. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/ptc-stock-falls-off-a-cliff-after-biotech-slapped-with-fda-refusal-to-file/414453/" class="analytics t-editors-bio-article">PTC stock falls off a cliff after biotech slapped with FDA 'refusal to file'</a></h3> <span class="secondary-label">Feb. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/7-big-pharma-companies-sign-on-to-parkinsons-development-group/414448/" class="analytics t-editors-bio-article">7 big pharma companies sign on to Parkinson's development group</a></h3> <span class="secondary-label">Feb. 24, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/how-the-opioid-crisis-convinced-these-senators-to-oppose-advancing-califfs/414374/" class="analytics t-editors-bio-article">How the opioid crisis convinced these senators to oppose advancing Califf's nomination, in charts</a></h3> <span class="secondary-label">Feb. 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-chief-nominee-califf-likely-to-be-confirmed-after-clearing-key-senate-v/414290/" class="analytics t-editors-bio-article">FDA chief nominee Califf likely to be confirmed after clearing key Senate vote</a></h3> <span class="secondary-label">Feb. 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cvs-reports-dramatic-drop-in-rx-spending-growth-after-2014s-double-digit-s/414367/" class="analytics t-editors-bio-article">CVS reports dramatic drop in Rx spending growth after 2014's double-digit spike</a></h3> <span class="secondary-label">Feb. 23, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-broad-researchers-find-hope-in-potential-gene-target-for-intracta/414286/" class="analytics t-editors-bio-article">Novartis, Broad researchers find hope in potential gene target for intractable cancers</a></h3> <span class="secondary-label">Feb. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sandoz-to-supreme-court-dont-let-branded-drugmakers-have-extra-leg-up-on/414204/" class="analytics t-editors-bio-article">Sandoz to Supreme Court: Don't let branded drugmakers have extra leg up on biosims</a></h3> <span class="secondary-label">Feb. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sun-pharma-to-seek-re-inspection-of-non-compliant-halol-plant/414135/" class="analytics t-editors-bio-article">Sun Pharma to seek re-inspection of non-compliant Halol plant</a></h3> <span class="secondary-label">Feb. 18, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-refusal-to-file-letter-sends-catalyst-tumbling/414051/" class="analytics t-editors-bio-article">FDA 'refusal to file' letter sends Catalyst tumbling</a></h3> <span class="secondary-label">Feb. 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/new-emotional-bio-ad-highlights-innovation-in-effort-push-back-on-pricing/414043/" class="analytics t-editors-bio-article">New, emotional BIO ad highlights innovation in effort push back on pricing critics</a></h3> <span class="secondary-label">Feb. 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/next-gen-t-cell-cancer-therapy-hopes-buoyed-by-promising-new-data/414039/" class="analytics t-editors-bio-article">Next-gen T-cell cancer therapy hopes buoyed by promising new data</a></h3> <span class="secondary-label">Feb. 17, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/looking-ahead-at-orphan-drugs-future-more-breakthroughs-exploding-sales/413974/" class="analytics t-editors-bio-article">Looking ahead at orphan drugs' future: More breakthroughs, exploding sales</a></h3> <span class="secondary-label">Feb. 16, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/disappointment-for-incyte-as-phase-3-failure-prompts-halt-on-jakafi-solid-t/413855/" class="analytics t-editors-bio-article">Disappointment for Incyte as phase 3 failure prompts halt on Jakafi solid tumor trials</a></h3> <span class="secondary-label">Feb. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/update-sandoz-continues-biosim-streak-acquires-rights-to-pfizers-remicad/413793/" class="analytics t-editors-bio-article">Update: Sandoz continues biosim streak, acquires rights to Pfizer's Remicade copy in Europe</a></h3> <span class="secondary-label">Feb. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/report-us-cmo-market-set-to-rebound-as-foreign-quality-concerns-grow/413784/" class="analytics t-editors-bio-article">Report: US CMO market set to rebound as foreign quality concerns grow</a></h3> <span class="secondary-label">Feb. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/from-hit-to-candidate-inside-sanofis-massive-compound-sharing-agreement/413693/" class="analytics t-editors-bio-article">From 'hit' to candidate: Inside Sanofi's massive compound sharing agreement with AZ</a></h3> <span class="secondary-label">Feb. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/imprimis-marches-on-with-price-cut-strategy-will-offer-cheaper-version-of/413776/" class="analytics t-editors-bio-article">Imprimis marches on with price cut strategy, will offer cheaper version of Retrophin's kidney stone med</a></h3> <span class="secondary-label">Feb. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/cms-pulls-memo-detailing-possible-changes-to-medicares-drug-reimbursements/413678/" class="analytics t-editors-bio-article">CMS pulls memo detailing possible changes to Medicare's drug reimbursements for docs</a></h3> <span class="secondary-label">Feb. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/juno-ceo-cfo-snag-bonuses-after-1-billion-celgene-deal/413675/" class="analytics t-editors-bio-article">Juno CEO, CFO snag bonuses after $1 billion Celgene deal </a></h3> <span class="secondary-label">Feb. 10, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-strikes-rare-p4p-deals-with-aetna-cigna-will-price-heart-med-ba/413591/" class="analytics t-editors-bio-article">Novartis strikes rare P4P deals with Aetna & Cigna, will price heart med based on outcomes</a></h3> <span class="secondary-label">Feb. 9, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/obama-asks-congress-for-18-billion-to-counter-zika-ahead-of-mosquito-seas/413516/" class="analytics t-editors-bio-article">Obama asks Congress for $1.8 billion to counter Zika ahead of mosquito season</a></h3> <span class="secondary-label">Feb. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/an-indian-biotech-is-already-developing-two-zika-vaccine-candidates/413508/" class="analytics t-editors-bio-article">An Indian biotech is already developing two Zika vaccine candidates</a></h3> <span class="secondary-label">Feb. 8, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/la-county-doctor-sentenced-to-30-years-to-life-for-over-prescribing-addicti/413433/" class="analytics t-editors-bio-article">LA county doctor sentenced to 30 years to life for over-prescribing addictive drugs</a></h3> <span class="secondary-label">Feb. 5, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-califf-to-overhaul-opioid-approval-process-following-intense-public-pr/413364/" class="analytics t-editors-bio-article">FDA, Califf to overhaul opioid approval process following intense public pressure</a></h3> <span class="secondary-label">Feb. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-to-funnel-160-million-into-clinical-research-infrastructure/413348/" class="analytics t-editors-bio-article">UK to funnel $160 million into clinical research infrastructure</a></h3> <span class="secondary-label">Feb. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/astrazenecas-potential-lung-cancer-blockbuster-nabs-eu-approval/413343/" class="analytics t-editors-bio-article">AstraZeneca's potential lung cancer blockbuster nabs EU approval</a></h3> <span class="secondary-label">Feb. 4, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-hunting-for-deals-as-q4-earnings-beat-expectations/413258/" class="analytics t-editors-bio-article">Gilead hunting for deals as Q4 earnings beat expectations</a></h3> <span class="secondary-label">Feb. 3, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/damaging-house-memos-reveal-calculated-drug-price-increases-at-turing-vale/413175/" class="analytics t-editors-bio-article">Damaging House memos reveal calculated drug price increases at Turing, Valeant</a></h3> <span class="secondary-label">Feb. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/sanofi-reportedly-planning-to-cut-600-jobs-over-3-years-in-france/413169/" class="analytics t-editors-bio-article">Sanofi reportedly planning to cut 600 jobs over 3 years in France</a></h3> <span class="secondary-label">Feb. 2, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/who-declares-zika-a-global-health-emergency-calls-for-greater-collaboratio/413101/" class="analytics t-editors-bio-article">WHO declares Zika a global health emergency, calls for greater collaboration</a></h3> <span class="secondary-label">Feb. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-hits-back-at-clintons-predatory-pricing-accusations/413081/" class="analytics t-editors-bio-article">Valeant hits back at Clinton's 'predatory pricing' accusations</a></h3> <span class="secondary-label">Feb. 1, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/senators-manchin-ayotte-join-growing-opposition-to-califf-fda-nomination/413008/" class="analytics t-editors-bio-article">Senators Manchin, Ayotte join growing opposition to Califf FDA nomination </a></h3> <span class="secondary-label">Jan. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/looking-ahead-at-lillys-2016-prospects-after-a-challenging-2015/413006/" class="analytics t-editors-bio-article">Looking ahead at Lilly's 2016 prospects after a challenging 2015</a></h3> <span class="secondary-label">Jan. 29, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-recalls-3-lots-of-lyrica-after-heat-damage/412931/" class="analytics t-editors-bio-article">Pfizer recalls 3 lots of Lyrica after heat damage</a></h3> <span class="secondary-label">Jan. 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/who-warns-of-zikas-explosive-spread-convenes-emergency-committee/412925/" class="analytics t-editors-bio-article">WHO warns of Zika's 'explosive spread,' convenes emergency committee</a></h3> <span class="secondary-label">Jan. 28, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-titans-seek-out-tech-partnerships-to-bring-big-data-to-healthcare/412774/" class="analytics t-editors-bio-article">Pharma titans seek out tech partnerships to bring big data to healthcare</a></h3> <span class="secondary-label">Jan. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/akashi-suspends-duchenne-trial-in-another-blow-to-treatment-hopes/412773/" class="analytics t-editors-bio-article">Akashi suspends Duchenne trial in another blow to treatment hopes</a></h3> <span class="secondary-label">Jan. 26, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-opdivo-notches-two-key-regulatory-victories-in-us-uk/412660/" class="analytics t-editors-bio-article">Bristol-Myers' Opdivo notches two key regulatory victories in US, UK</a></h3> <span class="secondary-label">Jan. 25, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/powerhouse-pharma-coalition-promises-more-antibiotics-rd-but-calls-for-be/412585/" class="analytics t-editors-bio-article">Powerhouse pharma coalition promises more antibiotics R&D, but calls for better incentives</a></h3> <span class="secondary-label">Jan. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/reviewing-gileads-formidable-2015-a-year-marked-by-higher-sales-and-new-c/412582/" class="analytics t-editors-bio-article">Reviewing Gilead's formidable 2015: A year marked by higher sales and new criticism </a></h3> <span class="secondary-label">Jan. 22, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/chinese-pharma-company-slapped-with-import-ban-by-fda/412503/" class="analytics t-editors-bio-article">Chinese pharma company slapped with import ban by FDA</a></h3> <span class="secondary-label">Jan. 21, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/webmd-were-not-in-negotiations-to-be-bought/412418/" class="analytics t-editors-bio-article">WebMD: We're not in negotiations to be bought</a></h3> <span class="secondary-label">Jan. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/multiple-violations-cause-production-halt-at-mylan-owned-agilas-polish-pla/412413/" class="analytics t-editors-bio-article">Multiple violations cause production halt at Mylan-owned Agila's Polish plant</a></h3> <span class="secondary-label">Jan. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/amidst-falling-sales-medicines-co-reportedly-mulling-sale/412412/" class="analytics t-editors-bio-article">Amidst falling sales, Medicines Co. reportedly mulling sale</a></h3> <span class="secondary-label">Jan. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/watchdog-report-spotlights-significant-failures-in-fda-postmarket-drug-trac/412338/" class="analytics t-editors-bio-article">Watchdog report spotlights significant failures in FDA postmarket drug tracking</a></h3> <span class="secondary-label">Jan. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gavi-commits-5-million-in-advance-for-mercks-ebola-vaccine/412409/" class="analytics t-editors-bio-article">Gavi commits $5 million in advance for Merck's Ebola vaccine</a></h3> <span class="secondary-label">Jan. 20, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-acorda-buys-finnish-firm-biotie-its-parkinsons-candidates-for-3/412334/" class="analytics t-editors-bio-article">Biotech Acorda buys Finnish firm Biotie & its Parkinson's candidates for $363M</a></h3> <span class="secondary-label">Jan. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/novartis-psoriasis-mega-blockbuster-hopeful-cosentyx-nabs-2-new-indication/412316/" class="analytics t-editors-bio-article">Novartis' psoriasis mega-blockbuster hopeful Cosentyx nabs 2 new indications</a></h3> <span class="secondary-label">Jan. 19, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/corrected-french-drug-trial-suspended-after-participant-left-brain-dead-f/412230/" class="analytics t-editors-bio-article">CORRECTED: French drug trial suspended after participant left brain dead, five others critically ill</a></h3> <span class="secondary-label">Jan. 15, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pfizer-partners-with-nonprofit-calibr-to-develop-heart-failure-drugs/412164/" class="analytics t-editors-bio-article">Pfizer partners with nonprofit Calibr to develop heart failure drugs</a></h3> <span class="secondary-label">Jan. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bayer-opens-otc-drug-manufacturing-plant-in-china/412150/" class="analytics t-editors-bio-article">Bayer opens OTC drug manufacturing plant in China</a></h3> <span class="secondary-label">Jan. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/who-declares-liberia-free-of-ebola-ending-west-african-outbreak/412144/" class="analytics t-editors-bio-article">WHO declares Liberia free of Ebola, ending West African outbreak</a></h3> <span class="secondary-label">Jan. 14, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/warning-letters-reveal-some-of-the-fdas-biggest-problems-with-indian-drugm/412076/" class="analytics t-editors-bio-article">Warning letters reveal some of the FDA's biggest problems with Indian drugmakers</a></h3> <span class="secondary-label">Jan. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/express-scripts-shares-slide-as-anthem-threatens-to-ditch-pbm-over-drug-sav/412067/" class="analytics t-editors-bio-article">Express Scripts shares slide as Anthem threatens to ditch PBM over drug savings</a></h3> <span class="secondary-label">Jan. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/pharma-battling-ballot-measures-designed-to-limit-drug-prices/412059/" class="analytics t-editors-bio-article">Pharma battling ballot measures designed to limit drug prices</a></h3> <span class="secondary-label">Jan. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/fda-flags-manufacturing-deficiencies-of-chinese-drug-supplier/412053/" class="analytics t-editors-bio-article">FDA flags manufacturing deficiencies of Chinese drug supplier</a></h3> <span class="secondary-label">Jan. 13, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/health-committee-sends-califf-fda-nom-to-full-senate-as-sanders-mulls-hold/411973/" class="analytics t-editors-bio-article">Health committee sends Califf FDA nom to full Senate as Sanders mulls hold</a></h3> <span class="secondary-label">Jan. 12, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/struggling-mannkind-appoints-new-ceo-after-withdrawing-offer-to-previous-ch/411889/" class="analytics t-editors-bio-article">Struggling Mannkind appoints new CEO after withdrawing offer to previous choice</a></h3> <span class="secondary-label">Jan. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/shire-buys-baxalta-for-32-billion-ending-months-long-pursuit/411886/" class="analytics t-editors-bio-article">Shire buys Baxalta for $32 billion, ending months-long pursuit </a></h3> <span class="secondary-label">Jan. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/uk-investor-woodford-reiterates-call-for-glaxo-to-be-split-four-ways/411883/" class="analytics t-editors-bio-article">UK investor Woodford reiterates call for Glaxo to be split four ways</a></h3> <span class="secondary-label">Jan. 11, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/flurry-of-venture-deals-hits-biopharma-ahead-of-jpmorgan-healthcare-confere/411734/" class="analytics t-editors-bio-article">Flurry of venture deals hits biopharma ahead of JPMorgan healthcare conference</a></h3> <span class="secondary-label">Jan. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/indias-cadila-to-snap-up-plant-animal-health-products-from-pfizer-spinoff/411642/" class="analytics t-editors-bio-article">India's Cadila to snap up plant, animal health products from Pfizer spinoff Zoetis</a></h3> <span class="secondary-label">Jan. 7, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/biotech-startup-vtesse-granted-fda-breakthrough-designation-for-orphan-npc/411645/" class="analytics t-editors-bio-article">Biotech startup Vtesse granted FDA breakthrough designation for orphan NPC drug</a></h3> <span class="secondary-label">Jan. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/gilead-grabs-priority-review-for-pangenotype-hep-c-combo-hep-b-med-shown-t/411626/" class="analytics t-editors-bio-article">Gilead grabs priority review for pangenotype hep C combo; Hep B med shown to be safe</a></h3> <span class="secondary-label">Jan. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/mannkind-cfo-were-searching-for-a-new-afrezza-marketing-partner-after-san/411621/" class="analytics t-editors-bio-article">MannKind CFO: We're searching for a new Afrezza marketing partner after Sanofi's departure</a></h3> <span class="secondary-label">Jan. 6, 2016</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/shkrelis-former-company-kalobios-files-for-bankruptcy/411400/" class="analytics t-editors-bio-article">Shkreli's former company KaloBios files for bankruptcy</a></h3> <span class="secondary-label">Dec. 31, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/valeant-ceo-pearson-on-medical-leave-company-being-run-by-3-man-exec-group/411370/" class="analytics t-editors-bio-article">Valeant CEO Pearson on medical leave, company being run by 3-man exec group</a></h3> <span class="secondary-label">Dec. 28, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/bristol-myers-spinning-off-its-entire-hiv-pipeline-to-glaxo-for-15-billio/411117/" class="analytics t-editors-bio-article">Bristol-Myers spinning off its entire HIV pipeline to Glaxo for $1.5 billion</a></h3> <span class="secondary-label">Dec. 18, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/lilly-gets-its-lantus-copycat-basaglar-approved-by-fdabut-not-as-a-biosimi/411035/" class="analytics t-editors-bio-article">Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar</a></h3> <span class="secondary-label">Dec. 17, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/kallyope-raises-44m-in-series-a-to-launch-nyc-based-gut-brain-biotech/410695/" class="analytics t-editors-bio-article">Kallyope raises $44M in Series A to launch NYC-based 'gut-brain' biotech</a></h3> <span class="secondary-label">Dec. 11, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/clinton-plan-would-pump-brakes-on-pfizer-allergan-deal-other-major-inversi/410620/" class="analytics t-editors-bio-article">Clinton plan would pump brakes on Pfizer-Allergan deal, other major inversion mergers</a></h3> <span class="secondary-label">Dec. 10, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/senators-mull-speedier-generics-pathway-amid-outrage-over-turing-valeant-p/410548/" class="analytics t-editors-bio-article">Senators mull speedier generics pathway amid outrage over Turing, Valeant price hikes</a></h3> <span class="secondary-label">Dec. 9, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/the-5-pharma-vets-and-3-newcomers-that-made-bcgs-50-most-innovative-firm/410217/" class="analytics t-editors-bio-article">The 5 pharma vets and 3 newcomers that made BCG's '50 most innovative' firms list</a></h3> <span class="secondary-label">Dec. 4, 2015</span> </li> <li class="feed__item" style="display:none;"> <h3 class="feed__title feed__title"><a href="/news/senators-grilled-obamas-nominee-for-fda-chief-heres-how-he-responded/409373/" class="analytics t-editors-bio-article">Senators grilled Obama's nominee for FDA chief. Here's how he responded</a></h3> <span class="secondary-label">Nov. 18, 2015</span> </li> </ul> <br/> <button id="load-more-button" type="submit" class="button button--medium">Load more</button> <form action="." id="article-list-form"> <input type=hidden name="month_filter_value" value=""/> <input type=hidden name="scroll-top" value=""/> </form> </div> </section> <aside class="sidebar large-4 columns"> <section class="divewire-promotion"> <div class="divewire-promotion__box"> <div class="divewire-promotion__box__image"> <a class="analytics t-pr-submit-editors" href=/press-release/get-started/> <img src="https://d12v9rtnomnebu.cloudfront.net/press-release/letter_to_globe_v2.svg" alt="mailing letter around the world"> </a> </div> <div class="divewire-promotion__box__content"> <a class="analytics t-pr-submit-editors" href=/press-release/get-started/> <h3 class="divewire-promotion__box__content__title display-heading-02">Reach a targeted audience</h3> </a> <p class="divewire-promotion__box__content__text">DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.</p> <p class="divewire-promotion__box__content__link"><a class="call-out-link analytics t-pr-submit-editors" href=/press-release/get-started/>Post a press release <span class="call-out-link__arrow">➔</span></a></p> </div> </div> </section> <div class="hybrid-ad-wrapper hide-small show-large"> <div class="hybrid-ad-inner-wrapper"> <div class="hide-small show-large"> <div data-container-ad-unit-id="/21662595662/biopharmadive/biopharmadivehybrid1-desktop"></div> <div id='dfp-hybrid1-desktop'> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script> waitToLoadAds.push(function() { googletag.cmd.push(function() { if (window.dfp_visibility == 'desktop' ) { googletag.display('dfp-hybrid1-desktop'); googletag.pubads().addEventListener('slotRenderEnded', function (event) { var adUnitPath = '/21662595662/biopharmadive/biopharmadivehybrid1'; var onProformative = false; if (onProformative && event.slot.getAdUnitPath() === adUnitPath && !event.isEmpty ) { var adUnitPathWithVisibility = adUnitPath + '-desktop'; var selector = '.pf-comments__ad-wrapper [data-container-ad-unit-id="' + adUnitPathWithVisibility + '"]'; if (!$(selector).closest('.pf-comments__ad-wrapper').hasClass('borders')) { $(selector).closest('.pf-comments__ad-wrapper').addClass('borders') } } }); } }); }); </script> </div> </div> </div> </div> <div class="signup sidebar-signup-box hide-small show-large" data-box-priority="0"> <h3 class="sidebar-signup-box__header">Get the free newsletter</h3> <p class="sidebar-signup-box__description">Subscribe to BioPharma Dive for top news, trends & analysis</p> <form class="form js-form-email-validate" name="signup" action="/signup/" method="POST"> <label for="id_59481_email" class="email-input js-email-input"> <span class="screen-reader-text">Email:</span> <input type="email" name="email" placeholder="Work email address" class="email" required id="id_59481_email"> </label> <input type="hidden" name="signup_box_location" value="sidebar"> <input type="hidden" name="signup_initial_url_path" value="/editors/npagliarulo/"> <input type="hidden" name="signup_internal_referrer"> <input type="hidden" name="signup_external_referrer"> <input type="hidden" name="referral_url"> <input type="hidden" name="js_enabled" value="0" id="id_59481_js_enabled"> <ul class="signup-list list-no-bullets"> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-sidebar-checkbox-20" type="checkbox" name="site_newsletters" value="20" class="checkbox" /> <label for="newsletter-sidebar-checkbox-20"> <span class="newsletter-title">Daily Dive</span> <span class="secondary-label">M-F</span> </label> </li> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-sidebar-checkbox-42" type="checkbox" name="site_newsletters" value="42" class="checkbox" /> <label for="newsletter-sidebar-checkbox-42"> <span class="newsletter-title">Commercialization Weekly</span> <span class="secondary-label">Every Wednesday</span> </label> </li> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-sidebar-checkbox-43" type="checkbox" name="site_newsletters" value="43" class="checkbox" /> <label for="newsletter-sidebar-checkbox-43"> <span class="newsletter-title">Gene Therapy Weekly</span> <span class="secondary-label">Every Thursday</span> </label> </li> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-sidebar-checkbox-2934" type="checkbox" name="site_newsletters" value="2934" class="checkbox" /> <label for="newsletter-sidebar-checkbox-2934"> <span class="newsletter-title">Emerging Biotech Weekly</span> <span class="secondary-label">Every Tuesday</span> </label> </li> <li> <label><span class="screen-reader-text">Select user consent:</span></label> <input type="checkbox" name="user_consent" id="id_user_consent-sidebar" value="1" class="checkbox"/> <label for="id_user_consent-sidebar"> <span class="signup-user-consent_box"> <span> By signing up to receive our newsletter, you agree to our <a href="https://www.techtarget.com/terms-of-use/" target="_blank">Terms of Use</a> and <a href="https://www.techtarget.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span> </span> </label> </li> </ul> <button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button> <script type="module" src="/static/js/dist/sendEmailToLytics.bundle.js?481016210225" ></script> <label class="error email_error" style="display:none;">A valid email address is required.</label> <label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label> </form> </div> <div class="subscriber-demographics demographics-form" id="demographics-box-sidebar"></div> <script src="/static/js/subscriberDemographicsForm.js?450216090125"></script> <script> var siteName = 'BioPharma Dive' || null; if (siteName) { setupFormCallbackAndCreateFormIfSub(siteName, 'sidebar'); } </script> <div class="sidebar-box" data-box-priority="2"> <h3 class="sidebar-box__header sidebar-box__header--loud"> Most Popular </h3> <ol class="sidebar-box-list sidebar-box-list--ordered"> <li class="sidebar-box-list__item sidebar-box-list__item--ordered flex">  <div class="sidebar-box-list__image-container"> <a class="analytics t-most-popular-sidebar-item-1 hide-small show-large" href="/news/biotech-nih-funding-research-trump-cuts-impact/740802/"> <img class="sidebar-box-list__image" src="https://imgproxy.divecdn.com/28CAbWBIMTzooat2ifz_UFt7f4LWs7kWhHJ1rPyYBuU/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjkxMTA4MDU3LmpwZw==.webp" width="600" height="338" srcset="https://imgproxy.divecdn.com/BnEFgiD1UMp_8C-xq2VG2ZpnzedG80hLFO_IVaOF47g/g:ce/rs:fill:300:169:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjkxMTA4MDU3LmpwZw==.webp 300w, https://imgproxy.divecdn.com/28CAbWBIMTzooat2ifz_UFt7f4LWs7kWhHJ1rPyYBuU/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjkxMTA4MDU3LmpwZw==.webp 600w" sizes="25vw" alt="An entrance to a National Institutes of Health building is lit by the sun on a clear day." loading="lazy" > </a> </div> <div class="sidebar-box-title-container">  <a class="analytics t-most-popular-sidebar-item-1 sidebar-box-list__item-title" href="/news/biotech-nih-funding-research-trump-cuts-impact/740802/">‘Fear and uncertainty’: Biotech investors warn of impact from NIH research cuts </a>  </div> </li> <li class="sidebar-box-list__item sidebar-box-list__item--ordered flex">  <div class="sidebar-box-list__image-container"> <a class="analytics t-most-popular-sidebar-item-2 hide-small show-large" href="/news/drug-compounders-sue-fda-wegovy-shortage-hims-zepbound-price-cut/740869/"> <img class="sidebar-box-list__image" src="https://imgproxy.divecdn.com/dG6C-rb1-zdTt46HyJpIkAAdBV42oM7wNO8q3OEDlTQ/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUwMDMyNDE2LmpwZw==.webp" width="600" height="338" srcset="https://imgproxy.divecdn.com/tVyPMSPTPUAZG0SqwYGLbEMGxj5_VizXgXRQ0RNsIi8/g:ce/rs:fill:300:169:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUwMDMyNDE2LmpwZw==.webp 300w, https://imgproxy.divecdn.com/dG6C-rb1-zdTt46HyJpIkAAdBV42oM7wNO8q3OEDlTQ/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUwMDMyNDE2LmpwZw==.webp 600w" sizes="25vw" alt="Two prescription drug cartons are seen stacked on top of each other, bearing the word Wegovy." loading="lazy" > </a> </div> <div class="sidebar-box-title-container">  <a class="analytics t-most-popular-sidebar-item-2 sidebar-box-list__item-title" href="/news/drug-compounders-sue-fda-wegovy-shortage-hims-zepbound-price-cut/740869/">Drug compounders sue FDA over declaration ending Wegovy shortage </a>  </div> </li> <li class="sidebar-box-list__item sidebar-box-list__item--ordered flex">  <div class="sidebar-box-list__image-container"> <a class="analytics t-most-popular-sidebar-item-3 hide-small show-large" href="/news/pfizer-patrizia-cavazzoni-fda-chief-medical-officer-appoint/740749/"> <img class="sidebar-box-list__image" src="https://imgproxy.divecdn.com/iczVVX7gsNDTvXpLPxuKwPAs7OLcnrwuvv0HH8QxN5E/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDkxNDg0MDMxLmpwZw==.webp" width="600" height="338" srcset="https://imgproxy.divecdn.com/AE7pPRrxXww4UexZm0mKYXaX6sOtUX4jvFQ3dprS50A/g:ce/rs:fill:300:169:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDkxNDg0MDMxLmpwZw==.webp 300w, https://imgproxy.divecdn.com/iczVVX7gsNDTvXpLPxuKwPAs7OLcnrwuvv0HH8QxN5E/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDkxNDg0MDMxLmpwZw==.webp 600w" sizes="25vw" alt="People pass an office building with signage spelling Pfizer in New York City." loading="lazy" > </a> </div> <div class="sidebar-box-title-container"> <a class="analytics t-most-popular-sidebar-item-3 sidebar-box-list__item-title" href="/news/pfizer-patrizia-cavazzoni-fda-chief-medical-officer-appoint/740749/">Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer </a>  </div> </li> <li class="sidebar-box-list__item sidebar-box-list__item--ordered flex">  <div class="sidebar-box-list__image-container"> <a class="analytics t-most-popular-sidebar-item-4 hide-small show-large" href="/news/fda-cdrh-device-staff-rehire-trump-cuts/740814/"> <img class="sidebar-box-list__image" src="https://imgproxy.divecdn.com/7zMEc3oUd0M7F2xmCacWnZfndHjKMGVaCLpwi72Pv7E/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNTA5X1k0bkloeDEuanBn.webp" width="600" height="338" srcset="https://imgproxy.divecdn.com/7NmUgRx4azBPY5vXXLn60-yB6bwnaPgh0AXHRUwedfc/g:ce/rs:fill:300:169:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNTA5X1k0bkloeDEuanBn.webp 300w, https://imgproxy.divecdn.com/7zMEc3oUd0M7F2xmCacWnZfndHjKMGVaCLpwi72Pv7E/g:ce/rs:fill:600:338:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNTA5X1k0bkloeDEuanBn.webp 600w" sizes="25vw" alt="Food And Drug Administration Headquarters In Maryland" loading="lazy" > </a> </div> <div class="sidebar-box-title-container"> <a class="analytics t-most-popular-sidebar-item-4 sidebar-box-list__item-title" href="/news/fda-cdrh-device-staff-rehire-trump-cuts/740814/">FDA brings back some fired device office staff </a>  </div> </li> </ol> </div> <div class="sidebar-box hide-small show-large" data-box-priority="4"> <h3 class="sidebar-box__header">Library resources</h3> <ul class="sidebar-box-list"> <li class="sidebar-box-list__item flex"> <div class='sidebar-box-list__icon sidebar-box-list__icon--soft'> <img src="/static/img/lib_icons/whitepaper-black.svg?141716111021" height="25" width="25" alt="studioID resource icon" loading="lazy"> </div> <div> <div class="label label--soft">Infographic</div> <a class="analytics t-library-sidebar-item-1 sidebar-box-list__item-title" target="_blank" href="https://biopharmadive.tradepub.com/c/pubRD.mpl?secure=1&sr=pp&_t=pp%3A&qf=w_defa7944&ch=Library&utm_source=BP&utm_medium=Library&utm_campaign=CardinalHealth"> Creating a Seamless Product Launch and Patient Support Plan </a> <span class="sponsor-label__leading-text secondary-label">Custom content for </span> <span class="sponsor-label__name secondary-label">Cardinal Health</span> </div> </li> <li class="sidebar-box-list__item flex"> <div class='sidebar-box-list__icon sidebar-box-list__icon--soft'> <img src="/static/img/lib_icons/playbook-black.svg?141716111021" height="25" width="25" alt="studioID resource icon" loading="lazy"> </div> <div> <div class="label label--soft">Playbook</div> <a class="analytics t-library-sidebar-item-2 sidebar-box-list__item-title" target="_blank" href="https://supplychaindive.tradepub.com/c/pubRD.mpl?secure=1&sr=pp&_t=pp%3A&qf=w_defa7934&ch=Library&utm_source=BP&utm_medium=Library&utm_campaign=HyTek"> How to Overcome Tech Gaps in Warehouse Automation </a> <span class="sponsor-label__leading-text secondary-label">Custom content for </span> <span class="sponsor-label__name secondary-label">Hy-Tek Intralogistics</span> </div> </li> <li class="sidebar-box-list__item flex"> <div class='sidebar-box-list__icon sidebar-box-list__icon--soft'> <img src="/static/img/lib_icons/whitepaper-black.svg?141716111021" height="25" width="25" alt="studioID resource icon" loading="lazy"> </div> <div> <a class="analytics t-library-sidebar-item-3 sidebar-box-list__item-title" target="_blank" href="https://resources.industrydive.com/biopharma-what-is-your-ai-readiness-level?utm_source=BP&utm_medium=Library&utm_campaign=Salesforce"> What’s Your AI Readiness Level? </a> <span class="sponsor-label__leading-text secondary-label">Custom content for </span> <span class="sponsor-label__name secondary-label">Salesforce</span> </div> </li> </ul> <a class="analytics t-library-sidebar-all sidebar-box__cta" aria-label="View all library items" href="/library/">View all</a> </div> <div class="sidebar-box js-pressrelease-sidebar-box" data-box-priority=" 6 "> <h3 class="sidebar-box__header">Company Announcements</h3> <ul class="sidebar-box-list"> <li class="sidebar-box-list__item flex js-pressrelease" data-pressrelease-full-url="https://www.biopharmadive.com/press-release/20250224-mako-medicals-cutting-edge-approach-to-healthcare-innovation-and-social-im/"> <div class="sidebar-box-list__thumbnail-container"> <img alt="Mako Medical logo" height="48" loading="lazy" src="https://res.cloudinary.com/dmgi9movl/image/upload/dpr_2.0,h_48,w_48/v1740395159/press_release/assets/company_logos/images_l5qe6i.png" width="48"/> </div> <div class="sidebar-box-title-container"> <a class="sidebar-box-list__item-title analytics t-pr-sidebar-item" href="/press-release/20250224-mako-medicals-cutting-edge-approach-to-healthcare-innovation-and-social-im/">MAKO Medical’s Cutting-Edge Approach to Healthcare Innovation and Social Impact</a> <span class="secondary-label"> From Mako Medical </span> </div> </li> <li class="sidebar-box-list__item flex js-pressrelease" data-pressrelease-full-url="https://www.biopharmadive.com/press-release/20250212-bioanalytical-cro-veloxity-labs-and-aplos-analytics-partner-to-transform-1/"> <div class="sidebar-box-list__thumbnail-container"> <img alt="Veloxity Labs logo" height="48" loading="lazy" src="https://res.cloudinary.com/dmgi9movl/image/upload/dpr_2.0,h_48,w_48/v1739379823/press_release/assets/company_logos/Color_2_fyebre.jpg" width="48"/> </div> <div class="sidebar-box-title-container"> <a class="sidebar-box-list__item-title analytics t-pr-sidebar-item" href="/press-release/20250212-bioanalytical-cro-veloxity-labs-and-aplos-analytics-partner-to-transform-1/">Bioanalytical CRO, Veloxity Labs, and Aplos Analytics Partner to Transform Pharmacokinetic and…</a> <span class="secondary-label"> From Veloxity Labs </span> </div> </li> <li class="sidebar-box-list__item flex js-pressrelease" data-pressrelease-full-url="https://www.biopharmadive.com/press-release/20250205-avalere-health-launches-new-commitment-to-make-every-patient-possible/"> <div class="sidebar-box-list__thumbnail-container"> <img alt="Avalere Health logo" height="48" loading="lazy" src="https://res.cloudinary.com/dmgi9movl/image/upload/dpr_2.0,h_48,w_48/v1738752286/press_release/assets/company_logos/AvalereHealth-EveryPatientPossible-Email-Signature_Black_1_tdbw1y.png" width="48"/> </div> <div class="sidebar-box-title-container"> <a class="sidebar-box-list__item-title analytics t-pr-sidebar-item" href="/press-release/20250205-avalere-health-launches-new-commitment-to-make-every-patient-possible/">Avalere Health launches new commitment to make EVERY PATIENT POSSIBLE</a> <span class="secondary-label"> From Avalere Health </span> </div> </li> <li class="sidebar-box-list__item flex js-pressrelease" data-pressrelease-full-url="https://www.biopharmadive.com/press-release/20250212-certis-oncology-announces-issuance-of-us-patent-for-its-proprietary-certi-2/"> <div class="sidebar-box-list__thumbnail-container"> <img alt="Certis Oncology Solutions logo" height="48" loading="lazy" src="https://res.cloudinary.com/dmgi9movl/image/upload/dpr_2.0,h_48,w_48/v1739384612/press_release/assets/company_logos/Certis_square_hfdx64.png" width="48"/> </div> <div class="sidebar-box-title-container"> <a class="sidebar-box-list__item-title analytics t-pr-sidebar-item" href="/press-release/20250212-certis-oncology-announces-issuance-of-us-patent-for-its-proprietary-certi-2/">Certis Oncology Announces Issuance of U.S. Patent for its Proprietary CertisAI Predictive Onco…</a> <span class="secondary-label"> From Certis Oncology Solutions </span> </div> </li> </ul> <span class="sidebar-box__cta"> <a class="analytics t-pr-sidebar-all" aria-label="View all press release items" href="/press-release/">View all</a> | <a class="analytics t-pr-sidebar-start" href="/press-release/get-started/">Post a press release</a> </span> </div> <div class="sidebar-box hide-small show-large" data-box-priority="8"> <h3 class="sidebar-box__header">What We're Reading</h3> <ul class="sidebar-box-list"> <li class="sidebar-box-list__item"> <img src="https://www.google.com/s2/favicons?domain=https%3A//www.fiercepharma.com/pharma/eli-lilly-novo-nordisk-lead-revenue-boom-always-tricky-fourth-quarter" height="16" width="16" alt="" loading="lazy"> <span class="label label--soft">Fierce Pharma</span> <a class="analytics t-wwr-sidebar-item sidebar-box-list__item-title" href="https://www.fiercepharma.com/pharma/eli-lilly-novo-nordisk-lead-revenue-boom-always-tricky-fourth-quarter" target="_blank"> Of 22 top drugmakers, 21 showed revenue increases in Q4 <img src="/static/img/offsite.svg?141716111021" class="off-site-link" alt="offsite link" height="12" width="12" loading="lazy"> </a> </li> <li class="sidebar-box-list__item"> <img src="https://www.google.com/s2/favicons?domain=https%3A//www.axios.com/2025/02/25/rare-disease-meeting-delayed-hhs" height="16" width="16" alt="" loading="lazy"> <span class="label label--soft">Axios</span> <a class="analytics t-wwr-sidebar-item sidebar-box-list__item-title" href="https://www.axios.com/2025/02/25/rare-disease-meeting-delayed-hhs" target="_blank"> Rare disease meeting gets pushed off by HHS <img src="/static/img/offsite.svg?141716111021" class="off-site-link" alt="offsite link" height="12" width="12" loading="lazy"> </a> </li> <li class="sidebar-box-list__item"> <img src="https://www.google.com/s2/favicons?domain=https%3A//firstwordpharma.com/story/5937532" height="16" width="16" alt="" loading="lazy"> <span class="label label--soft">FirstWord Pharma</span> <a class="analytics t-wwr-sidebar-item sidebar-box-list__item-title" href="https://firstwordpharma.com/story/5937532" target="_blank"> Fresh off FDA approval, Axsome’s migraine med proves mettle against CGRPs <img src="/static/img/offsite.svg?141716111021" class="off-site-link" alt="offsite link" height="12" width="12" loading="lazy"> </a> </li> </ul> <a class="analytics t-wwr-sidebar-all sidebar-box__cta" aria-label="View all what we are reading items" href="/what-we-are-reading">View all</a> </div> <div class="sidebar-box hide-small show-large" data-box-priority="8"> <h3 class="sidebar-box__header">Industry Intel</h3> <ul class="sidebar-box-list"> <li class="sidebar-box-list__item"> <a class="analytics t-intel-sidebar-item sidebar-box-list__item-title" target="_blank" href="http://resources.industrydive.com/publication-engagement-ai-solutions"> Understanding Publication Impact and Engagement with Data and AI-Driven Solutions </a> <span class="secondary-label secondary-label--all-caps">Webinar - on demand</span> <span class="secondary-label">•</span> <span class="secondary-label">Provided by Altmetric</span> </li> <li class="sidebar-box-list__item"> <a class="analytics t-intel-sidebar-item sidebar-box-list__item-title" target="_blank" href="http://resources.industrydive.com/developing-an-array-of-diverse-vaccine-platforms?utm_source=BP&utm_medium=Library&utm_campaign=Novavax"> Developing an Array of Diverse Vaccine Platforms </a> <span class="secondary-label secondary-label--all-caps">Webinar - on demand</span> <span class="secondary-label">•</span> <span class="secondary-label">Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID</span> </li> <li class="sidebar-box-list__item"> <a class="analytics t-intel-sidebar-item sidebar-box-list__item-title" target="_blank" href="https://resources.industrydive.com/top-ways-that-ai-will-change-life-sciences"> Top Ways that AI Will Change Life Sciences </a> <span class="secondary-label secondary-label--all-caps">Webinar - on demand</span> <span class="secondary-label">•</span> <span class="secondary-label">Provided by Salesforce</span> </li> </ul> </div> <div class="hybrid-ad-wrapper hide-small show-large"> <div class="hybrid-ad-inner-wrapper"> <div class="hide-small show-large"> <div data-container-ad-unit-id="/21662595662/biopharmadive/biopharmadivehybrid2-desktop"></div> <div id='dfp-hybrid2-desktop'> <script> waitToLoadAds.push(function() { googletag.cmd.push(function() { if (window.dfp_visibility == 'desktop' ) { googletag.display('dfp-hybrid2-desktop'); googletag.pubads().addEventListener('slotRenderEnded', function (event) { var adUnitPath = '/21662595662/biopharmadive/biopharmadivehybrid2'; var onProformative = false; if (onProformative && event.slot.getAdUnitPath() === adUnitPath && !event.isEmpty ) { var adUnitPathWithVisibility = adUnitPath + '-desktop'; var selector = '.pf-comments__ad-wrapper [data-container-ad-unit-id="' + adUnitPathWithVisibility + '"]'; if (!$(selector).closest('.pf-comments__ad-wrapper').hasClass('borders')) { $(selector).closest('.pf-comments__ad-wrapper').addClass('borders') } } }); } }); }); </script> </div> </div> </div> </div> </aside> </div> </div> </div>  <section class="pre-footer"> </section> <hr class="footer-hr"> <footer> <div class="custom-article-footer"> <div class="row columns"> <div class="footer-grid"> <div class="footer-links"> <a href="https://www.industrydive.com"> <img class="pub-logo-footer" src="https://d12v9rtnomnebu.cloudfront.net/logo/corporate/ID_black.svg" alt="Industry Dive Logo" height="28" loading="lazy"/> </a> <ul class="social-icon-list social-icon-list__footer"> <li> <a href="https://www.linkedin.com/company/biopharma-dive-biotech-and-pharma-news" aria-label="Industry Dive LinkedIn" class="social-icon-footer analytics t-sitefooter-linkedin"> <img src="/static/img/social_icons/article_page/linkedin.svg?092716141024" alt="linkedin icon"> </a> </li> <li> <a href="https://www.facebook.com/biopharmadive/" aria-label="Industry Dive Facebook" class="social-icon-footer analytics t-sitefooter-facebook"> <img src="/static/img/social_icons/article_page/facebook.svg?440116200824" alt="facebook icon"> </a> </li> <li> <a href="https://twitter.com/BioPharmaDive" aria-label="Industry Dive X/Twitter" class="social-icon-footer analytics t-sitefooter-twitter"> <img src="/static/img/social_icons/article_page/x.svg?092716141024" alt="x icon"> </a> </li> <li> <a href="https://www.biopharmadive.com/feeds/news/" aria-label="Industry Dive RSS feed" class="social-icon-footer analytics t-sitefooter-rss"> <img src="/static/img/social_icons/article_page/rss.svg?440116200824" alt="rss feed icon"> </a> </li> </ul> </div> <div class="link-wrapper"> <div class="footer-links"> <h4 class="uppercase-heading-01">Explore</h4> <ul class="list-no-bullets"> <li> <a href="/about/" class="analytics t-about-sitefooter">About</a> </li> <li> <a href="/editors/" class="analytics t-editors-sitefooter">Editorial Team</a> </li> <li> <a href="/contact/" class="analytics t-feedback-sitefooter">Contact Us</a> </li> <li> <a href="/signup/?signup_location=footer-list&signup_path=/editors/npagliarulo/" class="analytics t-signup-sitefooter">Newsletter</a> </li> <li> <a href="/selfservice/article-licensing/submit/" class="analytics t-licensing-sitefooter">Purchase Licensing Rights</a> </li> <li> <a class="analytics t-pr-sitefooter-all" href="/press-release/">Press Releases</a> </li> <li> <a href="/what-we-are-reading/" class="analytics t-wwr-sitefooter">What We're Reading</a> </li> </ul> </div> <div class="second-column"> <div class="footer-links"> <h4 class="uppercase-heading-01">Reach our audience</h4> <ul class="list-no-bullets"> <li> <a href="/advertise/" class="analytics t-advertising-sitefooter">Advertising</a> </li> <li> <a class="analytics t-pr-sitefooter-all" href="/press-release/get-started/">Post a press release</a> </li> <li> <a class="analytics t-events-sitefooter-start" href="/selfservice/event-listings/contact">Promote an event</a> </li> </ul> </div> <div class="footer-links"> <h4 class="uppercase-heading-01">Related Publications</h4> <ul class="list-no-bullets"> <li> <a href="https://www.healthcaredive.com/" class="analytics t-sitefooter-related-healthcare-dive">Healthcare Dive</a> </li> <li> <a href="https://www.medtechdive.com/" class="analytics t-sitefooter-related-medtech-dive">MedTech Dive</a> </li> </ul> </div> </div> </div> </div> </div> </div> </footer> <hr class="footer-hr"> <div class="baseline-footer-wrapper"> <div> <div> Industry Dive is an Informa TechTarget business. </div> </div> <div class="baseline-footer"> © 2025 TechTarget, Inc. or its subsidiaries. All rights reserved. | View our <a href="https://www.industrydive.com/industries/">other publications</a> | <a href="https://www.techtarget.com/privacy-policy/">Privacy policy</a> | <a href="https://www.techtarget.com/terms-of-use/">Terms of use</a> | <a href="https://www.industrydive.com/takedown-policy/">Take down policy</a>. <br> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')">Cookie Preferences / Do Not Sell</a> </div> <div class="informa-legal-notice"> This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466. </div> </div> </div> </div>  <nav class="mobile-menu"> <div class="mm-top-bar"> <button class="mobile-menu-toggle"> <img src="/static/img/menu_icons/close.svg?273117231121" width="20" height="20" alt="close menu"/> </button> <div class="mm-search"> <form action="/search/" method="GET" data-ajax="false"> <label for="search-mobile"> <span class="screen-reader-text">Search</span> <input id="search-mobile" type="search" name="q" placeholder="Search" data-role="none"> </label> <button type="submit" value="" data-role="none" class="search-button-front analytics t-search-navigation-mobile"> <img src="/static/img/menu_icons/search.svg?320116291121" width="15" height="15" alt="search"> </button> </form> </div> </div> <ul class="mm-list list-no-bullets"> <li> <a href="/" class="analytics t-dash-navigation-mobile"> <span>Home</span> </a> </li> <li class="mm-accordion"> <button> <span>Topics</span> <span class="accordion-toggle-arrow"> <img src="/static/img/menu_icons/chevron_down.svg?102717100918" width="16" height="9" alt="down arrow" loading="lazy"> </span> </button> <ul class="list-no-bullets"> <li> <a class="analytics t-topic-navigation-mobile-pharma" href="/topic/pharma/">Pharma</a> </li> <li> <a class="analytics t-topic-navigation-mobile-biotech" href="/topic/biotech/">Biotech</a> </li> <li> <a class="analytics t-topic-navigation-mobile-fda" href="/topic/fda/">FDA</a> </li> <li> <a class="analytics t-topic-navigation-mobile-clinical-trials" href="/topic/clinical-trials/">Clinical Trials</a> </li> <li> <a class="analytics t-topic-navigation-mobile-deals" href="/topic/deals/">Deals</a> </li> <li> <a class="analytics t-topic-navigation-mobile-drug-pricing" href="/topic/drug-pricing/">Drug Pricing</a> </li> <li> <a class="analytics t-topic-navigation-mobile-gene-therapy" href="/topic/gene-therapy/">Gene Therapy</a> </li> </ul> </li> <li> <a href="/deep-dive/" class="analytics t-deepdive-navigation-mobile"> <span>Deep Dive</span> </a> </li> <li> <a href="/library/" class="analytics t-library-navigation-mobile"> <span>Library</span> </a> </li> <li> <a href="/events/" class="analytics t-events-navigation-mobile"> <span>Events</span> </a> </li> <li> <a href="/press-release/" class="analytics t-press-releases-navigation-mobile"> <span>Press Releases</span> </a> </li> </ul> <section class="signup mm-signup"> <div class="row"> <div class="large-9 medium-10 medium-centered columns"> <h3 class="display-heading-03 display-heading-03--loud">Get BioPharma Dive in your inbox</h3> <p class="subhead">The free newsletter covering the top industry headlines</p> <form class="form js-form-email-validate" name="signup" action="/signup/" method="POST"> <label for="id_853420_email" class="email-input js-email-input"> <span class="screen-reader-text">Email:</span> <input type="email" name="email" placeholder="Work email address" class="email" required id="id_853420_email"> </label> <input type="hidden" name="signup_box_location" value="integrated_menu"> <input type="hidden" name="signup_initial_url_path" value="/editors/npagliarulo/"> <input type="hidden" name="signup_internal_referrer"> <input type="hidden" name="signup_external_referrer"> <input type="hidden" name="referral_url"> <input type="hidden" name="js_enabled" value="0" id="id_853420_js_enabled"> <ul class="signup-list list-no-bullets"> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-integrated_menu-checkbox-20" type="checkbox" name="site_newsletters" value="20" class="checkbox" /> <label for="newsletter-integrated_menu-checkbox-20"> <span class="newsletter-title">Daily Dive</span> <span class="secondary-label">M-F</span> </label> </li> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-integrated_menu-checkbox-42" type="checkbox" name="site_newsletters" value="42" class="checkbox" /> <label for="newsletter-integrated_menu-checkbox-42"> <span class="newsletter-title">Commercialization Weekly</span> <span class="secondary-label">Every Wednesday</span> </label> </li> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-integrated_menu-checkbox-43" type="checkbox" name="site_newsletters" value="43" class="checkbox" /> <label for="newsletter-integrated_menu-checkbox-43"> <span class="newsletter-title">Gene Therapy Weekly</span> <span class="secondary-label">Every Thursday</span> </label> </li> <li> <label><span class="screen-reader-text">Select Newsletter:</span></label> <input id="newsletter-integrated_menu-checkbox-2934" type="checkbox" name="site_newsletters" value="2934" class="checkbox" /> <label for="newsletter-integrated_menu-checkbox-2934"> <span class="newsletter-title">Emerging Biotech Weekly</span> <span class="secondary-label">Every Tuesday</span> </label> </li> <li> <label><span class="screen-reader-text">Select user consent:</span></label> <input type="checkbox" name="user_consent" id="id_user_consent-integrated_menu" value="1" class="checkbox"/> <label for="id_user_consent-integrated_menu"> <span class="signup-user-consent_box"> <span> By signing up to receive our newsletter, you agree to our <a href="https://www.techtarget.com/terms-of-use/" target="_blank">Terms of Use</a> and <a href="https://www.techtarget.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span> </span> </label> </li> </ul> <button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button> <script type="module" src="/static/js/dist/sendEmailToLytics.bundle.js?481016210225" ></script> <label class="error email_error" style="display:none;">A valid email address is required.</label> <label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label> </form> </div> </div> </section> </nav> <script type="text/javascript"> $(document).ready(function () { // track how many times the load more button has been clicked so we can compare it to our total article_list length var load_more_count = 1; // Show the display:none articles below the load more button without reloading the page $('#load-more-button').on('click', function () { load_more_count += 1; // Display 10 more articles over the original 25 we showed and any number of other times the user has clicked the // load more button $('.past-articles .feed__item').each(function (index, value) { if (index < 25 + (load_more_count * 10)) { $(this).slideDown(); } }); // hide load more button if we're out of articles if (25 + (load_more_count * 10) > 2579) { $(this).hide(); } }); // Fill out the "filter by month" drop down with years/months articles are published in: // first store all the English equivalents for different month numbers in order var months = ['January', 'February', 'March', 'April', 'May', 'June', 'July', 'August', 'September', 'October', 'November', 'December'], $list_select = $('.js-list-select'); var current_year = 2025; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2024; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2023; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2022; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2021; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2020; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2019; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2018; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2017; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2016; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="10' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[9] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="09' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[8] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="08' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[7] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="07' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[6] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="06' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[5] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="05' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[4] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="04' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[3] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="03' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[2] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="02' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[1] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="01' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[0] + '</option>' ); var current_year = 2015; $list_select.append('<option value="year" disabled>' + current_year.toString() + '</option>'); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="12' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[11] + '</option>' ); $list_select.append( // Value encodes month as a 2-digit string + 4-digit year to set option value '<option value="11' + current_year.toString() + '">' + // option display is the English month name // we use the add filter here since humans use month numbers 1-indexed // and we must discern the English equivalent in our months array via 0-index months[10] + '</option>' ); // Set up the display // Push us to the position in the page the user was on before $(document).scrollTop(0); // Set the dropdown selection based on whether the user queried by month already $list_select.val("all").change(); // Add copy related to what date we are filtered on if we were sent it by the view $('#article-count').append(''); // When user selects an option from the dropdown, send that request to the back end per submit function below. $list_select.change(function () { $('#article-list-form').submit(); }); $('#article-list-form').submit(function () { // Update our hidden fields for when we submit // Update the month_filter_value with what's in the list $('input[name="month_filter_value"]').val($list_select.val()) // Update scroll-top with the current scroll position // the view wants it to be an int so we floor it, close enough $('input[name="scroll-top"]').val(Math.floor($(document).scrollTop())); }); }); </script>  <script type="module" src="/static/js/dist/signupValidation.bundle.js?481016210225" ></script> <script type="module" src="/static/js/dist/gtmEvents.bundle.js?481016210225" ></script>  <script type="module" src="/static/js/dist/smartQuotes.bundle.js?481016210225" ></script> <script src="//platform.twitter.com/oct.js" type="text/javascript"></script> <script type="text/javascript"> if(typeof twttr !== 'undefined' && typeof twttr.conversion !== 'undefined') { twttr.conversion.trackPid('l6gua', { tw_sale_amount: 0, tw_order_quantity: 0 }); } else { window.console && console.log && console.log('twttr undefined; Unable to track twitter retargeting'); } </script> <noscript> <img height="1" width="1" style="display:none;" alt="" src="https://analytics.twitter.com/i/adsct?txn_id=l6gua&p_id=Twitter&tw_sale_amount=0&tw_order_quantity=0" /> <img height="1" width="1" style="display:none;" alt="" src="//t.co/i/adsct?txn_id=l6gua&p_id=Twitter&tw_sale_amount=0&tw_order_quantity=0" /> </noscript> <script> // Set cookie if we're on mobile app. Expire if we're not. This affects // which template is used to display the site to the user. $(document).ready(function() { // Get integer value of mobileapp param from URL and default to 0 if it doesn't exist var mobileapp = ''; // Set cookie if mobileapp is 1 or 2 or expire cookie if mobileapp == 0 if (mobileapp == '0') { document.cookie = 'mobileapp=; path=/; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; } else if (mobileapp == '1' || mobileapp == '2') { document.cookie = 'mobileapp=' + mobileapp + '; path=/;'; } // There's no need to immediately load or preload print.css since it's not needed on page // load. Therefore, load it when the document is ready var stylesheet=document.createElement("link"); stylesheet.setAttribute("rel", "stylesheet"); stylesheet.setAttribute("type", "text/css"); stylesheet.setAttribute("media", "print"); if (window.location.pathname.includes('trendline')) { stylesheet.setAttribute("href", "/static/css/print_trendline.css?021016210225"); } else { stylesheet.setAttribute("href", "/static/css/print.css?021016210225"); } document.getElementsByTagName("head")[0].appendChild(stylesheet); }); </script>   <script src="https://ak.sail-horizon.com/spm/spm.v1.min.js"></script> <script type="text/javascript"> $(function() { // Sailthru Personalization Engine Setup var sailthru_setup = { customerId: '12ab35a80530ffa5450add9c09f5de04', domain: 'horizon.biopharmadive.com', spider: false }; if (window.Sailthru) { Sailthru.init(sailthru_setup); } }); </script> </body> </html>

CINXE.COM

Ned Pagliarulo | BioPharma Dive